data_1nyn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nyn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.28 0.562 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -100.95 147.16 26.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -116.7 136.58 52.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -118.68 122.73 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -90.82 159.59 16.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -147.49 91.11 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -53.59 113.77 1.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.14 -161.85 33.27 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.3 mm-40 -70.92 -45.25 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.01 -41.69 2.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t -101.42 177.89 4.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.41 124.63 49.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.88 127.66 49.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.358 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 18' ' ' VAL . 5.1 mt -109.18 155.08 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' N ' HG21 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -131.82 154.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.54 153.92 17.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.16 159.18 44.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.96 -73.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 t -145.66 169.89 17.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.53 -26.65 66.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 25' ' ' LEU . 57.7 tt0 -65.49 -74.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' GLU . 5.2 mt -42.39 -33.4 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 27' ' ' ASP . 3.7 t -67.32 -70.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 26' ' ' VAL . 45.4 t0 -41.11 -39.87 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 109.479 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 29' ' ' TYR . 3.1 mm-40 -58.05 -58.8 6.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' GLU . 76.2 t80 -43.33 -51.86 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.938 . . . . 0.0 109.446 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.73 -40.32 83.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -68.55 -4.51 15.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -175.62 79.43 0.3 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.47 140.42 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.769 2.312 . . . . 0.0 112.216 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 t -164.33 94.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -48.54 -27.49 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.59 -9.64 74.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 38' ' ' LEU . 18.2 tttm -112.28 -25.46 9.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -39.13 -31.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -60.79 -69.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.494 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' SER . 35.9 mt-10 -41.33 -36.39 0.8 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.17 -70.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.7 t -85.12 130.31 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -95.17 -31.49 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.478 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -111.15 121.42 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -91.6 77.62 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 30.4 tt0 -165.86 143.88 5.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.464 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.58 127.29 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 72.7 m-85 -113.26 154.22 27.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 109.547 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -132.87 164.14 46.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 49' ' ' THR . 66.6 Cg_exo . . . . . 0 C--N 1.306 -1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.217 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.446 ' CD2' ' N ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.98 -173.84 14.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.18 151.07 26.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.85 132.88 39.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -74.75 149.29 39.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 29.9 mttt -43.82 -51.36 7.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.76 -34.92 20.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -73.05 -36.71 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -66.13 -34.45 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 109.447 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.53 -28.72 70.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.521 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -52.92 -19.65 2.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -113.75 -73.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -148.46 72.5 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' C ' ' A' ' 74' ' ' LYS . . . -135.24 0.54 3.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 73' ' ' GLY . 10.7 tptm -37.37 -49.37 0.99 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.467 -1.019 . . . . 0.0 109.475 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 3.32 0.83 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -75.64 -175.97 3.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -114.37 -140.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.31 -23.93 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -64.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' ASP . 37.4 mt-10 -47.08 -53.22 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 80' ' ' GLU . 4.7 t -44.3 -58.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.06 -22.47 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 3.9 t0 -69.35 -61.08 1.94 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.45 -46.17 47.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.84 -59.31 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 87' ' ' ARG . 19.5 mt -46.21 -33.78 3.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -35.78 -66.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.429 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.87 75.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.336 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.31 -117.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.344 -1.092 . . . . 0.0 109.412 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -122.37 131.57 53.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -105.96 131.62 53.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -97.31 123.38 41.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.587 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.65 149.69 22.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 22.8 t80 -144.69 119.0 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -95.03 132.97 39.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -109.26 -154.2 15.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.2 tp10 -42.82 -82.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -117.78 -34.56 4.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.577 ' CB ' HE22 ' A' ' 67' ' ' GLN . 1.4 t -79.0 174.05 11.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.42 145.35 48.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mt -130.38 156.88 43.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -134.98 155.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.927 . . . . 0.0 109.559 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.1 155.93 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -98.46 140.49 32.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.34 168.31 20.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.93 -87.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 p -136.11 171.89 13.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.517 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -68.58 -13.01 62.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.14 -74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.498 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -47.45 -46.63 26.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.527 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.6 t -51.72 -54.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -53.42 -45.86 69.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 37' ' ' LYS . 3.2 mm-40 -56.81 -30.09 63.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.457 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 33' ' ' PRO . 60.4 t80 -72.22 -61.24 1.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.402 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 mt -48.27 -44.4 33.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -72.33 -20.94 61.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -150.31 70.59 9.11 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.522 ' O ' ' OG ' ' A' ' 34' ' ' SER . 54.2 Cg_endo -74.32 162.55 38.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.881 2.387 . . . . 0.0 112.209 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 33' ' ' PRO . 73.8 m -171.26 -104.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.476 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 tp -169.08 -20.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.93 -40.33 5.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.403 ' HZ2' ' HB3' ' A' ' 28' ' ' GLU . 23.8 tttt -69.05 -18.31 64.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -1.13 . . . . 0.0 109.415 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.99 -29.12 67.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.918 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -33.47 75.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -78.4 -57.25 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -46.62 -60.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.5 122.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.527 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -104.49 -1.37 26.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp -156.29 107.4 2.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.39 87.35 3.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.7 114.22 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.77 144.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -129.7 165.78 21.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.34 151.82 11.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.836 2.358 . . . . 0.0 112.173 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -142.83 174.81 23.39 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.05 127.4 51.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.157 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 144.69 54.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -93.09 155.31 17.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.411 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -38.96 -50.14 1.74 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -56.16 -59.8 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.577 HE22 ' CB ' ' A' ' 14' ' ' THR . 20.7 mm100 -35.91 -39.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 38.4 t -84.01 -31.76 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 66' ' ' ALA . 49.5 tt0 -65.37 -39.26 92.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -18.87 65.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.61 -70.18 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -160.07 54.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.09 170.2 21.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 177.81 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 109.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.58 7.15 0.33 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -82.49 166.11 19.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -71.84 -149.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tp -109.4 -13.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.06 -18.72 62.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 -53.33 4.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.43 -39.74 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -72.28 -49.5 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -44.57 -44.79 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' ARG . 14.3 mt -67.44 -60.6 2.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.428 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 84' ' ' LEU . 13.3 mt -40.4 -39.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 87' ' ' ARG . 84.6 mt -70.44 -36.01 73.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.703 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -41.7 -62.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.509 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.44 -86.94 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.08 117.14 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mttp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.23 -1.159 . . . . 0.0 109.543 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 163.46 12.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -122.84 130.6 53.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -114.68 114.34 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -83.65 142.08 31.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -123.74 144.6 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -114.98 129.12 56.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.05 24.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.51 -34.06 58.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -1.151 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -149.7 -35.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.1 m -89.51 157.92 17.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 39.3 t0 -106.17 152.17 23.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.634 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 42.9 mt -136.34 160.03 39.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.462 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 mt -145.01 148.87 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.01 147.35 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -86.21 142.37 28.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.94 -171.75 2.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.05 -90.68 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 m -121.53 171.62 8.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.69 -9.6 59.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.03 -54.62 4.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.22 -38.6 83.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.479 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.8 -55.94 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.508 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -54.68 -50.5 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -52.39 -31.52 34.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 76.2 t80 -68.3 -41.87 80.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.6 mt -60.46 -23.43 64.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -90.64 -4.49 56.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -167.66 71.55 0.93 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' ' CE1' ' A' ' 29' ' ' TYR . 56.9 Cg_endo -75.29 139.67 23.81 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.812 2.341 . . . . 0.0 112.258 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 m -160.67 -133.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 tp -135.44 15.7 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -112.79 -82.97 1.21 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 36' ' ' GLY . 4.1 ttmt -45.05 -22.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.483 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 36' ' ' GLY . 6.0 tp -49.28 -62.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.5 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.89 -47.64 31.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.426 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -29.04 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 t -86.98 -54.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.63 113.44 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.15 -43.26 24.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 tp -111.15 115.16 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.893 . . . . 0.0 109.453 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' CE1' ' OE2' ' A' ' 79' ' ' GLU . 46.8 m-85 -73.93 65.92 1.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.72 174.9 10.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.447 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.3 t -134.85 128.17 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.93 151.92 22.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.35 150.76 77.35 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 C-N-CA 122.854 2.369 . . . . 0.0 112.176 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.4 172.09 23.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.67 154.81 17.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -1.138 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.54 133.71 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 169.36 18.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ALA . 63.5 tttt -57.38 -65.86 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.437 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' LYS . . . -43.97 -39.9 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -57.17 -24.08 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -68.23 -24.95 64.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -72.66 -21.34 61.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -105.62 -63.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -165.84 64.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -128.21 -0.01 6.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 73' ' ' GLY . 20.1 tttt -51.69 -101.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.455 -1.027 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 44.56 1.6 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -121.7 133.16 54.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -1.112 . . . . 0.0 109.473 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -56.41 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -84.96 -42.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.462 ' N ' HG22 ' A' ' 78' ' ' ILE . 8.2 mm-40 -49.48 -55.44 13.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 83' ' ' ASP . 2.1 mt-10 -48.3 -54.26 14.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -45.47 -46.46 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.907 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.1 mm -62.87 -25.93 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.149 -0.969 . . . . 0.0 109.437 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' GLU . 52.0 t0 -70.97 -61.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 65.5 mt -49.12 -29.87 5.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 88' ' ' ASN . 58.3 mt -67.74 -66.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ILE . 95.8 mt -43.82 -46.4 7.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -56.58 -30.93 63.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 7.1 t-20 -83.76 -81.79 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 57.08 116.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 tptm . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.213 -1.169 . . . . 0.0 109.521 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -127.81 147.18 50.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -105.27 159.24 16.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.454 ' HH ' ' HG3' ' A' ' 23' ' ' GLU . 3.6 m-85 -126.05 112.17 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.45 162.74 28.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -153.3 100.42 2.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -66.74 104.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.55 33.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -47.01 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -1.19 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -106.98 -52.15 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -80.66 174.08 11.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 6.8 t70 -119.43 156.28 30.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.431 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.492 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 22.3 mt -123.2 157.32 33.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.21 143.76 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.24 142.18 36.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.59 -178.45 5.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.557 ' C ' ' HG ' ' A' ' 22' ' ' SER . . . -95.16 -73.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 109.502 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.557 ' HG ' ' C ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -148.11 166.48 27.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HG3' ' HH ' ' A' ' 7' ' ' TYR . 2.4 tt0 -69.23 -37.18 77.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.07 -51.79 29.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -51.08 -43.93 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.28 -41.7 97.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.377 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -65.36 -35.03 79.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -65.65 -54.07 32.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.4 mt -52.31 -19.86 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.62 -44.06 52.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.372 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.05 76.48 77.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.448 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.586 ' O ' ' CB ' ' A' ' 34' ' ' SER . 55.5 Cg_exo -47.01 164.19 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.836 2.358 . . . . 0.0 112.24 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.722 ' HG ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 159.61 -173.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.722 ' N ' ' HG ' ' A' ' 34' ' ' SER . 0.6 OUTLIER -114.98 -14.27 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' H ' ' HG ' ' A' ' 34' ' ' SER . . . -78.84 -17.99 76.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -103.14 -18.97 14.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -1.142 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -63.05 -33.31 75.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p -70.32 -20.5 63.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -83.77 -50.41 8.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.64 -36.4 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.97 110.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -80.51 -18.36 48.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.08 142.09 23.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -98.99 68.55 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -150.65 128.34 11.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.09 128.39 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.21 155.06 26.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.83 152.09 79.7 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 C--N 1.305 -1.749 0 C-N-CA 122.743 2.295 . . . . 0.0 112.192 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.249 0.547 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.96 113.13 2.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.37 111.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -1.141 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.48 130.49 43.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' ALA . 73.0 m -93.22 139.66 30.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.1 mttt -41.26 -27.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.423 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -61.4 -39.36 90.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.482 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.11 -57.94 3.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 t -53.16 -24.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.389 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 17.9 mt-10 -68.77 -45.97 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.03 -19.81 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.604 ' OE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.5 tm-20 -88.68 -52.53 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.604 ' CZ ' ' OE1' ' A' ' 71' ' ' GLU . 67.9 m-85 -116.22 32.05 6.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 46.65 -160.32 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.7 29.69 7.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -1.134 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.92 -32.62 8.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -98.3 155.59 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -1.2 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -83.28 -177.55 6.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -15.52 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -70.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -52.8 -35.62 57.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -56.4 -64.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.1 mt -48.79 -31.67 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -59.47 -73.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -35.56 -44.11 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mt -60.59 -32.28 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.419 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.672 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.6 mt -72.04 -20.4 61.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.897 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.643 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -88.29 -3.48 58.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -113.92 -86.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 67.16 121.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.16 148.03 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -106.89 129.68 54.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.42 120.63 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -82.07 158.38 23.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.444 ' CD1' HD13 ' A' ' 85' ' ' ILE . 83.8 t80 -145.44 102.55 3.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.499 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -85.5 104.3 15.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 -157.41 11.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -58.93 -49.24 78.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -1.153 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.65 -33.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -84.78 134.91 34.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.564 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -105.76 138.05 42.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 mt -134.99 151.49 50.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.572 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.6 mt -120.27 150.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.82 151.19 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.521 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.2 144.55 25.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.04 177.64 8.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 -88.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.88 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.0 t -125.62 168.93 13.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.19 -29.9 34.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -56.53 -47.99 78.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.32 -47.88 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -49.93 -43.06 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -24.95 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.5 -47.03 28.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 32' ' ' ASN . 63.9 t80 -57.89 -50.02 74.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.471 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 29' ' ' TYR . 82.8 mt -43.82 -32.75 1.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.479 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 4.0 mptp? -91.19 10.03 28.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' TYR . 49.5 m-80 -161.25 62.11 1.49 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.81 113.46 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.815 2.343 . . . . 0.0 112.191 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.518 ' O ' ' OG ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -173.07 34.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.575 ' CG2' ' H ' ' A' ' 36' ' ' GLY . 29.3 mm 51.24 -177.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.575 ' H ' ' CG2' ' A' ' 35' ' ' ILE . . . 87.29 -74.78 2.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -67.56 -10.9 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -1.133 . . . . 0.0 109.458 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' VAL . 1.1 tp -59.2 -54.45 46.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' LEU . 70.3 m -43.18 -37.8 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.566 ' N ' ' CD ' ' A' ' 40' ' ' GLU . 1.7 mp0 -70.09 -35.88 74.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' LEU . 41.7 t -71.68 -54.8 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.574 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 118.44 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.18 -26.26 25.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tp -125.55 124.05 40.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -90.5 95.99 10.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -167.87 140.09 3.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.428 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -108.96 141.14 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -128.78 178.83 6.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.03 149.08 29.06 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 C-N-CA 122.735 2.29 . . . . 0.0 112.138 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.293 0.568 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.41 128.16 9.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.36 168.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -1.156 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.91 7.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' GLN . 2.8 t -99.49 133.12 44.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -46.7 -30.56 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.442 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.97 64.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.0 mm-40 -69.98 -27.82 65.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.65 -44.5 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 23.5 mt-10 -57.33 -39.36 75.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -49.71 -17.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 69' ' ' GLU . 28.5 mt-10 -98.8 -52.21 3.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.546 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.43 -28.96 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 104.6 -178.32 24.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 76' ' ' LYS . 2.8 mttm -91.22 -157.57 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.416 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.14 -8.02 9.38 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 74' ' ' LYS . 57.0 mttp -120.48 162.49 19.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -1.171 . . . . 0.0 109.454 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -108.88 -150.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -93.62 -18.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.948 . . . . 0.0 109.502 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.15 -43.29 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.0 -55.16 24.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' ILE . 14.6 t -50.74 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.501 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.7 mm -44.72 -62.14 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 82' ' ' ILE . 6.0 t70 -37.98 -51.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 85' ' ' ILE . 81.4 mt -57.03 -53.19 60.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 84' ' ' LEU . 46.0 mm -42.03 -49.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.392 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.469 ' O ' ' C ' ' A' ' 87' ' ' ARG . 49.4 mt -57.7 -40.67 80.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.718 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -40.36 -34.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.433 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -105.21 -82.87 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 96.13 0.23 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.5 mttt . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.269 -1.136 . . . . 0.0 109.551 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.57 139.2 47.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -113.6 160.25 18.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -122.05 139.83 53.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -98.26 160.39 14.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.42 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -150.4 94.88 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -65.04 113.64 4.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.46 172.83 49.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -46.55 -30.38 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.591 ' ND2' ' N ' ' A' ' 14' ' ' THR . 2.6 p-10 -149.6 -50.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.591 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 53.9 m -83.48 146.58 28.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.77 135.47 46.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.46 162.01 21.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.9 mt -138.04 153.4 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.09 177.9 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -103.45 168.42 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.78 152.84 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.11 -99.85 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.37 145.46 32.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -44.75 96.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.54 -32.89 8.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.68 -51.82 11.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.7 t -50.01 -54.01 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -53.61 54.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -48.38 -41.73 29.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 32' ' ' ASN . 70.5 t80 -61.99 -46.72 88.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 mt -46.65 -41.23 14.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.837 . . . . 0.0 109.459 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -81.66 1.57 33.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' TYR . 9.8 t30 -154.66 64.66 4.51 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' C ' ' HG ' ' A' ' 34' ' ' SER . 38.8 Cg_endo -70.72 109.46 2.5 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.849 2.366 . . . . 0.0 112.199 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.449 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 1.8 m -143.17 -136.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tp -138.76 1.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -93.46 -74.16 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.66 ' HZ3' ' CG2' ' A' ' 41' ' ' VAL . 37.0 tttm -52.9 -14.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -1.151 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' GLY . 2.7 tp -49.45 -65.47 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.445 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -50.52 -46.28 57.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -52.19 -16.9 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.66 ' CG2' ' HZ3' ' A' ' 37' ' ' LYS . 92.0 t -102.55 -60.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.06 124.18 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.575 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.17 -29.36 12.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mt -119.49 117.46 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -87.77 76.76 8.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.653 ' OE2' ' CE2' ' A' ' 48' ' ' PHE . 15.6 tt0 -161.75 138.31 8.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.12 116.19 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.653 ' CE2' ' OE2' ' A' ' 46' ' ' GLU . 34.6 m-85 -99.21 148.34 24.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.588 ' HG1' ' N ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -147.94 154.54 43.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.588 ' N ' ' HG1' ' A' ' 49' ' ' THR . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.822 2.348 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.324 0.583 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.63 -173.82 25.84 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.88 157.1 28.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.98 -174.54 2.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 66' ' ' ALA . 27.1 t -134.01 153.15 51.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 17.1 mmtm -43.47 -23.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -77.48 -50.55 12.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.34 -43.69 79.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.94 -21.46 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.393 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.4 mt-10 -82.94 -60.29 2.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-20 -41.08 -31.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 69' ' ' GLU . 12.6 mm-40 -82.06 -77.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -72.31 -48.93 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.439 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 110.52 150.02 12.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.445 ' HG2' ' H ' ' A' ' 75' ' ' GLY . 4.5 ttpp -64.91 162.18 16.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.462 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 74' ' ' LYS . . . 116.88 -19.88 11.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -117.37 177.58 4.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -1.162 . . . . 0.0 109.453 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.52 -177.25 3.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.38 -21.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.85 -51.94 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -63.36 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.65 -58.08 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.5 mt -49.24 -25.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' LEU . 50.3 t0 -65.97 -62.27 1.59 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 83' ' ' ASP . 79.7 mt -44.04 -32.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mt -68.05 -49.8 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.47 -11.41 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -77.71 -26.45 50.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.644 HD21 ' NZ ' ' A' ' 90' ' ' LYS . 1.4 m120 -102.77 -67.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.1 125.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.644 ' NZ ' HD21 ' A' ' 88' ' ' ASN . 25.7 mttm . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.03 164.9 12.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -131.35 144.96 51.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -114.43 146.59 40.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 9.6 m-85 -112.21 155.27 24.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 9' ' ' TYR . 61.7 t80 -143.32 94.91 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -67.0 98.59 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -73.88 173.25 50.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.55 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 3.3 tp10 -41.96 -42.8 2.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.477 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 7.0 m120 -144.4 -37.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.478 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -87.46 142.22 28.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.26 130.69 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.49 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mt -118.32 138.93 52.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.469 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.1 mt -120.21 146.1 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.49 165.01 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.528 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -92.09 166.23 12.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.42 151.37 22.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.465 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 -72.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 t -140.22 156.88 46.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.98 -51.58 53.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -45.2 -54.55 6.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -57.49 -31.53 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.606 ' O ' ' N ' ' A' ' 28' ' ' GLU . 87.3 t -71.74 -70.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.532 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -40.97 -20.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -82.67 -49.08 10.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 32' ' ' ASN . 40.4 t80 -52.06 -50.57 61.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 29' ' ' TYR . 6.9 mt -40.78 -42.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -77.88 -13.92 59.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.665 ' N ' ' O ' ' A' ' 29' ' ' TYR . 10.7 m120 -129.35 73.39 81.67 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.34 125.31 9.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.746 2.298 . . . . 0.0 112.232 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 172.61 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.8 mm -73.5 61.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.99 -47.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -87.52 -28.17 22.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 109.449 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -54.38 -24.73 20.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.528 ' HG ' ' N ' ' A' ' 40' ' ' GLU . 40.7 p -72.86 -31.62 64.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.528 ' N ' ' HG ' ' A' ' 39' ' ' SER . 12.7 tt0 -79.26 -26.03 42.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.93 -64.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 62.6 t -71.94 128.27 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.85 -50.82 10.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.912 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 4.5 mp -111.13 147.77 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.67 88.24 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 47' ' ' VAL . 7.9 tt0 -168.72 -173.53 1.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.401 ' H ' ' HG2' ' A' ' 46' ' ' GLU . 38.9 t -131.49 126.48 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.98 150.74 36.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.12 165.31 18.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--N 1.305 -1.754 0 C-N-CA 122.851 2.368 . . . . 0.0 112.262 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.09 143.22 8.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 151.24 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.59 -171.55 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -118.62 164.72 14.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -64.27 -32.75 74.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -44.3 68.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -72.13 -60.22 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.32 -26.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -70.68 -39.13 73.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -60.09 -21.5 61.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.45 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 10.0 mp0 -96.76 -67.01 0.87 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -161.53 76.6 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.409 ' C ' ' CG ' ' A' ' 74' ' ' LYS . . . -127.74 -129.01 3.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' CG ' ' C ' ' A' ' 73' ' ' GLY . 9.3 mttt 68.04 -75.07 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -1.178 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.4 30.69 4.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -118.22 100.47 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -1.193 . . . . 0.0 109.52 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -50.47 163.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -0.821 . . . . 0.0 109.537 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tp -54.75 -29.4 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.872 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.13 -60.7 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 83' ' ' ASP . 21.0 mt-10 -55.06 -55.12 34.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 80' ' ' GLU . 9.4 t -38.33 -50.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.429 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.3 mt -61.95 -37.72 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.624 ' OD2' ' NH2' ' A' ' 87' ' ' ARG . 9.0 t0 -65.93 -65.14 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 83' ' ' ASP . 85.7 mt -38.17 -30.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 87' ' ' ARG . 41.4 mt -73.92 -68.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.414 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.1 mt -46.55 -12.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.402 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.72 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -75.66 -43.45 47.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.464 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.582 ' ND2' ' C ' ' A' ' 88' ' ' ASN . 0.6 OUTLIER -149.93 66.44 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.15 -113.7 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.208 -1.172 . . . . 0.0 109.531 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 m -113.89 141.25 47.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -110.58 136.85 49.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.544 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.465 ' CZ ' HG12 ' A' ' 26' ' ' VAL . 1.7 m-85 -103.69 110.5 22.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.868 . . . . 0.0 109.501 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.32 162.57 23.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.51 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 57.9 t80 -161.23 137.7 8.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 108.2 19.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.426 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.55 -154.9 0.22 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.04 -39.6 92.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -1.167 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -146.69 -36.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.526 ' HG1' ' H ' ' A' ' 15' ' ' ASP . 14.5 t -83.78 169.16 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.9 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.526 ' H ' ' HG1' ' A' ' 14' ' ' THR . 43.2 t0 -115.3 137.02 52.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.9 153.49 39.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -131.4 143.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.16 152.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -90.06 152.97 20.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.13 -171.59 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.39 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.922 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 24' ' ' GLU . 15.7 t -153.52 135.8 14.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 22' ' ' SER . 5.4 tt0 -40.0 -28.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' SER . 23.8 tt0 -62.58 -76.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.943 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 24' ' ' GLU . 11.2 mt -44.11 -35.53 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 t -62.11 -57.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.496 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -51.38 -52.25 47.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.428 ' CB ' ' HZ2' ' A' ' 37' ' ' LYS . 9.1 mm-40 -48.52 -41.03 28.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.19 -59.32 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.9 mt -53.6 -27.86 29.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -23.61 61.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.09 77.49 2.73 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -51.69 118.75 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.817 2.344 . . . . 0.0 112.164 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -156.55 139.12 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 36' ' ' GLY . 9.8 tp -62.04 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 109.43 -80.11 0.26 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.428 ' HZ2' ' CB ' ' A' ' 28' ' ' GLU . 21.0 tttt -53.38 -16.74 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -1.178 . . . . 0.0 109.441 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.12 -47.46 85.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -57.6 -27.9 63.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.8 -33.78 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.8 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.5 t -79.66 134.95 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -96.3 -52.24 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.97 134.94 46.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -93.92 59.81 2.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 16.9 tt0 -140.59 123.44 16.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.5 139.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE2' ' O ' ' A' ' 46' ' ' GLU . 20.5 m-85 -117.66 174.82 5.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -168.36 155.73 7.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.86 2.373 . . . . 0.0 112.189 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.298 0.571 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -163.58 -156.2 8.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.7 117.07 21.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -1.14 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.445 ' HB3' HE21 ' A' ' 67' ' ' GLN . . . -54.43 173.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.91 148.43 50.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.419 ' O ' ' CD ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -46.47 -26.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.13 34.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 63' ' ' ALA . 18.2 tt0 -62.31 -50.29 72.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 t -60.21 -20.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 65' ' ' LYS . 14.2 mt-10 -76.91 -25.27 52.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.542 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 -22.21 45.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.23 -54.7 2.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -167.94 70.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 138.05 6.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -166.97 -27.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.85 31.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -103.69 177.57 4.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.395 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' ILE . 16.3 mttm -83.95 133.86 34.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 5.3 tp -40.54 -32.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' LYS . 60.8 mt-10 -54.71 -56.16 22.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 tp10 -48.63 -62.64 1.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 80' ' ' GLU . 65.8 t -39.66 -58.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.421 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.32 -20.35 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 80' ' ' GLU . 1.2 t70 -76.47 -69.17 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 83' ' ' ASP . 7.7 mt -38.55 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.6 mt -74.58 -70.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' ILE . 8.2 mt -42.16 -38.26 1.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.719 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -43.79 -26.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 86' ' ' LEU . 9.5 t-20 -107.78 -70.85 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 123.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.155 -1.203 . . . . 0.0 109.457 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.532 ' C ' ' HG1' ' A' ' 5' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.532 ' HG1' ' C ' ' A' ' 4' ' ' VAL . 19.1 m -158.64 150.47 21.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' ' 5' ' ' THR . 5.5 mtmp? -111.95 123.72 50.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.12 123.55 37.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.11 140.93 29.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.457 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.34 104.5 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -81.97 124.73 30.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 -153.12 28.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -52.98 -70.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -125.31 -21.02 4.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -92.37 161.26 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -121.73 144.95 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -137.95 148.6 45.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.1 mt -120.64 153.78 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 173.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.424 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -109.84 154.03 23.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.392 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' ALA . . . -154.05 128.24 9.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' ALA . . . -47.37 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.503 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.35 165.97 12.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -73.99 -28.17 61.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.33 -56.72 17.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.02 -51.48 69.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.396 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -46.44 -45.89 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 27' ' ' ASP . 1.6 t70 -62.66 -43.58 98.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 37' ' ' LYS . 6.4 mt-10 -60.94 -27.87 68.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -70.38 -36.56 74.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.86 -48.83 77.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -25.21 50.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.448 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 1.1 t-20 -136.21 68.16 62.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 154.23 53.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.849 2.366 . . . . 0.0 112.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.35 173.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 tp -88.24 -31.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.96 -14.38 80.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 28' ' ' GLU . 67.5 tttt -101.93 -12.4 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.57 -48.75 53.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' VAL . 3.1 m -49.23 -45.37 44.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.54 -56.96 14.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.5 t -50.21 -59.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.512 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.7 t -78.27 126.89 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.33 -0.51 46.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.1 tp -163.72 122.16 1.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.414 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -77.15 83.69 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -163.12 155.12 17.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.8 t -123.29 132.94 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.86 154.7 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.1 164.56 24.42 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.849 2.366 . . . . 0.0 112.244 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.41 159.37 24.4 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.75 156.26 17.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -1.19 . . . . 0.0 109.422 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.55 171.6 7.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' LYS . 76.7 p -121.89 150.52 41.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' SER . 7.8 pttt -41.92 -30.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 67' ' ' GLN . . . -73.65 -58.53 3.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.244 -0.91 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -38.16 -49.05 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.31 -51.87 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.639 ' O ' ' N ' ' A' ' 73' ' ' GLY . 31.1 tt0 -49.33 -29.01 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 109.399 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.94 -19.21 63.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.92 -27.02 14.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.521 ' C ' ' H ' ' A' ' 74' ' ' LYS . 84.3 m-85 -113.14 -11.0 13.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.488 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 62.14 0.31 2.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 72' ' ' PHE . 6.4 mtpp -139.09 -49.37 0.5 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.495 -1.003 . . . . 0.0 109.537 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.74 -61.7 3.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 49.49 -168.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -56.59 133.18 53.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 tp -55.36 -26.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -56.44 -41.91 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 81' ' ' VAL . 35.5 mt-10 -73.42 -58.62 3.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.473 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 80' ' ' GLU . 2.9 t -42.48 -38.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 61.2 mt -63.68 -46.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 35.7 t0 -60.58 -52.29 65.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.6 mt -45.29 -41.85 9.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.87 -40.25 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 88' ' ' ASN . 82.2 mt -60.24 -42.72 95.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -44.95 -20.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.43 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' LEU . 10.5 m120 -124.51 -81.98 0.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 75.15 124.74 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 89' ' ' GLY . 5.2 mmmt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.217 -1.167 . . . . 0.0 109.373 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.313 0.578 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -92.62 161.47 14.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -113.1 122.65 48.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CE1' HG12 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -92.63 104.61 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.18 137.57 47.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.91 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.13 105.91 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -75.95 114.43 14.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' ASN . . . -75.44 170.89 54.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.65 -17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -1.177 . . . . 0.0 109.389 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 t-20 -168.93 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 118.65 29.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 132.75 49.97 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.18 -0.95 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -129.18 142.53 50.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.37 142.37 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.5 175.13 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.75 160.84 14.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.46 164.57 29.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.82 -76.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 152.03 40.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -38.29 85.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.82 -61.32 2.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.3 mt -58.64 -63.58 1.23 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 25' ' ' LEU . 90.6 t -35.53 -35.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' LEU . 19.6 t0 -77.3 -35.02 55.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.368 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 25' ' ' LEU . 4.8 pt-20 -64.9 -28.2 69.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.403 ' N ' ' HG2' ' A' ' 28' ' ' GLU . 48.0 t80 -74.67 -50.23 18.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.7 mt -46.62 -23.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -74.07 -45.36 49.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -123.95 78.02 58.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.0 109.426 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 34' ' ' SER . 56.4 Cg_exo -47.17 156.87 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.792 2.328 . . . . 0.0 112.204 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 162.39 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.52 20.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.29 -45.39 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.448 ' NZ ' ' HG3' ' A' ' 28' ' ' GLU . 24.6 tttt -73.76 -11.29 60.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 109.435 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.25 -27.43 65.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.47 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -67.21 -18.27 65.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -89.21 -41.21 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.86 -66.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -70.24 113.64 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 109.549 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.63 -60.76 2.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.18 150.89 21.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -103.6 52.45 0.77 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -137.16 159.76 40.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.47 144.41 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 14.0 m-85 -118.91 154.23 33.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -144.75 156.71 55.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.425 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.446 ' N ' ' HG1' ' A' ' 49' ' ' THR . 39.1 Cg_endo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.175 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.28 -170.26 24.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.2 115.68 20.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -1.128 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.78 154.99 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 66' ' ' ALA . 4.7 m -98.09 147.85 24.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' O ' ' OE1' ' A' ' 69' ' ' GLU . 4.5 pttp -43.79 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -83.81 -48.29 10.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.603 ' C ' ' NE2' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -54.86 -43.68 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.22 -41.52 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 28.1 mt-10 -64.01 -40.22 95.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.4 -40.17 81.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.26 -67.68 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -90.91 -75.88 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.05 166.68 11.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.2 -2.55 52.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.527 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.78 -7.19 20.81 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -133.37 149.14 51.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -67.98 -167.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.53 -37.83 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -28.26 69.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.64 -44.47 33.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 t -53.35 -46.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.543 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 82' ' ' ILE . 1.6 mp -60.67 -40.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -48.35 -53.71 16.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.55 -32.36 68.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.8 mt -67.68 -29.19 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.549 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.7 mt -82.39 -26.32 32.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -93.2 3.63 55.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 88' ' ' ASN . 1.1 t-20 -161.54 57.73 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.92 -131.04 6.53 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.495 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.0 m -149.79 135.47 18.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -99.06 129.07 45.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -104.13 160.31 14.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -127.95 157.39 40.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -142.87 129.72 20.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.858 . . . . 0.0 109.509 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -105.03 105.79 15.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.67 -150.58 24.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -49.67 -51.27 39.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -148.01 -46.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.447 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -72.54 143.6 48.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.77 138.07 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.1 mt -113.13 157.17 21.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.475 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 mt -130.26 154.32 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.424 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.9 179.91 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.88 153.45 35.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.51 177.3 11.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.51 -46.81 5.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.65 137.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -49.55 -31.3 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.436 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -67.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.06 -48.43 44.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' A' ' 27' ' ' ASP . 76.3 t -50.8 -66.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' C ' ' O ' ' A' ' 26' ' ' VAL . 37.6 t70 -36.3 -43.33 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.92 -50.61 70.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 32' ' ' ASN . 62.1 t80 -51.3 -49.7 60.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 29' ' ' TYR . 19.9 mt -41.72 -56.29 2.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -73.9 -3.5 29.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 29' ' ' TYR . 8.7 m120 -135.83 69.36 65.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -73.64 131.6 16.24 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.873 2.382 . . . . 0.0 112.219 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.25 154.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -85.72 66.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.46 -50.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -75.69 -26.02 57.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.449 ' CD1' ' CE2' ' A' ' 29' ' ' TYR . 2.7 tp -57.9 -33.37 68.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -36.62 76.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.78 -39.24 66.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.76 -69.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.67 117.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -81.76 -40.97 21.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.27 128.38 56.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.67 78.29 4.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -163.73 159.95 22.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.08 143.15 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -128.1 155.22 44.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -118.99 149.38 46.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 C--N 1.305 -1.728 0 C-N-CA 122.75 2.3 . . . . 0.0 112.221 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.8 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.74 108.33 0.82 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.34 142.12 17.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -1.182 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.29 28.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -88.26 148.04 24.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.6 mttt -41.43 -19.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -68.2 -61.51 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -53.23 -34.73 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.18 -31.32 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.1 mt-10 -68.91 -63.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 69' ' ' GLU . 20.0 m-20 -39.36 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -85.52 -67.71 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.454 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 71' ' ' GLU . 20.4 m-85 -115.02 25.5 10.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.506 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.65 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 52.72 -162.12 2.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 76' ' ' LYS . 2.3 tttp -109.94 -149.46 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -1.152 . . . . 0.0 109.454 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 -26.14 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 74' ' ' LYS . 21.4 mttt -91.42 -172.35 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -122.99 157.17 33.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tp -51.41 -30.74 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.41 -50.29 66.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.413 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -57.69 -52.83 63.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.1 t -47.87 -59.08 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.97 -42.47 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.495 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 28.5 t0 -52.68 -51.02 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.459 ' O ' ' OD1' ' A' ' 88' ' ' ASN . 10.5 mt -60.03 -43.15 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.9 mm -47.98 -62.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.3 -23.3 22.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -67.02 -36.37 81.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -93.48 -77.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.469 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.58 130.25 1.16 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 tptp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.43 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -101.67 -173.61 2.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CB ' ' HZ3' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -136.01 133.92 37.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -99.14 119.35 37.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.59 166.24 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -165.31 109.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -90.31 103.08 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.58 -157.36 0.79 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 3.8 tt0 -48.23 -67.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.146 . . . . 0.0 109.427 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 2.9 m120 -128.54 -26.26 2.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.12 155.38 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -113.45 136.86 52.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -132.7 153.44 51.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.1 mt -134.18 145.21 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.922 . . . . 0.0 109.489 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.24 173.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -108.72 148.05 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.09 178.58 6.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.446 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.03 -55.01 3.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -172.4 166.63 5.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -72.02 -21.96 61.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.57 -66.61 0.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -53.81 -49.58 68.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -49.32 -50.37 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.83 -29.4 64.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.73 -34.69 64.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 32' ' ' ASN . 54.0 t80 -62.55 -48.06 81.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' TYR . 67.8 mt -43.36 -59.53 2.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.867 . . . . 0.0 109.498 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -18.95 65.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TYR . 64.5 t30 -121.98 87.44 47.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.42 54.43 5.18 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -106.13 105.02 14.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.443 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' SER . 14.6 tt -42.64 -32.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.26 -41.2 78.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -73.12 -27.48 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -1.164 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.401 HD13 ' CZ ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -52.09 -39.84 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.0 t -58.22 -21.04 46.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -87.18 -34.73 18.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 t -75.81 -72.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.3 t -57.73 118.26 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.561 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.26 -32.78 20.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -137.31 114.95 11.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.98 94.22 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -167.4 158.17 11.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.81 140.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.54 -170.27 1.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.43 150.12 0.97 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--N 1.305 -1.732 0 C-N-CA 122.833 2.355 . . . . 0.0 112.254 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.21 -167.45 11.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.96 110.21 16.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -1.188 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.8 155.65 1.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -93.87 155.91 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.937 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -59.03 -16.07 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 -39.54 13.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -60.26 -46.28 90.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.74 -42.97 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.56 -23.34 66.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.85 -26.68 49.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.27 -32.79 55.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.429 ' CE2' ' CG1' ' A' ' 81' ' ' VAL . 78.5 m-85 -104.41 -61.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.63 136.9 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -64.4 98.48 0.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.05 -6.8 0.12 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -101.63 129.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -1.107 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -59.78 -165.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.1 tp -91.89 -34.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.46 -35.28 73.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.07 -43.69 82.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.429 ' CG1' ' CE2' ' A' ' 72' ' ' PHE . 54.8 t -65.55 -60.77 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.9 mm -46.04 -32.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 84' ' ' LEU . 19.8 t70 -66.94 -65.14 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' ASP . 15.5 mt -38.44 -30.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' ASP . 90.1 mt -76.95 -50.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.903 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -58.26 -13.93 6.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -82.46 -38.08 24.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 1.9 t-20 -85.28 -68.07 0.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 59.68 119.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.43 ' HG3' ' HZ2' ' A' ' 90' ' ' LYS . 56.5 tttp . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.457 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.3 m -148.39 142.19 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -108.26 127.54 53.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.903 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.13 144.44 30.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.495 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -113.06 121.13 43.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 10' ' ' LYS . 69.6 t80 -126.92 140.85 52.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.485 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 9.7 tttt -101.26 140.96 34.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.94 -166.68 27.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -94.99 -33.07 12.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.134 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.44 -30.01 7.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 t -145.28 179.1 7.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.1 t70 -98.1 161.99 13.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 62.1 mt -140.24 140.03 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.9 136.99 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 109.409 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 171.3 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.95 163.49 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.446 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.99 -177.05 6.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.62 -71.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.388 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.13 140.09 37.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 26' ' ' VAL . 39.0 mt-10 -50.75 -55.95 14.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.918 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 23' ' ' GLU . 13.5 tp10 -37.65 -44.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.56 -27.28 64.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' A' ' 23' ' ' GLU . 89.6 t -73.3 -54.08 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.2 -24.22 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -75.31 -38.56 60.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 32' ' ' ASN . 76.6 t80 -60.04 -49.54 77.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mt -45.68 -32.43 2.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -91.06 -3.0 57.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' TYR . 52.5 m-80 -142.72 61.47 11.08 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.85 93.31 0.95 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.85 2.366 . . . . 0.0 112.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -162.53 132.31 4.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.3 mm -46.46 117.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.11 -63.1 0.38 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -79.88 -28.67 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.401 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' LYS . 5.0 tp -42.77 -40.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 t -67.83 -37.19 81.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' LYS . 17.6 tt0 -62.7 -18.34 62.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.93 -74.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 t -57.55 157.54 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.378 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -117.87 -68.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.1 tp -95.38 111.57 23.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.86 74.37 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 47' ' ' VAL . 11.6 tp10 -156.03 157.87 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.442 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 6.6 t -128.17 128.29 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.56 156.98 22.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.493 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.95 156.92 34.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.305 -1.733 0 C-N-CA 122.793 2.328 . . . . 0.0 112.192 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.33 9.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.29 134.0 56.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -1.126 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.49 130.13 39.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.561 ' O ' ' N ' ' A' ' 67' ' ' GLN . 13.6 m -81.23 131.08 35.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 64' ' ' SER . 1.7 ptpt -40.47 -40.24 1.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.16 67.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.29 -50.96 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.16 -41.7 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 71' ' ' GLU . 39.9 mt-10 -55.58 -41.6 73.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.9 t-20 -40.37 -19.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.648 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.5 mm-40 -114.37 -60.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -164.98 72.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.45 ' N ' ' HA ' ' A' ' 69' ' ' GLU . . . -129.4 0.13 5.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -85.5 106.58 16.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.516 -0.99 . . . . 0.0 109.485 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.9 32.6 63.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -130.84 100.18 5.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -1.147 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.552 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 9.4 mtpm? -46.55 155.09 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.49 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.5 -21.5 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.552 ' OE1' ' NZ ' ' A' ' 77' ' ' LYS . 9.6 mt-10 -69.0 -51.99 33.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.14 -42.94 83.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -48.21 -51.49 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.1 mt -61.21 -35.59 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.877 . . . . 0.0 109.535 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' LEU . 46.0 t0 -60.34 -66.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 83' ' ' ASP . 16.4 mt -40.47 -32.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 mt -80.57 -31.17 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.9 mt -77.66 -0.39 26.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -75.67 -40.86 55.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.621 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 0.4 OUTLIER -96.25 -73.38 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.88 117.31 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.427 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.262 0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.26 159.43 15.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -121.73 132.43 54.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -95.75 117.59 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -81.92 138.04 35.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -131.54 90.06 2.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.965 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -56.77 96.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 12' ' ' GLU . . . -71.51 -162.59 5.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.569 ' CG ' ' N ' ' A' ' 13' ' ' ASN . 1.1 tt0 -49.37 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.477 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.569 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -100.21 -0.63 38.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 109.478 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.497 ' HG1' ' H ' ' A' ' 15' ' ' ASP . 5.6 t -113.05 174.85 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' H ' ' HG1' ' A' ' 14' ' ' THR . 46.9 t0 -117.26 122.49 44.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.473 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.401 HD21 ' CG1' ' A' ' 47' ' ' VAL . 53.1 mt -106.17 132.24 52.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.3 mt -118.55 146.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.593 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.11 169.81 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -103.37 155.23 18.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.84 -171.4 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.52 2.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -168.69 135.52 1.9 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -45.69 -24.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.66 -65.64 0.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.438 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.65 -20.42 21.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -79.15 -52.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -44.36 96.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 109.406 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.8 mt-10 -56.5 -54.88 40.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -46.98 -44.13 19.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.46 -20.57 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.323 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 14.2 mtmt -92.81 -22.34 19.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 31' ' ' LYS . 9.0 m-20 -143.57 66.16 15.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' SER . 42.2 Cg_endo -71.53 170.03 19.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.801 2.334 . . . . 0.0 112.208 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER 166.92 22.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 mm 47.13 13.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' SER . . . -107.48 -53.59 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -71.86 -25.75 62.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.2 tp -48.7 -22.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.486 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 36' ' ' GLY . 2.7 p -71.39 -18.39 62.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -98.18 -20.94 16.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.84 -42.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.44 141.6 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.485 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -102.09 -44.48 5.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.512 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 46' ' ' GLU . 7.5 mt -121.7 105.92 10.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -66.43 72.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.522 ' CG ' ' H ' ' A' ' 47' ' ' VAL . 5.8 tt0 -152.65 178.57 9.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.522 ' H ' ' CG ' ' A' ' 46' ' ' GLU . 82.2 t -123.5 131.73 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -118.35 176.83 5.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.492 ' HG1' ' N ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 173.94 151.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.492 ' N ' ' HG1' ' A' ' 49' ' ' THR . 42.5 Cg_endo . . . . . 0 C--N 1.304 -1.776 0 C-N-CA 122.839 2.359 . . . . 0.0 112.156 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.9 -177.87 38.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.75 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.49 -178.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -103.22 136.16 43.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 3.5 mttt -43.28 -27.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.52 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -78.45 -20.5 50.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 64' ' ' SER . 3.2 mt-30 -81.17 -39.66 25.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.77 -32.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.7 mt-10 -62.41 -21.58 65.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -82.35 -33.77 28.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.556 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -80.82 -24.19 38.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.69 -30.02 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.647 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . 115.79 -130.45 9.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 75' ' ' GLY . 5.3 mtpt -67.02 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.142 -1.211 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . 40.08 66.79 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 77' ' ' LYS . 30.2 mttp -51.71 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -1.194 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 76' ' ' LYS . 28.3 mttp -41.13 130.97 2.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' LYS . 2.7 tp -41.9 -37.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -52.91 -56.72 13.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.55 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -53.05 -41.5 64.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 82' ' ' ILE . 7.5 t -58.7 -68.19 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 81' ' ' VAL . 15.8 mt -42.95 -39.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 109.486 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -61.74 -63.82 1.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 83' ' ' ASP . 5.5 mt -43.64 -35.29 1.72 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.22 -66.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.421 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 5.0 mt -49.62 -26.71 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -42.19 -43.88 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -77.53 0.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.6 132.85 3.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.494 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.35 158.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -118.34 139.44 51.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.86 117.64 31.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.18 126.61 45.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.853 . . . . 0.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -120.88 106.51 11.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -79.36 94.83 5.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.93 -166.84 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -63.13 -53.74 48.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.38 -1.54 3.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 137.32 54.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.52 121.64 45.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -119.19 147.19 44.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.6 mt -116.81 147.55 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.65 161.93 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -95.16 149.38 21.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.03 144.36 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.92 -69.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 149.37 46.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.08 -35.51 80.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.24 -58.29 8.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 26' ' ' VAL . 9.2 mt -50.07 -59.26 4.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.508 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.47 ' C ' ' O ' ' A' ' 25' ' ' LEU . 4.4 t -39.88 -59.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -48.41 -42.36 31.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 25' ' ' LEU . 6.0 mt-10 -60.65 -46.22 91.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.848 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' N ' ' NZ ' ' A' ' 37' ' ' LYS . 31.0 t80 -49.83 -54.92 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.2 mt -52.55 -22.87 5.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -88.27 -26.51 22.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -130.89 58.35 38.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 93.94 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.896 2.397 . . . . 0.0 112.245 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.8 t -155.66 27.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.8 mm 59.41 169.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.92 -38.54 3.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.587 ' NZ ' ' N ' ' A' ' 29' ' ' TYR . 25.9 tttm -105.5 -6.36 19.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -1.123 . . . . 0.0 109.453 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.407 ' HB2' ' HH ' ' A' ' 29' ' ' TYR . 5.8 tp -66.93 -23.11 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.23 -33.38 59.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.47 -27.56 61.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -86.59 -64.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.76 146.66 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -97.9 -55.5 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.42 154.71 19.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.01 65.9 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -156.53 157.27 35.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.81 140.65 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.2 m-85 -114.92 170.13 8.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.23 152.98 72.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.05 -174.19 27.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.5 49.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -1.131 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 128.88 36.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.27 150.04 47.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -50.32 -25.23 3.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.505 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.12 -42.65 79.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 68' ' ' VAL . 4.2 tt0 -62.64 -61.51 2.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 67' ' ' GLN . 19.0 t -42.96 -48.34 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -47.92 -24.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -77.39 -19.97 55.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' VAL . 5.6 mm-40 -92.18 -66.05 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -156.8 66.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.93 130.31 2.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -164.74 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.98 -22.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -72.16 -165.57 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -109.78 -161.98 0.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -90.81 -42.77 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -49.82 -55.47 14.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -56.3 -48.83 75.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.2 t -44.56 -54.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 0.0 109.482 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.46 -35.55 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -53.93 -49.3 68.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' ARG . 16.4 mt -57.16 -54.54 45.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 84' ' ' LEU . 56.3 mt -43.19 -44.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.3 mt -69.52 -27.29 65.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 84' ' ' LEU . 4.2 tpt180 -51.75 -28.41 15.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.545 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.411 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 0.0 OUTLIER -115.53 -83.17 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 69.13 127.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' GLY . 7.0 mttp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 0.0 109.353 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -146.33 146.15 30.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 6' ' ' LYS . 11.0 mtpp -114.73 133.31 55.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.498 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.87 132.01 43.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.94 147.22 24.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -141.1 107.85 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -89.73 92.64 9.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 13' ' ' ASN . . . -56.46 171.33 2.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.5 -5.81 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -1.145 . . . . 0.0 109.542 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' GLY . 23.1 t30 -161.09 -54.81 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.509 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -84.91 152.87 23.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -115.87 130.58 56.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.83 156.92 46.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 mt -121.75 152.75 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.49 166.78 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.503 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.51 153.4 22.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.45 161.41 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.5 -76.17 0.28 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -135.9 155.04 50.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -67.06 -31.62 72.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -50.1 -61.13 2.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.458 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 28' ' ' GLU . 12.6 mt -55.55 -52.45 63.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' LEU . 10.9 t -45.5 -50.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.9 -24.56 67.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 42.4 mm-40 -79.53 -37.63 36.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.35 -44.38 95.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.06 -35.62 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.498 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -76.39 -37.98 56.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.4 72.08 80.21 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.53 136.77 20.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.857 2.371 . . . . 0.0 112.248 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.06 130.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.48 -44.21 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -10.52 5.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -49.27 5.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -1.122 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tp -47.2 -21.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -32.06 73.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.21 -45.76 11.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.6 -54.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 45' ' ' PHE . 91.6 t -71.62 134.33 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 35.17 3.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.41 -40.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.426 ' CD1' HG13 ' A' ' 42' ' ' VAL . 36.2 m-85 56.4 62.01 2.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.539 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -158.1 161.73 37.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.61 123.78 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -110.59 171.18 7.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.68 159.01 37.0 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 C-N-CA 122.856 2.371 . . . . 0.0 112.192 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.58 152.51 20.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.54 146.18 26.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -1.14 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.8 -170.76 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.6 m -113.38 147.24 38.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 74.5 mttt -49.04 -32.58 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' O ' ' OD1' ' A' ' 70' ' ' ASN . . . -64.6 -42.72 95.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.48 -38.27 86.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.48 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' GLU . 41.4 t -66.34 -55.19 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 73' ' ' GLY . 2.0 mt-10 -44.96 -35.55 2.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.556 ' OD1' ' O ' ' A' ' 66' ' ' ALA . 14.9 m120 -66.29 -17.97 65.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 68' ' ' VAL . 2.3 mp0 -108.88 -6.97 15.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.545 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -146.1 16.74 1.38 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 48.32 -133.96 19.31 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER -42.78 109.03 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -1.155 . . . . 0.0 109.447 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.13 87.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' LYS . 16.7 mttt -66.52 -179.1 0.78 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.398 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -47.82 138.76 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.37 -22.41 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.92 -28.97 62.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.563 ' CA ' ' OE1' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.05 -47.95 14.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.514 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -50.99 -48.83 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.96 -36.52 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' LEU . 56.8 t0 -58.66 -64.18 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ASP . 98.5 mt -42.18 -46.32 4.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 87' ' ' ARG . 74.2 mt -57.86 -58.16 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.16 -7.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.69 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -111.21 -20.82 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -140.91 66.44 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.57 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -147.64 -138.92 3.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 89' ' ' GLY . 16.8 ttpp . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.573 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.293 0.568 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.8 142.57 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -102.4 131.6 48.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.437 ' HH ' HG23 ' A' ' 26' ' ' VAL . 1.1 m-85 -99.85 116.58 32.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 17.9 m-85 -91.23 142.9 27.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -132.72 102.2 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -81.4 93.37 6.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.14 -156.57 8.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -46.77 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -13.82 9.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.59 147.49 23.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -117.28 115.85 26.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.95 152.69 24.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.8 mt -137.77 114.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -172.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.415 ' CD2' ' CD1' ' A' ' 44' ' ' LEU . 4.5 m-85 -104.57 169.63 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.15 149.79 5.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.69 -59.54 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 p -155.92 142.92 19.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -53.69 -33.93 57.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.225 -0.922 . . . . 0.0 109.514 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 13.6 tt0 -54.65 -64.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.8 mt -44.64 -58.04 3.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' LEU . 96.1 t -40.39 -45.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -60.51 -36.06 77.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 25' ' ' LEU . 5.6 mt-10 -67.28 -23.14 65.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -85.07 -28.69 25.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.93 -40.42 95.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -74.45 -32.77 62.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.561 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -124.67 73.52 62.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.74 114.37 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.76 2.306 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -144.27 -112.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -162.68 -14.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.11 -52.49 4.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -65.45 -8.38 18.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.149 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.14 -54.31 31.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 p -48.84 -20.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -84.06 -44.09 14.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.66 -70.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.14 129.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.419 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.77 -36.45 15.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -123.89 112.51 17.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.485 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.44 80.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' LEU . 4.6 tp10 -165.39 157.25 14.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.91 129.55 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -111.97 160.01 17.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 168.62 16.15 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.838 2.359 . . . . 0.0 112.233 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.47 178.97 16.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.73 148.8 47.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -1.172 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.7 150.55 21.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.72 174.6 6.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.426 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -70.58 -31.84 69.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.16 -43.3 87.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -62.71 -52.48 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' GLU . 95.3 t -60.05 -41.99 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.972 . . . . 0.0 109.541 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -45.04 -42.44 8.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.9 . . . . 0.0 109.525 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -69.96 -26.07 63.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -81.58 -25.43 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -137.66 -71.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.51 -172.02 36.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -115.33 159.22 21.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.52 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.62 -22.37 38.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -78.67 -168.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -1.113 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 78' ' ' ILE . 22.8 mttm -124.71 137.87 54.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -39.55 -45.39 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 4.8 mt-10 -64.22 -43.92 93.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' LYS . 2.5 tp10 -59.2 -36.24 75.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' C ' ' A' ' 82' ' ' ILE . 6.5 t -70.44 -60.38 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 81' ' ' VAL . 94.8 mt -39.54 -42.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.497 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -56.6 -57.08 13.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -54.63 -30.97 56.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 86' ' ' LEU . 1.9 mm -68.44 -64.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ILE . 4.8 mt -45.19 -42.92 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -46.46 -53.26 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.81 -82.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.476 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.49 119.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.318 -1.107 . . . . 0.0 109.465 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 m -93.6 139.43 30.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.5 115.79 30.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.447 ' HH ' ' CG1' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -95.39 137.83 33.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 41.8 m-85 -115.4 150.47 36.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -139.78 123.91 17.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -101.0 99.79 10.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.71 -147.52 0.08 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -97.08 -43.22 7.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.468 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.6 -3.29 3.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.927 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.58 158.62 40.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.7 144.33 47.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -134.91 160.85 36.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 92.2 mt -140.89 140.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.13 156.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -93.25 154.28 18.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.66 168.9 18.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.12 -58.36 2.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.528 ' HG ' ' H ' ' A' ' 25' ' ' LEU . 2.4 p -156.11 148.82 23.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.96 -26.68 68.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.76 -41.18 75.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.483 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 22' ' ' SER . 31.2 mt -69.97 -26.32 64.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.447 ' CG1' ' HH ' ' A' ' 7' ' ' TYR . 45.7 t -76.6 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' VAL . 1.5 t0 -43.61 -43.45 5.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.333 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 1.7 mt-10 -61.58 -45.7 93.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.441 ' CE1' ' N ' ' A' ' 34' ' ' SER . 91.6 t80 -59.86 -33.29 71.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.36 -40.03 77.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -59.87 -23.92 63.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 5.6 p-10 -153.72 81.37 4.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.78 144.62 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.836 2.357 . . . . 0.0 112.296 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.441 ' N ' ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -154.42 -169.78 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -126.52 -19.6 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.1 -57.64 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -49.66 -25.5 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tp -47.0 -24.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.427 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -69.95 -62.5 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.52 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.68 -39.78 37.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.28 -48.31 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 39' ' ' SER . 21.7 t -105.53 128.85 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 -1.86 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.18 123.72 4.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.36 94.43 8.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -168.68 152.21 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.975 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 t -120.03 119.15 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.493 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.1 152.18 23.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.411 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -117.13 149.87 45.12 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 C-N-CA 122.784 2.323 . . . . 0.0 112.147 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.68 36.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.3 49.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -1.15 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 169.99 10.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.0 161.64 13.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -57.78 -46.23 84.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.62 -22.16 12.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -83.36 -58.62 2.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.34 -29.14 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.9 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' GLU . 46.5 mt-10 -71.55 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 69' ' ' GLU . 7.9 t30 -38.53 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.518 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 69' ' ' GLU . 15.6 mm-40 -75.74 -62.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -94.08 -72.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.567 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.29 177.45 41.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -96.87 170.61 9.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -1.096 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.1 -29.9 4.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -76.85 156.4 32.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -1.131 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -97.35 -176.31 3.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.905 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 tp -73.87 -36.37 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.77 -49.51 74.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -55.64 -60.85 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.454 ' C ' ' O ' ' A' ' 80' ' ' GLU . 3.4 t -41.68 -62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 83' ' ' ASP . 17.0 mt -45.14 -51.52 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -37.32 -55.26 1.04 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 45.6 mt -56.03 -59.64 4.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 84' ' ' LEU . 76.9 mt -38.26 -41.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.98 -33.75 76.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 84' ' ' LEU . 14.5 ttt180 -62.95 -14.08 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -105.35 -89.11 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.75 127.5 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tptt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.497 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.13 133.57 54.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.455 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -106.17 117.6 34.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.428 ' CZ ' ' HD2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -89.45 126.82 35.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 2.3 m-85 -89.25 160.14 17.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -150.63 105.61 3.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.45 126.27 29.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.72 -149.61 24.93 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -70.86 -31.28 67.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -153.39 -51.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -77.4 169.53 18.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD2' ' CD2' ' A' ' 8' ' ' PHE . 48.8 t0 -116.59 134.86 54.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.5 mt -111.24 136.2 50.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.0 mt -115.98 131.74 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 m -117.74 156.67 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -92.27 150.8 20.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.94 166.03 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.1 -50.21 5.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -165.03 142.53 6.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.468 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.87 -35.76 69.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.444 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -63.89 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -50.22 -45.68 54.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.95 -49.08 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -60.93 -38.15 84.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.4 -36.07 81.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.95 -32.68 69.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.0 mt -54.05 -31.88 52.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.468 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 31' ' ' LYS . 7.4 tttm -96.32 32.9 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -175.37 58.41 0.19 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.36 99.02 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.879 2.386 . . . . 0.0 112.232 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 m -127.31 -107.04 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 tp -159.32 -23.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -81.52 -73.5 1.19 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -41.17 -22.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.422 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.0 tp -66.81 -38.86 87.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -58.87 -36.12 74.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 41' ' ' VAL . 2.3 tt0 -74.27 -57.38 3.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 40' ' ' GLU . 53.6 t -41.68 -35.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 75.3 t -104.43 122.15 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.02 -27.04 30.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 2.3 mp -129.38 140.26 51.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.28 59.27 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -153.39 163.86 39.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -117.47 151.71 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.91 148.83 51.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.1 155.78 35.02 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 122.861 2.374 . . . . 0.0 112.224 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.43 135.88 11.53 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.1 158.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -1.153 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.89 155.71 19.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.2 p -83.04 145.29 29.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -56.17 -16.0 4.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.14 -36.27 16.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.86 -41.72 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.898 . . . . 0.0 109.496 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.06 -46.22 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.516 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.63 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.4 mt-10 -47.73 -38.6 15.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -78.64 -20.99 49.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.75 -31.21 59.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 81' ' ' VAL . 50.7 m-85 -126.69 -18.52 4.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 117.52 -152.59 17.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -138.75 92.96 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -1.126 . . . . 0.0 109.512 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.49 -18.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -95.54 -178.03 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 0.0 109.448 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -107.98 -157.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.88 -31.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -59.93 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.05 -31.35 7.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 72' ' ' PHE . 6.4 t -68.57 -61.96 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 45.9 mt -55.92 -21.58 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -66.28 -56.12 12.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mt -59.19 -25.54 64.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 72.6 mt -69.93 -50.85 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 16.0 mt -72.19 -5.81 38.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.39 -34.98 11.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.48 42.19 1.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -104.97 -133.67 7.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 89' ' ' GLY . 33.2 tttm . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 m -106.69 166.86 10.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.419 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt -128.4 143.76 51.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.443 ' CD2' ' HA3' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -123.65 113.12 18.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.0 109.479 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -83.66 164.02 19.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 109.408 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -154.21 131.98 11.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.475 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -110.79 112.6 24.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.548 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.0 -149.27 4.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -79.8 -47.37 15.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.453 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.87 -26.65 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 158.25 16.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.6 t0 -114.17 154.76 27.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.421 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.673 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 44.0 mt -137.52 157.72 45.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 18' ' ' VAL . 19.6 mt -134.73 151.42 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.348 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.406 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -142.48 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.9 154.87 27.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 162.68 32.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.47 -65.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.74 129.05 18.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -46.57 -38.88 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.19 -61.44 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' C ' ' A' ' 26' ' ' VAL . 32.0 mt -47.26 -59.6 3.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' C ' ' O ' ' A' ' 25' ' ' LEU . 97.8 t -38.21 -46.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -46.15 84.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.98 -46.78 87.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CE1' HD12 ' A' ' 38' ' ' LEU . 35.8 t80 -47.22 -52.64 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.64 -25.91 60.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -71.49 -31.68 67.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -158.88 80.36 2.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.19 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.804 2.336 . . . . 0.0 112.271 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 36' ' ' GLY . 1.6 t -118.48 120.26 37.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.245 -0.91 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.55 0.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 34' ' ' SER . . . -85.48 -16.17 64.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' LEU . 4.6 ptmm? -115.66 -10.81 11.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.133 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -38.42 -53.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 41' ' ' VAL . 4.6 p -52.77 -61.37 2.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 39' ' ' SER . 4.6 mm-40 -37.77 -22.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.7 t -96.54 -54.86 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.5 149.38 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.57 -16.46 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.68 98.33 2.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -63.29 89.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -169.04 118.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -79.67 144.82 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -130.86 163.39 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.13 163.82 37.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.305 -1.758 0 C-N-CA 122.823 2.348 . . . . 0.0 112.24 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.79 137.19 15.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 152.44 22.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.463 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.73 -168.8 1.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.441 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.27 166.42 18.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -20.66 66.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.18 -44.83 13.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.38 -41.44 89.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.22 -56.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.73 -34.98 70.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.85 . . . . 0.0 109.515 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -27.89 50.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.33 -66.77 0.86 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 81' ' ' VAL . 25.5 m-85 -71.38 -67.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.38 175.25 21.56 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.86 172.9 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.42 9.94 74.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -131.78 171.0 14.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -1.202 . . . . 0.0 109.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -119.21 -163.16 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -82.57 -35.22 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.525 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 78' ' ' ILE . 59.1 mt-10 -64.44 -31.59 72.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -84.17 -45.24 13.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' A' ' 72' ' ' PHE . 22.8 t -58.56 -34.86 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.05 -46.56 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.21 -45.38 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.32 -56.57 18.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mt -47.14 -50.92 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 88' ' ' ASN . 45.0 mt -58.83 -31.12 68.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -55.74 -9.41 0.54 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 86' ' ' LEU . 2.8 m120 -134.22 -91.68 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 65.51 125.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 89' ' ' GLY . 23.3 mtmt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.344 -1.092 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mtt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.273 0.559 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t 173.82 6.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.9 p -133.01 136.53 46.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.923 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.1 m -89.87 162.84 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -100.95 147.16 26.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -116.7 136.58 52.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -118.68 122.73 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -90.82 159.59 16.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -147.49 91.11 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -53.59 113.77 1.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.14 -161.85 33.27 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.3 mm-40 -70.92 -45.25 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.01 -41.69 2.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t -101.42 177.89 4.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.41 124.63 49.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.88 127.66 49.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.358 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.437 HG21 ' N ' ' A' ' 18' ' ' VAL . 5.1 mt -109.18 155.08 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' N ' HG21 ' A' ' 17' ' ' ILE . 0.3 OUTLIER -131.82 154.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.54 153.92 17.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.16 159.18 44.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.96 -73.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 t -145.66 169.89 17.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.53 -26.65 66.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 25' ' ' LEU . 57.7 tt0 -65.49 -74.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' GLU . 5.2 mt -42.39 -33.4 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 27' ' ' ASP . 3.7 t -67.32 -70.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 26' ' ' VAL . 45.4 t0 -41.11 -39.87 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 109.479 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 29' ' ' TYR . 3.1 mm-40 -58.05 -58.8 6.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' GLU . 76.2 t80 -43.33 -51.86 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.938 . . . . 0.0 109.446 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.73 -40.32 83.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -68.55 -4.51 15.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -175.62 79.43 0.3 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.47 140.42 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.769 2.312 . . . . 0.0 112.216 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 t -164.33 94.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -48.54 -27.49 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.59 -9.64 74.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 38' ' ' LEU . 18.2 tttm -112.28 -25.46 9.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -39.13 -31.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -60.79 -69.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.494 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' SER . 35.9 mt-10 -41.33 -36.39 0.8 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.17 -70.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.7 t -85.12 130.31 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -95.17 -31.49 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.478 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -111.15 121.42 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -91.6 77.62 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.408 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 30.4 tt0 -165.86 143.88 5.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.464 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.58 127.29 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 72.7 m-85 -113.26 154.22 27.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 109.547 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -132.87 164.14 46.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 49' ' ' THR . 66.6 Cg_exo -45.3 -172.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.217 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 53' ' ' GLY . 11.4 pt20 -94.19 172.85 7.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 27.0 p30 -62.94 59.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 51' ' ' GLN . . . 155.51 -164.74 32.2 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.726 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -88.2 129.11 35.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -1.17 . . . . 0.0 109.43 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.82 112.34 1.05 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.19 -16.77 39.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.3 -10.91 59.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.13 -143.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 60' ' ' LEU . 51.9 mt-10 -113.65 94.66 4.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.574 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.501 ' C ' ' O ' ' A' ' 59' ' ' GLU . 0.9 OUTLIER -38.42 150.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.98 -173.84 14.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.18 151.07 26.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.85 132.88 39.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -74.75 149.29 39.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 29.9 mttt -43.82 -51.36 7.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.76 -34.92 20.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -73.05 -36.71 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -66.13 -34.45 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 109.447 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.53 -28.72 70.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.521 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -52.92 -19.65 2.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -113.75 -73.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -148.46 72.5 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' C ' ' A' ' 74' ' ' LYS . . . -135.24 0.54 3.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 73' ' ' GLY . 10.7 tptm -37.37 -49.37 0.99 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.467 -1.019 . . . . 0.0 109.475 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 3.32 0.83 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -75.64 -175.97 3.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -114.37 -140.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.31 -23.93 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -64.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' ASP . 37.4 mt-10 -47.08 -53.22 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 80' ' ' GLU . 4.7 t -44.3 -58.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.06 -22.47 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 3.9 t0 -69.35 -61.08 1.94 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.45 -46.17 47.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.84 -59.31 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 87' ' ' ARG . 19.5 mt -46.21 -33.78 3.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -35.78 -66.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.429 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.87 75.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.336 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.31 -117.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -143.79 92.92 6.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -1.092 . . . . 0.0 109.412 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.5 165.27 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.711 2.274 . . . . 0.0 112.178 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -119.82 139.68 51.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -61.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -166.37 165.03 17.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -107.39 56.19 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.494 ' O ' ' OG ' ' A' ' 97' ' ' SER . 7.0 t -53.56 172.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.494 ' OG ' ' O ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -171.34 -77.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -91.46 -13.79 31.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.26 -160.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 101' ' ' LYS . 2.7 t -147.73 -165.91 2.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.506 ' N ' ' OG1' ' A' ' 100' ' ' THR . 41.8 mttp -88.13 -157.86 0.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.22 161.44 10.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.55 88.69 0.18 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.47 -78.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.13 53.61 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.87 151.21 0.37 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 p -107.19 -20.07 13.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.495 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -149.86 3.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.62 -94.31 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -111.72 131.84 55.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.3 p30 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.526 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.6 p -133.47 14.08 4.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -133.72 91.52 2.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.459 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -55.27 -179.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -122.37 131.57 53.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -105.96 131.62 53.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -97.31 123.38 41.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.587 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.65 149.69 22.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 9' ' ' TYR . 22.8 t80 -144.69 119.0 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -95.03 132.97 39.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -109.26 -154.2 15.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.2 tp10 -42.82 -82.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -117.78 -34.56 4.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.577 ' CB ' HE22 ' A' ' 67' ' ' GLN . 1.4 t -79.0 174.05 11.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.42 145.35 48.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mt -130.38 156.88 43.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 48.4 mt -134.98 155.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.927 . . . . 0.0 109.559 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.9 m -136.1 155.93 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -98.46 140.49 32.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.34 168.31 20.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.93 -87.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 p -136.11 171.89 13.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.517 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -68.58 -13.01 62.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.14 -74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.498 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -47.45 -46.63 26.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.527 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.6 t -51.72 -54.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.449 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -53.42 -45.86 69.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HB3' ' HZ2' ' A' ' 37' ' ' LYS . 3.2 mm-40 -56.81 -30.09 63.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.457 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 33' ' ' PRO . 60.4 t80 -72.22 -61.24 1.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.402 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 mt -48.27 -44.4 33.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -72.33 -20.94 61.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -150.31 70.59 9.11 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.522 ' O ' ' OG ' ' A' ' 34' ' ' SER . 54.2 Cg_endo -74.32 162.55 38.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.881 2.387 . . . . 0.0 112.209 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 33' ' ' PRO . 73.8 m -171.26 -104.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.476 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 tp -169.08 -20.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.93 -40.33 5.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.403 ' HZ2' ' HB3' ' A' ' 28' ' ' GLU . 23.8 tttt -69.05 -18.31 64.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -1.13 . . . . 0.0 109.415 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.99 -29.12 67.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.918 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -33.47 75.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -78.4 -57.25 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -46.62 -60.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.5 122.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.527 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -104.49 -1.37 26.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp -156.29 107.4 2.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.39 87.35 3.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.7 114.22 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.77 144.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -129.7 165.78 21.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.34 151.82 11.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.86 140.66 35.63 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.836 2.358 . . . . 0.0 112.173 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.484 ' C ' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.8 -32.73 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.484 ' OD1' ' C ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -129.28 -32.29 2.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.414 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.641 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -56.68 -16.88 18.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 57.94 -3.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.641 ' H ' ' C ' ' A' ' 53' ' ' GLY . . . -162.65 -151.12 6.24 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.29 10.66 40.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.57 107.27 17.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.2 -131.79 2.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -129.85 9.75 5.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.527 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt 57.54 -170.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -142.83 174.81 23.39 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.05 127.4 51.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.157 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 144.69 54.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -93.09 155.31 17.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.411 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -38.96 -50.14 1.74 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -56.16 -59.8 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.577 HE22 ' CB ' ' A' ' 14' ' ' THR . 20.7 mm100 -35.91 -39.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 38.4 t -84.01 -31.76 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 66' ' ' ALA . 49.5 tt0 -65.37 -39.26 92.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -18.87 65.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.61 -70.18 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -160.07 54.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.09 170.2 21.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 177.81 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 109.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.58 7.15 0.33 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -82.49 166.11 19.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -71.84 -149.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tp -109.4 -13.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.06 -18.72 62.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 -53.33 4.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.43 -39.74 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -72.28 -49.5 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -44.57 -44.79 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' ARG . 14.3 mt -67.44 -60.6 2.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.428 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 84' ' ' LEU . 13.3 mt -40.4 -39.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 87' ' ' ARG . 84.6 mt -70.44 -36.01 73.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.703 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -41.7 -62.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.509 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.44 -86.94 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.08 117.14 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' PRO . 47.0 mttp -140.34 62.37 19.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.23 -1.159 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' O ' ' O ' ' A' ' 90' ' ' LYS . 50.8 Cg_exo -48.81 -160.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.805 2.336 . . . . 0.0 112.211 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -82.83 -11.83 57.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 78.27 6.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.477 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' THR . 11.2 p -135.38 4.99 3.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 94' ' ' THR . 12.5 p -51.14 -170.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -89.64 94.92 10.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.58 97.49 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' O ' ' CB ' ' A' ' 99' ' ' LYS . 3.2 mt -109.85 -80.23 0.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.4 tttp 80.34 93.06 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.81 149.6 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.424 ' HZ2' ' HG3' ' A' ' 101' ' ' LYS . 34.8 tttp -51.29 110.24 0.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.491 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.25 -156.97 9.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.81 -62.19 0.36 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -168.81 104.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -1.144 . . . . 0.0 109.46 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.74 -146.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.497 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.43 28.8 65.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.86 98.71 6.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -76.95 -132.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.484 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 110' ' ' TYR . . . -95.67 6.3 49.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.541 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 109' ' ' ALA . 4.6 t80 70.43 175.4 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.549 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -104.56 -16.86 14.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.513 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -93.31 148.11 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.86 171.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 163.46 12.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -122.84 130.6 53.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -114.68 114.34 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -83.65 142.08 31.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -123.74 144.6 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -114.98 129.12 56.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.05 24.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.51 -34.06 58.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -1.151 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -149.7 -35.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.1 m -89.51 157.92 17.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 39.3 t0 -106.17 152.17 23.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.634 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 42.9 mt -136.34 160.03 39.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.462 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 mt -145.01 148.87 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.01 147.35 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -86.21 142.37 28.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.94 -171.75 2.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.05 -90.68 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 m -121.53 171.62 8.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.69 -9.6 59.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.03 -54.62 4.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.22 -38.6 83.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.479 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.8 t -63.8 -55.94 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.508 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -54.68 -50.5 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -52.39 -31.52 34.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.402 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 76.2 t80 -68.3 -41.87 80.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.6 mt -60.46 -23.43 64.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -90.64 -4.49 56.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -167.66 71.55 0.93 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' ' CE1' ' A' ' 29' ' ' TYR . 56.9 Cg_endo -75.29 139.67 23.81 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.812 2.341 . . . . 0.0 112.258 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 m -160.67 -133.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.2 tp -135.44 15.7 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -112.79 -82.97 1.21 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 36' ' ' GLY . 4.1 ttmt -45.05 -22.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.483 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 36' ' ' GLY . 6.0 tp -49.28 -62.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.5 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.89 -47.64 31.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.426 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -29.04 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 34.6 t -86.98 -54.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.5 t -87.63 113.44 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.15 -43.26 24.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 tp -111.15 115.16 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.893 . . . . 0.0 109.453 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' CE1' ' OE2' ' A' ' 79' ' ' GLU . 46.8 m-85 -73.93 65.92 1.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.72 174.9 10.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.447 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.3 t -134.85 128.17 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.93 151.92 22.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.35 150.76 77.35 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' GLN . 41.8 Cg_endo -71.56 138.11 31.68 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.854 2.369 . . . . 0.0 112.176 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.505 ' C ' ' O ' ' A' ' 50' ' ' PRO . 17.7 mt-30 -36.99 -89.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.2 p30 -162.06 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.47 -137.63 9.02 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -91.07 136.34 33.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.11 64.04 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.86 37.76 2.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' CD ' ' C ' ' A' ' 57' ' ' GLU . 13.5 tm-20 -110.77 -37.4 5.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 59' ' ' GLU . . . -132.47 146.17 17.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE1' ' C ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER 68.17 92.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -1.159 . . . . 0.0 109.544 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -124.24 -169.35 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.437 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.4 172.09 23.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.67 154.81 17.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -1.138 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.54 133.71 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 169.36 18.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ALA . 63.5 tttt -57.38 -65.86 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.437 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' LYS . . . -43.97 -39.9 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -57.17 -24.08 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -68.23 -24.95 64.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -72.66 -21.34 61.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -105.62 -63.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -165.84 64.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -128.21 -0.01 6.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 73' ' ' GLY . 20.1 tttt -51.69 -101.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.455 -1.027 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 44.56 1.6 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -121.7 133.16 54.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -1.112 . . . . 0.0 109.473 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -56.41 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -84.96 -42.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.462 ' N ' HG22 ' A' ' 78' ' ' ILE . 8.2 mm-40 -49.48 -55.44 13.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 83' ' ' ASP . 2.1 mt-10 -48.3 -54.26 14.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -45.47 -46.46 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.907 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 19.1 mm -62.87 -25.93 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.149 -0.969 . . . . 0.0 109.437 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' GLU . 52.0 t0 -70.97 -61.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 65.5 mt -49.12 -29.87 5.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 88' ' ' ASN . 58.3 mt -67.74 -66.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ILE . 95.8 mt -43.82 -46.4 7.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -56.58 -30.93 63.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 7.1 t-20 -83.76 -81.79 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 57.08 116.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -128.5 60.31 47.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.213 -1.169 . . . . 0.0 109.521 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.94 122.96 8.56 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.845 2.363 . . . . 0.0 112.172 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 20.1 t-20 -152.99 68.31 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.92 57.74 1.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.1 p -136.42 128.98 30.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.3 p -82.59 -66.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.492 ' N ' ' OG1' ' A' ' 95' ' ' THR . 0.7 OUTLIER -58.92 80.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -89.65 -178.14 5.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.9 150.86 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -115.88 117.91 31.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 51.9 p -119.6 93.18 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 100' ' ' THR . 3.0 tttp 78.59 106.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.82 -147.82 8.27 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.2 -61.16 4.7 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 105' ' ' ALA . 2.9 t-20 -161.17 -19.61 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 0.0 109.522 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 104' ' ' ASN . . . 42.32 -171.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' THR . . . -83.98 -107.82 0.57 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.565 ' HG1' ' H ' ' A' ' 108' ' ' LYS . 25.2 p 36.17 -102.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.565 ' H ' ' HG1' ' A' ' 107' ' ' THR . 3.3 mttt -48.19 -56.86 6.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 110' ' ' TYR . . . 47.94 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.443 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER 59.6 124.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.516 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.477 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -124.16 119.69 30.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.449 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 61.41 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.475 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 m -93.47 179.62 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -127.81 147.18 50.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -105.27 159.24 16.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.454 ' HH ' ' HG3' ' A' ' 23' ' ' GLU . 3.6 m-85 -126.05 112.17 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.45 162.74 28.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -153.3 100.42 2.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -66.74 104.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.55 33.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -47.01 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -1.19 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -106.98 -52.15 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -80.66 174.08 11.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 6.8 t70 -119.43 156.28 30.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.431 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.492 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 22.3 mt -123.2 157.32 33.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.21 143.76 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.24 142.18 36.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.59 -178.45 5.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.557 ' C ' ' HG ' ' A' ' 22' ' ' SER . . . -95.16 -73.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 109.502 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.557 ' HG ' ' C ' ' A' ' 21' ' ' ALA . 0.7 OUTLIER -148.11 166.48 27.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HG3' ' HH ' ' A' ' 7' ' ' TYR . 2.4 tt0 -69.23 -37.18 77.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.07 -51.79 29.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -51.08 -43.93 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.28 -41.7 97.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.377 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -65.36 -35.03 79.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -65.65 -54.07 32.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.4 mt -52.31 -19.86 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.62 -44.06 52.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.372 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.05 76.48 77.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.448 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.586 ' O ' ' CB ' ' A' ' 34' ' ' SER . 55.5 Cg_exo -47.01 164.19 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.836 2.358 . . . . 0.0 112.24 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.722 ' HG ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 159.61 -173.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.722 ' N ' ' HG ' ' A' ' 34' ' ' SER . 0.6 OUTLIER -114.98 -14.27 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' H ' ' HG ' ' A' ' 34' ' ' SER . . . -78.84 -17.99 76.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -103.14 -18.97 14.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -1.142 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -63.05 -33.31 75.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p -70.32 -20.5 63.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -83.77 -50.41 8.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.64 -36.4 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.97 110.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -80.51 -18.36 48.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.08 142.09 23.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -98.99 68.55 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -150.65 128.34 11.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.0 t -93.09 128.39 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -114.21 155.06 26.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.83 152.09 79.7 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.22 122.42 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.743 2.295 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.512 ' CG ' ' H ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -73.71 -143.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.512 ' H ' ' CG ' ' A' ' 51' ' ' GLN . 1.1 m-20 -53.54 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.56 132.89 32.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 -158.51 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ALA . . . 76.09 25.09 67.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' GLY . . . 58.24 113.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -1.111 . . . . 0.0 109.449 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -133.23 -52.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 148.83 -15.58 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 58.0 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -1.108 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.91 -173.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.895 . . . . 0.0 109.54 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.96 113.13 2.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.37 111.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -1.141 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -65.48 130.49 43.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' ALA . 73.0 m -93.22 139.66 30.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.1 mttt -41.26 -27.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.423 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -61.4 -39.36 90.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.482 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.11 -57.94 3.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.6 t -53.16 -24.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.389 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 17.9 mt-10 -68.77 -45.97 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.03 -19.81 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.604 ' OE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.5 tm-20 -88.68 -52.53 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.604 ' CZ ' ' OE1' ' A' ' 71' ' ' GLU . 67.9 m-85 -116.22 32.05 6.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 46.65 -160.32 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.7 29.69 7.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -1.134 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.92 -32.62 8.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -98.3 155.59 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -1.2 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -83.28 -177.55 6.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -15.52 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -70.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -52.8 -35.62 57.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -56.4 -64.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.1 mt -48.79 -31.67 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -59.47 -73.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -35.56 -44.11 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mt -60.59 -32.28 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.419 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.672 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.6 mt -72.04 -20.4 61.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.897 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.643 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -88.29 -3.48 58.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -113.92 -86.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 67.16 121.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER 39.93 59.25 7.0 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 90' ' ' LYS . 61.6 Cg_exo -46.39 149.68 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.773 2.315 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 93' ' ' SER . 37.4 m-80 -134.31 -159.31 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.541 ' O ' ' C ' ' A' ' 94' ' ' THR . 1.0 OUTLIER 164.98 -93.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 93' ' ' SER . 60.7 p 35.94 -128.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.17 84.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.0 m -101.64 130.3 47.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.8 OUTLIER -130.67 126.34 36.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.6 mt 47.25 -97.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 97' ' ' SER . 26.7 mtpt -71.22 107.46 4.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.506 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.0 m -45.1 137.72 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt 63.56 53.83 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -50.38 173.41 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -143.33 -76.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -122.85 -149.32 0.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.33 19.09 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.58 116.64 3.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -55.56 -59.55 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -1.102 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -159.27 -24.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.355 -0.841 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.05 -118.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' C ' ' A' ' 111' ' ' ASN . 55.5 m-85 52.16 32.52 10.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 110' ' ' TYR . 10.3 m120 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ttt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.1 -135.31 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.4 p -117.05 119.87 36.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.485 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.06 139.78 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.16 148.03 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -106.89 129.68 54.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.42 120.63 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -82.07 158.38 23.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.444 ' CD1' HD13 ' A' ' 85' ' ' ILE . 83.8 t80 -145.44 102.55 3.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.499 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -85.5 104.3 15.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 -157.41 11.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -58.93 -49.24 78.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -1.153 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.65 -33.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -84.78 134.91 34.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.564 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -105.76 138.05 42.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 mt -134.99 151.49 50.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.572 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.6 mt -120.27 150.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.82 151.19 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.521 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.2 144.55 25.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.04 177.64 8.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 -88.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.88 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.0 t -125.62 168.93 13.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.19 -29.9 34.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -56.53 -47.99 78.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.32 -47.88 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -49.93 -43.06 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -24.95 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.5 -47.03 28.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 32' ' ' ASN . 63.9 t80 -57.89 -50.02 74.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.471 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 29' ' ' TYR . 82.8 mt -43.82 -32.75 1.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.479 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 4.0 mptp? -91.19 10.03 28.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' TYR . 49.5 m-80 -161.25 62.11 1.49 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.81 113.46 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.815 2.343 . . . . 0.0 112.191 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.518 ' O ' ' OG ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -173.07 34.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.575 ' CG2' ' H ' ' A' ' 36' ' ' GLY . 29.3 mm 51.24 -177.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.575 ' H ' ' CG2' ' A' ' 35' ' ' ILE . . . 87.29 -74.78 2.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -67.56 -10.9 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -1.133 . . . . 0.0 109.458 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' VAL . 1.1 tp -59.2 -54.45 46.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' LEU . 70.3 m -43.18 -37.8 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' N ' ' CD ' ' A' ' 40' ' ' GLU . 1.7 mp0 -70.09 -35.88 74.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' LEU . 41.7 t -71.68 -54.8 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.574 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 118.44 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.18 -26.26 25.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tp -125.55 124.05 40.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -90.5 95.99 10.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -167.87 140.09 3.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.428 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -108.96 141.14 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 0.3 OUTLIER -128.78 178.83 6.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.03 149.08 29.06 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.31 134.7 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.735 2.29 . . . . 0.0 112.138 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -90.1 68.28 7.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.0 t0 51.13 50.87 18.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.404 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.47 175.79 16.06 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -96.91 32.03 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.474 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.72 -157.02 22.19 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 151.26 39.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -1.181 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -130.29 -45.23 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.4 -29.08 0.34 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -136.02 89.78 2.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.2 mt -77.17 161.26 28.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.41 128.16 9.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.36 168.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -1.156 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.91 7.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' GLN . 2.8 t -99.49 133.12 44.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -46.7 -30.56 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.442 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.97 64.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.0 mm-40 -69.98 -27.82 65.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.65 -44.5 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 23.5 mt-10 -57.33 -39.36 75.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -49.71 -17.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 69' ' ' GLU . 28.5 mt-10 -98.8 -52.21 3.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.546 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.43 -28.96 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 104.6 -178.32 24.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 76' ' ' LYS . 2.8 mttm -91.22 -157.57 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.416 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.14 -8.02 9.38 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 74' ' ' LYS . 57.0 mttp -120.48 162.49 19.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -1.171 . . . . 0.0 109.454 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -108.88 -150.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -93.62 -18.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.948 . . . . 0.0 109.502 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.15 -43.29 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.0 -55.16 24.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' ILE . 14.6 t -50.74 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.501 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.7 mm -44.72 -62.14 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 82' ' ' ILE . 6.0 t70 -37.98 -51.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 85' ' ' ILE . 81.4 mt -57.03 -53.19 60.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 84' ' ' LEU . 46.0 mm -42.03 -49.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.392 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.469 ' O ' ' C ' ' A' ' 87' ' ' ARG . 49.4 mt -57.7 -40.67 80.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.718 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -40.36 -34.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.433 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -105.21 -82.87 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 96.13 0.23 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.5 mttt 58.61 62.1 4.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.269 -1.136 . . . . 0.0 109.551 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.78 107.51 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.846 2.364 . . . . 0.0 112.262 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.722 HD21 ' N ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -64.49 125.45 24.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.722 ' N ' HD21 ' A' ' 92' ' ' ASN . 22.8 t -72.02 137.36 47.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.5 p -71.11 -71.91 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' A' ' 95' ' ' THR . 4.6 p 47.3 60.32 3.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -104.43 18.35 22.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.4 p -95.09 -133.42 0.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.908 . . . . 0.0 109.437 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mt -104.06 156.14 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -96.23 -13.37 23.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.416 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 p -81.37 64.57 6.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -118.66 -27.22 5.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -120.46 6.21 11.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.85 -141.5 9.84 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.93 157.41 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 154.14 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 108' ' ' LYS . . . -144.01 47.76 0.77 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 106' ' ' GLY . 23.3 p 50.68 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -1.163 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 36.49 44.02 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.99 95.21 5.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.9 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.69 -73.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.484 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' H ' ' H ' ' A' ' 2' ' ' SER . 2.7 mmt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.576 ' C ' ' H ' ' A' ' 4' ' ' VAL . 3.6 m -57.01 -26.6 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.455 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.6 OUTLIER 70.7 -19.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 2' ' ' SER . 6.7 m -145.11 -165.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.419 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.57 139.2 47.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -113.6 160.25 18.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -122.05 139.83 53.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -98.26 160.39 14.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.42 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -150.4 94.88 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -65.04 113.64 4.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.46 172.83 49.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -46.55 -30.38 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.591 ' ND2' ' N ' ' A' ' 14' ' ' THR . 2.6 p-10 -149.6 -50.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.591 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 53.9 m -83.48 146.58 28.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.77 135.47 46.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.46 162.01 21.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.9 mt -138.04 153.4 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.09 177.9 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -103.45 168.42 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.78 152.84 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.416 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.11 -99.85 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.37 145.46 32.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -44.75 96.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.54 -32.89 8.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.68 -51.82 11.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.7 t -50.01 -54.01 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -53.61 54.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -48.38 -41.73 29.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.52 ' O ' ' N ' ' A' ' 32' ' ' ASN . 70.5 t80 -61.99 -46.72 88.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 mt -46.65 -41.23 14.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.837 . . . . 0.0 109.459 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -81.66 1.57 33.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 29' ' ' TYR . 9.8 t30 -154.66 64.66 4.51 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' C ' ' HG ' ' A' ' 34' ' ' SER . 38.8 Cg_endo -70.72 109.46 2.5 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.849 2.366 . . . . 0.0 112.199 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.449 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 1.8 m -143.17 -136.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tp -138.76 1.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -93.46 -74.16 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.66 ' HZ3' ' CG2' ' A' ' 41' ' ' VAL . 37.0 tttm -52.9 -14.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -1.151 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 36' ' ' GLY . 2.7 tp -49.45 -65.47 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.445 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -50.52 -46.28 57.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -52.19 -16.9 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.66 ' CG2' ' HZ3' ' A' ' 37' ' ' LYS . 92.0 t -102.55 -60.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.06 124.18 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.575 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.17 -29.36 12.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mt -119.49 117.46 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -87.77 76.76 8.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.653 ' OE2' ' CE2' ' A' ' 48' ' ' PHE . 15.6 tt0 -161.75 138.31 8.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.12 116.19 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.653 ' CE2' ' OE2' ' A' ' 46' ' ' GLU . 34.6 m-85 -99.21 148.34 24.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.588 ' HG1' ' N ' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -147.94 154.54 43.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.588 ' N ' ' HG1' ' A' ' 49' ' ' THR . 45.6 Cg_endo -72.6 151.34 52.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.822 2.348 . . . . 0.0 112.203 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.426 ' C ' ' N ' ' A' ' 53' ' ' GLY . 37.5 mt-30 -132.75 -85.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -50.41 -15.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 51' ' ' GLN . . . 80.45 171.11 43.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 52.23 64.35 1.89 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.56 -96.31 0.54 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 46.46 42.96 11.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -1.169 . . . . 0.0 109.529 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -165.7 -17.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.461 ' C ' ' H ' ' A' ' 60' ' ' LEU . . . -105.37 -165.1 23.7 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.62 11.94 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -1.197 . . . . 0.0 109.432 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 58' ' ' GLY . 15.3 mt 56.01 -177.17 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.63 -173.82 25.84 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.88 157.1 28.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.98 -174.54 2.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 66' ' ' ALA . 27.1 t -134.01 153.15 51.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 17.1 mmtm -43.47 -23.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -77.48 -50.55 12.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.34 -43.69 79.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.94 -21.46 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.393 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.4 mt-10 -82.94 -60.29 2.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-20 -41.08 -31.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 69' ' ' GLU . 12.6 mm-40 -82.06 -77.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -72.31 -48.93 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.439 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 110.52 150.02 12.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.445 ' HG2' ' H ' ' A' ' 75' ' ' GLY . 4.5 ttpp -64.91 162.18 16.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.462 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.445 ' H ' ' HG2' ' A' ' 74' ' ' LYS . . . 116.88 -19.88 11.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -117.37 177.58 4.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -1.162 . . . . 0.0 109.453 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.52 -177.25 3.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 tp -74.38 -21.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.85 -51.94 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -63.36 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 t -65.65 -58.08 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.5 mt -49.24 -25.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' LEU . 50.3 t0 -65.97 -62.27 1.59 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 83' ' ' ASP . 79.7 mt -44.04 -32.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mt -68.05 -49.8 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.47 -11.41 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -77.71 -26.45 50.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.644 HD21 ' NZ ' ' A' ' 90' ' ' LYS . 1.4 m120 -102.77 -67.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.1 125.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.644 ' NZ ' HD21 ' A' ' 88' ' ' ASN . 25.7 mttm -141.68 49.16 1.35 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 31.0 Cg_endo -67.44 9.99 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.764 2.309 . . . . 0.0 112.143 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 93' ' ' SER . 31.3 m-20 -86.28 131.21 34.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 92' ' ' ASN . 12.0 p 59.04 140.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.19 178.45 6.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.09 52.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.7 p -119.94 -150.94 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.6 t -83.38 -140.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.505 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 pp -107.45 156.7 18.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -145.22 -20.12 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 101' ' ' LYS . 1.2 m 63.8 118.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' THR . 5.1 mttt -42.92 167.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.06 176.76 18.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.492 ' C ' HD21 ' A' ' 104' ' ' ASN . . . -100.71 51.53 0.98 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 106' ' ' GLY . 1.3 m120 -112.17 82.89 1.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' ASN . . . -43.81 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 84.09 -163.9 40.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.87 76.87 1.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -1.151 . . . . 0.0 109.454 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -105.67 118.11 35.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.24 -161.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -91.49 -62.29 1.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.508 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.526 ' O ' ' O ' ' A' ' 2' ' ' SER . 24.5 mtt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 1' ' ' MET . 70.9 m -39.66 -93.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.95 . . . . 0.0 109.414 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 167.69 2.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.3 176.49 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.03 164.9 12.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -131.35 144.96 51.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -114.43 146.59 40.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 9.6 m-85 -112.21 155.27 24.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.454 ' CD2' ' O ' ' A' ' 9' ' ' TYR . 61.7 t80 -143.32 94.91 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -67.0 98.59 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -73.88 173.25 50.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.55 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 3.3 tp10 -41.96 -42.8 2.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.477 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 7.0 m120 -144.4 -37.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.478 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -87.46 142.22 28.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.26 130.69 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.49 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.2 mt -118.32 138.93 52.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.469 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.1 mt -120.21 146.1 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.49 165.01 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.528 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -92.09 166.23 12.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.42 151.37 22.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.465 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 -72.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.4 t -140.22 156.88 46.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.98 -51.58 53.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -45.2 -54.55 6.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 56.5 mt -57.49 -31.53 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.606 ' O ' ' N ' ' A' ' 28' ' ' GLU . 87.3 t -71.74 -70.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.532 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -40.97 -20.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -82.67 -49.08 10.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 32' ' ' ASN . 40.4 t80 -52.06 -50.57 61.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 29' ' ' TYR . 6.9 mt -40.78 -42.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -77.88 -13.92 59.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.665 ' N ' ' O ' ' A' ' 29' ' ' TYR . 10.7 m120 -129.35 73.39 81.67 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.34 125.31 9.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.746 2.298 . . . . 0.0 112.232 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 172.61 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.8 mm -73.5 61.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.452 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.99 -47.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -87.52 -28.17 22.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 109.449 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -54.38 -24.73 20.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.528 ' HG ' ' N ' ' A' ' 40' ' ' GLU . 40.7 p -72.86 -31.62 64.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.528 ' N ' ' HG ' ' A' ' 39' ' ' SER . 12.7 tt0 -79.26 -26.03 42.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.93 -64.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 62.6 t -71.94 128.27 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.85 -50.82 10.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.912 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 4.5 mp -111.13 147.77 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.67 88.24 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 47' ' ' VAL . 7.9 tt0 -168.72 -173.53 1.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.401 ' H ' ' HG2' ' A' ' 46' ' ' GLU . 38.9 t -131.49 126.48 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.98 150.74 36.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.12 165.31 18.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.4 149.43 56.54 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.851 2.368 . . . . 0.0 112.262 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -139.81 -49.59 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 3.2 p30 -126.28 167.16 15.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.68 177.74 32.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.726 HH11 ' CG ' ' A' ' 54' ' ' ARG . 1.5 mtt-85 -68.01 -38.2 82.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 0.0 109.53 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' CB ' ' A' ' 56' ' ' ALA . . . 127.81 155.96 8.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.641 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 73.08 149.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -1.149 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.8 tp10 38.75 21.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -122.7 175.5 16.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 49.2 mp0 -58.37 170.06 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -1.175 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.1 mt -142.53 -177.38 5.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.09 143.22 8.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 151.24 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.59 -171.55 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -118.62 164.72 14.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -64.27 -32.75 74.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -44.3 68.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -72.13 -60.22 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.32 -26.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -70.68 -39.13 73.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -60.09 -21.5 61.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.45 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 10.0 mp0 -96.76 -67.01 0.87 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -161.53 76.6 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.409 ' C ' ' CG ' ' A' ' 74' ' ' LYS . . . -127.74 -129.01 3.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' CG ' ' C ' ' A' ' 73' ' ' GLY . 9.3 mttt 68.04 -75.07 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -1.178 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.4 30.69 4.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -118.22 100.47 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -1.193 . . . . 0.0 109.52 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -50.47 163.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -0.821 . . . . 0.0 109.537 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tp -54.75 -29.4 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.872 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.13 -60.7 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 83' ' ' ASP . 21.0 mt-10 -55.06 -55.12 34.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 80' ' ' GLU . 9.4 t -38.33 -50.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.429 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 37.3 mt -61.95 -37.72 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.475 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.624 ' OD2' ' NH2' ' A' ' 87' ' ' ARG . 9.0 t0 -65.93 -65.14 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 83' ' ' ASP . 85.7 mt -38.17 -30.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 87' ' ' ARG . 41.4 mt -73.92 -68.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.414 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.1 mt -46.55 -12.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.402 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.72 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -75.66 -43.45 47.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.464 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.582 ' ND2' ' C ' ' A' ' 88' ' ' ASN . 0.6 OUTLIER -149.93 66.44 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.15 -113.7 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.406 ' C ' ' H ' ' A' ' 92' ' ' ASN . 1.4 ptpt -67.85 154.86 92.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.208 -1.172 . . . . 0.0 109.531 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.03 32.33 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.805 2.337 . . . . 0.0 112.162 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.468 ' C ' ' OG ' ' A' ' 93' ' ' SER . 5.1 t30 -60.48 -15.61 28.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.468 ' OG ' ' C ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 167.7 145.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.6 p -94.21 -176.79 4.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.457 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.75 65.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.14 130.12 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 p -68.33 108.96 3.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 99' ' ' LYS . 9.2 mt -122.7 106.7 11.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' THR . 5.7 mttt 45.09 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 99' ' ' LYS . 0.2 OUTLIER 50.04 179.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -86.91 -9.12 56.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.38 175.05 27.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.2 68.83 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.52 ' ND2' ' N ' ' A' ' 104' ' ' ASN . 1.0 OUTLIER -91.34 82.7 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 0.0 109.466 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -117.1 171.6 7.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 107' ' ' THR . . . -82.92 76.11 2.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.522 ' HG1' ' N ' ' A' ' 108' ' ' LYS . 27.3 p 41.74 -130.81 0.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -1.214 . . . . 0.0 109.421 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.522 ' N ' ' HG1' ' A' ' 107' ' ' THR . 40.1 mttt 49.32 40.02 17.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -141.94 95.18 2.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.401 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 109' ' ' ALA . 73.4 m-85 -39.64 110.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.445 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 78.1 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.515 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.275 0.56 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -36.24 65.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t -142.84 140.84 31.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.2 m -67.02 -177.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 m -113.89 141.25 47.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -110.58 136.85 49.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.544 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.465 ' CZ ' HG12 ' A' ' 26' ' ' VAL . 1.7 m-85 -103.69 110.5 22.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.868 . . . . 0.0 109.501 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.32 162.57 23.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.51 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 57.9 t80 -161.23 137.7 8.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 108.2 19.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.426 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.55 -154.9 0.22 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.04 -39.6 92.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -1.167 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -146.69 -36.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' HG1' ' H ' ' A' ' 15' ' ' ASP . 14.5 t -83.78 169.16 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.9 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.526 ' H ' ' HG1' ' A' ' 14' ' ' THR . 43.2 t0 -115.3 137.02 52.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.9 153.49 39.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -131.4 143.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.16 152.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -90.06 152.97 20.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.13 -171.59 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.39 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.922 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 24' ' ' GLU . 15.7 t -153.52 135.8 14.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 22' ' ' SER . 5.4 tt0 -40.0 -28.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' SER . 23.8 tt0 -62.58 -76.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.943 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 24' ' ' GLU . 11.2 mt -44.11 -35.53 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 t -62.11 -57.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.496 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -51.38 -52.25 47.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.428 ' CB ' ' HZ2' ' A' ' 37' ' ' LYS . 9.1 mm-40 -48.52 -41.03 28.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.19 -59.32 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.9 mt -53.6 -27.86 29.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -23.61 61.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.09 77.49 2.73 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -51.69 118.75 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.817 2.344 . . . . 0.0 112.164 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -156.55 139.12 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 36' ' ' GLY . 9.8 tp -62.04 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 35' ' ' ILE . . . 109.43 -80.11 0.26 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.428 ' HZ2' ' CB ' ' A' ' 28' ' ' GLU . 21.0 tttt -53.38 -16.74 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -1.178 . . . . 0.0 109.441 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.12 -47.46 85.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -57.6 -27.9 63.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.8 -33.78 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.8 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.5 t -79.66 134.95 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -96.3 -52.24 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.97 134.94 46.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -93.92 59.81 2.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 16.9 tt0 -140.59 123.44 16.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.5 139.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.514 ' CE2' ' O ' ' A' ' 46' ' ' GLU . 20.5 m-85 -117.66 174.82 5.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -168.36 155.73 7.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.44 80.37 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.86 2.373 . . . . 0.0 112.189 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -125.36 -31.42 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -114.0 -139.4 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.87 87.78 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.94 45.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 56' ' ' ALA . . . 146.75 162.5 9.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 55' ' ' GLY . . . 74.54 -171.21 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.62 ' OE2' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -48.22 -16.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.473 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 139.83 2.32 1.69 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -132.13 110.67 10.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.159 . . . . 0.0 109.481 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 tt -148.17 152.99 38.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -163.58 -156.2 8.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.7 117.07 21.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -1.14 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.445 ' HB3' HE21 ' A' ' 67' ' ' GLN . . . -54.43 173.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.91 148.43 50.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' O ' ' CD ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -46.47 -26.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.13 34.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 63' ' ' ALA . 18.2 tt0 -62.31 -50.29 72.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 t -60.21 -20.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 65' ' ' LYS . 14.2 mt-10 -76.91 -25.27 52.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.542 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 -22.21 45.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.23 -54.7 2.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -167.94 70.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 138.05 6.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -166.97 -27.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.85 31.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -103.69 177.57 4.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.395 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' ILE . 16.3 mttm -83.95 133.86 34.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 5.3 tp -40.54 -32.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' LYS . 60.8 mt-10 -54.71 -56.16 22.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 tp10 -48.63 -62.64 1.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 80' ' ' GLU . 65.8 t -39.66 -58.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.421 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.32 -20.35 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 80' ' ' GLU . 1.2 t70 -76.47 -69.17 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 83' ' ' ASP . 7.7 mt -38.55 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.6 mt -74.58 -70.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' ILE . 8.2 mt -42.16 -38.26 1.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.719 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -43.79 -26.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 86' ' ' LEU . 9.5 t-20 -107.78 -70.85 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 123.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 91' ' ' PRO . 17.7 mtpp -134.24 74.14 67.96 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.155 -1.203 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' O ' ' O ' ' A' ' 90' ' ' LYS . 52.8 Cg_exo -50.69 -145.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.782 2.321 . . . . 0.0 112.179 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 154.45 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.524 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 94' ' ' THR . 0.1 OUTLIER -64.56 -179.3 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.528 ' N ' ' OG ' ' A' ' 93' ' ' SER . 19.1 p -101.38 96.1 6.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -127.52 74.18 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.464 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.532 ' OG ' ' O ' ' A' ' 96' ' ' SER . 3.5 p -64.17 59.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' THR . 3.7 m -108.73 55.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.2 126.4 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.83 115.37 5.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 p -130.87 156.73 44.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -52.75 149.34 6.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.415 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 103' ' ' GLY . . . -77.94 -105.28 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 102' ' ' GLY . . . 52.52 110.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -121.25 98.64 6.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.37 -166.26 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.92 22.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.1 t -165.09 132.97 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.448 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.7 mttm 53.79 67.86 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.05 -176.98 3.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 64.9 t80 57.76 17.94 4.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.446 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttm . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.17 120.89 8.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 21' ' ' ALA . 1.4 p -88.62 86.3 6.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.492 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.532 ' C ' ' HG1' ' A' ' 5' ' ' THR . 0.8 OUTLIER -66.84 166.08 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.957 . . . . 0.0 109.449 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.532 ' HG1' ' C ' ' A' ' 4' ' ' VAL . 19.1 m -158.64 150.47 21.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.402 ' N ' HG21 ' A' ' 5' ' ' THR . 5.5 mtmp? -111.95 123.72 50.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.12 123.55 37.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.11 140.93 29.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.457 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.34 104.5 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -81.97 124.73 30.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 -153.12 28.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -52.98 -70.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -125.31 -21.02 4.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -92.37 161.26 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -121.73 144.95 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -137.95 148.6 45.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.1 mt -120.64 153.78 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 173.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.424 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -109.84 154.03 23.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.392 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' ALA . . . -154.05 128.24 9.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' ALA . . . -47.37 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.503 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.35 165.97 12.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -73.99 -28.17 61.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.33 -56.72 17.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.02 -51.48 69.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.396 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -46.44 -45.89 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 27' ' ' ASP . 1.6 t70 -62.66 -43.58 98.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.435 ' HB3' ' NZ ' ' A' ' 37' ' ' LYS . 6.4 mt-10 -60.94 -27.87 68.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -70.38 -36.56 74.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.86 -48.83 77.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -25.21 50.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.448 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 1.1 t-20 -136.21 68.16 62.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 154.23 53.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.849 2.366 . . . . 0.0 112.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.35 173.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 tp -88.24 -31.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.96 -14.38 80.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.435 ' NZ ' ' HB3' ' A' ' 28' ' ' GLU . 67.5 tttt -101.93 -12.4 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.57 -48.75 53.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' VAL . 3.1 m -49.23 -45.37 44.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.54 -56.96 14.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.5 t -50.21 -59.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.512 ' O ' ' O ' ' A' ' 39' ' ' SER . 2.7 t -78.27 126.89 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.33 -0.51 46.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.1 tp -163.72 122.16 1.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.414 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -77.15 83.69 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -163.12 155.12 17.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.8 t -123.29 132.94 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.86 154.7 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.1 164.56 24.42 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.85 164.53 35.31 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.849 2.366 . . . . 0.0 112.244 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -112.74 173.04 6.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' GLN . 18.1 t0 37.03 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.472 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.528 ' O ' ' C ' ' A' ' 54' ' ' ARG . . . -148.73 -126.97 1.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.557 ' H ' ' CD ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -37.0 107.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.143 . . . . 0.0 109.436 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.94 136.45 3.02 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -169.7 79.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -1.127 . . . . 0.0 109.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -144.69 -131.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.87 -26.28 50.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -86.09 102.99 14.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mt -115.66 -170.17 1.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.41 159.37 24.4 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.75 156.26 17.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -1.19 . . . . 0.0 109.422 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.55 171.6 7.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' LYS . 76.7 p -121.89 150.52 41.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' SER . 7.8 pttt -41.92 -30.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 67' ' ' GLN . . . -73.65 -58.53 3.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.244 -0.91 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -38.16 -49.05 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.31 -51.87 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.639 ' O ' ' N ' ' A' ' 73' ' ' GLY . 31.1 tt0 -49.33 -29.01 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 109.399 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.94 -19.21 63.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.92 -27.02 14.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.521 ' C ' ' H ' ' A' ' 74' ' ' LYS . 84.3 m-85 -113.14 -11.0 13.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.488 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 62.14 0.31 2.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 72' ' ' PHE . 6.4 mtpp -139.09 -49.37 0.5 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.495 -1.003 . . . . 0.0 109.537 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.74 -61.7 3.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 49.49 -168.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -56.59 133.18 53.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 tp -55.36 -26.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -56.44 -41.91 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 81' ' ' VAL . 35.5 mt-10 -73.42 -58.62 3.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.473 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 80' ' ' GLU . 2.9 t -42.48 -38.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 61.2 mt -63.68 -46.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.422 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 35.7 t0 -60.58 -52.29 65.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.6 mt -45.29 -41.85 9.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.87 -40.25 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 88' ' ' ASN . 82.2 mt -60.24 -42.72 95.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -44.95 -20.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.43 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' LEU . 10.5 m120 -124.51 -81.98 0.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 75.15 124.74 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 89' ' ' GLY . 5.2 mmmt 38.77 58.51 5.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.217 -1.167 . . . . 0.0 109.373 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' C ' ' N ' ' A' ' 93' ' ' SER . 34.8 Cg_endo -68.35 -48.58 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.825 2.35 . . . . 0.0 112.3 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m120 50.18 14.27 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 109.375 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.446 ' N ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -94.78 20.41 8.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.498 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.1 p -96.6 154.63 17.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.28 -169.83 3.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -142.5 9.64 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.61 111.08 6.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.493 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.07 100.54 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -123.44 108.79 13.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.1 p -112.74 174.34 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.581 ' O ' ' N ' ' A' ' 103' ' ' GLY . 8.9 mmtm -81.7 76.33 8.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.8 50.85 0.1 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 101' ' ' LYS . . . -108.44 16.19 34.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 104' ' ' ASN . 16.7 p-10 -115.53 97.32 6.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -1.168 . . . . 0.0 109.507 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.83 100.62 11.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.53 158.67 14.15 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.05 96.6 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -1.14 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 -52.66 39.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.424 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 155.72 36.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.455 ' C ' HD21 ' A' ' 111' ' ' ASN . 1.8 m-85 -56.76 -40.38 75.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.744 ' N ' HD21 ' A' ' 111' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.09 179.71 5.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.593 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -176.61 -171.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.593 ' N ' ' OG1' ' A' ' 3' ' ' THR . 1.6 m -127.07 147.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -92.62 161.47 14.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -113.1 122.65 48.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.455 ' CE1' HG12 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -92.63 104.61 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.18 137.57 47.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.91 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.13 105.91 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -75.95 114.43 14.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' ASN . . . -75.44 170.89 54.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.65 -17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -1.177 . . . . 0.0 109.389 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 t-20 -168.93 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 118.65 29.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 132.75 49.97 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.18 -0.95 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -129.18 142.53 50.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.37 142.37 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.5 175.13 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.75 160.84 14.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.46 164.57 29.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.82 -76.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 152.03 40.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -38.29 85.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.82 -61.32 2.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.3 mt -58.64 -63.58 1.23 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 25' ' ' LEU . 90.6 t -35.53 -35.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' LEU . 19.6 t0 -77.3 -35.02 55.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.368 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 25' ' ' LEU . 4.8 pt-20 -64.9 -28.2 69.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.403 ' N ' ' HG2' ' A' ' 28' ' ' GLU . 48.0 t80 -74.67 -50.23 18.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.7 mt -46.62 -23.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -74.07 -45.36 49.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -123.95 78.02 58.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.0 109.426 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 34' ' ' SER . 56.4 Cg_exo -47.17 156.87 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.792 2.328 . . . . 0.0 112.204 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 162.39 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 22.0 mm -88.52 20.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.29 -45.39 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.448 ' NZ ' ' HG3' ' A' ' 28' ' ' GLU . 24.6 tttt -73.76 -11.29 60.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 109.435 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.25 -27.43 65.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.47 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -67.21 -18.27 65.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -89.21 -41.21 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.86 -66.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -70.24 113.64 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 109.549 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.63 -60.76 2.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.18 150.89 21.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -103.6 52.45 0.77 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -137.16 159.76 40.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.47 144.41 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 14.0 m-85 -118.91 154.23 33.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.446 ' HG1' ' N ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -144.75 156.71 55.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.425 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.446 ' N ' ' HG1' ' A' ' 49' ' ' THR . 39.1 Cg_endo -70.82 135.39 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.175 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.67 -26.41 67.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -117.93 -116.8 0.32 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.66 -24.31 0.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.724 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -129.92 97.66 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 0.0 109.478 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.14 119.61 0.8 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.41 0.98 12.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -1.111 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.97 146.14 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.418 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -157.4 16.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.64 171.52 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 mt -118.61 172.81 7.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.28 -170.26 24.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.2 115.68 20.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -1.128 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.78 154.99 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 66' ' ' ALA . 4.7 m -98.09 147.85 24.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' O ' ' OE1' ' A' ' 69' ' ' GLU . 4.5 pttp -43.79 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -83.81 -48.29 10.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.603 ' C ' ' NE2' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -54.86 -43.68 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.22 -41.52 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 28.1 mt-10 -64.01 -40.22 95.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.4 -40.17 81.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.26 -67.68 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -90.91 -75.88 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.05 166.68 11.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.2 -2.55 52.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.527 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.78 -7.19 20.81 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -133.37 149.14 51.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -67.98 -167.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -86.53 -37.83 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.67 -28.26 69.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.64 -44.47 33.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 t -53.35 -46.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.543 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.453 HD11 ' N ' ' A' ' 82' ' ' ILE . 1.6 mp -60.67 -40.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -48.35 -53.71 16.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.55 -32.36 68.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 85.8 mt -67.68 -29.19 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.549 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.7 mt -82.39 -26.32 32.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -93.2 3.63 55.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 88' ' ' ASN . 1.1 t-20 -161.54 57.73 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.92 -131.04 6.53 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -153.98 62.65 3.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.495 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.54 114.23 3.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.818 2.345 . . . . 0.0 112.252 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -85.89 -71.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 59.56 119.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.488 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.419 HG23 ' ND2' ' A' ' 92' ' ' ASN . 11.2 p -117.15 114.09 23.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.451 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 78.0 m -163.95 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.7 t 47.45 25.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 70.3 m -94.0 -154.99 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.58 171.68 14.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -63.3 112.09 2.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.1 t -124.36 69.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -106.06 179.23 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 163.68 84.99 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.62 124.25 6.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.4 11.65 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.11 . . . . 0.0 109.446 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.17 51.39 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.427 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.7 123.41 0.07 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 m -96.93 -35.9 10.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -1.112 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' TYR . 76.5 mttt -132.45 102.16 5.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.16 51.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.402 ' N ' ' O ' ' A' ' 108' ' ' LYS . 1.7 t80 63.43 54.21 2.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.467 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.552 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 t 179.18 149.91 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.0 t -122.61 110.92 16.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.14 -173.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.0 m -149.79 135.47 18.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -99.06 129.07 45.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -104.13 160.31 14.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -127.95 157.39 40.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -142.87 129.72 20.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.858 . . . . 0.0 109.509 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -105.03 105.79 15.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.67 -150.58 24.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -49.67 -51.27 39.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -148.01 -46.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.447 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -72.54 143.6 48.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.77 138.07 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.1 mt -113.13 157.17 21.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.475 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 7.8 mt -130.26 154.32 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.424 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.9 179.91 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.88 153.45 35.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.51 177.3 11.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.51 -46.81 5.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.65 137.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -49.55 -31.3 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.436 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -67.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.06 -48.43 44.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' A' ' 27' ' ' ASP . 76.3 t -50.8 -66.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' C ' ' O ' ' A' ' 26' ' ' VAL . 37.6 t70 -36.3 -43.33 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.92 -50.61 70.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 32' ' ' ASN . 62.1 t80 -51.3 -49.7 60.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 29' ' ' TYR . 19.9 mt -41.72 -56.29 2.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -73.9 -3.5 29.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 29' ' ' TYR . 8.7 m120 -135.83 69.36 65.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -73.64 131.6 16.24 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.873 2.382 . . . . 0.0 112.219 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.25 154.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -85.72 66.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.46 -50.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -75.69 -26.02 57.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.449 ' CD1' ' CE2' ' A' ' 29' ' ' TYR . 2.7 tp -57.9 -33.37 68.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -36.62 76.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.78 -39.24 66.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.76 -69.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.67 117.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -81.76 -40.97 21.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 mp -112.27 128.38 56.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.67 78.29 4.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -163.73 159.95 22.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.08 143.15 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -128.1 155.22 44.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.5 p -118.99 149.38 46.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.58 91.87 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.75 2.3 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.73 -159.49 0.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' GLY . 53.0 t0 -55.86 125.12 20.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.462 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 160.16 151.24 6.11 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 106.59 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 31.74 0.42 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.9 28.72 3.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -1.107 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.59 101.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 52' ' ' ASP . . . -176.86 90.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 52.6 79.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.8 mt -78.12 170.21 16.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.509 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.74 108.33 0.82 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.34 142.12 17.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -1.182 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.29 28.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -88.26 148.04 24.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.6 mttt -41.43 -19.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -68.2 -61.51 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -53.23 -34.73 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.18 -31.32 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.1 mt-10 -68.91 -63.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 69' ' ' GLU . 20.0 m-20 -39.36 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -85.52 -67.71 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.454 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 71' ' ' GLU . 20.4 m-85 -115.02 25.5 10.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.506 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.65 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 52.72 -162.12 2.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 76' ' ' LYS . 2.3 tttp -109.94 -149.46 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -1.152 . . . . 0.0 109.454 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 -26.14 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 74' ' ' LYS . 21.4 mttt -91.42 -172.35 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -122.99 157.17 33.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tp -51.41 -30.74 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.41 -50.29 66.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.413 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -57.69 -52.83 63.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.1 t -47.87 -59.08 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.97 -42.47 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.495 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 28.5 t0 -52.68 -51.02 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.459 ' O ' ' OD1' ' A' ' 88' ' ' ASN . 10.5 mt -60.03 -43.15 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.9 mm -47.98 -62.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.3 -23.3 22.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -67.02 -36.37 81.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -93.48 -77.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.469 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.58 130.25 1.16 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -123.44 68.67 40.42 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.43 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.434 ' C ' HD21 ' A' ' 92' ' ' ASN . 56.1 Cg_endo -74.95 3.02 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.86 2.373 . . . . 0.0 112.232 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.434 HD21 ' C ' ' A' ' 91' ' ' PRO . 2.4 m-80 -134.49 131.62 38.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -112.24 161.37 16.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 95' ' ' THR . 1.4 m -139.33 144.4 38.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' SER . 0.2 OUTLIER 44.28 -165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.447 ' O ' ' O ' ' A' ' 95' ' ' THR . 60.1 p 47.8 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 p -149.57 -172.57 4.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.35 122.17 9.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.526 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.544 ' C ' ' HG1' ' A' ' 100' ' ' THR . 5.3 tttt -90.37 112.94 24.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.544 ' HG1' ' C ' ' A' ' 99' ' ' LYS . 0.2 OUTLIER -165.63 15.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.504 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.43 144.6 42.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.531 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.18 134.9 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ALA . . . 132.73 -26.59 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 61.54 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 109.545 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 103' ' ' GLY . . . -81.4 -60.05 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.96 -111.14 0.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.3 p -81.31 14.4 2.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -1.178 . . . . 0.0 109.468 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -125.24 79.89 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 110' ' ' TYR . . . -145.22 -127.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 109' ' ' ALA . 26.4 m-85 -152.31 148.45 27.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.49 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.446 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.613 ' C ' ' SD ' ' A' ' 1' ' ' MET . 1.3 tmm? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.552 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -72.58 33.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.404 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.544 ' H ' ' C ' ' A' ' 1' ' ' MET . 54.3 p -52.23 -90.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.88 161.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -101.67 -173.61 2.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HZ3' ' CB ' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -136.01 133.92 37.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -99.14 119.35 37.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.59 166.24 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -165.31 109.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -90.31 103.08 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.58 -157.36 0.79 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 3.8 tt0 -48.23 -67.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.146 . . . . 0.0 109.427 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 2.9 m120 -128.54 -26.26 2.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.12 155.38 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -113.45 136.86 52.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -132.7 153.44 51.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 41.1 mt -134.18 145.21 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.922 . . . . 0.0 109.489 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.24 173.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -108.72 148.05 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.09 178.58 6.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.446 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.03 -55.01 3.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -172.4 166.63 5.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -72.02 -21.96 61.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.57 -66.61 0.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -53.81 -49.58 68.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -49.32 -50.37 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.83 -29.4 64.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.73 -34.69 64.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 32' ' ' ASN . 54.0 t80 -62.55 -48.06 81.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' TYR . 67.8 mt -43.36 -59.53 2.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.867 . . . . 0.0 109.498 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -18.95 65.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TYR . 64.5 t30 -121.98 87.44 47.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.42 54.43 5.18 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -106.13 105.02 14.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.443 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' SER . 14.6 tt -42.64 -32.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.26 -41.2 78.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -73.12 -27.48 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -1.164 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.401 HD13 ' CZ ' ' A' ' 29' ' ' TYR . 0.7 OUTLIER -52.09 -39.84 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.0 t -58.22 -21.04 46.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -87.18 -34.73 18.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.3 t -75.81 -72.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.3 t -57.73 118.26 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.561 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.26 -32.78 20.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -137.31 114.95 11.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.98 94.22 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -167.4 158.17 11.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.81 140.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.54 -170.27 1.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.43 150.12 0.97 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.86 92.55 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.833 2.355 . . . . 0.0 112.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.524 ' C ' ' OD1' ' A' ' 52' ' ' ASP . 1.1 tp-100 -55.51 -45.17 77.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' OD1' ' C ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -176.78 164.18 2.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.2 -21.59 4.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.17 101.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.279 -1.13 . . . . 0.0 109.531 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.91 172.29 12.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.11 138.98 37.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.156 . . . . 0.0 109.446 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 60.31 89.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 59' ' ' GLU . . . 165.68 88.22 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.1 tp10 75.69 79.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -108.2 178.69 4.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.21 -167.45 11.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.96 110.21 16.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -1.188 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.8 155.65 1.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -93.87 155.91 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.937 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -59.03 -16.07 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 -39.54 13.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -60.26 -46.28 90.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.74 -42.97 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.56 -23.34 66.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.85 -26.68 49.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.27 -32.79 55.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.429 ' CE2' ' CG1' ' A' ' 81' ' ' VAL . 78.5 m-85 -104.41 -61.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.63 136.9 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -64.4 98.48 0.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.05 -6.8 0.12 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -101.63 129.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -1.107 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -59.78 -165.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.1 tp -91.89 -34.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.46 -35.28 73.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.07 -43.69 82.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.429 ' CG1' ' CE2' ' A' ' 72' ' ' PHE . 54.8 t -65.55 -60.77 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.9 mm -46.04 -32.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 84' ' ' LEU . 19.8 t70 -66.94 -65.14 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' ASP . 15.5 mt -38.44 -30.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' ASP . 90.1 mt -76.95 -50.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.903 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -58.26 -13.93 6.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -82.46 -38.08 24.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 1.9 t-20 -85.28 -68.07 0.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 59.68 119.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 92' ' ' ASN . 56.5 tttp -136.58 69.87 59.93 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.457 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.7 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.798 2.332 . . . . 0.0 112.202 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 90' ' ' LYS . 1.5 p30 -99.66 97.18 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 m -133.11 47.68 2.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -13.55 53.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.434 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -81.43 1.81 31.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 124.14 16.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.371 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 p 55.24 -166.51 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.441 HD13 ' H ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -152.83 178.9 9.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -174.33 -22.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -176.7 119.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.514 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.75 9.5 2.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.06 -130.72 3.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.64 -139.87 4.25 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.525 ' C ' HD21 ' A' ' 104' ' ' ASN . 0.1 OUTLIER -127.03 76.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -1.156 . . . . 0.0 109.478 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 -4.74 52.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.99 -94.24 0.15 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m 49.15 -135.03 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -1.191 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.427 ' HA ' ' CE2' ' A' ' 110' ' ' TYR . 30.7 tttt -72.03 99.98 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.95 30.16 2.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.427 ' CE2' ' HA ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -94.05 145.6 24.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 109.406 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.469 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 m -125.38 89.94 3.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 21' ' ' ALA . 4.2 t -51.4 176.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.51 171.06 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.3 m -148.39 142.19 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -108.26 127.54 53.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.903 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.13 144.44 30.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.495 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -113.06 121.13 43.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 10' ' ' LYS . 69.6 t80 -126.92 140.85 52.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.485 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 9.7 tttt -101.26 140.96 34.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.94 -166.68 27.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -94.99 -33.07 12.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.134 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.44 -30.01 7.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 t -145.28 179.1 7.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.1 t70 -98.1 161.99 13.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 62.1 mt -140.24 140.03 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.9 136.99 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 109.409 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 171.3 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.95 163.49 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.446 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.99 -177.05 6.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 3' ' ' THR . . . -106.62 -71.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.13 140.09 37.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 26' ' ' VAL . 39.0 mt-10 -50.75 -55.95 14.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.918 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 23' ' ' GLU . 13.5 tp10 -37.65 -44.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.56 -27.28 64.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' A' ' 23' ' ' GLU . 89.6 t -73.3 -54.08 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.2 -24.22 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -75.31 -38.56 60.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 32' ' ' ASN . 76.6 t80 -60.04 -49.54 77.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mt -45.68 -32.43 2.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -91.06 -3.0 57.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' TYR . 52.5 m-80 -142.72 61.47 11.08 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.85 93.31 0.95 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.85 2.366 . . . . 0.0 112.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -162.53 132.31 4.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.3 mm -46.46 117.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.11 -63.1 0.38 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -79.88 -28.67 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.401 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' LYS . 5.0 tp -42.77 -40.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 t -67.83 -37.19 81.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' LYS . 17.6 tt0 -62.7 -18.34 62.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.93 -74.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 t -57.55 157.54 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.378 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -117.87 -68.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.1 tp -95.38 111.57 23.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.86 74.37 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 47' ' ' VAL . 11.6 tp10 -156.03 157.87 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.442 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 6.6 t -128.17 128.29 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.56 156.98 22.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.493 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.95 156.92 34.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.01 178.41 4.75 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.793 2.328 . . . . 0.0 112.192 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.71 -112.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -123.66 26.49 7.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 -125.13 0.72 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.707 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -123.21 -19.26 6.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -1.137 . . . . 0.0 109.463 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 56' ' ' ALA . . . 139.49 135.58 3.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 55' ' ' GLY . . . 40.79 69.77 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -122.35 -64.97 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' GLU . . . -115.99 -158.58 11.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' GLY . 10.4 pt-20 -52.94 -172.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -1.139 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -114.29 165.93 12.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.33 9.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.29 134.0 56.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -1.126 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.49 130.13 39.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.561 ' O ' ' N ' ' A' ' 67' ' ' GLN . 13.6 m -81.23 131.08 35.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 64' ' ' SER . 1.7 ptpt -40.47 -40.24 1.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.16 67.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.29 -50.96 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.16 -41.7 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 71' ' ' GLU . 39.9 mt-10 -55.58 -41.6 73.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.9 t-20 -40.37 -19.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.648 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.5 mm-40 -114.37 -60.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -164.98 72.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.45 ' N ' ' HA ' ' A' ' 69' ' ' GLU . . . -129.4 0.13 5.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -85.5 106.58 16.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.516 -0.99 . . . . 0.0 109.485 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.9 32.6 63.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -130.84 100.18 5.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -1.147 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.552 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 9.4 mtpm? -46.55 155.09 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.49 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.5 -21.5 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.552 ' OE1' ' NZ ' ' A' ' 77' ' ' LYS . 9.6 mt-10 -69.0 -51.99 33.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.14 -42.94 83.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -48.21 -51.49 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.1 mt -61.21 -35.59 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.877 . . . . 0.0 109.535 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' LEU . 46.0 t0 -60.34 -66.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 83' ' ' ASP . 16.4 mt -40.47 -32.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 mt -80.57 -31.17 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.9 mt -77.66 -0.39 26.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -75.67 -40.86 55.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.621 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 0.4 OUTLIER -96.25 -73.38 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.88 117.31 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 mttt 53.97 60.02 11.57 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.56 91.54 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.829 2.353 . . . . 0.0 112.227 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.583 ' C ' ' H ' ' A' ' 94' ' ' THR . 1.2 m120 -152.2 -67.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.652 ' C ' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -69.53 17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.583 ' H ' ' C ' ' A' ' 92' ' ' ASN . 77.8 p -66.84 23.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.652 ' H ' ' C ' ' A' ' 93' ' ' SER . 18.6 p -134.08 81.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.7 88.12 4.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.444 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.474 ' H ' ' HG ' ' A' ' 97' ' ' SER . 0.9 OUTLIER -112.34 -178.1 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mp -52.78 170.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.943 . . . . 0.0 109.482 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -86.13 139.62 30.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -133.48 12.15 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 100' ' ' THR . 75.4 mttt 36.92 -121.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -180.0 -167.59 37.35 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.541 ' C ' ' H ' ' A' ' 105' ' ' ALA . . . 170.89 -23.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.68 -2.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -1.183 . . . . 0.0 109.476 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.541 ' H ' ' C ' ' A' ' 103' ' ' GLY . . . -82.77 153.92 25.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.563 ' C ' ' H ' ' A' ' 108' ' ' LYS . . . 169.28 46.33 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 p -59.71 1.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -1.131 . . . . 0.0 109.504 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.563 ' H ' ' C ' ' A' ' 106' ' ' GLY . 5.6 pttm -136.57 61.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -153.2 -78.25 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 109' ' ' ALA . 14.5 m-85 -38.85 -63.81 0.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.425 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' O ' ' O ' ' A' ' 2' ' ' SER . 30.5 tpp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 44.17 99.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -143.07 -14.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 167.14 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.26 159.43 15.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -121.73 132.43 54.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -95.75 117.59 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -81.92 138.04 35.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -131.54 90.06 2.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.965 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -56.77 96.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 12' ' ' GLU . . . -71.51 -162.59 5.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.569 ' CG ' ' N ' ' A' ' 13' ' ' ASN . 1.1 tt0 -49.37 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.477 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.569 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -100.21 -0.63 38.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 109.478 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.497 ' HG1' ' H ' ' A' ' 15' ' ' ASP . 5.6 t -113.05 174.85 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.42 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' H ' ' HG1' ' A' ' 14' ' ' THR . 46.9 t0 -117.26 122.49 44.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.473 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.401 HD21 ' CG1' ' A' ' 47' ' ' VAL . 53.1 mt -106.17 132.24 52.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.3 mt -118.55 146.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.593 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.11 169.81 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -103.37 155.23 18.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.84 -171.4 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.52 2.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -168.69 135.52 1.9 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -45.69 -24.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.66 -65.64 0.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.438 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.65 -20.42 21.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -79.15 -52.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -44.36 96.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 109.406 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.8 mt-10 -56.5 -54.88 40.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -46.98 -44.13 19.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.46 -20.57 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.323 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 14.2 mtmt -92.81 -22.34 19.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 31' ' ' LYS . 9.0 m-20 -143.57 66.16 15.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' SER . 42.2 Cg_endo -71.53 170.03 19.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.801 2.334 . . . . 0.0 112.208 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER 166.92 22.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.3 mm 47.13 13.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' SER . . . -107.48 -53.59 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -71.86 -25.75 62.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 15.2 tp -48.7 -22.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.486 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 36' ' ' GLY . 2.7 p -71.39 -18.39 62.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -98.18 -20.94 16.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.84 -42.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.44 141.6 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.485 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -102.09 -44.48 5.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.512 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 46' ' ' GLU . 7.5 mt -121.7 105.92 10.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -66.43 72.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.522 ' CG ' ' H ' ' A' ' 47' ' ' VAL . 5.8 tt0 -152.65 178.57 9.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.522 ' H ' ' CG ' ' A' ' 46' ' ' GLU . 82.2 t -123.5 131.73 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -118.35 176.83 5.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.492 ' HG1' ' N ' ' A' ' 50' ' ' PRO . 0.0 OUTLIER 173.94 151.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.492 ' N ' ' HG1' ' A' ' 49' ' ' THR . 42.5 Cg_endo -71.84 -178.4 3.1 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.839 2.359 . . . . 0.0 112.156 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.433 ' NE2' ' OD1' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -160.41 16.03 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.918 . . . . 0.0 109.466 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD1' ' NE2' ' A' ' 51' ' ' GLN . 7.4 p-10 -158.88 0.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.15 176.95 46.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -92.66 37.85 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -1.115 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.18 24.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.18 28.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -123.95 22.13 8.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.87 -120.6 0.69 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -60.93 114.21 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.21 -179.26 3.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.9 -177.87 38.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.75 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -63.49 -178.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -103.22 136.16 43.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 3.5 mttt -43.28 -27.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.52 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -78.45 -20.5 50.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 64' ' ' SER . 3.2 mt-30 -81.17 -39.66 25.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.77 -32.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.7 mt-10 -62.41 -21.58 65.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -82.35 -33.77 28.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.556 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -80.82 -24.19 38.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.69 -30.02 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.647 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . 115.79 -130.45 9.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 75' ' ' GLY . 5.3 mtpt -67.02 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.142 -1.211 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . 40.08 66.79 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 77' ' ' LYS . 30.2 mttp -51.71 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -1.194 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 76' ' ' LYS . 28.3 mttp -41.13 130.97 2.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 77' ' ' LYS . 2.7 tp -41.9 -37.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -52.91 -56.72 13.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.55 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -53.05 -41.5 64.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.433 ' O ' ' C ' ' A' ' 82' ' ' ILE . 7.5 t -58.7 -68.19 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 81' ' ' VAL . 15.8 mt -42.95 -39.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 109.486 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -61.74 -63.82 1.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 83' ' ' ASP . 5.5 mt -43.64 -35.29 1.72 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.22 -66.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.421 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 5.0 mt -49.62 -26.71 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -42.19 -43.88 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -77.53 0.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.6 132.85 3.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 5.4 mmtp 46.88 51.85 10.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 45.7 Cg_endo -72.32 92.97 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.776 2.317 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.74 ' ND2' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -97.68 114.96 27.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 m -97.4 -89.32 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.435 ' O ' ' CG2' ' A' ' 94' ' ' THR . 5.6 t -153.79 129.52 10.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.68 7.82 8.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.395 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.42 88.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -127.52 5.23 6.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.57 87.12 3.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' C ' ' H ' ' A' ' 101' ' ' LYS . 30.5 tttp -164.37 -67.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.46 48.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' H ' ' C ' ' A' ' 99' ' ' LYS . 23.3 mttm 47.41 27.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.455 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.0 44.67 6.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.32 161.15 0.67 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.94 -169.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.44 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.09 -81.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 121.45 -96.12 0.58 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.81 13.51 0.81 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -1.127 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.09 34.05 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -77.57 91.12 3.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 109' ' ' ALA . 53.5 m-85 40.14 87.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.474 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 41.22 33.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.446 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 m -47.44 -25.84 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.426 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.45 -170.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.35 158.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -118.34 139.44 51.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.86 117.64 31.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.379 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.18 126.61 45.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.853 . . . . 0.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -120.88 106.51 11.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -79.36 94.83 5.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.93 -166.84 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -63.13 -53.74 48.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.38 -1.54 3.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 137.32 54.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.52 121.64 45.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -119.19 147.19 44.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.6 mt -116.81 147.55 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.65 161.93 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -95.16 149.38 21.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.03 144.36 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.92 -69.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 149.37 46.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.08 -35.51 80.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.24 -58.29 8.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' O ' ' C ' ' A' ' 26' ' ' VAL . 9.2 mt -50.07 -59.26 4.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.508 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.47 ' C ' ' O ' ' A' ' 25' ' ' LEU . 4.4 t -39.88 -59.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -48.41 -42.36 31.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 25' ' ' LEU . 6.0 mt-10 -60.65 -46.22 91.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.848 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' N ' ' NZ ' ' A' ' 37' ' ' LYS . 31.0 t80 -49.83 -54.92 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.2 mt -52.55 -22.87 5.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -88.27 -26.51 22.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -130.89 58.35 38.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 93.94 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.896 2.397 . . . . 0.0 112.245 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.8 t -155.66 27.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.8 mm 59.41 169.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.92 -38.54 3.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.587 ' NZ ' ' N ' ' A' ' 29' ' ' TYR . 25.9 tttm -105.5 -6.36 19.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -1.123 . . . . 0.0 109.453 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.407 ' HB2' ' HH ' ' A' ' 29' ' ' TYR . 5.8 tp -66.93 -23.11 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.23 -33.38 59.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.47 -27.56 61.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.7 t -86.59 -64.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.76 146.66 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -97.9 -55.5 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.42 154.71 19.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.01 65.9 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -156.53 157.27 35.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.81 140.65 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.2 m-85 -114.92 170.13 8.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.23 152.98 72.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.54 126.43 11.52 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.57 5.83 48.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 109.472 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -171.34 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.494 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.98 -5.37 2.76 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ALA . 16.9 mtm180 -131.21 -26.91 2.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -1.189 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -68.96 67.9 0.46 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' ARG . . . -70.8 6.23 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -1.208 . . . . 0.0 109.516 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 55' ' ' GLY . 4.4 mm-40 -133.57 -173.76 3.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.87 -131.58 12.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.454 ' OE1' ' C ' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -137.01 147.43 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -1.145 . . . . 0.0 109.461 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.44 -164.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.433 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.05 -174.19 27.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.5 49.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -1.131 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 128.88 36.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.27 150.04 47.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -50.32 -25.23 3.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.505 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.12 -42.65 79.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 68' ' ' VAL . 4.2 tt0 -62.64 -61.51 2.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 67' ' ' GLN . 19.0 t -42.96 -48.34 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -47.92 -24.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 67' ' ' GLN . 0.5 OUTLIER -77.39 -19.97 55.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' VAL . 5.6 mm-40 -92.18 -66.05 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -156.8 66.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.93 130.31 2.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -164.74 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.98 -22.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -72.16 -165.57 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -109.78 -161.98 0.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -90.81 -42.77 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.626 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -49.82 -55.47 14.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -56.3 -48.83 75.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.2 t -44.56 -54.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 0.0 109.482 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.46 -35.55 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -53.93 -49.3 68.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' ARG . 16.4 mt -57.16 -54.54 45.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 84' ' ' LEU . 56.3 mt -43.19 -44.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.3 mt -69.52 -27.29 65.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 84' ' ' LEU . 4.2 tpt180 -51.75 -28.41 15.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.545 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.411 ' H ' ' ND2' ' A' ' 88' ' ' ASN . 0.0 OUTLIER -115.53 -83.17 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 69.13 127.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 7.0 mttp 42.4 56.72 10.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 44.3 Cg_endo -72.4 18.09 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.904 2.403 . . . . 0.0 112.246 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 90' ' ' LYS . 1.8 p30 -47.29 151.28 0.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.76 159.44 36.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.874 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -106.5 70.46 0.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.4 m -86.49 91.12 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.2 p -63.94 172.34 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.77 156.58 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.51 -24.57 22.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -62.08 -156.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.53 169.59 10.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -61.17 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.33 88.26 1.0 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -138.87 -38.91 0.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -141.34 0.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 0.0 109.425 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.24 -54.09 20.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.183 -0.948 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.78 124.48 1.98 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' ALA . 1.6 t -88.08 15.32 7.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.83 -90.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.448 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 107' ' ' THR . . . -174.92 -160.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.7 59.67 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.447 ' C ' ' OG ' ' A' ' 2' ' ' SER . 6.5 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.8 OUTLIER -171.41 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.479 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER -43.43 173.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.907 . . . . 0.0 109.468 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 m -85.07 -172.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -146.33 146.15 30.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HZ1' ' HB3' ' A' ' 6' ' ' LYS . 11.0 mtpp -114.73 133.31 55.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.498 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.564 ' OH ' ' OD1' ' A' ' 92' ' ' ASN . 0.3 OUTLIER -97.87 132.01 43.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.399 -179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.94 147.22 24.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -141.1 107.85 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -89.73 92.64 9.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 13' ' ' ASN . . . -56.46 171.33 2.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.5 -5.81 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -1.145 . . . . 0.0 109.542 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 11' ' ' GLY . 23.1 t30 -161.09 -54.81 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.509 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -84.91 152.87 23.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -115.87 130.58 56.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.83 156.92 46.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 mt -121.75 152.75 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.49 166.78 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.503 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.51 153.4 22.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.45 161.41 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.5 -76.17 0.28 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -135.9 155.04 50.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -67.06 -31.62 72.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -50.1 -61.13 2.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.458 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 28' ' ' GLU . 12.6 mt -55.55 -52.45 63.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' LEU . 10.9 t -45.5 -50.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.9 -24.56 67.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 42.4 mm-40 -79.53 -37.63 36.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.3 t80 -60.35 -44.38 95.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.06 -35.62 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.498 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -76.39 -37.98 56.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.4 72.08 80.21 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.53 136.77 20.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.857 2.371 . . . . 0.0 112.248 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.06 130.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.48 -44.21 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -10.52 5.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -49.27 5.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -1.122 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tp -47.2 -21.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -32.06 73.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.21 -45.76 11.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.6 -54.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 45' ' ' PHE . 91.6 t -71.62 134.33 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 35.17 3.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.41 -40.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.426 ' CD1' HG13 ' A' ' 42' ' ' VAL . 36.2 m-85 56.4 62.01 2.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.539 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -158.1 161.73 37.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.61 123.78 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -110.59 171.18 7.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.68 159.01 37.0 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.66 168.84 21.58 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.856 2.371 . . . . 0.0 112.192 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.43 ' HG3' ' H ' ' A' ' 52' ' ' ASP . 1.1 tp60 -124.98 168.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' H ' ' HG3' ' A' ' 51' ' ' GLN . 3.5 m-20 -64.57 117.35 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -46.37 0.31 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 177.34 -21.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.56 -75.89 0.31 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 57' ' ' GLU . . . -86.18 -66.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -1.14 . . . . 0.0 109.461 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.5 mm-40 38.65 33.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 46.22 -162.23 0.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 45.02 70.64 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.487 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -86.79 165.45 16.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.58 152.51 20.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.54 146.18 26.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -1.14 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.8 -170.76 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.6 m -113.38 147.24 38.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 74.5 mttt -49.04 -32.58 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' O ' ' OD1' ' A' ' 70' ' ' ASN . . . -64.6 -42.72 95.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.48 -38.27 86.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.48 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' GLU . 41.4 t -66.34 -55.19 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 73' ' ' GLY . 2.0 mt-10 -44.96 -35.55 2.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.556 ' OD1' ' O ' ' A' ' 66' ' ' ALA . 14.9 m120 -66.29 -17.97 65.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 68' ' ' VAL . 2.3 mp0 -108.88 -6.97 15.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.545 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -146.1 16.74 1.38 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 48.32 -133.96 19.31 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER -42.78 109.03 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -1.155 . . . . 0.0 109.447 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.13 87.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' LYS . 16.7 mttt -66.52 -179.1 0.78 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.398 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -47.82 138.76 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.37 -22.41 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.92 -28.97 62.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.563 ' CA ' ' OE1' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.05 -47.95 14.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.514 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -50.99 -48.83 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.96 -36.52 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' LEU . 56.8 t0 -58.66 -64.18 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ASP . 98.5 mt -42.18 -46.32 4.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.475 ' C ' ' H ' ' A' ' 87' ' ' ARG . 74.2 mt -57.86 -58.16 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mt -56.16 -7.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.69 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -111.21 -20.82 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -140.91 66.44 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.57 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -147.64 -138.92 3.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 89' ' ' GLY . 16.8 ttpp -35.09 98.75 0.16 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.494 ' N ' ' O ' ' A' ' 89' ' ' GLY . 31.7 Cg_exo -55.07 91.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.535 2.157 . . . . 0.0 112.13 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.564 ' OD1' ' OH ' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -71.63 153.45 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.597 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 92' ' ' ASN . 8.2 p 43.34 80.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.509 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 p -76.73 61.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.4 m -140.91 129.46 22.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 t -116.04 -23.66 8.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 98.8 p -76.78 115.77 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.416 ' C ' ' H ' ' A' ' 100' ' ' THR . 3.5 mt -108.88 -144.4 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' CG ' ' A' ' 99' ' ' LYS . 9.5 tttm 51.27 14.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 ' H ' ' C ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -125.35 -49.42 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -0.879 . . . . 0.0 109.482 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -80.65 79.71 7.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.18 168.01 31.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.74 70.87 1.07 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -152.03 -74.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -1.14 . . . . 0.0 109.457 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.69 68.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.37 117.35 3.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -80.15 -24.36 40.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -1.171 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.524 ' C ' ' H ' ' A' ' 110' ' ' TYR . 14.8 mttt 52.35 33.02 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.78 28.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 108' ' ' LYS . 5.7 m-85 -120.62 160.13 23.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.44 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.271 0.558 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.479 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.32 148.29 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.95 -169.9 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.8 142.57 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -102.4 131.6 48.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.437 ' HH ' HG23 ' A' ' 26' ' ' VAL . 1.1 m-85 -99.85 116.58 32.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 17.9 m-85 -91.23 142.9 27.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -132.72 102.2 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -81.4 93.37 6.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.14 -156.57 8.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -46.77 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -13.82 9.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.59 147.49 23.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -117.28 115.85 26.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.95 152.69 24.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.8 mt -137.77 114.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -172.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.415 ' CD2' ' CD1' ' A' ' 44' ' ' LEU . 4.5 m-85 -104.57 169.63 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.15 149.79 5.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.69 -59.54 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 p -155.92 142.92 19.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -53.69 -33.93 57.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.225 -0.922 . . . . 0.0 109.514 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 13.6 tt0 -54.65 -64.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.8 mt -44.64 -58.04 3.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' LEU . 96.1 t -40.39 -45.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -60.51 -36.06 77.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 25' ' ' LEU . 5.6 mt-10 -67.28 -23.14 65.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -85.07 -28.69 25.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.93 -40.42 95.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -74.45 -32.77 62.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.561 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -124.67 73.52 62.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.74 114.37 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.76 2.306 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -144.27 -112.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -162.68 -14.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.11 -52.49 4.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -65.45 -8.38 18.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.149 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.14 -54.31 31.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 p -48.84 -20.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -84.06 -44.09 14.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.66 -70.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 t -68.14 129.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.419 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.77 -36.45 15.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -123.89 112.51 17.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.485 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.44 80.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' LEU . 4.6 tp10 -165.39 157.25 14.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.91 129.55 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -111.97 160.01 17.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 168.62 16.15 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -47.02 161.28 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.838 2.359 . . . . 0.0 112.233 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -94.91 -78.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 109.501 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -162.14 85.72 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.48 -127.07 7.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.708 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -65.77 116.42 6.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -1.16 . . . . 0.0 109.405 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.14 159.03 25.09 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -170.79 2.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -167.25 -173.81 2.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 -138.46 16.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.637 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 2.1 mp0 -87.54 80.53 8.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -1.183 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.29 -169.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.47 178.97 16.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.73 148.8 47.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -1.172 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.7 150.55 21.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.72 174.6 6.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.426 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -70.58 -31.84 69.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.16 -43.3 87.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -62.71 -52.48 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' GLU . 95.3 t -60.05 -41.99 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.972 . . . . 0.0 109.541 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -45.04 -42.44 8.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.9 . . . . 0.0 109.525 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -69.96 -26.07 63.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -81.58 -25.43 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -137.66 -71.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.51 -172.02 36.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -115.33 159.22 21.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.52 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.62 -22.37 38.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -78.67 -168.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -1.113 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 78' ' ' ILE . 22.8 mttm -124.71 137.87 54.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -39.55 -45.39 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 4.8 mt-10 -64.22 -43.92 93.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' LYS . 2.5 tp10 -59.2 -36.24 75.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' C ' ' A' ' 82' ' ' ILE . 6.5 t -70.44 -60.38 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 81' ' ' VAL . 94.8 mt -39.54 -42.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.497 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -56.6 -57.08 13.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -54.63 -30.97 56.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 86' ' ' LEU . 1.9 mm -68.44 -64.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 85' ' ' ILE . 4.8 mt -45.19 -42.92 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -46.46 -53.26 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.81 -82.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.476 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.49 119.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -128.72 77.77 77.06 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -1.107 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.26 -37.28 24.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.866 2.377 . . . . 0.0 112.213 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -55.88 173.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.7 t 55.81 55.87 6.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 95' ' ' THR . 1.2 t -100.33 -176.21 3.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.457 ' N ' ' OG1' ' A' ' 94' ' ' THR . 2.6 t -167.6 95.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.519 ' O ' ' C ' ' A' ' 97' ' ' SER . 26.7 p -120.3 160.5 22.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.405 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -36.62 -55.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.42 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.83 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 97' ' ' SER . 45.4 tttt -167.69 -23.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 101' ' ' LYS . 29.2 m -78.03 -23.53 48.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 100' ' ' THR . 16.8 mmtm 41.78 -131.0 0.5 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.53 43.43 24.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.81 55.37 4.49 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -110.24 136.02 50.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.394 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -172.22 77.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 109.534 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.529 ' O ' ' OG1' ' A' ' 107' ' ' THR . . . 88.9 -29.25 6.0 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 106' ' ' GLY . 7.5 p 58.57 112.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -85.95 -13.03 48.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.06 -125.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -132.1 45.92 2.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.471 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -74.16 -56.19 5.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.646 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -96.21 -168.05 1.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.456 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.646 ' N ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -79.85 -179.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 m -93.6 139.43 30.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.5 115.79 30.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.447 ' HH ' ' CG1' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -95.39 137.83 33.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 41.8 m-85 -115.4 150.47 36.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -139.78 123.91 17.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -101.0 99.79 10.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.71 -147.52 0.08 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -97.08 -43.22 7.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.468 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.6 -3.29 3.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.927 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.58 158.62 40.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.7 144.33 47.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -134.91 160.85 36.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 92.2 mt -140.89 140.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.13 156.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -93.25 154.28 18.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.66 168.9 18.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.12 -58.36 2.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.528 ' HG ' ' H ' ' A' ' 25' ' ' LEU . 2.4 p -156.11 148.82 23.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.96 -26.68 68.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.76 -41.18 75.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.483 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 22' ' ' SER . 31.2 mt -69.97 -26.32 64.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.447 ' CG1' ' HH ' ' A' ' 7' ' ' TYR . 45.7 t -76.6 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' VAL . 1.5 t0 -43.61 -43.45 5.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.333 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 1.7 mt-10 -61.58 -45.7 93.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.441 ' CE1' ' N ' ' A' ' 34' ' ' SER . 91.6 t80 -59.86 -33.29 71.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.1 mt -69.36 -40.03 77.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -59.87 -23.92 63.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.562 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 5.6 p-10 -153.72 81.37 4.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.78 144.62 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.836 2.357 . . . . 0.0 112.296 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.441 ' N ' ' CE1' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -154.42 -169.78 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -126.52 -19.6 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.1 -57.64 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -49.66 -25.5 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tp -47.0 -24.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.427 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -69.95 -62.5 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.52 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.68 -39.78 37.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.28 -48.31 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.537 ' O ' ' O ' ' A' ' 39' ' ' SER . 21.7 t -105.53 128.85 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 -1.86 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 tp -157.18 123.72 4.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.36 94.43 8.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -168.68 152.21 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.975 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 t -120.03 119.15 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.493 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.1 152.18 23.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.411 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -117.13 149.87 45.12 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 51' ' ' GLN . 43.9 Cg_endo -71.94 157.52 54.59 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.784 2.323 . . . . 0.0 112.147 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.9 mm-40 -59.79 -131.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.519 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 54' ' ' ARG . 42.4 p-10 -108.72 70.13 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.61 -41.81 0.18 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.5 ttp180 -91.58 113.69 26.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 109.446 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.06 134.85 6.66 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.1 4.5 2.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -1.11 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -160.58 87.1 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 176.36 92.4 0.08 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.09 82.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -1.078 . . . . 0.0 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt -80.46 156.47 26.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.68 36.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.3 49.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -1.15 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 169.99 10.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.0 161.64 13.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -57.78 -46.23 84.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.62 -22.16 12.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -83.36 -58.62 2.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.34 -29.14 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.9 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' GLU . 46.5 mt-10 -71.55 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 69' ' ' GLU . 7.9 t30 -38.53 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.518 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 69' ' ' GLU . 15.6 mm-40 -75.74 -62.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -94.08 -72.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.567 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.29 177.45 41.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -96.87 170.61 9.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -1.096 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.1 -29.9 4.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -76.85 156.4 32.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -1.131 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -97.35 -176.31 3.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.905 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.9 tp -73.87 -36.37 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -62.77 -49.51 74.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -55.64 -60.85 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.454 ' C ' ' O ' ' A' ' 80' ' ' GLU . 3.4 t -41.68 -62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 83' ' ' ASP . 17.0 mt -45.14 -51.52 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -37.32 -55.26 1.04 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 45.6 mt -56.03 -59.64 4.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.481 ' C ' ' O ' ' A' ' 84' ' ' LEU . 76.9 mt -38.26 -41.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.98 -33.75 76.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 84' ' ' LEU . 14.5 ttt180 -62.95 -14.08 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -105.35 -89.11 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.75 127.5 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' N ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 tptt -139.09 60.55 17.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 90' ' ' LYS . 52.2 Cg_exo -48.41 132.72 24.83 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.855 2.37 . . . . 0.0 112.149 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 93' ' ' SER . 44.9 t30 -55.17 125.41 20.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 109.43 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 92' ' ' ASN . 44.6 m -40.96 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' ASN . 9.2 p -81.86 149.48 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 p -122.2 54.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.4 t -163.38 111.31 1.22 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 p -158.9 123.87 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.51 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.71 -50.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.955 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.63 48.16 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 101' ' ' LYS . 6.8 p -117.51 -62.9 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.424 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' N ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -81.87 144.7 30.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.6 0.08 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 136.75 -64.83 0.57 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -141.06 156.37 46.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.47 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -138.48 -163.93 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.91 -164.93 40.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -130.77 135.18 47.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -154.81 -105.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.504 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.2 57.37 1.81 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -67.23 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.403 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.661 ' SD ' ' OG ' ' A' ' 2' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.661 ' OG ' ' SD ' ' A' ' 1' ' ' MET . 66.2 m -116.28 -9.58 11.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 2' ' ' SER . 89.2 m -170.59 83.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.53 -169.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.475 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.13 133.57 54.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.455 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -106.17 117.6 34.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.428 ' CZ ' ' HD2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -89.45 126.82 35.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 2.3 m-85 -89.25 160.14 17.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -150.63 105.61 3.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.45 126.27 29.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.72 -149.61 24.93 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -70.86 -31.28 67.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -153.39 -51.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -77.4 169.53 18.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD2' ' CD2' ' A' ' 8' ' ' PHE . 48.8 t0 -116.59 134.86 54.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 91.5 mt -111.24 136.2 50.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.0 mt -115.98 131.74 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 m -117.74 156.67 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -92.27 150.8 20.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.94 166.03 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.1 -50.21 5.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -165.03 142.53 6.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.468 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.87 -35.76 69.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.444 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -63.89 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -50.22 -45.68 54.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.95 -49.08 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -60.93 -38.15 84.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.4 -36.07 81.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.95 -32.68 69.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.0 mt -54.05 -31.88 52.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.468 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' ' CG ' ' A' ' 31' ' ' LYS . 7.4 tttm -96.32 32.9 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -175.37 58.41 0.19 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.36 99.02 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.879 2.386 . . . . 0.0 112.232 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 m -127.31 -107.04 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 tp -159.32 -23.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -81.52 -73.5 1.19 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -41.17 -22.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.422 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.0 tp -66.81 -38.86 87.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -58.87 -36.12 74.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 41' ' ' VAL . 2.3 tt0 -74.27 -57.38 3.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 40' ' ' GLU . 53.6 t -41.68 -35.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 75.3 t -104.43 122.15 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.02 -27.04 30.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 2.3 mp -129.38 140.26 51.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.28 59.27 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -153.39 163.86 39.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -117.47 151.71 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.91 148.83 51.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -151.1 155.78 35.02 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 143.03 37.76 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.861 2.374 . . . . 0.0 112.224 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.559 ' CG ' ' N ' ' A' ' 52' ' ' ASP . 19.2 pt20 -133.64 -51.52 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 0.1 OUTLIER -73.75 -39.21 64.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.91 -154.68 8.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.707 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -110.78 -157.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -1.145 . . . . 0.0 109.556 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.49 110.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.62 90.3 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.15 -21.68 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.78 -5.92 12.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -105.13 44.74 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -1.184 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.4 171.89 12.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.42 ' HA3' ' NE2' ' A' ' 51' ' ' GLN . . . -119.43 135.88 11.53 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.1 158.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -1.153 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.89 155.71 19.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.2 p -83.04 145.29 29.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -56.17 -16.0 4.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.14 -36.27 16.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.86 -41.72 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.898 . . . . 0.0 109.496 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.06 -46.22 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.516 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.63 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.4 mt-10 -47.73 -38.6 15.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -78.64 -20.99 49.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.75 -31.21 59.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.423 ' CE2' HG13 ' A' ' 81' ' ' VAL . 50.7 m-85 -126.69 -18.52 4.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 117.52 -152.59 17.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -138.75 92.96 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -1.126 . . . . 0.0 109.512 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.49 -18.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -95.54 -178.03 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 0.0 109.448 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -107.98 -157.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.88 -31.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -59.93 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.05 -31.35 7.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.423 HG13 ' CE2' ' A' ' 72' ' ' PHE . 6.4 t -68.57 -61.96 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 45.9 mt -55.92 -21.58 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -66.28 -56.12 12.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mt -59.19 -25.54 64.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 72.6 mt -69.93 -50.85 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 16.0 mt -72.19 -5.81 38.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.39 -34.98 11.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.48 42.19 1.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -104.97 -133.67 7.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.772 ' NZ ' HD21 ' A' ' 92' ' ' ASN . 33.2 tttm 36.11 75.0 0.53 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.9 -68.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.831 2.354 . . . . 0.0 112.2 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.772 HD21 ' NZ ' ' A' ' 90' ' ' LYS . 5.8 t-20 45.69 -163.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.498 ' O ' ' OG ' ' A' ' 93' ' ' SER . 14.2 p -112.02 82.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 120.45 9.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.7 p -69.12 156.27 38.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -65.45 152.72 43.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -84.99 143.1 29.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 97' ' ' SER . 9.4 mt 39.81 -133.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -101.05 -89.07 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.97 119.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -87.72 150.47 23.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.84 102.41 0.54 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.74 176.02 16.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.84 10.16 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.93 112.76 24.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 108' ' ' LYS . . . 171.7 141.98 3.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.93 5.73 1.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -1.178 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 106' ' ' GLY . 21.6 mttm -79.38 -94.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.85 178.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -88.07 99.24 12.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 p30 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.526 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' SER . 33.0 mtt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.502 ' C ' ' HG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER 70.6 -79.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.502 ' HG1' ' C ' ' A' ' 2' ' ' SER . 19.4 m -150.49 158.72 44.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' N ' HG21 ' A' ' 3' ' ' THR . 0.9 OUTLIER -153.54 -170.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.444 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 m -106.69 166.86 10.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.419 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt -128.4 143.76 51.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.443 ' CD2' ' HA3' ' A' ' 89' ' ' GLY . 0.7 OUTLIER -123.65 113.12 18.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.0 109.479 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -83.66 164.02 19.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 109.408 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -154.21 131.98 11.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.475 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -110.79 112.6 24.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.548 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.0 -149.27 4.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -79.8 -47.37 15.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.453 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.87 -26.65 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 158.25 16.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.6 t0 -114.17 154.76 27.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.421 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.673 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 44.0 mt -137.52 157.72 45.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.406 HG23 ' N ' ' A' ' 18' ' ' VAL . 19.6 mt -134.73 151.42 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.348 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.406 ' N ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -142.48 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.9 154.87 27.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 162.68 32.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.47 -65.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.74 129.05 18.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -46.57 -38.88 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.19 -61.44 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' C ' ' A' ' 26' ' ' VAL . 32.0 mt -47.26 -59.6 3.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' C ' ' O ' ' A' ' 25' ' ' LEU . 97.8 t -38.21 -46.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -46.15 84.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.98 -46.78 87.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.432 ' CE1' HD12 ' A' ' 38' ' ' LEU . 35.8 t80 -47.22 -52.64 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.64 -25.91 60.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -71.49 -31.68 67.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -158.88 80.36 2.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.19 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.804 2.336 . . . . 0.0 112.271 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.454 ' C ' ' H ' ' A' ' 36' ' ' GLY . 1.6 t -118.48 120.26 37.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.245 -0.91 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.55 0.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' A' ' 34' ' ' SER . . . -85.48 -16.17 64.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' LEU . 4.6 ptmm? -115.66 -10.81 11.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.133 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -38.42 -53.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 41' ' ' VAL . 4.6 p -52.77 -61.37 2.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 39' ' ' SER . 4.6 mm-40 -37.77 -22.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.7 t -96.54 -54.86 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.5 149.38 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.57 -16.46 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.68 98.33 2.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -63.29 89.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -169.04 118.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.6 t -79.67 144.82 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.54 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -130.86 163.39 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.13 163.82 37.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 126.19 10.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.823 2.348 . . . . 0.0 112.24 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.2 tt0 -109.12 -177.35 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -50.6 179.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.461 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.67 -131.59 8.59 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -139.14 18.14 2.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 109.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.63 -80.06 0.16 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.96 54.21 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -1.149 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -118.58 156.02 29.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 59' ' ' GLU . . . 83.86 165.27 38.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' GLY . 46.4 tt0 -43.54 115.5 0.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.3 mt -64.04 155.89 29.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.79 137.19 15.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 152.44 22.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.463 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.73 -168.8 1.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.441 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.27 166.42 18.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -20.66 66.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.18 -44.83 13.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.38 -41.44 89.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.22 -56.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.73 -34.98 70.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.85 . . . . 0.0 109.515 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -27.89 50.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.33 -66.77 0.86 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.427 ' CZ ' HG13 ' A' ' 81' ' ' VAL . 25.5 m-85 -71.38 -67.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.38 175.25 21.56 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.86 172.9 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.42 9.94 74.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -131.78 171.0 14.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -1.202 . . . . 0.0 109.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -119.21 -163.16 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -82.57 -35.22 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.525 -179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.41 ' N ' HG22 ' A' ' 78' ' ' ILE . 59.1 mt-10 -64.44 -31.59 72.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -84.17 -45.24 13.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.427 HG13 ' CZ ' ' A' ' 72' ' ' PHE . 22.8 t -58.56 -34.86 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.05 -46.56 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.21 -45.38 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.5 mt -61.32 -56.57 18.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mt -47.14 -50.92 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' A' ' 88' ' ' ASN . 45.0 mt -58.83 -31.12 68.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -55.74 -9.41 0.54 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 86' ' ' LEU . 2.8 m120 -134.22 -91.68 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 65.51 125.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 89' ' ' GLY . 23.3 mtmt 35.75 62.76 2.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.344 -1.092 . . . . 0.0 109.545 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.407 ' HB3' HD21 ' A' ' 88' ' ' ASN . 51.0 Cg_endo -73.59 157.79 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.96 84.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 p -149.75 51.42 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.7 m -105.3 -75.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 95' ' ' THR . 17.5 p -90.8 72.43 6.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.81 108.72 10.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 p -149.82 -2.2 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 99' ' ' LYS . 4.1 mm? -71.27 -92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.385 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 98' ' ' LEU . 9.5 mttt 37.42 -148.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 p -137.82 62.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -62.59 -53.75 49.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.4 96.23 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 105' ' ' ALA . . . -131.13 44.81 1.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.635 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 0.3 OUTLIER -72.96 29.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.548 ' H ' ' C ' ' A' ' 103' ' ' GLY . . . -117.24 15.84 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.36 120.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.24 123.23 19.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -1.185 . . . . 0.0 109.528 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.37 -74.64 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.13 -148.28 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -97.29 -52.68 3.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 m120 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.495 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.28 0.562 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -100.95 147.16 26.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -116.7 136.58 52.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' HB2' HG23 ' A' ' 18' ' ' VAL . 2.3 m-85 -118.68 122.73 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -90.82 159.59 16.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -147.49 91.11 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -53.59 113.77 1.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.14 -161.85 33.27 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 1.3 mm-40 -70.92 -45.25 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.01 -41.69 2.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t -101.42 177.89 4.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.41 124.63 49.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.88 127.66 49.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.358 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.18 155.08 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' HB2' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -131.82 154.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.54 153.92 17.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.16 159.18 44.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.96 -73.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 t -145.66 169.89 17.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.53 -26.65 66.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 25' ' ' LEU . 57.7 tt0 -65.49 -74.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' GLU . 5.2 mt -42.39 -33.4 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 27' ' ' ASP . 3.7 t -67.32 -70.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 26' ' ' VAL . 45.4 t0 -41.11 -39.87 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 109.479 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 29' ' ' TYR . 3.1 mm-40 -58.05 -58.8 6.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' GLU . 76.2 t80 -43.33 -51.86 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.938 . . . . 0.0 109.446 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.73 -40.32 83.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -68.55 -4.51 15.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -175.62 79.43 0.3 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.47 140.42 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.769 2.312 . . . . 0.0 112.216 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 t -164.33 94.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -48.54 -27.49 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.59 -9.64 74.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 38' ' ' LEU . 18.2 tttm -112.28 -25.46 9.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -39.13 -31.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -60.79 -69.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.494 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' SER . 35.9 mt-10 -41.33 -36.39 0.8 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.17 -70.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.7 t -85.12 130.31 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 44' ' ' LEU . 2.0 pt-20 -95.17 -31.49 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 43' ' ' GLU . 8.0 mp -111.15 121.42 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -91.6 77.62 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 30.4 tt0 -165.86 143.88 5.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.464 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.58 127.29 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 72.7 m-85 -113.26 154.22 27.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 109.547 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -132.87 164.14 46.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 49' ' ' THR . 66.6 Cg_exo . . . . . 0 C--N 1.306 -1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.217 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.98 -173.84 14.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.18 151.07 26.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.85 132.88 39.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -74.75 149.29 39.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 29.9 mttt -43.82 -51.36 7.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.76 -34.92 20.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -73.05 -36.71 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -66.13 -34.45 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 109.447 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.53 -28.72 70.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.521 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -52.92 -19.65 2.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -113.75 -73.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -148.46 72.5 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' C ' ' A' ' 74' ' ' LYS . . . -135.24 0.54 3.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 73' ' ' GLY . 10.7 tptm -37.37 -49.37 0.99 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.467 -1.019 . . . . 0.0 109.475 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 3.32 0.83 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -75.64 -175.97 3.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -114.37 -140.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.31 -23.93 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -64.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' ASP . 37.4 mt-10 -47.08 -53.22 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 80' ' ' GLU . 4.7 t -44.3 -58.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.06 -22.47 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 3.9 t0 -69.35 -61.08 1.94 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.45 -46.17 47.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.84 -59.31 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 87' ' ' ARG . 19.5 mt -46.21 -33.78 3.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.74 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -35.78 -66.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.429 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.87 75.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.336 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.31 -117.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.344 -1.092 . . . . 0.0 109.412 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -122.37 131.57 53.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -105.96 131.62 53.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 4.5 m-85 -97.31 123.38 41.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.65 149.69 22.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 22.8 t80 -144.69 119.0 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -95.03 132.97 39.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -109.26 -154.2 15.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.2 tp10 -42.82 -82.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -117.78 -34.56 4.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 t -79.0 174.05 11.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.42 145.35 48.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mt -130.38 156.88 43.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 18' ' ' VAL . 48.4 mt -134.98 155.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.927 . . . . 0.0 109.559 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.426 ' N ' HG22 ' A' ' 17' ' ' ILE . 18.9 m -136.1 155.93 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -98.46 140.49 32.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.34 168.31 20.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.93 -87.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 p -136.11 171.89 13.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.517 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -68.58 -13.01 62.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.14 -74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.498 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -47.45 -46.63 26.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.527 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 47.6 t -51.72 -54.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -53.42 -45.86 69.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.81 -30.09 63.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 33' ' ' PRO . 60.4 t80 -72.22 -61.24 1.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.402 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.513 HD21 ' O ' ' A' ' 86' ' ' LEU . 10.6 mt -48.27 -44.4 33.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -72.33 -20.94 61.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -150.31 70.59 9.11 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 34' ' ' SER . 54.2 Cg_endo -74.32 162.55 38.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.881 2.387 . . . . 0.0 112.209 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 33' ' ' PRO . 73.8 m -171.26 -104.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.476 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 tp -169.08 -20.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.93 -40.33 5.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -69.05 -18.31 64.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -1.13 . . . . 0.0 109.415 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.99 -29.12 67.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.918 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -33.47 75.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -78.4 -57.25 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -46.62 -60.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.5 122.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.527 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -104.49 -1.37 26.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp -156.29 107.4 2.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.39 87.35 3.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.7 114.22 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.77 144.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -129.7 165.78 21.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.34 151.82 11.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.836 2.358 . . . . 0.0 112.173 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -142.83 174.81 23.39 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.05 127.4 51.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.157 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 144.69 54.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -93.09 155.31 17.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.411 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -38.96 -50.14 1.74 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -56.16 -59.8 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 66' ' ' ALA . 75.3 mm-40 -35.91 -39.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 38.4 t -84.01 -31.76 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 66' ' ' ALA . 49.5 tt0 -65.37 -39.26 92.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -18.87 65.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.61 -70.18 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -160.07 54.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.09 170.2 21.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 177.81 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 109.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.58 7.15 0.33 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -82.49 166.11 19.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -71.84 -149.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tp -109.4 -13.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.06 -18.72 62.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 -53.33 4.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.43 -39.74 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -72.28 -49.5 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -44.57 -44.79 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' ARG . 14.3 mt -67.44 -60.6 2.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.428 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 84' ' ' LEU . 13.3 mt -40.4 -39.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' HD21 ' A' ' 30' ' ' LEU . 84.6 mt -70.44 -36.01 73.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.716 HH11 ' CG ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -41.7 -62.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.509 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.44 -86.94 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.08 117.14 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mttp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.23 -1.159 . . . . 0.0 109.543 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 163.46 12.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -122.84 130.6 53.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 6.0 m-85 -114.68 114.34 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -83.65 142.08 31.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -123.74 144.6 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -114.98 129.12 56.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.05 24.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.51 -34.06 58.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -1.151 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -149.7 -35.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 15' ' ' ASP . 85.1 m -89.51 157.92 17.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 39.3 t0 -106.17 152.17 23.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.634 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 42.9 mt -136.34 160.03 39.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.462 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 mt -145.01 148.87 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.01 147.35 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -86.21 142.37 28.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.94 -171.75 2.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.05 -90.68 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 m -121.53 171.62 8.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.69 -9.6 59.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.03 -54.62 4.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.22 -38.6 83.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.479 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 75.8 t -63.8 -55.94 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.508 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -54.68 -50.5 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -52.39 -31.52 34.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 76.2 t80 -68.3 -41.87 80.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.6 mt -60.46 -23.43 64.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -90.64 -4.49 56.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -167.66 71.55 0.93 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HA ' ' CE1' ' A' ' 29' ' ' TYR . 56.9 Cg_endo -75.29 139.67 23.81 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.812 2.341 . . . . 0.0 112.258 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 m -160.67 -133.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.2 tp -135.44 15.7 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -112.79 -82.97 1.21 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 36' ' ' GLY . 4.1 ttmt -45.05 -22.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.483 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 36' ' ' GLY . 6.0 tp -49.28 -62.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.5 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.89 -47.64 31.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.426 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -29.04 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 37' ' ' LYS . 34.6 t -86.98 -54.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 82' ' ' ILE . 21.5 t -87.63 113.44 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.15 -43.26 24.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 tp -111.15 115.16 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.893 . . . . 0.0 109.453 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' CE1' ' OE2' ' A' ' 79' ' ' GLU . 46.8 m-85 -73.93 65.92 1.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.72 174.9 10.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.447 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.3 t -134.85 128.17 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.93 151.92 22.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.35 150.76 77.35 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 C-N-CA 122.854 2.369 . . . . 0.0 112.176 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.4 172.09 23.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.67 154.81 17.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -1.138 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.54 133.71 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 169.36 18.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ALA . 63.5 tttt -57.38 -65.86 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.437 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' LYS . . . -43.97 -39.9 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -57.17 -24.08 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -68.23 -24.95 64.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -72.66 -21.34 61.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -105.62 -63.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -165.84 64.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -128.21 -0.01 6.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 73' ' ' GLY . 20.1 tttt -51.69 -101.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.455 -1.027 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 44.56 1.6 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -121.7 133.16 54.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -1.112 . . . . 0.0 109.473 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -56.41 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -84.96 -42.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 8.2 mm-40 -49.48 -55.44 13.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 83' ' ' ASP . 2.1 mt-10 -48.3 -54.26 14.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -45.47 -46.46 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.907 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.557 HG21 HG21 ' A' ' 42' ' ' VAL . 19.1 mm -62.87 -25.93 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.149 -0.969 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' GLU . 52.0 t0 -70.97 -61.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 65.5 mt -49.12 -29.87 5.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 88' ' ' ASN . 58.3 mt -67.74 -66.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ILE . 95.8 mt -43.82 -46.4 7.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -56.58 -30.93 63.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 37.6 t30 -83.76 -81.79 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 57.08 116.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 tptm . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.213 -1.169 . . . . 0.0 109.521 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -127.81 147.18 50.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -105.27 159.24 16.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.05 112.17 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.45 162.74 28.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -153.3 100.42 2.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -66.74 104.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.55 33.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -47.01 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -1.19 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -106.98 -52.15 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -80.66 174.08 11.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 6.8 t70 -119.43 156.28 30.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.431 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.492 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 22.3 mt -123.2 157.32 33.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.21 143.76 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.24 142.18 36.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.59 -178.45 5.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.16 -73.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.11 166.48 27.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.23 -37.18 77.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.07 -51.79 29.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -51.08 -43.93 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.28 -41.7 97.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.377 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -65.36 -35.03 79.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -65.65 -54.07 32.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.4 mt -52.31 -19.86 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.62 -44.06 52.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.372 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.05 76.48 77.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.448 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.586 ' O ' ' CB ' ' A' ' 34' ' ' SER . 55.5 Cg_exo -47.01 164.19 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.836 2.358 . . . . 0.0 112.24 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 159.61 -173.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.587 ' N ' ' OG ' ' A' ' 34' ' ' SER . 0.6 OUTLIER -114.98 -14.27 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.84 -17.99 76.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -103.14 -18.97 14.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -1.142 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -63.05 -33.31 75.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p -70.32 -20.5 63.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -83.77 -50.41 8.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.64 -36.4 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.97 110.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -80.51 -18.36 48.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.08 142.09 23.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -98.99 68.55 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.0 tp10 -150.65 128.34 11.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 2.0 t -93.09 128.39 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 91.2 m-85 -114.21 155.06 26.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -131.83 152.09 79.7 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 C--N 1.305 -1.749 0 C-N-CA 122.743 2.295 . . . . 0.0 112.192 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.249 0.547 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.96 113.13 2.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.37 111.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -1.141 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.533 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -65.48 130.49 43.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' ALA . 73.0 m -93.22 139.66 30.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.1 mttt -41.26 -27.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.423 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -61.4 -39.36 90.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.482 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.11 -57.94 3.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 68' ' ' VAL . 5.6 t -53.16 -24.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.389 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 17.9 mt-10 -68.77 -45.97 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.03 -19.81 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.604 ' OE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.5 tm-20 -88.68 -52.53 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.604 ' CZ ' ' OE1' ' A' ' 71' ' ' GLU . 67.9 m-85 -116.22 32.05 6.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 46.65 -160.32 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.7 29.69 7.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -1.134 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.92 -32.62 8.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -98.3 155.59 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -1.2 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -83.28 -177.55 6.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -15.52 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -70.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -52.8 -35.62 57.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 82' ' ' ILE . 3.0 t -56.4 -64.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.473 ' N ' HG12 ' A' ' 81' ' ' VAL . 31.1 mt -48.79 -31.67 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.469 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -59.47 -73.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -35.56 -44.11 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mt -60.59 -32.28 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.419 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.672 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.6 mt -72.04 -20.4 61.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.897 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.665 ' CB ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -88.29 -3.48 58.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -113.92 -86.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 67.16 121.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.16 148.03 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -106.89 129.68 54.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.42 120.63 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -82.07 158.38 23.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -145.44 102.55 3.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.499 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -85.5 104.3 15.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 -157.41 11.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -58.93 -49.24 78.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -1.153 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.65 -33.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -84.78 134.91 34.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.564 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -105.76 138.05 42.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 mt -134.99 151.49 50.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.572 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.6 mt -120.27 150.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.82 151.19 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.521 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.2 144.55 25.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.04 177.64 8.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 -88.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.88 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 26' ' ' VAL . 18.0 t -125.62 168.93 13.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.19 -29.9 34.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -56.53 -47.99 78.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.32 -47.88 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 22' ' ' SER . 94.7 t -49.93 -43.06 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -24.95 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.5 -47.03 28.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 32' ' ' ASN . 63.9 t80 -57.89 -50.02 74.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.471 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 30' ' ' LEU . 82.8 mt -43.82 -32.75 1.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.479 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -91.19 10.03 28.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' TYR . 17.0 m120 -161.25 62.11 1.49 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 47.1 Cg_endo -72.81 113.46 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.815 2.343 . . . . 0.0 112.191 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.518 ' O ' ' OG ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -173.07 34.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.889 HG22 ' H ' ' A' ' 36' ' ' GLY . 29.3 mm 51.24 -177.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.889 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 87.29 -74.78 2.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -67.56 -10.9 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -1.133 . . . . 0.0 109.458 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' VAL . 1.1 tp -59.2 -54.45 46.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' LEU . 70.3 m -43.18 -37.8 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.566 ' CD ' ' N ' ' A' ' 40' ' ' GLU . 1.7 mp0 -70.09 -35.88 74.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' LEU . 41.7 t -71.68 -54.8 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.574 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 118.44 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.18 -26.26 25.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tp -125.55 124.05 40.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -90.5 95.99 10.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -167.87 140.09 3.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.428 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -108.96 141.14 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -128.78 178.83 6.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.03 149.08 29.06 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 C-N-CA 122.735 2.29 . . . . 0.0 112.138 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.293 0.568 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.41 128.16 9.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.36 168.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -1.156 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.91 7.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' GLN . 2.8 t -99.49 133.12 44.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -46.7 -30.56 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.442 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.97 64.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.0 mm-40 -69.98 -27.82 65.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.65 -44.5 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 23.5 mt-10 -57.33 -39.36 75.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -49.71 -17.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 69' ' ' GLU . 28.5 mt-10 -98.8 -52.21 3.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.546 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.43 -28.96 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 104.6 -178.32 24.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -91.22 -157.57 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.416 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.14 -8.02 9.38 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -120.48 162.49 19.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -1.171 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -108.88 -150.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -93.62 -18.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.948 . . . . 0.0 109.502 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.15 -43.29 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.0 -55.16 24.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' ILE . 14.6 t -50.74 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.501 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.7 mm -44.72 -62.14 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 82' ' ' ILE . 6.0 t70 -37.98 -51.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 85' ' ' ILE . 81.4 mt -57.03 -53.19 60.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 84' ' ' LEU . 46.0 mm -42.03 -49.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.392 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.469 ' O ' ' C ' ' A' ' 87' ' ' ARG . 49.4 mt -57.7 -40.67 80.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -40.36 -34.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.433 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -105.21 -82.87 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 96.13 0.23 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.5 mttt . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.269 -1.136 . . . . 0.0 109.551 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -111.57 139.2 47.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -113.6 160.25 18.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -122.05 139.83 53.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -98.26 160.39 14.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.42 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -150.4 94.88 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -65.04 113.64 4.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.46 172.83 49.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -46.55 -30.38 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 14' ' ' THR . 9.5 p30 -149.6 -50.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.44 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 53.9 m -83.48 146.58 28.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.77 135.47 46.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.46 162.01 21.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.9 mt -138.04 153.4 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.09 177.9 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -103.45 168.42 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 5' ' ' THR . . . -157.78 152.84 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.416 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.11 -99.85 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.37 145.46 32.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -44.75 96.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.54 -32.89 8.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.68 -51.82 11.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.7 t -50.01 -54.01 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -53.61 54.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -48.38 -41.73 29.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 70.5 t80 -61.99 -46.72 88.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 30' ' ' LEU . 7.3 mt -46.65 -41.23 14.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.837 . . . . 0.0 109.459 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -81.66 1.57 33.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 29' ' ' TYR . 9.8 t30 -154.66 64.66 4.51 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 38.8 Cg_endo -70.72 109.46 2.5 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.849 2.366 . . . . 0.0 112.199 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.449 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 1.8 m -143.17 -136.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tp -138.76 1.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.46 -74.16 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.536 ' NZ ' ' CG2' ' A' ' 41' ' ' VAL . 37.0 tttm -52.9 -14.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -1.151 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tp -49.45 -65.47 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.445 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -50.52 -46.28 57.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -52.19 -16.9 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.536 ' CG2' ' NZ ' ' A' ' 37' ' ' LYS . 92.0 t -102.55 -60.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.06 124.18 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.575 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.17 -29.36 12.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mt -119.49 117.46 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -87.77 76.76 8.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.653 ' OE2' ' CE2' ' A' ' 48' ' ' PHE . 15.6 tt0 -161.75 138.31 8.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.12 116.19 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.653 ' CE2' ' OE2' ' A' ' 46' ' ' GLU . 34.6 m-85 -99.21 148.34 24.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.466 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -147.94 154.54 43.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.822 2.348 . . . . 0.0 112.203 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.324 0.583 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.63 -173.82 25.84 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.88 157.1 28.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -105.98 -174.54 2.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 66' ' ' ALA . 27.1 t -134.01 153.15 51.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 17.1 mmtm -43.47 -23.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -77.48 -50.55 12.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.34 -43.69 79.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.94 -21.46 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.393 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.4 mt-10 -82.94 -60.29 2.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-20 -41.08 -31.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 69' ' ' GLU . 12.6 mm-40 -82.06 -77.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 81' ' ' VAL . 76.5 m-85 -72.31 -48.93 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.439 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 110.52 150.02 12.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 75' ' ' GLY . 4.5 ttpp -64.91 162.18 16.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.462 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 74' ' ' LYS . . . 116.88 -19.88 11.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -117.37 177.58 4.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -1.162 . . . . 0.0 109.453 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.52 -177.25 3.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 78' ' ' ILE . 10.3 tp -74.38 -21.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.85 -51.94 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -63.36 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.55 HG13 ' CE2' ' A' ' 72' ' ' PHE . 2.9 t -65.65 -58.08 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.5 mt -49.24 -25.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' LEU . 50.3 t0 -65.97 -62.27 1.59 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 83' ' ' ASP . 79.7 mt -44.04 -32.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mt -68.05 -49.8 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.47 -11.41 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -77.71 -26.45 50.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -102.77 -67.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.1 125.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.7 mttm . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.488 179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.03 164.9 12.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -131.35 144.96 51.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -114.43 146.59 40.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 9.6 m-85 -112.21 155.27 24.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 85' ' ' ILE . 61.7 t80 -143.32 94.91 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -67.0 98.59 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -73.88 173.25 50.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' GLY . 3.3 tp10 -41.96 -42.8 2.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.477 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 12' ' ' GLU . 18.8 m-20 -144.4 -37.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.478 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -87.46 142.22 28.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.26 130.69 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.49 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD22 HG11 ' A' ' 47' ' ' VAL . 8.2 mt -118.32 138.93 52.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.1 mt -120.21 146.1 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.49 165.01 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.528 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -92.09 166.23 12.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.42 151.37 22.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.465 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 -72.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.724 ' O ' HG23 ' A' ' 26' ' ' VAL . 19.4 t -140.22 156.88 46.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.98 -51.58 53.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -45.2 -54.55 6.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 25' ' ' LEU . 56.5 mt -57.49 -31.53 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 22' ' ' SER . 87.3 t -71.74 -70.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.532 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -40.97 -20.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -82.67 -49.08 10.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 32' ' ' ASN . 40.4 t80 -52.06 -50.57 61.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 29' ' ' TYR . 6.9 mt -40.78 -42.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -77.88 -13.92 59.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.665 ' N ' ' O ' ' A' ' 29' ' ' TYR . 95.9 m-20 -129.35 73.39 81.67 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.34 125.31 9.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.746 2.298 . . . . 0.0 112.232 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 172.61 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 35' ' ' ILE . 45.8 mm -73.5 61.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.99 -47.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -87.52 -28.17 22.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 109.449 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -54.38 -24.73 20.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 p -72.86 -31.62 64.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -79.26 -26.03 42.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.93 -64.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 62.6 t -71.94 128.27 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.85 -50.82 10.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.912 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 4.5 mp -111.13 147.77 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.67 88.24 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -168.72 -173.53 1.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG11 HD22 ' A' ' 16' ' ' LEU . 38.9 t -131.49 126.48 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.98 150.74 36.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -148.12 165.31 18.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--N 1.305 -1.754 0 C-N-CA 122.851 2.368 . . . . 0.0 112.262 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 60' ' ' LEU . 25.1 mt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.09 143.22 8.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 151.24 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -94.59 -171.55 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -118.62 164.72 14.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -64.27 -32.75 74.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -44.3 68.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -72.13 -60.22 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.32 -26.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -70.68 -39.13 73.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -60.09 -21.5 61.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 10.0 mp0 -96.76 -67.01 0.87 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -161.53 76.6 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.409 ' C ' ' CG ' ' A' ' 74' ' ' LYS . . . -127.74 -129.01 3.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' CG ' ' C ' ' A' ' 73' ' ' GLY . 9.3 mttt 68.04 -75.07 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -1.178 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' GLY . . . -123.4 30.69 4.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -118.22 100.47 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -1.193 . . . . 0.0 109.52 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -50.47 163.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -0.821 . . . . 0.0 109.537 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tp -54.75 -29.4 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.872 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.13 -60.7 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 83' ' ' ASP . 21.0 mt-10 -55.06 -55.12 34.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 80' ' ' GLU . 9.4 t -38.33 -50.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.429 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 85' ' ' ILE . 37.3 mt -61.95 -37.72 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.475 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.624 ' OD2' ' NH2' ' A' ' 87' ' ' ARG . 9.0 t0 -65.93 -65.14 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 83' ' ' ASP . 85.7 mt -38.17 -30.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 9' ' ' TYR . 41.4 mt -73.92 -68.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.414 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.1 mt -46.55 -12.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.402 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.734 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -75.66 -43.45 47.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.464 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.522 ' CG ' ' O ' ' A' ' 88' ' ' ASN . 7.2 t30 -149.93 66.44 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.15 -113.7 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.208 -1.172 . . . . 0.0 109.531 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 m -113.89 141.25 47.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -110.58 136.85 49.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.544 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.724 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 1.7 m-85 -103.69 110.5 22.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.868 . . . . 0.0 109.501 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.32 162.57 23.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.51 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 57.9 t80 -161.23 137.7 8.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 108.2 19.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.426 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.55 -154.9 0.22 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.04 -39.6 92.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -1.167 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -146.69 -36.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -83.78 169.16 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.9 . . . . 0.0 109.482 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 9' ' ' TYR . 43.2 t0 -115.3 137.02 52.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.9 153.49 39.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -131.4 143.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.16 152.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -90.06 152.97 20.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.13 -171.59 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.39 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.922 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.7 t -153.52 135.8 14.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 22' ' ' SER . 5.4 tt0 -40.0 -28.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' SER . 23.8 tt0 -62.58 -76.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.943 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 24' ' ' GLU . 11.2 mt -44.11 -35.53 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 t -62.11 -57.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.496 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -51.38 -52.25 47.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -48.52 -41.03 28.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.469 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.19 -59.32 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 42.9 mt -53.6 -27.86 29.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -23.61 61.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -160.09 77.49 2.73 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -51.69 118.75 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.817 2.344 . . . . 0.0 112.164 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -156.55 139.12 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.04 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.43 -80.11 0.26 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.38 -16.74 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -1.178 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.12 -47.46 85.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -57.6 -27.9 63.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.8 -33.78 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.8 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.814 HG21 HG21 ' A' ' 82' ' ' ILE . 89.5 t -79.66 134.95 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -96.3 -52.24 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.97 134.94 46.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -93.92 59.81 2.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 16.9 tt0 -140.59 123.44 16.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.5 139.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.524 ' C ' HG22 ' A' ' 49' ' ' THR . 20.5 m-85 -117.66 174.82 5.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -168.36 155.73 7.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.86 2.373 . . . . 0.0 112.189 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.298 0.571 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -163.58 -156.2 8.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.7 117.07 21.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -1.14 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.43 173.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.91 148.43 50.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.419 ' O ' ' CD ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -46.47 -26.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.13 34.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.31 -50.29 72.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 t -60.21 -20.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 65' ' ' LYS . 14.2 mt-10 -76.91 -25.27 52.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.542 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 -22.21 45.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.23 -54.7 2.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -167.94 70.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 138.05 6.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -166.97 -27.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.85 31.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -103.69 177.57 4.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.395 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' ILE . 16.3 mttm -83.95 133.86 34.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 5.3 tp -40.54 -32.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' LYS . 60.8 mt-10 -54.71 -56.16 22.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 tp10 -48.63 -62.64 1.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 80' ' ' GLU . 65.8 t -39.66 -58.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.421 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.814 HG21 HG21 ' A' ' 42' ' ' VAL . 96.7 mt -50.32 -20.35 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 80' ' ' GLU . 1.2 t70 -76.47 -69.17 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 83' ' ' ASP . 7.7 mt -38.55 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.6 mt -74.58 -70.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.571 ' N ' HG22 ' A' ' 85' ' ' ILE . 8.2 mt -42.16 -38.26 1.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -43.79 -26.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 86' ' ' LEU . 9.5 t-20 -107.78 -70.85 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 123.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.155 -1.203 . . . . 0.0 109.457 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 m -158.64 150.47 21.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -111.95 123.72 50.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.12 123.55 37.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.11 140.93 29.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.457 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.34 104.5 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -81.97 124.73 30.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 -153.12 28.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -52.98 -70.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -125.31 -21.02 4.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -92.37 161.26 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -121.73 144.95 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -137.95 148.6 45.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.1 mt -120.64 153.78 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 173.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.424 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -109.84 154.03 23.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.392 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' ALA . . . -154.05 128.24 9.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' ALA . . . -47.37 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.503 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.35 165.97 12.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -73.99 -28.17 61.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.33 -56.72 17.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.02 -51.48 69.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.396 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -46.44 -45.89 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 27' ' ' ASP . 1.6 t70 -62.66 -43.58 98.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 37' ' ' LYS . 6.4 mt-10 -60.94 -27.87 68.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -70.38 -36.56 74.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.86 -48.83 77.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -25.21 50.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.448 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 11.1 t30 -136.21 68.16 62.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 154.23 53.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.849 2.366 . . . . 0.0 112.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.35 173.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 tp -88.24 -31.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.96 -14.38 80.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.48 ' O ' HG23 ' A' ' 41' ' ' VAL . 67.5 tttt -101.93 -12.4 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.57 -48.75 53.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' VAL . 3.1 m -49.23 -45.37 44.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.54 -56.96 14.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' LYS . 55.5 t -50.21 -59.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 82' ' ' ILE . 2.7 t -78.27 126.89 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.33 -0.51 46.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.404 ' H ' HG12 ' A' ' 42' ' ' VAL . 12.1 tp -163.72 122.16 1.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.414 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -77.15 83.69 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -163.12 155.12 17.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.8 t -123.29 132.94 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.86 154.7 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.1 164.56 24.42 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.849 2.366 . . . . 0.0 112.244 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.41 159.37 24.4 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.75 156.26 17.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -1.19 . . . . 0.0 109.422 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.55 171.6 7.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' LYS . 76.7 p -121.89 150.52 41.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' SER . 7.8 pttt -41.92 -30.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 67' ' ' GLN . . . -73.65 -58.53 3.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.244 -0.91 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -38.16 -49.05 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.31 -51.87 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.639 ' O ' ' N ' ' A' ' 73' ' ' GLY . 31.1 tt0 -49.33 -29.01 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 109.399 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.94 -19.21 63.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.92 -27.02 14.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CE2' HG13 ' A' ' 81' ' ' VAL . 84.3 m-85 -113.14 -11.0 13.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.488 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 62.14 0.31 2.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 72' ' ' PHE . 6.4 mtpp -139.09 -49.37 0.5 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.495 -1.003 . . . . 0.0 109.537 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 81' ' ' VAL . . . 78.74 -61.7 3.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 49.49 -168.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -56.59 133.18 53.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 tp -55.36 -26.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -56.44 -41.91 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 81' ' ' VAL . 35.5 mt-10 -73.42 -58.62 3.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.473 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 72' ' ' PHE . 2.9 t -42.48 -38.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.515 HG21 HG21 ' A' ' 42' ' ' VAL . 61.2 mt -63.68 -46.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 35.7 t0 -60.58 -52.29 65.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.6 mt -45.29 -41.85 9.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.87 -40.25 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 88' ' ' ASN . 82.2 mt -60.24 -42.72 95.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -44.95 -20.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.43 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' LEU . 82.4 m-20 -124.51 -81.98 0.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 75.15 124.74 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 89' ' ' GLY . 5.2 mmmt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.217 -1.167 . . . . 0.0 109.373 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.313 0.578 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -92.62 161.47 14.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -113.1 122.65 48.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.46 ' CE1' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -92.63 104.61 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.18 137.57 47.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.91 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.13 105.91 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -75.95 114.43 14.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' ASN . . . -75.44 170.89 54.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.65 -17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -1.177 . . . . 0.0 109.389 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 t-20 -168.93 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 118.65 29.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 132.75 49.97 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.18 -0.95 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -129.18 142.53 50.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.37 142.37 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.5 175.13 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.75 160.84 14.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.46 164.57 29.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.82 -76.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 152.03 40.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -38.29 85.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.82 -61.32 2.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.3 mt -58.64 -63.58 1.23 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 25' ' ' LEU . 90.6 t -35.53 -35.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' LEU . 19.6 t0 -77.3 -35.02 55.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.368 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 25' ' ' LEU . 4.8 pt-20 -64.9 -28.2 69.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.416 ' N ' ' HG2' ' A' ' 28' ' ' GLU . 48.0 t80 -74.67 -50.23 18.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.7 mt -46.62 -23.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -74.07 -45.36 49.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -123.95 78.02 58.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.0 109.426 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 34' ' ' SER . 56.4 Cg_exo -47.17 156.87 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.792 2.328 . . . . 0.0 112.204 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 162.39 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 35' ' ' ILE . 22.0 mm -88.52 20.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.29 -45.39 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.621 ' HZ3' ' HG3' ' A' ' 28' ' ' GLU . 24.6 tttt -73.76 -11.29 60.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 109.435 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.25 -27.43 65.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.47 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -67.21 -18.27 65.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -89.21 -41.21 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.86 -66.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -70.24 113.64 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 109.549 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.63 -60.76 2.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.18 150.89 21.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -103.6 52.45 0.77 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -137.16 159.76 40.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.47 144.41 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 14.0 m-85 -118.91 154.23 33.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -144.75 156.71 55.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.425 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.175 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.28 -170.26 24.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.2 115.68 20.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -1.128 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -53.78 154.99 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 66' ' ' ALA . 4.7 m -98.09 147.85 24.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' O ' ' OE1' ' A' ' 69' ' ' GLU . 4.5 pttp -43.79 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -83.81 -48.29 10.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.603 ' NE2' ' C ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -54.86 -43.68 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.22 -41.52 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 28.1 mt-10 -64.01 -40.22 95.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.4 -40.17 81.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.26 -67.68 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -90.91 -75.88 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.05 166.68 11.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.2 -2.55 52.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.527 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.78 -7.19 20.81 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -133.37 149.14 51.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -67.98 -167.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -86.53 -37.83 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -61.67 -28.26 69.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.64 -44.47 33.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 t -53.35 -46.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.543 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.583 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.6 mp -60.67 -40.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -48.35 -53.71 16.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.55 -32.36 68.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 82' ' ' ILE . 85.8 mt -67.68 -29.19 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.549 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.7 mt -82.39 -26.32 32.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -93.2 3.63 55.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 88' ' ' ASN . 18.8 t30 -161.54 57.73 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.92 -131.04 6.53 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.495 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.0 m -149.79 135.47 18.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -99.06 129.07 45.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.605 ' O ' HG23 ' A' ' 17' ' ' ILE . 1.3 m-85 -104.13 160.31 14.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -127.95 157.39 40.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -142.87 129.72 20.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.858 . . . . 0.0 109.509 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -105.03 105.79 15.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.67 -150.58 24.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 15.1 mm-40 -49.67 -51.27 39.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -148.01 -46.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.447 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -72.54 143.6 48.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.77 138.07 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 16' ' ' LEU . 76.1 mt -113.13 157.17 21.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.475 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 7' ' ' TYR . 7.8 mt -130.26 154.32 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.424 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.627 HG21 HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -137.9 179.91 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.88 153.45 35.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.51 177.3 11.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.51 -46.81 5.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.65 137.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -49.55 -31.3 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.436 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -67.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.06 -48.43 44.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' A' ' 27' ' ' ASP . 76.3 t -50.8 -66.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' C ' ' O ' ' A' ' 26' ' ' VAL . 37.6 t70 -36.3 -43.33 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.92 -50.61 70.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 32' ' ' ASN . 62.1 t80 -51.3 -49.7 60.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 30' ' ' LEU . 19.9 mt -41.72 -56.29 2.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -73.9 -3.5 29.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 29' ' ' TYR . 8.7 m120 -135.83 69.36 65.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -73.64 131.6 16.24 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.873 2.382 . . . . 0.0 112.219 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.25 154.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -85.72 66.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.46 -50.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -75.69 -26.02 57.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD13 ' CZ ' ' A' ' 29' ' ' TYR . 2.7 tp -57.9 -33.37 68.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -36.62 76.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.78 -39.24 66.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' A' ' 26' ' ' VAL . 48.7 t -70.76 -69.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.67 117.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' C ' HD12 ' A' ' 44' ' ' LEU . 95.2 mt-10 -81.76 -40.97 21.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 43' ' ' GLU . 9.3 mp -112.27 128.38 56.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.67 78.29 4.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -163.73 159.95 22.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.08 143.15 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -128.1 155.22 44.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.488 ' O ' HD23 ' A' ' 60' ' ' LEU . 41.5 p -118.99 149.38 46.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 C--N 1.305 -1.728 0 C-N-CA 122.75 2.3 . . . . 0.0 112.221 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 49' ' ' THR . 5.8 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.74 108.33 0.82 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.34 142.12 17.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -1.182 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.29 28.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -88.26 148.04 24.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.6 mttt -41.43 -19.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -68.2 -61.51 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -53.23 -34.73 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.18 -31.32 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.1 mt-10 -68.91 -63.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 69' ' ' GLU . 20.0 m-20 -39.36 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -85.52 -67.71 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.454 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 71' ' ' GLU . 20.4 m-85 -115.02 25.5 10.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.506 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.65 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 52.72 -162.12 2.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 76' ' ' LYS . 2.3 tttp -109.94 -149.46 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -1.152 . . . . 0.0 109.454 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 -26.14 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 74' ' ' LYS . 21.4 mttt -91.42 -172.35 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -122.99 157.17 33.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tp -51.41 -30.74 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.41 -50.29 66.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.413 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -57.69 -52.83 63.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.1 t -47.87 -59.08 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.97 -42.47 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.495 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 28.5 t0 -52.68 -51.02 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.459 ' O ' ' OD1' ' A' ' 88' ' ' ASN . 10.5 mt -60.03 -43.15 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.627 HG21 HG21 ' A' ' 18' ' ' VAL . 27.9 mm -47.98 -62.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.3 -23.3 22.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -67.02 -36.37 81.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -93.48 -77.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.469 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.58 130.25 1.16 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 tptp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.43 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -101.67 -173.61 2.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.649 ' NZ ' HG21 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -136.01 133.92 37.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -99.14 119.35 37.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.59 166.24 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -165.31 109.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -90.31 103.08 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.58 -157.36 0.79 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 3.8 tt0 -48.23 -67.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.146 . . . . 0.0 109.427 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 2.9 m120 -128.54 -26.26 2.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.12 155.38 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -113.45 136.86 52.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -132.7 153.44 51.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.649 HG21 ' NZ ' ' A' ' 6' ' ' LYS . 41.1 mt -134.18 145.21 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.922 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.24 173.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -108.72 148.05 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.09 178.58 6.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.446 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.03 -55.01 3.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -172.4 166.63 5.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -72.02 -21.96 61.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.57 -66.61 0.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -53.81 -49.58 68.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -49.32 -50.37 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.83 -29.4 64.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.73 -34.69 64.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 32' ' ' ASN . 54.0 t80 -62.55 -48.06 81.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' TYR . 67.8 mt -43.36 -59.53 2.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.867 . . . . 0.0 109.498 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -18.95 65.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TYR . 64.5 t30 -121.98 87.44 47.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.42 54.43 5.18 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -106.13 105.02 14.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.443 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' SER . 14.6 tt -42.64 -32.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.26 -41.2 78.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -73.12 -27.48 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -1.164 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.09 -39.84 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.0 t -58.22 -21.04 46.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -87.18 -34.73 18.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 42' ' ' VAL . 9.3 t -75.81 -72.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.509 ' N ' HG12 ' A' ' 41' ' ' VAL . 23.3 t -57.73 118.26 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.26 -32.78 20.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -137.31 114.95 11.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.98 94.22 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -167.4 158.17 11.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.81 140.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.54 -170.27 1.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.43 150.12 0.97 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--N 1.305 -1.732 0 C-N-CA 122.833 2.355 . . . . 0.0 112.254 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.21 -167.45 11.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.96 110.21 16.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -1.188 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.8 155.65 1.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -93.87 155.91 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.937 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -59.03 -16.07 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 -39.54 13.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -60.26 -46.28 90.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.74 -42.97 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.56 -23.34 66.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.85 -26.68 49.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.27 -32.79 55.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.832 ' CE2' HG13 ' A' ' 81' ' ' VAL . 78.5 m-85 -104.41 -61.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.63 136.9 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -64.4 98.48 0.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.05 -6.8 0.12 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -101.63 129.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -1.107 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -59.78 -165.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.1 tp -91.89 -34.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.46 -35.28 73.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.07 -43.69 82.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.832 HG13 ' CE2' ' A' ' 72' ' ' PHE . 54.8 t -65.55 -60.77 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 82' ' ' ILE . 5.9 mm -46.04 -32.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 84' ' ' LEU . 19.8 t70 -66.94 -65.14 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' ASP . 15.5 mt -38.44 -30.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' ASP . 90.1 mt -76.95 -50.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.903 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -58.26 -13.93 6.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -82.46 -38.08 24.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 1.9 t-20 -85.28 -68.07 0.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 59.68 119.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.5 tttp . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.457 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.3 m -148.39 142.19 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -108.26 127.54 53.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.903 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.13 144.44 30.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.495 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -113.06 121.13 43.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 10' ' ' LYS . 69.6 t80 -126.92 140.85 52.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.485 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 9.7 tttt -101.26 140.96 34.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.94 -166.68 27.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -94.99 -33.07 12.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.134 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.44 -30.01 7.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 t -145.28 179.1 7.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.1 t70 -98.1 161.99 13.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 62.1 mt -140.24 140.03 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.9 136.99 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 109.409 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 171.3 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.95 163.49 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.446 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.99 -177.05 6.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.62 -71.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.388 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.13 140.09 37.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 26' ' ' VAL . 39.0 mt-10 -50.75 -55.95 14.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.918 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 23' ' ' GLU . 13.5 tp10 -37.65 -44.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.56 -27.28 64.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' A' ' 23' ' ' GLU . 89.6 t -73.3 -54.08 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.2 -24.22 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -75.31 -38.56 60.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 32' ' ' ASN . 76.6 t80 -60.04 -49.54 77.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mt -45.68 -32.43 2.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -91.06 -3.0 57.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' TYR . 52.5 m-80 -142.72 61.47 11.08 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.85 93.31 0.95 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.85 2.366 . . . . 0.0 112.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -162.53 132.31 4.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.3 mm -46.46 117.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.11 -63.1 0.38 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -79.88 -28.67 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.401 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' LYS . 5.0 tp -42.77 -40.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 t -67.83 -37.19 81.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' LYS . 17.6 tt0 -62.7 -18.34 62.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.93 -74.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 42' ' ' VAL . 5.7 t -57.55 157.54 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.378 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -117.87 -68.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.1 tp -95.38 111.57 23.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.86 74.37 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 47' ' ' VAL . 11.6 tp10 -156.03 157.87 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.428 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 6.6 t -128.17 128.29 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.56 156.98 22.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.493 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.95 156.92 34.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.305 -1.733 0 C-N-CA 122.793 2.328 . . . . 0.0 112.192 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.33 9.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.29 134.0 56.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -1.126 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.49 130.13 39.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.561 ' O ' ' N ' ' A' ' 67' ' ' GLN . 13.6 m -81.23 131.08 35.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 64' ' ' SER . 1.7 ptpt -40.47 -40.24 1.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.16 67.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.29 -50.96 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.16 -41.7 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 71' ' ' GLU . 39.9 mt-10 -55.58 -41.6 73.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.9 t-20 -40.37 -19.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.648 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.5 mm-40 -114.37 -60.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -164.98 72.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' A' ' 69' ' ' GLU . . . -129.4 0.13 5.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -85.5 106.58 16.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.516 -0.99 . . . . 0.0 109.485 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.9 32.6 63.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -130.84 100.18 5.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -1.147 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.552 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 9.4 mtpm? -46.55 155.09 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.49 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.5 -21.5 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.552 ' OE1' ' NZ ' ' A' ' 77' ' ' LYS . 9.6 mt-10 -69.0 -51.99 33.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.14 -42.94 83.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -48.21 -51.49 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.1 mt -61.21 -35.59 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.877 . . . . 0.0 109.535 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' LEU . 46.0 t0 -60.34 -66.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 83' ' ' ASP . 16.4 mt -40.47 -32.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 mt -80.57 -31.17 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.9 mt -77.66 -0.39 26.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -75.67 -40.86 55.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.621 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 0.4 OUTLIER -96.25 -73.38 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.88 117.31 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.427 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.262 0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.26 159.43 15.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -121.73 132.43 54.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.645 ' OH ' HG11 ' A' ' 26' ' ' VAL . 1.9 m-85 -95.75 117.59 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -81.92 138.04 35.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -131.54 90.06 2.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.965 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -56.77 96.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 12' ' ' GLU . . . -71.51 -162.59 5.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' H ' ' CG ' ' A' ' 71' ' ' GLU . 1.1 tt0 -49.37 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.477 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.569 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -100.21 -0.63 38.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 109.478 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -113.05 174.85 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -117.26 122.49 44.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.663 HD22 ' CG1' ' A' ' 47' ' ' VAL . 53.1 mt -106.17 132.24 52.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.3 mt -118.55 146.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.593 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG21 HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -131.11 169.81 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -103.37 155.23 18.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.84 -171.4 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.52 2.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -168.69 135.52 1.9 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -45.69 -24.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.66 -65.64 0.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.438 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.65 -20.42 21.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.645 HG11 ' OH ' ' A' ' 7' ' ' TYR . 4.4 t -79.15 -52.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -44.36 96.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 109.406 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.8 mt-10 -56.5 -54.88 40.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 68.4 t80 -46.98 -44.13 19.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.46 -20.57 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.323 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 14.2 mtmt -92.81 -22.34 19.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 31' ' ' LYS . 9.0 m-20 -143.57 66.16 15.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' SER . 42.2 Cg_endo -71.53 170.03 19.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.801 2.334 . . . . 0.0 112.208 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER 166.92 22.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 35' ' ' ILE . 38.3 mm 47.13 13.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' SER . . . -107.48 -53.59 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -71.86 -25.75 62.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 38' ' ' LEU . 15.2 tp -48.7 -22.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 36' ' ' GLY . 2.7 p -71.39 -18.39 62.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -98.18 -20.94 16.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.84 -42.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.44 141.6 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.485 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' HD23 ' A' ' 44' ' ' LEU . 39.1 mt-10 -102.09 -44.48 5.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 43' ' ' GLU . 7.5 mt -121.7 105.92 10.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -66.43 72.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CG ' ' H ' ' A' ' 47' ' ' VAL . 5.8 tt0 -152.65 178.57 9.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.663 ' CG1' HD22 ' A' ' 16' ' ' LEU . 82.2 t -123.5 131.73 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.569 ' C ' HG22 ' A' ' 49' ' ' THR . 57.7 m-85 -118.35 176.83 5.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER 173.94 151.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.304 -1.776 0 C-N-CA 122.839 2.359 . . . . 0.0 112.156 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.9 -177.87 38.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.75 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -63.49 -178.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -103.22 136.16 43.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 3.5 mttt -43.28 -27.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.52 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -78.45 -20.5 50.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 64' ' ' SER . 10.5 mt-30 -81.17 -39.66 25.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.77 -32.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.7 mt-10 -62.41 -21.58 65.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -82.35 -33.77 28.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.579 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -80.82 -24.19 38.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.69 -30.02 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . 115.79 -130.45 9.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 75' ' ' GLY . 5.3 mtpt -67.02 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.142 -1.211 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . 40.08 66.79 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 77' ' ' LYS . 30.2 mttp -51.71 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -1.194 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 76' ' ' LYS . 28.3 mttp -41.13 130.97 2.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 79' ' ' GLU . 2.7 tp -41.9 -37.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 78' ' ' ILE . 10.8 mt-10 -52.91 -56.72 13.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.55 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -53.05 -41.5 64.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 82' ' ' ILE . 7.5 t -58.7 -68.19 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.456 ' N ' HG12 ' A' ' 81' ' ' VAL . 15.8 mt -42.95 -39.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 109.486 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -61.74 -63.82 1.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 83' ' ' ASP . 5.5 mt -43.64 -35.29 1.72 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.49 HG21 HG21 ' A' ' 18' ' ' VAL . 71.7 mt -65.22 -66.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.421 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 5.0 mt -49.62 -26.71 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.739 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -42.19 -43.88 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -77.53 0.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.6 132.85 3.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.494 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.35 158.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -118.34 139.44 51.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.483 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -114.86 117.64 31.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.379 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.18 126.61 45.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.853 . . . . 0.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -120.88 106.51 11.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -79.36 94.83 5.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.93 -166.84 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -63.13 -53.74 48.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.38 -1.54 3.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 137.32 54.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.52 121.64 45.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -119.19 147.19 44.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.6 mt -116.81 147.55 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.65 161.93 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -95.16 149.38 21.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.03 144.36 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.92 -69.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 149.37 46.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.08 -35.51 80.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.24 -58.29 8.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB3' HG22 ' A' ' 41' ' ' VAL . 9.2 mt -50.07 -59.26 4.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.508 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.483 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 4.4 t -39.88 -59.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -48.41 -42.36 31.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 25' ' ' LEU . 6.0 mt-10 -60.65 -46.22 91.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.848 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' N ' ' NZ ' ' A' ' 37' ' ' LYS . 31.0 t80 -49.83 -54.92 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.2 mt -52.55 -22.87 5.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -88.27 -26.51 22.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -130.89 58.35 38.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 93.94 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.896 2.397 . . . . 0.0 112.245 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.8 t -155.66 27.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 36' ' ' GLY . 27.8 mm 59.41 169.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.589 ' N ' HG22 ' A' ' 35' ' ' ILE . . . 92.92 -38.54 3.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.587 ' NZ ' ' N ' ' A' ' 29' ' ' TYR . 25.9 tttm -105.5 -6.36 19.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -1.123 . . . . 0.0 109.453 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.93 -23.11 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.23 -33.38 59.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.47 -27.56 61.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 25' ' ' LEU . 40.7 t -86.59 -64.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.76 146.66 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -97.9 -55.5 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.42 154.71 19.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.01 65.9 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -156.53 157.27 35.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.81 140.65 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.2 m-85 -114.92 170.13 8.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.23 152.98 72.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.05 -174.19 27.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.5 49.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -1.131 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 128.88 36.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.27 150.04 47.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -50.32 -25.23 3.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.505 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.12 -42.65 79.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 68' ' ' VAL . 4.2 tt0 -62.64 -61.51 2.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 67' ' ' GLN . 19.0 t -42.96 -48.34 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -47.92 -24.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.39 -19.97 55.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' VAL . 5.6 mm-40 -92.18 -66.05 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -156.8 66.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.93 130.31 2.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -164.74 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.98 -22.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -72.16 -165.57 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.6 mttm -109.78 -161.98 0.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -90.81 -42.77 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -49.82 -55.47 14.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -56.3 -48.83 75.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 77' ' ' LYS . 21.2 t -44.56 -54.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.46 -35.55 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -53.93 -49.3 68.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' ARG . 16.4 mt -57.16 -54.54 45.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 84' ' ' LEU . 56.3 mt -43.19 -44.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.3 mt -69.52 -27.29 65.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 84' ' ' LEU . 4.2 tpt180 -51.75 -28.41 15.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.545 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -83.17 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 69.13 127.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' GLY . 7.0 mttp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 0.0 109.353 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -146.33 146.15 30.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' A' ' 6' ' ' LYS . 11.0 mtpp -114.73 133.31 55.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.498 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.87 132.01 43.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.94 147.22 24.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -141.1 107.85 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -89.73 92.64 9.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 13' ' ' ASN . . . -56.46 171.33 2.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.5 -5.81 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -1.145 . . . . 0.0 109.542 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' GLY . 23.1 t30 -161.09 -54.81 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.509 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -84.91 152.87 23.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -115.87 130.58 56.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.83 156.92 46.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 mt -121.75 152.75 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.49 166.78 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.503 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.51 153.4 22.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.45 161.41 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.5 -76.17 0.28 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -135.9 155.04 50.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -67.06 -31.62 72.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -50.1 -61.13 2.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.458 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 28' ' ' GLU . 12.6 mt -55.55 -52.45 63.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' LEU . 10.9 t -45.5 -50.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.9 -24.56 67.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 42.4 mm-40 -79.53 -37.63 36.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.474 ' CE1' HD13 ' A' ' 38' ' ' LEU . 60.3 t80 -60.35 -44.38 95.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.06 -35.62 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.498 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -76.39 -37.98 56.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.4 72.08 80.21 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.53 136.77 20.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.857 2.371 . . . . 0.0 112.248 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.06 130.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.48 -44.21 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -10.52 5.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -49.27 5.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -1.122 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD13 ' CE1' ' A' ' 29' ' ' TYR . 3.4 tp -47.2 -21.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -32.06 73.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.21 -45.76 11.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.6 -54.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG11 ' CD1' ' A' ' 45' ' ' PHE . 91.6 t -71.62 134.33 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 35.17 3.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.41 -40.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CD1' HG11 ' A' ' 42' ' ' VAL . 36.2 m-85 56.4 62.01 2.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.539 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -158.1 161.73 37.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.61 123.78 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -110.59 171.18 7.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.68 159.01 37.0 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 C-N-CA 122.856 2.371 . . . . 0.0 112.192 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.58 152.51 20.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.54 146.18 26.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -1.14 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.8 -170.76 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.6 m -113.38 147.24 38.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 74.5 mttt -49.04 -32.58 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.704 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -64.6 -42.72 95.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.48 -38.27 86.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.48 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' GLU . 41.4 t -66.34 -55.19 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 73' ' ' GLY . 2.0 mt-10 -44.96 -35.55 2.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.704 ' ND2' ' O ' ' A' ' 66' ' ' ALA . 27.8 m-80 -66.29 -17.97 65.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 68' ' ' VAL . 2.3 mp0 -108.88 -6.97 15.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.545 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -146.1 16.74 1.38 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 48.32 -133.96 19.31 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER -42.78 109.03 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -1.155 . . . . 0.0 109.447 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.13 87.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' LYS . 16.7 mttt -66.52 -179.1 0.78 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.398 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -47.82 138.76 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.37 -22.41 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.92 -28.97 62.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.563 ' CA ' ' OE1' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.05 -47.95 14.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.514 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -50.99 -48.83 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.506 HG22 HD11 ' A' ' 86' ' ' LEU . 74.4 mt -63.96 -36.52 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' LEU . 56.8 t0 -58.66 -64.18 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ASP . 98.5 mt -42.18 -46.32 4.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 87' ' ' ARG . 74.2 mt -57.86 -58.16 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.506 HD11 HG22 ' A' ' 82' ' ' ILE . 10.2 mt -56.16 -7.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.701 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -111.21 -20.82 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -140.91 66.44 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.57 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -147.64 -138.92 3.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 89' ' ' GLY . 16.8 ttpp . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.573 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.293 0.568 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.8 142.57 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -102.4 131.6 48.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 26' ' ' VAL . 1.1 m-85 -99.85 116.58 32.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 17.9 m-85 -91.23 142.9 27.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -132.72 102.2 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -81.4 93.37 6.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.14 -156.57 8.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -46.77 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.26 -13.82 9.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.59 147.49 23.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -117.28 115.85 26.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.95 152.69 24.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.8 mt -137.77 114.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -172.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.415 ' CD2' ' CD1' ' A' ' 44' ' ' LEU . 4.5 m-85 -104.57 169.63 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.15 149.79 5.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.69 -59.54 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 p -155.92 142.92 19.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -53.69 -33.93 57.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.225 -0.922 . . . . 0.0 109.514 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 13.6 tt0 -54.65 -64.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.8 mt -44.64 -58.04 3.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' LEU . 96.1 t -40.39 -45.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -60.51 -36.06 77.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 25' ' ' LEU . 5.6 mt-10 -67.28 -23.14 65.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -85.07 -28.69 25.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.93 -40.42 95.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -74.45 -32.77 62.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.561 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -124.67 73.52 62.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.74 114.37 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.76 2.306 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -144.27 -112.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -162.68 -14.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.11 -52.49 4.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -65.45 -8.38 18.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.149 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.14 -54.31 31.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 p -48.84 -20.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -84.06 -44.09 14.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.66 -70.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 42' ' ' VAL . 2.4 t -68.14 129.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.419 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.77 -36.45 15.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -123.89 112.51 17.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.485 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.44 80.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' LEU . 4.6 tp10 -165.39 157.25 14.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.91 129.55 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -111.97 160.01 17.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 168.62 16.15 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.838 2.359 . . . . 0.0 112.233 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.47 178.97 16.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.73 148.8 47.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -1.172 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.7 150.55 21.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.72 174.6 6.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.426 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -70.58 -31.84 69.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.16 -43.3 87.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -62.71 -52.48 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' GLU . 95.3 t -60.05 -41.99 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.972 . . . . 0.0 109.541 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -45.04 -42.44 8.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.9 . . . . 0.0 109.525 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -69.96 -26.07 63.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -81.58 -25.43 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -137.66 -71.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.51 -172.02 36.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 75' ' ' GLY . 56.5 tttp -115.33 159.22 21.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 74' ' ' LYS . . . 101.62 -22.37 38.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -78.67 -168.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -1.113 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 78' ' ' ILE . 22.8 mttm -124.71 137.87 54.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -39.55 -45.39 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 4.8 mt-10 -64.22 -43.92 93.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' LYS . 2.5 tp10 -59.2 -36.24 75.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' C ' ' A' ' 82' ' ' ILE . 6.5 t -70.44 -60.38 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 81' ' ' VAL . 94.8 mt -39.54 -42.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.497 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -56.6 -57.08 13.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -54.63 -30.97 56.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 86' ' ' LEU . 1.9 mm -68.44 -64.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.45 ' N ' HG22 ' A' ' 85' ' ' ILE . 4.8 mt -45.19 -42.92 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -46.46 -53.26 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.81 -82.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.476 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.49 119.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.318 -1.107 . . . . 0.0 109.465 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 m -93.6 139.43 30.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.5 115.79 30.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.683 ' OH ' HG11 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -95.39 137.83 33.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 41.8 m-85 -115.4 150.47 36.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.572 ' HB2' HG23 ' A' ' 85' ' ' ILE . 67.0 t80 -139.78 123.91 17.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -101.0 99.79 10.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.71 -147.52 0.08 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -97.08 -43.22 7.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.468 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.6 -3.29 3.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.927 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.58 158.62 40.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.7 144.33 47.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -134.91 160.85 36.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 92.2 mt -140.89 140.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.13 156.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -93.25 154.28 18.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.66 168.9 18.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.12 -58.36 2.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.4 p -156.11 148.82 23.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.96 -26.68 68.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.76 -41.18 75.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.483 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.2 mt -69.97 -26.32 64.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.683 HG11 ' OH ' ' A' ' 7' ' ' TYR . 45.7 t -76.6 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' VAL . 1.5 t0 -43.61 -43.45 5.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.333 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 1.7 mt-10 -61.58 -45.7 93.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.493 ' OH ' ' O ' ' A' ' 34' ' ' SER . 91.6 t80 -59.86 -33.29 71.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 30' ' ' LEU . 40.1 mt -69.36 -40.03 77.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -59.87 -23.92 63.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.562 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 5.6 p-10 -153.72 81.37 4.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.78 144.62 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.836 2.357 . . . . 0.0 112.296 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.493 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -154.42 -169.78 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -126.52 -19.6 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.1 -57.64 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -49.66 -25.5 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tp -47.0 -24.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.427 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -69.95 -62.5 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.52 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.68 -39.78 37.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.28 -48.31 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 44' ' ' LEU . 21.7 t -105.53 128.85 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 -1.86 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.665 ' H ' HG12 ' A' ' 42' ' ' VAL . 2.7 tp -157.18 123.72 4.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.36 94.43 8.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -168.68 152.21 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.975 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 t -120.03 119.15 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.493 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.1 152.18 23.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.411 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -117.13 149.87 45.12 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 C-N-CA 122.784 2.323 . . . . 0.0 112.147 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.68 36.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.3 49.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -1.15 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 169.99 10.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.0 161.64 13.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -57.78 -46.23 84.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.62 -22.16 12.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -83.36 -58.62 2.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.34 -29.14 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.9 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' GLU . 46.5 mt-10 -71.55 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 69' ' ' GLU . 7.9 t30 -38.53 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.518 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 69' ' ' GLU . 15.6 mm-40 -75.74 -62.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.667 ' CE2' HG13 ' A' ' 81' ' ' VAL . 90.8 m-85 -94.08 -72.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.567 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.29 177.45 41.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -96.87 170.61 9.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -1.096 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.1 -29.9 4.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -76.85 156.4 32.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -1.131 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -97.35 -176.31 3.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.905 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 79' ' ' GLU . 2.9 tp -73.87 -36.37 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 78' ' ' ILE . 10.8 pt-20 -62.77 -49.51 74.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -55.64 -60.85 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.667 HG13 ' CE2' ' A' ' 72' ' ' PHE . 3.4 t -41.68 -62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 83' ' ' ASP . 17.0 mt -45.14 -51.52 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -37.32 -55.26 1.04 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 45.6 mt -56.03 -59.64 4.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 9' ' ' TYR . 76.9 mt -38.26 -41.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.98 -33.75 76.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 84' ' ' LEU . 14.5 ttt180 -62.95 -14.08 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -105.35 -89.11 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.75 127.5 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tptt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.497 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.13 133.57 54.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.455 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -106.17 117.6 34.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CZ ' ' HD2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -89.45 126.82 35.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 2.3 m-85 -89.25 160.14 17.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.521 ' HB2' HG23 ' A' ' 85' ' ' ILE . 44.8 t80 -150.63 105.61 3.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.45 126.27 29.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.72 -149.61 24.93 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -70.86 -31.28 67.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -153.39 -51.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -77.4 169.53 18.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD2' ' CD2' ' A' ' 8' ' ' PHE . 48.8 t0 -116.59 134.86 54.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 16' ' ' LEU . 91.5 mt -111.24 136.2 50.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.0 mt -115.98 131.74 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 m -117.74 156.67 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -92.27 150.8 20.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.94 166.03 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.1 -50.21 5.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -165.03 142.53 6.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.468 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.87 -35.76 69.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.444 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -63.89 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -50.22 -45.68 54.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.95 -49.08 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -60.93 -38.15 84.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.4 -36.07 81.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.95 -32.68 69.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 30' ' ' LEU . 6.0 mt -54.05 -31.88 52.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.468 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' ' CG ' ' A' ' 31' ' ' LYS . 7.4 tttm -96.32 32.9 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -175.37 58.41 0.19 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.36 99.02 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.879 2.386 . . . . 0.0 112.232 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 m -127.31 -107.04 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 tp -159.32 -23.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -81.52 -73.5 1.19 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -41.17 -22.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.422 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.0 tp -66.81 -38.86 87.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -58.87 -36.12 74.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 41' ' ' VAL . 2.3 tt0 -74.27 -57.38 3.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 40' ' ' GLU . 53.6 t -41.68 -35.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 75.3 t -104.43 122.15 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.02 -27.04 30.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 2.3 mp -129.38 140.26 51.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.28 59.27 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -153.39 163.86 39.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -117.47 151.71 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.91 148.83 51.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.452 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -151.1 155.78 35.02 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 122.861 2.374 . . . . 0.0 112.224 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.43 135.88 11.53 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.1 158.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -1.153 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -88.89 155.71 19.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.2 p -83.04 145.29 29.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -56.17 -16.0 4.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.14 -36.27 16.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.86 -41.72 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.898 . . . . 0.0 109.496 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.06 -46.22 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.516 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.63 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.4 mt-10 -47.73 -38.6 15.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -78.64 -20.99 49.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.75 -31.21 59.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 81' ' ' VAL . 50.7 m-85 -126.69 -18.52 4.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 117.52 -152.59 17.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -138.75 92.96 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -1.126 . . . . 0.0 109.512 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.49 -18.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -95.54 -178.03 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 0.0 109.448 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -107.98 -157.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.88 -31.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -59.93 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.05 -31.35 7.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 72' ' ' PHE . 6.4 t -68.57 -61.96 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' A' ' 85' ' ' ILE . 45.9 mt -55.92 -21.58 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -66.28 -56.12 12.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mt -59.19 -25.54 64.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 82' ' ' ILE . 72.6 mt -69.93 -50.85 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 16.0 mt -72.19 -5.81 38.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.39 -34.98 11.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.48 42.19 1.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -104.97 -133.67 7.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 89' ' ' GLY . 33.2 tttm . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 6' ' ' LYS . 14.9 m -106.69 166.86 10.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.419 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 5' ' ' THR . 13.7 mtpt -128.4 143.76 51.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.643 ' OH ' HG11 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -123.65 113.12 18.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.0 109.479 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -83.66 164.02 19.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 109.408 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -154.21 131.98 11.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.475 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -110.79 112.6 24.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.548 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.0 -149.27 4.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -79.8 -47.37 15.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.453 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.87 -26.65 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 158.25 16.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.6 t0 -114.17 154.76 27.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.421 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.673 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 44.0 mt -137.52 157.72 45.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.73 151.42 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.48 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.9 154.87 27.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 162.68 32.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.47 -65.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.74 129.05 18.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -46.57 -38.88 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.19 -61.44 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' C ' ' A' ' 26' ' ' VAL . 32.0 mt -47.26 -59.6 3.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.643 HG11 ' OH ' ' A' ' 7' ' ' TYR . 97.8 t -38.21 -46.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -46.15 84.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.98 -46.78 87.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -47.22 -52.64 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.64 -25.91 60.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -71.49 -31.68 67.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -158.88 80.36 2.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.19 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.804 2.336 . . . . 0.0 112.271 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 36' ' ' GLY . 1.6 t -118.48 120.26 37.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.245 -0.91 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.55 0.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 34' ' ' SER . . . -85.48 -16.17 64.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' LEU . 4.6 ptmm? -115.66 -10.81 11.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.133 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -38.42 -53.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 41' ' ' VAL . 4.6 p -52.77 -61.37 2.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 39' ' ' SER . 4.6 mm-40 -37.77 -22.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.7 t -96.54 -54.86 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.5 149.38 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.57 -16.46 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.68 98.33 2.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -63.29 89.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -169.04 118.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.406 ' CG1' HD22 ' A' ' 16' ' ' LEU . 61.6 t -79.67 144.82 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.54 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -130.86 163.39 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.13 163.82 37.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.305 -1.758 0 C-N-CA 122.823 2.348 . . . . 0.0 112.24 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.79 137.19 15.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 152.44 22.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.463 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.73 -168.8 1.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.441 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.27 166.42 18.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -20.66 66.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.18 -44.83 13.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -59.38 -41.44 89.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.22 -56.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.73 -34.98 70.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.85 . . . . 0.0 109.515 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -55.39 -27.89 50.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.33 -66.77 0.86 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.536 ' CE1' HG13 ' A' ' 81' ' ' VAL . 25.5 m-85 -71.38 -67.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.38 175.25 21.56 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.86 172.9 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.42 9.94 74.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -131.78 171.0 14.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -1.202 . . . . 0.0 109.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -119.21 -163.16 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.57 -35.22 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.525 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -64.44 -31.59 72.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -84.17 -45.24 13.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.536 HG13 ' CE1' ' A' ' 72' ' ' PHE . 22.8 t -58.56 -34.86 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.05 -46.56 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.21 -45.38 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 84' ' ' LEU . 79.5 mt -61.32 -56.57 18.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mt -47.14 -50.92 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' N ' ' A' ' 88' ' ' ASN . 45.0 mt -58.83 -31.12 68.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -55.74 -9.41 0.54 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 86' ' ' LEU . 2.8 m120 -134.22 -91.68 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 65.51 125.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 89' ' ' GLY . 23.3 mtmt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.344 -1.092 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mtt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.273 0.559 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t 173.82 6.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.9 p -133.01 136.53 46.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.923 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.1 m -89.87 162.84 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -100.95 147.16 26.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -116.7 136.58 52.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' HB2' HG23 ' A' ' 18' ' ' VAL . 2.3 m-85 -118.68 122.73 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -90.82 159.59 16.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -147.49 91.11 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -53.59 113.77 1.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.14 -161.85 33.27 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 1.3 mm-40 -70.92 -45.25 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.01 -41.69 2.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t -101.42 177.89 4.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.41 124.63 49.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.88 127.66 49.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.358 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.18 155.08 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' HB2' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -131.82 154.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.54 153.92 17.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.16 159.18 44.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.96 -73.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 t -145.66 169.89 17.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.53 -26.65 66.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 25' ' ' LEU . 57.7 tt0 -65.49 -74.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' GLU . 5.2 mt -42.39 -33.4 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 27' ' ' ASP . 3.7 t -67.32 -70.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 26' ' ' VAL . 45.4 t0 -41.11 -39.87 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 109.479 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 29' ' ' TYR . 3.1 mm-40 -58.05 -58.8 6.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' GLU . 76.2 t80 -43.33 -51.86 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.938 . . . . 0.0 109.446 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.73 -40.32 83.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -68.55 -4.51 15.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -175.62 79.43 0.3 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.47 140.42 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.769 2.312 . . . . 0.0 112.216 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 t -164.33 94.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -48.54 -27.49 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.59 -9.64 74.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 38' ' ' LEU . 18.2 tttm -112.28 -25.46 9.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -39.13 -31.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -60.79 -69.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.494 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' SER . 35.9 mt-10 -41.33 -36.39 0.8 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.17 -70.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.7 t -85.12 130.31 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 44' ' ' LEU . 2.0 pt-20 -95.17 -31.49 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 43' ' ' GLU . 8.0 mp -111.15 121.42 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -91.6 77.62 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 30.4 tt0 -165.86 143.88 5.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.464 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.58 127.29 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 72.7 m-85 -113.26 154.22 27.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 109.547 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -132.87 164.14 46.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 49' ' ' THR . 66.6 Cg_exo -45.3 -172.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.217 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 53' ' ' GLY . 4.5 pt20 -94.19 172.85 7.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 27.0 p30 -62.94 59.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 51' ' ' GLN . . . 155.51 -164.74 32.2 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -88.2 129.11 35.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -1.17 . . . . 0.0 109.43 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.82 112.34 1.05 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.19 -16.77 39.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.3 -10.91 59.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.13 -143.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 60' ' ' LEU . 51.9 mt-10 -113.65 94.66 4.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.574 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.61 HD23 ' N ' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -38.42 150.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.98 -173.84 14.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.18 151.07 26.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.85 132.88 39.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -74.75 149.29 39.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 29.9 mttt -43.82 -51.36 7.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.76 -34.92 20.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -73.05 -36.71 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -66.13 -34.45 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 109.447 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.53 -28.72 70.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.521 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -52.92 -19.65 2.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -113.75 -73.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -148.46 72.5 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' C ' ' A' ' 74' ' ' LYS . . . -135.24 0.54 3.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 73' ' ' GLY . 10.7 tptm -37.37 -49.37 0.99 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.467 -1.019 . . . . 0.0 109.475 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 3.32 0.83 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -75.64 -175.97 3.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -114.37 -140.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.31 -23.93 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -64.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' ASP . 37.4 mt-10 -47.08 -53.22 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 80' ' ' GLU . 4.7 t -44.3 -58.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.06 -22.47 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 3.9 t0 -69.35 -61.08 1.94 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.45 -46.17 47.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.84 -59.31 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 87' ' ' ARG . 19.5 mt -46.21 -33.78 3.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.74 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -35.78 -66.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.429 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.87 75.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.336 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.31 -117.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -143.79 92.92 6.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -1.092 . . . . 0.0 109.412 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.5 165.27 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.711 2.274 . . . . 0.0 112.178 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -119.82 139.68 51.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -61.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -166.37 165.03 17.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -107.39 56.19 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' A' ' 97' ' ' SER . 7.0 t -53.56 172.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -171.34 -77.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -91.46 -13.79 31.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.26 -160.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 101' ' ' LYS . 2.7 t -147.73 -165.91 2.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.506 ' N ' ' OG1' ' A' ' 100' ' ' THR . 41.8 mttp -88.13 -157.86 0.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.22 161.44 10.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.55 88.69 0.18 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.47 -78.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.13 53.61 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.87 151.21 0.37 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 p -107.19 -20.07 13.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.495 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -149.86 3.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.62 -94.31 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -111.72 131.84 55.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.3 p30 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.526 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.403 ' H3 ' ' HG2' ' A' ' 1' ' ' MET . 5.3 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.6 p -133.47 14.08 4.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -133.72 91.52 2.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.459 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -55.27 -179.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -122.37 131.57 53.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -105.96 131.62 53.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 4.5 m-85 -97.31 123.38 41.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.65 149.69 22.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 9' ' ' TYR . 22.8 t80 -144.69 119.0 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -95.03 132.97 39.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -109.26 -154.2 15.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.2 tp10 -42.82 -82.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -117.78 -34.56 4.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 t -79.0 174.05 11.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.42 145.35 48.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mt -130.38 156.88 43.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 18' ' ' VAL . 48.4 mt -134.98 155.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.927 . . . . 0.0 109.559 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' N ' HG22 ' A' ' 17' ' ' ILE . 18.9 m -136.1 155.93 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -98.46 140.49 32.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.34 168.31 20.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.93 -87.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 p -136.11 171.89 13.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.517 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -68.58 -13.01 62.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.14 -74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.498 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -47.45 -46.63 26.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.527 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 47.6 t -51.72 -54.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -53.42 -45.86 69.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.81 -30.09 63.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 33' ' ' PRO . 60.4 t80 -72.22 -61.24 1.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.402 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.513 HD21 ' O ' ' A' ' 86' ' ' LEU . 10.6 mt -48.27 -44.4 33.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -72.33 -20.94 61.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -150.31 70.59 9.11 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 34' ' ' SER . 54.2 Cg_endo -74.32 162.55 38.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.881 2.387 . . . . 0.0 112.209 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 33' ' ' PRO . 73.8 m -171.26 -104.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.476 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 tp -169.08 -20.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.93 -40.33 5.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -69.05 -18.31 64.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -1.13 . . . . 0.0 109.415 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.99 -29.12 67.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.918 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -33.47 75.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -78.4 -57.25 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -46.62 -60.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.5 122.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.527 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -104.49 -1.37 26.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp -156.29 107.4 2.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.39 87.35 3.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.7 114.22 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.77 144.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -129.7 165.78 21.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.34 151.82 11.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.86 140.66 35.63 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.836 2.358 . . . . 0.0 112.173 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.484 ' C ' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.8 -32.73 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.484 ' OD1' ' C ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -129.28 -32.29 2.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.414 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -56.68 -16.88 18.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 57.94 -3.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' GLY . . . -162.65 -151.12 6.24 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.29 10.66 40.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.57 107.27 17.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.2 -131.79 2.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -129.85 9.75 5.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.527 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt 57.54 -170.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -142.83 174.81 23.39 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.05 127.4 51.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.157 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 144.69 54.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -93.09 155.31 17.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.411 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -38.96 -50.14 1.74 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -56.16 -59.8 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.531 ' C ' ' O ' ' A' ' 66' ' ' ALA . 75.3 mm-40 -35.91 -39.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 38.4 t -84.01 -31.76 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 66' ' ' ALA . 49.5 tt0 -65.37 -39.26 92.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -18.87 65.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.61 -70.18 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -160.07 54.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.09 170.2 21.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 177.81 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 109.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.58 7.15 0.33 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -82.49 166.11 19.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -71.84 -149.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tp -109.4 -13.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.06 -18.72 62.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 -53.33 4.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.43 -39.74 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -72.28 -49.5 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -44.57 -44.79 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' ARG . 14.3 mt -67.44 -60.6 2.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.428 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 84' ' ' LEU . 13.3 mt -40.4 -39.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' HD21 ' A' ' 30' ' ' LEU . 84.6 mt -70.44 -36.01 73.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.716 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -41.7 -62.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.509 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.44 -86.94 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.08 117.14 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' PRO . 47.0 mttp -140.34 62.37 19.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.23 -1.159 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' O ' ' O ' ' A' ' 90' ' ' LYS . 50.8 Cg_exo -48.81 -160.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.805 2.336 . . . . 0.0 112.211 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -82.83 -11.83 57.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 78.27 6.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.477 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' THR . 11.2 p -135.38 4.99 3.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 94' ' ' THR . 12.5 p -51.14 -170.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -89.64 94.92 10.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.58 97.49 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' O ' ' CB ' ' A' ' 99' ' ' LYS . 3.2 mt -109.85 -80.23 0.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.4 tttp 80.34 93.06 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.81 149.6 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 tttp -51.29 110.24 0.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.25 -156.97 9.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.81 -62.19 0.36 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -168.81 104.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -1.144 . . . . 0.0 109.46 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.74 -146.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.497 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.43 28.8 65.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.86 98.71 6.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.44 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 8.0 mttt -76.95 -132.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.484 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 110' ' ' TYR . . . -95.67 6.3 49.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.541 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 109' ' ' ALA . 4.6 t80 70.43 175.4 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.549 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -104.56 -16.86 14.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.513 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -93.31 148.11 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.86 171.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 163.46 12.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -122.84 130.6 53.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 6.0 m-85 -114.68 114.34 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -83.65 142.08 31.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -123.74 144.6 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -114.98 129.12 56.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.05 24.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.51 -34.06 58.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -1.151 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -149.7 -35.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 15' ' ' ASP . 85.1 m -89.51 157.92 17.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 39.3 t0 -106.17 152.17 23.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.634 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 42.9 mt -136.34 160.03 39.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.462 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 mt -145.01 148.87 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.01 147.35 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -86.21 142.37 28.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.94 -171.75 2.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.05 -90.68 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 m -121.53 171.62 8.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.69 -9.6 59.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.03 -54.62 4.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.22 -38.6 83.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.479 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 75.8 t -63.8 -55.94 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.508 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -54.68 -50.5 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -52.39 -31.52 34.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 76.2 t80 -68.3 -41.87 80.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.6 mt -60.46 -23.43 64.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -90.64 -4.49 56.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -167.66 71.55 0.93 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HA ' ' CE1' ' A' ' 29' ' ' TYR . 56.9 Cg_endo -75.29 139.67 23.81 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.812 2.341 . . . . 0.0 112.258 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 m -160.67 -133.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.2 tp -135.44 15.7 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -112.79 -82.97 1.21 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 36' ' ' GLY . 4.1 ttmt -45.05 -22.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.483 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 36' ' ' GLY . 6.0 tp -49.28 -62.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.5 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.89 -47.64 31.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.426 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -29.04 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 37' ' ' LYS . 34.6 t -86.98 -54.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 82' ' ' ILE . 21.5 t -87.63 113.44 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.15 -43.26 24.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 tp -111.15 115.16 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.893 . . . . 0.0 109.453 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' CE1' ' OE2' ' A' ' 79' ' ' GLU . 46.8 m-85 -73.93 65.92 1.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.72 174.9 10.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.447 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.3 t -134.85 128.17 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.93 151.92 22.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.35 150.76 77.35 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' GLN . 41.8 Cg_endo -71.56 138.11 31.68 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.854 2.369 . . . . 0.0 112.176 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.505 ' C ' ' O ' ' A' ' 50' ' ' PRO . 17.7 mt-30 -36.99 -89.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.2 p30 -162.06 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.47 -137.63 9.02 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -91.07 136.34 33.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.11 64.04 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.86 37.76 2.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' C ' ' CD ' ' A' ' 57' ' ' GLU . 13.5 tm-20 -110.77 -37.4 5.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 59' ' ' GLU . . . -132.47 146.17 17.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' C ' ' OE1' ' A' ' 59' ' ' GLU . 0.4 OUTLIER 68.17 92.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -1.159 . . . . 0.0 109.544 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -124.24 -169.35 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.437 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.4 172.09 23.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.67 154.81 17.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -1.138 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.54 133.71 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 169.36 18.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ALA . 63.5 tttt -57.38 -65.86 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.437 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' LYS . . . -43.97 -39.9 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -57.17 -24.08 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -68.23 -24.95 64.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -72.66 -21.34 61.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -105.62 -63.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -165.84 64.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -128.21 -0.01 6.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 73' ' ' GLY . 20.1 tttt -51.69 -101.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.455 -1.027 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 44.56 1.6 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -121.7 133.16 54.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -1.112 . . . . 0.0 109.473 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -56.41 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -84.96 -42.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 8.2 mm-40 -49.48 -55.44 13.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 83' ' ' ASP . 2.1 mt-10 -48.3 -54.26 14.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -45.47 -46.46 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.907 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.557 HG21 HG21 ' A' ' 42' ' ' VAL . 19.1 mm -62.87 -25.93 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.149 -0.969 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' GLU . 52.0 t0 -70.97 -61.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 65.5 mt -49.12 -29.87 5.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 88' ' ' ASN . 58.3 mt -67.74 -66.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ILE . 95.8 mt -43.82 -46.4 7.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -56.58 -30.93 63.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 37.6 t30 -83.76 -81.79 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 57.08 116.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -128.5 60.31 47.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.213 -1.169 . . . . 0.0 109.521 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.94 122.96 8.56 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.845 2.363 . . . . 0.0 112.172 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.615 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.5 OUTLIER -152.99 68.31 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.92 57.74 1.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.1 p -136.42 128.98 30.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.3 p -82.59 -66.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.492 ' N ' ' OG1' ' A' ' 95' ' ' THR . 0.7 OUTLIER -58.92 80.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -89.65 -178.14 5.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.9 150.86 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -115.88 117.91 31.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 51.9 p -119.6 93.18 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 100' ' ' THR . 3.0 tttp 78.59 106.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.82 -147.82 8.27 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.2 -61.16 4.7 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 105' ' ' ALA . 2.9 t-20 -161.17 -19.61 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 0.0 109.522 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 104' ' ' ASN . . . 42.32 -171.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' THR . . . -83.98 -107.82 0.57 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.524 ' C ' ' O ' ' A' ' 106' ' ' GLY . 25.2 p 36.17 -102.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 109' ' ' ALA . 3.3 mttt -48.19 -56.86 6.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 110' ' ' TYR . . . 47.94 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.443 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER 59.6 124.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.516 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.477 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -124.16 119.69 30.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.449 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 61.41 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.475 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 m -93.47 179.62 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -127.81 147.18 50.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -105.27 159.24 16.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.05 112.17 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.45 162.74 28.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -153.3 100.42 2.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -66.74 104.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.55 33.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -47.01 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -1.19 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -106.98 -52.15 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -80.66 174.08 11.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 6.8 t70 -119.43 156.28 30.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.431 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.492 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 22.3 mt -123.2 157.32 33.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.21 143.76 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.24 142.18 36.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.59 -178.45 5.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.16 -73.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.11 166.48 27.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.23 -37.18 77.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.07 -51.79 29.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -51.08 -43.93 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.28 -41.7 97.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.377 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -65.36 -35.03 79.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -65.65 -54.07 32.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.4 mt -52.31 -19.86 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.62 -44.06 52.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.372 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.05 76.48 77.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.448 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.586 ' O ' ' CB ' ' A' ' 34' ' ' SER . 55.5 Cg_exo -47.01 164.19 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.836 2.358 . . . . 0.0 112.24 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 159.61 -173.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.587 ' N ' ' OG ' ' A' ' 34' ' ' SER . 0.6 OUTLIER -114.98 -14.27 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.84 -17.99 76.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -103.14 -18.97 14.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -1.142 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -63.05 -33.31 75.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p -70.32 -20.5 63.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -83.77 -50.41 8.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.64 -36.4 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.97 110.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -80.51 -18.36 48.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.08 142.09 23.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -98.99 68.55 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.0 tp10 -150.65 128.34 11.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 2.0 t -93.09 128.39 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 91.2 m-85 -114.21 155.06 26.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -131.83 152.09 79.7 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.22 122.42 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.743 2.295 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -73.71 -143.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' A' ' 51' ' ' GLN . 1.1 m-20 -53.54 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.56 132.89 32.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 -158.51 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ALA . . . 76.09 25.09 67.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' GLY . . . 58.24 113.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -1.111 . . . . 0.0 109.449 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -133.23 -52.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 148.83 -15.58 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 58.0 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -1.108 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.91 -173.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.895 . . . . 0.0 109.54 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.96 113.13 2.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.37 111.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -1.141 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.533 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -65.48 130.49 43.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' ALA . 73.0 m -93.22 139.66 30.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.1 mttt -41.26 -27.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.423 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -61.4 -39.36 90.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.482 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.11 -57.94 3.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 68' ' ' VAL . 5.6 t -53.16 -24.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.389 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 17.9 mt-10 -68.77 -45.97 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.03 -19.81 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.604 ' OE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.5 tm-20 -88.68 -52.53 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.604 ' CZ ' ' OE1' ' A' ' 71' ' ' GLU . 67.9 m-85 -116.22 32.05 6.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 46.65 -160.32 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.7 29.69 7.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -1.134 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.92 -32.62 8.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -98.3 155.59 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -1.2 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -83.28 -177.55 6.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -15.52 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -70.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -52.8 -35.62 57.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 82' ' ' ILE . 3.0 t -56.4 -64.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.473 ' N ' HG12 ' A' ' 81' ' ' VAL . 31.1 mt -48.79 -31.67 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.469 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -59.47 -73.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -35.56 -44.11 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mt -60.59 -32.28 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.419 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.672 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.6 mt -72.04 -20.4 61.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.897 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.665 ' CB ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -88.29 -3.48 58.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -113.92 -86.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 67.16 121.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER 39.93 59.25 7.0 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 90' ' ' LYS . 61.6 Cg_exo -46.39 149.68 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.773 2.315 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 93' ' ' SER . 17.8 m120 -134.31 -159.31 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.541 ' O ' ' C ' ' A' ' 94' ' ' THR . 1.0 OUTLIER 164.98 -93.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 93' ' ' SER . 60.7 p 35.94 -128.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.17 84.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.0 m -101.64 130.3 47.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.8 OUTLIER -130.67 126.34 36.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.6 mt 47.25 -97.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 97' ' ' SER . 26.7 mtpt -71.22 107.46 4.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.506 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.0 m -45.1 137.72 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt 63.56 53.83 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -50.38 173.41 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -143.33 -76.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -122.85 -149.32 0.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.33 19.09 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.58 116.64 3.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -55.56 -59.55 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -1.102 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -159.27 -24.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.355 -0.841 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.05 -118.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' C ' ' A' ' 111' ' ' ASN . 55.5 m-85 52.16 32.52 10.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 110' ' ' TYR . 75.9 m-20 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ttt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.1 -135.31 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.4 p -117.05 119.87 36.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.485 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.06 139.78 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.16 148.03 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -106.89 129.68 54.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.42 120.63 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -82.07 158.38 23.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -145.44 102.55 3.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.499 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -85.5 104.3 15.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 -157.41 11.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -58.93 -49.24 78.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -1.153 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.65 -33.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -84.78 134.91 34.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.564 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -105.76 138.05 42.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 mt -134.99 151.49 50.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.572 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.6 mt -120.27 150.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.82 151.19 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.521 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.2 144.55 25.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.04 177.64 8.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 -88.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.88 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 26' ' ' VAL . 18.0 t -125.62 168.93 13.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.19 -29.9 34.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -56.53 -47.99 78.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.32 -47.88 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 22' ' ' SER . 94.7 t -49.93 -43.06 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -24.95 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.5 -47.03 28.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 32' ' ' ASN . 63.9 t80 -57.89 -50.02 74.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.471 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 30' ' ' LEU . 82.8 mt -43.82 -32.75 1.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.479 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -91.19 10.03 28.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' TYR . 17.0 m120 -161.25 62.11 1.49 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 47.1 Cg_endo -72.81 113.46 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.815 2.343 . . . . 0.0 112.191 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.518 ' O ' ' OG ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -173.07 34.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.889 HG22 ' H ' ' A' ' 36' ' ' GLY . 29.3 mm 51.24 -177.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.889 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 87.29 -74.78 2.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -67.56 -10.9 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -1.133 . . . . 0.0 109.458 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' VAL . 1.1 tp -59.2 -54.45 46.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' LEU . 70.3 m -43.18 -37.8 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' CD ' ' N ' ' A' ' 40' ' ' GLU . 1.7 mp0 -70.09 -35.88 74.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' LEU . 41.7 t -71.68 -54.8 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.574 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 118.44 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.18 -26.26 25.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tp -125.55 124.05 40.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -90.5 95.99 10.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -167.87 140.09 3.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.428 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -108.96 141.14 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -128.78 178.83 6.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.03 149.08 29.06 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.31 134.7 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.735 2.29 . . . . 0.0 112.138 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -90.1 68.28 7.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.0 t0 51.13 50.87 18.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.404 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.47 175.79 16.06 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -96.91 32.03 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.474 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.72 -157.02 22.19 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 151.26 39.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -1.181 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -130.29 -45.23 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.4 -29.08 0.34 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -136.02 89.78 2.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.2 mt -77.17 161.26 28.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.41 128.16 9.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.36 168.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -1.156 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.91 7.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' GLN . 2.8 t -99.49 133.12 44.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -46.7 -30.56 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.442 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.97 64.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.0 mm-40 -69.98 -27.82 65.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.65 -44.5 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 23.5 mt-10 -57.33 -39.36 75.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -49.71 -17.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 69' ' ' GLU . 28.5 mt-10 -98.8 -52.21 3.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.546 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.43 -28.96 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 104.6 -178.32 24.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -91.22 -157.57 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.416 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.14 -8.02 9.38 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -120.48 162.49 19.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -1.171 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -108.88 -150.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -93.62 -18.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.948 . . . . 0.0 109.502 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.15 -43.29 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.0 -55.16 24.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' ILE . 14.6 t -50.74 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.501 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.7 mm -44.72 -62.14 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 82' ' ' ILE . 6.0 t70 -37.98 -51.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 85' ' ' ILE . 81.4 mt -57.03 -53.19 60.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 84' ' ' LEU . 46.0 mm -42.03 -49.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.392 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.469 ' O ' ' C ' ' A' ' 87' ' ' ARG . 49.4 mt -57.7 -40.67 80.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -40.36 -34.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.433 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -105.21 -82.87 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 96.13 0.23 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.5 mttt 58.61 62.1 4.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.269 -1.136 . . . . 0.0 109.551 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.78 107.51 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.846 2.364 . . . . 0.0 112.262 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -64.49 125.45 24.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.8 t -72.02 137.36 47.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.5 p -71.11 -71.91 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p 47.3 60.32 3.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -104.43 18.35 22.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.4 p -95.09 -133.42 0.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.908 . . . . 0.0 109.437 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mt -104.06 156.14 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -96.23 -13.37 23.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.416 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 p -81.37 64.57 6.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -118.66 -27.22 5.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -120.46 6.21 11.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.85 -141.5 9.84 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.93 157.41 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 154.14 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 108' ' ' LYS . . . -144.01 47.76 0.77 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 106' ' ' GLY . 23.3 p 50.68 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -1.163 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 36.49 44.02 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.99 95.21 5.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.9 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.69 -73.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.484 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 4' ' ' VAL . 3.6 m -57.01 -26.6 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.455 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.6 OUTLIER 70.7 -19.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.533 ' H ' ' C ' ' A' ' 2' ' ' SER . 6.7 m -145.11 -165.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.419 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -111.57 139.2 47.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -113.6 160.25 18.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -122.05 139.83 53.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -98.26 160.39 14.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.42 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -150.4 94.88 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -65.04 113.64 4.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.46 172.83 49.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -46.55 -30.38 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 14' ' ' THR . 9.5 p30 -149.6 -50.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.44 ' N ' ' OD1' ' A' ' 13' ' ' ASN . 53.9 m -83.48 146.58 28.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.77 135.47 46.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.46 162.01 21.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.9 mt -138.04 153.4 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.09 177.9 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -103.45 168.42 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 5' ' ' THR . . . -157.78 152.84 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.416 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.11 -99.85 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.37 145.46 32.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -44.75 96.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.54 -32.89 8.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.68 -51.82 11.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.7 t -50.01 -54.01 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -53.61 54.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -48.38 -41.73 29.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 70.5 t80 -61.99 -46.72 88.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 30' ' ' LEU . 7.3 mt -46.65 -41.23 14.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.837 . . . . 0.0 109.459 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -81.66 1.57 33.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 29' ' ' TYR . 9.8 t30 -154.66 64.66 4.51 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 38.8 Cg_endo -70.72 109.46 2.5 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.849 2.366 . . . . 0.0 112.199 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.449 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 1.8 m -143.17 -136.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tp -138.76 1.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.46 -74.16 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' NZ ' ' CG2' ' A' ' 41' ' ' VAL . 37.0 tttm -52.9 -14.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -1.151 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tp -49.45 -65.47 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.445 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -50.52 -46.28 57.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -52.19 -16.9 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.536 ' CG2' ' NZ ' ' A' ' 37' ' ' LYS . 92.0 t -102.55 -60.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.06 124.18 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.575 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.17 -29.36 12.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mt -119.49 117.46 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -87.77 76.76 8.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.653 ' OE2' ' CE2' ' A' ' 48' ' ' PHE . 15.6 tt0 -161.75 138.31 8.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.12 116.19 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.653 ' CE2' ' OE2' ' A' ' 46' ' ' GLU . 34.6 m-85 -99.21 148.34 24.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.466 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -147.94 154.54 43.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.6 151.34 52.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.822 2.348 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.426 ' C ' ' N ' ' A' ' 53' ' ' GLY . 37.5 mt-30 -132.75 -85.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -50.41 -15.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 51' ' ' GLN . . . 80.45 171.11 43.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 52.23 64.35 1.89 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.56 -96.31 0.54 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 46.46 42.96 11.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -1.169 . . . . 0.0 109.529 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -165.7 -17.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 60' ' ' LEU . . . -105.37 -165.1 23.7 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.62 11.94 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -1.197 . . . . 0.0 109.432 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 58' ' ' GLY . 15.3 mt 56.01 -177.17 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.63 -173.82 25.84 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.88 157.1 28.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -105.98 -174.54 2.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 66' ' ' ALA . 27.1 t -134.01 153.15 51.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 17.1 mmtm -43.47 -23.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -77.48 -50.55 12.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.34 -43.69 79.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.94 -21.46 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.393 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.4 mt-10 -82.94 -60.29 2.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-20 -41.08 -31.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 69' ' ' GLU . 12.6 mm-40 -82.06 -77.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 81' ' ' VAL . 76.5 m-85 -72.31 -48.93 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.439 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 110.52 150.02 12.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 75' ' ' GLY . 4.5 ttpp -64.91 162.18 16.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.462 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 74' ' ' LYS . . . 116.88 -19.88 11.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -117.37 177.58 4.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -1.162 . . . . 0.0 109.453 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.52 -177.25 3.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 78' ' ' ILE . 10.3 tp -74.38 -21.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.85 -51.94 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -63.36 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.55 HG13 ' CE2' ' A' ' 72' ' ' PHE . 2.9 t -65.65 -58.08 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.5 mt -49.24 -25.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' LEU . 50.3 t0 -65.97 -62.27 1.59 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 83' ' ' ASP . 79.7 mt -44.04 -32.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mt -68.05 -49.8 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.47 -11.41 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -77.71 -26.45 50.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -102.77 -67.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.1 125.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 25.7 mttm -141.68 49.16 1.35 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 31.0 Cg_endo -67.44 9.99 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.764 2.309 . . . . 0.0 112.143 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 93' ' ' SER . 31.3 m-20 -86.28 131.21 34.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 92' ' ' ASN . 12.0 p 59.04 140.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -132.19 178.45 6.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.473 ' H ' HG22 ' A' ' 94' ' ' THR . 0.2 OUTLIER -104.09 52.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.7 p -119.94 -150.94 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.6 t -83.38 -140.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.505 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 pp -107.45 156.7 18.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -145.22 -20.12 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 101' ' ' LYS . 1.2 m 63.8 118.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' THR . 5.1 mttt -42.92 167.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.06 176.76 18.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.71 51.53 0.98 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 106' ' ' GLY . 14.2 m-20 -112.17 82.89 1.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' ASN . . . -43.81 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 84.09 -163.9 40.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.87 76.87 1.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -1.151 . . . . 0.0 109.454 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -105.67 118.11 35.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.24 -161.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -91.49 -62.29 1.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.508 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.526 ' O ' ' O ' ' A' ' 2' ' ' SER . 24.5 mtt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 1' ' ' MET . 70.9 m -39.66 -93.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.95 . . . . 0.0 109.414 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 167.69 2.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.3 176.49 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.03 164.9 12.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -131.35 144.96 51.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -114.43 146.59 40.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 9.6 m-85 -112.21 155.27 24.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 85' ' ' ILE . 61.7 t80 -143.32 94.91 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -67.0 98.59 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -73.88 173.25 50.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 11' ' ' GLY . 3.3 tp10 -41.96 -42.8 2.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.477 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' ' 12' ' ' GLU . 18.8 m-20 -144.4 -37.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.478 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -87.46 142.22 28.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.26 130.69 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.49 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.436 HD22 HG11 ' A' ' 47' ' ' VAL . 8.2 mt -118.32 138.93 52.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.1 mt -120.21 146.1 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.49 165.01 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.528 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -92.09 166.23 12.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.42 151.37 22.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.465 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 -72.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.724 ' O ' HG23 ' A' ' 26' ' ' VAL . 19.4 t -140.22 156.88 46.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.98 -51.58 53.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -45.2 -54.55 6.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 25' ' ' LEU . 56.5 mt -57.49 -31.53 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 22' ' ' SER . 87.3 t -71.74 -70.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.532 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -40.97 -20.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -82.67 -49.08 10.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 32' ' ' ASN . 40.4 t80 -52.06 -50.57 61.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 29' ' ' TYR . 6.9 mt -40.78 -42.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -77.88 -13.92 59.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.665 ' N ' ' O ' ' A' ' 29' ' ' TYR . 95.9 m-20 -129.35 73.39 81.67 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.34 125.31 9.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.746 2.298 . . . . 0.0 112.232 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 172.61 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 35' ' ' ILE . 45.8 mm -73.5 61.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.99 -47.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -87.52 -28.17 22.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 109.449 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -54.38 -24.73 20.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 p -72.86 -31.62 64.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -79.26 -26.03 42.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.93 -64.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 62.6 t -71.94 128.27 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.85 -50.82 10.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.912 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 4.5 mp -111.13 147.77 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.67 88.24 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -168.72 -173.53 1.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG11 HD22 ' A' ' 16' ' ' LEU . 38.9 t -131.49 126.48 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.98 150.74 36.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -148.12 165.31 18.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.4 149.43 56.54 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.851 2.368 . . . . 0.0 112.262 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -139.81 -49.59 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 3.2 p30 -126.28 167.16 15.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.68 177.74 32.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 54' ' ' ARG . 1.5 mtt-85 -68.01 -38.2 82.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 0.0 109.53 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.665 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . 127.81 155.96 8.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . 73.08 149.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -1.149 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.8 tp10 38.75 21.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -122.7 175.5 16.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 49.2 mp0 -58.37 170.06 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -1.175 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 60' ' ' LEU . 25.1 mt -142.53 -177.38 5.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.09 143.22 8.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 151.24 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -94.59 -171.55 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -118.62 164.72 14.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -64.27 -32.75 74.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -44.3 68.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -72.13 -60.22 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.32 -26.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -70.68 -39.13 73.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -60.09 -21.5 61.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 10.0 mp0 -96.76 -67.01 0.87 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -161.53 76.6 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.409 ' C ' ' CG ' ' A' ' 74' ' ' LYS . . . -127.74 -129.01 3.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' CG ' ' C ' ' A' ' 73' ' ' GLY . 9.3 mttt 68.04 -75.07 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -1.178 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' GLY . . . -123.4 30.69 4.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -118.22 100.47 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -1.193 . . . . 0.0 109.52 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -50.47 163.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -0.821 . . . . 0.0 109.537 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tp -54.75 -29.4 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.872 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.13 -60.7 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 83' ' ' ASP . 21.0 mt-10 -55.06 -55.12 34.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 80' ' ' GLU . 9.4 t -38.33 -50.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.429 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 85' ' ' ILE . 37.3 mt -61.95 -37.72 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.475 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.624 ' OD2' ' NH2' ' A' ' 87' ' ' ARG . 9.0 t0 -65.93 -65.14 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 83' ' ' ASP . 85.7 mt -38.17 -30.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 9' ' ' TYR . 41.4 mt -73.92 -68.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.414 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.1 mt -46.55 -12.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.402 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.734 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -75.66 -43.45 47.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.464 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.522 ' CG ' ' O ' ' A' ' 88' ' ' ASN . 7.2 t30 -149.93 66.44 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.15 -113.7 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -67.85 154.86 92.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.208 -1.172 . . . . 0.0 109.531 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.03 32.33 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.805 2.337 . . . . 0.0 112.162 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.468 ' C ' ' OG ' ' A' ' 93' ' ' SER . 5.1 t30 -60.48 -15.61 28.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.468 ' OG ' ' C ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 167.7 145.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.6 p -94.21 -176.79 4.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.457 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.75 65.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.14 130.12 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 p -68.33 108.96 3.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 99' ' ' LYS . 9.2 mt -122.7 106.7 11.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' THR . 5.7 mttt 45.09 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 99' ' ' LYS . 0.2 OUTLIER 50.04 179.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -86.91 -9.12 56.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.38 175.05 27.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.2 68.83 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -91.34 82.7 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 0.0 109.466 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -117.1 171.6 7.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 107' ' ' THR . . . -82.92 76.11 2.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 106' ' ' GLY . 27.3 p 41.74 -130.81 0.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -1.214 . . . . 0.0 109.421 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.403 ' N ' ' OG1' ' A' ' 107' ' ' THR . 40.1 mttt 49.32 40.02 17.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -141.94 95.18 2.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.401 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 109' ' ' ALA . 73.4 m-85 -39.64 110.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.445 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 78.1 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.515 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.275 0.56 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -36.24 65.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t -142.84 140.84 31.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 4' ' ' VAL . 15.2 m -67.02 -177.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 m -113.89 141.25 47.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -110.58 136.85 49.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.544 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.724 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 1.7 m-85 -103.69 110.5 22.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.868 . . . . 0.0 109.501 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.32 162.57 23.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.51 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 57.9 t80 -161.23 137.7 8.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 108.2 19.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.426 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.55 -154.9 0.22 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.04 -39.6 92.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -1.167 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -146.69 -36.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -83.78 169.16 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.9 . . . . 0.0 109.482 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 9' ' ' TYR . 43.2 t0 -115.3 137.02 52.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.9 153.49 39.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -131.4 143.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.16 152.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -90.06 152.97 20.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.13 -171.59 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.39 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.922 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.7 t -153.52 135.8 14.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 22' ' ' SER . 5.4 tt0 -40.0 -28.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' SER . 23.8 tt0 -62.58 -76.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.943 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 24' ' ' GLU . 11.2 mt -44.11 -35.53 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 t -62.11 -57.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.496 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -51.38 -52.25 47.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -48.52 -41.03 28.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.469 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.19 -59.32 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 42.9 mt -53.6 -27.86 29.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -23.61 61.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -160.09 77.49 2.73 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -51.69 118.75 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.817 2.344 . . . . 0.0 112.164 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -156.55 139.12 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.04 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.43 -80.11 0.26 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.38 -16.74 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -1.178 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.12 -47.46 85.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -57.6 -27.9 63.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.8 -33.78 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.8 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.814 HG21 HG21 ' A' ' 82' ' ' ILE . 89.5 t -79.66 134.95 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -96.3 -52.24 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.97 134.94 46.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -93.92 59.81 2.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 16.9 tt0 -140.59 123.44 16.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.5 139.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.524 ' C ' HG22 ' A' ' 49' ' ' THR . 20.5 m-85 -117.66 174.82 5.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -168.36 155.73 7.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.44 80.37 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.86 2.373 . . . . 0.0 112.189 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -125.36 -31.42 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -114.0 -139.4 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.87 87.78 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.94 45.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.663 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . 146.75 162.5 9.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . 74.54 -171.21 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.62 ' N ' ' OE2' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -48.22 -16.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.473 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 139.83 2.32 1.69 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -132.13 110.67 10.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.159 . . . . 0.0 109.481 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 tt -148.17 152.99 38.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -163.58 -156.2 8.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.7 117.07 21.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -1.14 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.43 173.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.91 148.43 50.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' O ' ' CD ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -46.47 -26.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.13 34.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.31 -50.29 72.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 t -60.21 -20.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 65' ' ' LYS . 14.2 mt-10 -76.91 -25.27 52.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.542 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 -22.21 45.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.23 -54.7 2.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -167.94 70.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 138.05 6.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -166.97 -27.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.85 31.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -103.69 177.57 4.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.395 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' ILE . 16.3 mttm -83.95 133.86 34.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 5.3 tp -40.54 -32.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' LYS . 60.8 mt-10 -54.71 -56.16 22.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 tp10 -48.63 -62.64 1.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 80' ' ' GLU . 65.8 t -39.66 -58.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.421 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.814 HG21 HG21 ' A' ' 42' ' ' VAL . 96.7 mt -50.32 -20.35 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 80' ' ' GLU . 1.2 t70 -76.47 -69.17 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 83' ' ' ASP . 7.7 mt -38.55 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.6 mt -74.58 -70.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.571 ' N ' HG22 ' A' ' 85' ' ' ILE . 8.2 mt -42.16 -38.26 1.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -43.79 -26.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 86' ' ' LEU . 9.5 t-20 -107.78 -70.85 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 123.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 91' ' ' PRO . 17.7 mtpp -134.24 74.14 67.96 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.155 -1.203 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' O ' ' O ' ' A' ' 90' ' ' LYS . 52.8 Cg_exo -50.69 -145.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.782 2.321 . . . . 0.0 112.179 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 154.45 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.524 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 94' ' ' THR . 0.1 OUTLIER -64.56 -179.3 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.528 ' N ' ' OG ' ' A' ' 93' ' ' SER . 19.1 p -101.38 96.1 6.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -127.52 74.18 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.464 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.529 ' O ' ' OG ' ' A' ' 96' ' ' SER . 3.5 p -64.17 59.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' THR . 3.7 m -108.73 55.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 97' ' ' SER . 7.9 mp -120.2 126.4 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.83 115.37 5.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 p -130.87 156.73 44.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -52.75 149.34 6.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.415 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 103' ' ' GLY . . . -77.94 -105.28 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 102' ' ' GLY . . . 52.52 110.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -121.25 98.64 6.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.37 -166.26 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.92 22.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 107' ' ' THR . 15.1 t -165.09 132.97 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.448 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.7 mttm 53.79 67.86 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.05 -176.98 3.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 64.9 t80 57.76 17.94 4.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.446 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttm . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.17 120.89 8.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 21' ' ' ALA . 1.4 p -88.62 86.3 6.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.492 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -66.84 166.08 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.957 . . . . 0.0 109.449 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 m -158.64 150.47 21.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -111.95 123.72 50.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.12 123.55 37.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.11 140.93 29.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.457 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.34 104.5 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -81.97 124.73 30.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 -153.12 28.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -52.98 -70.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -125.31 -21.02 4.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -92.37 161.26 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -121.73 144.95 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -137.95 148.6 45.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.1 mt -120.64 153.78 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 173.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.424 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -109.84 154.03 23.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.392 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' ALA . . . -154.05 128.24 9.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' ALA . . . -47.37 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.503 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.35 165.97 12.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -73.99 -28.17 61.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.33 -56.72 17.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.02 -51.48 69.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.396 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -46.44 -45.89 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' OD1' ' C ' ' A' ' 27' ' ' ASP . 1.6 t70 -62.66 -43.58 98.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 37' ' ' LYS . 6.4 mt-10 -60.94 -27.87 68.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -70.38 -36.56 74.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.86 -48.83 77.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -25.21 50.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.448 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 11.1 t30 -136.21 68.16 62.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 154.23 53.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.849 2.366 . . . . 0.0 112.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.35 173.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 tp -88.24 -31.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.96 -14.38 80.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.48 ' O ' HG23 ' A' ' 41' ' ' VAL . 67.5 tttt -101.93 -12.4 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.57 -48.75 53.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' VAL . 3.1 m -49.23 -45.37 44.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.54 -56.96 14.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' LYS . 55.5 t -50.21 -59.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 82' ' ' ILE . 2.7 t -78.27 126.89 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.33 -0.51 46.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' H ' HG12 ' A' ' 42' ' ' VAL . 12.1 tp -163.72 122.16 1.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.414 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -77.15 83.69 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -163.12 155.12 17.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.8 t -123.29 132.94 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.86 154.7 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.1 164.56 24.42 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.85 164.53 35.31 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.849 2.366 . . . . 0.0 112.244 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -112.74 173.04 6.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' GLN . 18.1 t0 37.03 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.472 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.528 ' O ' ' C ' ' A' ' 54' ' ' ARG . . . -148.73 -126.97 1.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.644 ' CD ' ' H ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -37.0 107.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.143 . . . . 0.0 109.436 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.94 136.45 3.02 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -169.7 79.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -1.127 . . . . 0.0 109.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -144.69 -131.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.87 -26.28 50.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -86.09 102.99 14.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mt -115.66 -170.17 1.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.41 159.37 24.4 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.75 156.26 17.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -1.19 . . . . 0.0 109.422 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.55 171.6 7.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' LYS . 76.7 p -121.89 150.52 41.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' SER . 7.8 pttt -41.92 -30.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 67' ' ' GLN . . . -73.65 -58.53 3.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.244 -0.91 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -38.16 -49.05 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.31 -51.87 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.639 ' O ' ' N ' ' A' ' 73' ' ' GLY . 31.1 tt0 -49.33 -29.01 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 109.399 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.94 -19.21 63.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.92 -27.02 14.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CE2' HG13 ' A' ' 81' ' ' VAL . 84.3 m-85 -113.14 -11.0 13.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.488 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 62.14 0.31 2.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 72' ' ' PHE . 6.4 mtpp -139.09 -49.37 0.5 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.495 -1.003 . . . . 0.0 109.537 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 81' ' ' VAL . . . 78.74 -61.7 3.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 49.49 -168.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -56.59 133.18 53.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 tp -55.36 -26.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -56.44 -41.91 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 81' ' ' VAL . 35.5 mt-10 -73.42 -58.62 3.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.473 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 72' ' ' PHE . 2.9 t -42.48 -38.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.515 HG21 HG21 ' A' ' 42' ' ' VAL . 61.2 mt -63.68 -46.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 35.7 t0 -60.58 -52.29 65.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.6 mt -45.29 -41.85 9.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.87 -40.25 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 88' ' ' ASN . 82.2 mt -60.24 -42.72 95.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -44.95 -20.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.43 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' LEU . 82.4 m-20 -124.51 -81.98 0.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 75.15 124.74 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 89' ' ' GLY . 5.2 mmmt 38.77 58.51 5.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.217 -1.167 . . . . 0.0 109.373 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' C ' ' N ' ' A' ' 93' ' ' SER . 34.8 Cg_endo -68.35 -48.58 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.825 2.35 . . . . 0.0 112.3 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m120 50.18 14.27 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 109.375 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.446 ' N ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -94.78 20.41 8.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.498 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.1 p -96.6 154.63 17.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.28 -169.83 3.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -142.5 9.64 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.61 111.08 6.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.493 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.07 100.54 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -123.44 108.79 13.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.1 p -112.74 174.34 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 103' ' ' GLY . 8.9 mmtm -81.7 76.33 8.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.8 50.85 0.1 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 101' ' ' LYS . . . -108.44 16.19 34.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 104' ' ' ASN . 16.7 p-10 -115.53 97.32 6.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -1.168 . . . . 0.0 109.507 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.83 100.62 11.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.53 158.67 14.15 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.05 96.6 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -1.14 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 -52.66 39.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.424 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 155.72 36.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -56.76 -40.38 75.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.496 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.521 179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.09 179.71 5.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.593 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -176.61 -171.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.593 ' N ' ' OG1' ' A' ' 3' ' ' THR . 1.6 m -127.07 147.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -92.62 161.47 14.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -113.1 122.65 48.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.46 ' CE1' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -92.63 104.61 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.18 137.57 47.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.91 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.13 105.91 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -75.95 114.43 14.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' ASN . . . -75.44 170.89 54.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.65 -17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -1.177 . . . . 0.0 109.389 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 t-20 -168.93 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 118.65 29.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 132.75 49.97 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.18 -0.95 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -129.18 142.53 50.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.37 142.37 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.5 175.13 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.75 160.84 14.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.46 164.57 29.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.82 -76.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 152.03 40.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -38.29 85.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.82 -61.32 2.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.3 mt -58.64 -63.58 1.23 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 25' ' ' LEU . 90.6 t -35.53 -35.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' LEU . 19.6 t0 -77.3 -35.02 55.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.368 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 25' ' ' LEU . 4.8 pt-20 -64.9 -28.2 69.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.416 ' N ' ' HG2' ' A' ' 28' ' ' GLU . 48.0 t80 -74.67 -50.23 18.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.7 mt -46.62 -23.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -74.07 -45.36 49.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -123.95 78.02 58.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.0 109.426 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 34' ' ' SER . 56.4 Cg_exo -47.17 156.87 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.792 2.328 . . . . 0.0 112.204 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 162.39 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 35' ' ' ILE . 22.0 mm -88.52 20.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.29 -45.39 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.621 ' HZ3' ' HG3' ' A' ' 28' ' ' GLU . 24.6 tttt -73.76 -11.29 60.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 109.435 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.25 -27.43 65.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.47 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -67.21 -18.27 65.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -89.21 -41.21 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.86 -66.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -70.24 113.64 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 109.549 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.63 -60.76 2.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.18 150.89 21.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -103.6 52.45 0.77 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -137.16 159.76 40.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.47 144.41 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 14.0 m-85 -118.91 154.23 33.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -144.75 156.71 55.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.425 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.82 135.39 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.175 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.67 -26.41 67.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -117.93 -116.8 0.32 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.66 -24.31 0.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -129.92 97.66 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 0.0 109.478 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.14 119.61 0.8 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.41 0.98 12.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -1.111 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.97 146.14 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.418 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -157.4 16.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.64 171.52 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 mt -118.61 172.81 7.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.28 -170.26 24.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.2 115.68 20.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -1.128 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -53.78 154.99 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 66' ' ' ALA . 4.7 m -98.09 147.85 24.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' O ' ' OE1' ' A' ' 69' ' ' GLU . 4.5 pttp -43.79 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -83.81 -48.29 10.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.603 ' NE2' ' C ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -54.86 -43.68 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.22 -41.52 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 28.1 mt-10 -64.01 -40.22 95.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.4 -40.17 81.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.26 -67.68 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -90.91 -75.88 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.05 166.68 11.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.2 -2.55 52.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.527 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.78 -7.19 20.81 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -133.37 149.14 51.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -67.98 -167.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -86.53 -37.83 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -61.67 -28.26 69.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.64 -44.47 33.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 t -53.35 -46.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.543 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.583 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.6 mp -60.67 -40.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -48.35 -53.71 16.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.55 -32.36 68.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 82' ' ' ILE . 85.8 mt -67.68 -29.19 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.549 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.7 mt -82.39 -26.32 32.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -93.2 3.63 55.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.45 ' CG ' ' O ' ' A' ' 88' ' ' ASN . 18.8 t30 -161.54 57.73 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.92 -131.04 6.53 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -153.98 62.65 3.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.495 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.54 114.23 3.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.818 2.345 . . . . 0.0 112.252 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 93' ' ' SER . 17.0 t-20 -85.89 -71.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 59.56 119.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.488 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.2 p -117.15 114.09 23.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 97' ' ' SER . 78.0 m -163.95 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.7 t 47.45 25.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.499 ' H ' HG22 ' A' ' 95' ' ' THR . 70.3 m -94.0 -154.99 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.454 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.58 171.68 14.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -63.3 112.09 2.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.554 ' O ' HG23 ' A' ' 100' ' ' THR . 5.1 t -124.36 69.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -106.06 179.23 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 163.68 84.99 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.62 124.25 6.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.4 11.65 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.11 . . . . 0.0 109.446 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.17 51.39 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.427 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.7 123.41 0.07 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 m -96.93 -35.9 10.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -1.112 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 110' ' ' TYR . 76.5 mttt -132.45 102.16 5.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.16 51.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 108' ' ' LYS . 1.7 t80 63.43 54.21 2.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.467 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.552 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.52 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 t 179.18 149.91 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.605 ' O ' HG23 ' A' ' 3' ' ' THR . 5.0 t -122.61 110.92 16.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.14 -173.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.0 m -149.79 135.47 18.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -99.06 129.07 45.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.605 ' O ' HG23 ' A' ' 17' ' ' ILE . 1.3 m-85 -104.13 160.31 14.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -127.95 157.39 40.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -142.87 129.72 20.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.858 . . . . 0.0 109.509 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -105.03 105.79 15.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.67 -150.58 24.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 15.1 mm-40 -49.67 -51.27 39.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -148.01 -46.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.447 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -72.54 143.6 48.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.77 138.07 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 16' ' ' LEU . 76.1 mt -113.13 157.17 21.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.475 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 7' ' ' TYR . 7.8 mt -130.26 154.32 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.424 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.627 HG21 HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -137.9 179.91 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.88 153.45 35.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.51 177.3 11.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.51 -46.81 5.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.65 137.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -49.55 -31.3 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.436 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -67.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.06 -48.43 44.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' A' ' 27' ' ' ASP . 76.3 t -50.8 -66.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' C ' ' O ' ' A' ' 26' ' ' VAL . 37.6 t70 -36.3 -43.33 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.92 -50.61 70.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 32' ' ' ASN . 62.1 t80 -51.3 -49.7 60.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 30' ' ' LEU . 19.9 mt -41.72 -56.29 2.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -73.9 -3.5 29.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 29' ' ' TYR . 8.7 m120 -135.83 69.36 65.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -73.64 131.6 16.24 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.873 2.382 . . . . 0.0 112.219 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.25 154.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -85.72 66.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.46 -50.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -75.69 -26.02 57.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD13 ' CZ ' ' A' ' 29' ' ' TYR . 2.7 tp -57.9 -33.37 68.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -36.62 76.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.78 -39.24 66.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' A' ' 26' ' ' VAL . 48.7 t -70.76 -69.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.67 117.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' C ' HD12 ' A' ' 44' ' ' LEU . 95.2 mt-10 -81.76 -40.97 21.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 43' ' ' GLU . 9.3 mp -112.27 128.38 56.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.67 78.29 4.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -163.73 159.95 22.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.08 143.15 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -128.1 155.22 44.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.488 ' O ' HD23 ' A' ' 60' ' ' LEU . 41.5 p -118.99 149.38 46.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.58 91.87 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.75 2.3 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.73 -159.49 0.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' GLY . 53.0 t0 -55.86 125.12 20.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.462 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 160.16 151.24 6.11 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 106.59 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 31.74 0.42 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.9 28.72 3.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -1.107 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.59 101.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 52' ' ' ASP . . . -176.86 90.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 52.6 79.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 49' ' ' THR . 5.8 mt -78.12 170.21 16.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.509 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.74 108.33 0.82 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.34 142.12 17.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -1.182 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.29 28.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -88.26 148.04 24.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.6 mttt -41.43 -19.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -68.2 -61.51 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -53.23 -34.73 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.18 -31.32 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.1 mt-10 -68.91 -63.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 69' ' ' GLU . 20.0 m-20 -39.36 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -85.52 -67.71 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.454 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 71' ' ' GLU . 20.4 m-85 -115.02 25.5 10.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.506 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.65 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 52.72 -162.12 2.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 76' ' ' LYS . 2.3 tttp -109.94 -149.46 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -1.152 . . . . 0.0 109.454 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 -26.14 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 74' ' ' LYS . 21.4 mttt -91.42 -172.35 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -122.99 157.17 33.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tp -51.41 -30.74 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.41 -50.29 66.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.413 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -57.69 -52.83 63.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.1 t -47.87 -59.08 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.97 -42.47 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.495 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 28.5 t0 -52.68 -51.02 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.459 ' O ' ' OD1' ' A' ' 88' ' ' ASN . 10.5 mt -60.03 -43.15 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.627 HG21 HG21 ' A' ' 18' ' ' VAL . 27.9 mm -47.98 -62.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.3 -23.3 22.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -67.02 -36.37 81.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -93.48 -77.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.469 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.58 130.25 1.16 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -123.44 68.67 40.42 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.43 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -74.95 3.02 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.86 2.373 . . . . 0.0 112.232 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -134.49 131.62 38.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -112.24 161.37 16.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.529 HG22 ' OG1' ' A' ' 95' ' ' THR . 1.4 m -139.33 144.4 38.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 96' ' ' SER . 0.2 OUTLIER 44.28 -165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.578 ' H ' HG22 ' A' ' 95' ' ' THR . 60.1 p 47.8 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 p -149.57 -172.57 4.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.35 122.17 9.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.526 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -90.37 112.94 24.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.63 15.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.504 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.43 144.6 42.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.531 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.18 134.9 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ALA . . . 132.73 -26.59 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 61.54 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 109.545 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 103' ' ' GLY . . . -81.4 -60.05 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.96 -111.14 0.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.3 p -81.31 14.4 2.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -1.178 . . . . 0.0 109.468 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -125.24 79.89 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 110' ' ' TYR . . . -145.22 -127.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 109' ' ' ALA . 26.4 m-85 -152.31 148.45 27.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.49 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.446 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.613 ' C ' ' SD ' ' A' ' 1' ' ' MET . 1.3 tmm? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.552 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -72.58 33.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.404 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 1' ' ' MET . 54.3 p -52.23 -90.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.88 161.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -101.67 -173.61 2.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.649 ' NZ ' HG21 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -136.01 133.92 37.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -99.14 119.35 37.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.59 166.24 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -165.31 109.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -90.31 103.08 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.58 -157.36 0.79 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 3.8 tt0 -48.23 -67.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.146 . . . . 0.0 109.427 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 2.9 m120 -128.54 -26.26 2.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.12 155.38 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -113.45 136.86 52.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -132.7 153.44 51.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.649 HG21 ' NZ ' ' A' ' 6' ' ' LYS . 41.1 mt -134.18 145.21 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.922 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.24 173.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -108.72 148.05 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.09 178.58 6.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.446 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.03 -55.01 3.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -172.4 166.63 5.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -72.02 -21.96 61.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.57 -66.61 0.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -53.81 -49.58 68.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -49.32 -50.37 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.83 -29.4 64.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.73 -34.69 64.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 32' ' ' ASN . 54.0 t80 -62.55 -48.06 81.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' TYR . 67.8 mt -43.36 -59.53 2.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.867 . . . . 0.0 109.498 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -18.95 65.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TYR . 64.5 t30 -121.98 87.44 47.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.42 54.43 5.18 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -106.13 105.02 14.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.443 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' SER . 14.6 tt -42.64 -32.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.26 -41.2 78.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -73.12 -27.48 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -1.164 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.09 -39.84 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.0 t -58.22 -21.04 46.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -87.18 -34.73 18.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 42' ' ' VAL . 9.3 t -75.81 -72.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.509 ' N ' HG12 ' A' ' 41' ' ' VAL . 23.3 t -57.73 118.26 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.26 -32.78 20.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -137.31 114.95 11.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.98 94.22 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -167.4 158.17 11.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.81 140.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.54 -170.27 1.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.43 150.12 0.97 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.86 92.55 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.833 2.355 . . . . 0.0 112.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.524 ' C ' ' OD1' ' A' ' 52' ' ' ASP . 1.1 tp-100 -55.51 -45.17 77.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' OD1' ' C ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -176.78 164.18 2.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.2 -21.59 4.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.17 101.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.279 -1.13 . . . . 0.0 109.531 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.91 172.29 12.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.11 138.98 37.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.156 . . . . 0.0 109.446 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 60.31 89.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 59' ' ' GLU . . . 165.68 88.22 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.1 tp10 75.69 79.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -108.2 178.69 4.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.21 -167.45 11.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.96 110.21 16.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -1.188 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.8 155.65 1.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -93.87 155.91 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.937 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -59.03 -16.07 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 -39.54 13.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -60.26 -46.28 90.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.74 -42.97 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.56 -23.34 66.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.85 -26.68 49.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.27 -32.79 55.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.832 ' CE2' HG13 ' A' ' 81' ' ' VAL . 78.5 m-85 -104.41 -61.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.63 136.9 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -64.4 98.48 0.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.05 -6.8 0.12 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -101.63 129.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -1.107 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -59.78 -165.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.1 tp -91.89 -34.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.46 -35.28 73.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.07 -43.69 82.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.832 HG13 ' CE2' ' A' ' 72' ' ' PHE . 54.8 t -65.55 -60.77 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 82' ' ' ILE . 5.9 mm -46.04 -32.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 84' ' ' LEU . 19.8 t70 -66.94 -65.14 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' ASP . 15.5 mt -38.44 -30.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' ASP . 90.1 mt -76.95 -50.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.903 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -58.26 -13.93 6.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -82.46 -38.08 24.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 1.9 t-20 -85.28 -68.07 0.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 59.68 119.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 92' ' ' ASN . 56.5 tttp -136.58 69.87 59.93 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.457 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.7 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.798 2.332 . . . . 0.0 112.202 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -99.66 97.18 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 m -133.11 47.68 2.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -13.55 53.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.434 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -81.43 1.81 31.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 124.14 16.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.371 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 p 55.24 -166.51 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -152.83 178.9 9.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -174.33 -22.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -176.7 119.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.514 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.75 9.5 2.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.06 -130.72 3.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.64 -139.87 4.25 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 33.6 t-20 -127.03 76.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -1.156 . . . . 0.0 109.478 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 -4.74 52.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.99 -94.24 0.15 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m 49.15 -135.03 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -1.191 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.436 ' HA ' ' CE2' ' A' ' 110' ' ' TYR . 30.7 tttt -72.03 99.98 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.95 30.16 2.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -94.05 145.6 24.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 109.406 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.469 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 m -125.38 89.94 3.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 21' ' ' ALA . 4.2 t -51.4 176.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.51 171.06 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.3 m -148.39 142.19 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -108.26 127.54 53.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.903 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.13 144.44 30.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.495 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -113.06 121.13 43.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 10' ' ' LYS . 69.6 t80 -126.92 140.85 52.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.485 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 9.7 tttt -101.26 140.96 34.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.94 -166.68 27.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -94.99 -33.07 12.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.134 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.44 -30.01 7.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 t -145.28 179.1 7.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.1 t70 -98.1 161.99 13.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 62.1 mt -140.24 140.03 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.9 136.99 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 109.409 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 171.3 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.95 163.49 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.446 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.99 -177.05 6.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 3' ' ' THR . . . -106.62 -71.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.13 140.09 37.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 26' ' ' VAL . 39.0 mt-10 -50.75 -55.95 14.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.918 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 23' ' ' GLU . 13.5 tp10 -37.65 -44.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.56 -27.28 64.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' A' ' 23' ' ' GLU . 89.6 t -73.3 -54.08 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.2 -24.22 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -75.31 -38.56 60.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 32' ' ' ASN . 76.6 t80 -60.04 -49.54 77.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mt -45.68 -32.43 2.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -91.06 -3.0 57.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' TYR . 52.5 m-80 -142.72 61.47 11.08 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.85 93.31 0.95 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.85 2.366 . . . . 0.0 112.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -162.53 132.31 4.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.3 mm -46.46 117.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.11 -63.1 0.38 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -79.88 -28.67 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.401 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' LYS . 5.0 tp -42.77 -40.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 t -67.83 -37.19 81.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' LYS . 17.6 tt0 -62.7 -18.34 62.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.93 -74.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 42' ' ' VAL . 5.7 t -57.55 157.54 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.378 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -117.87 -68.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.1 tp -95.38 111.57 23.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.86 74.37 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 47' ' ' VAL . 11.6 tp10 -156.03 157.87 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.428 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 6.6 t -128.17 128.29 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.56 156.98 22.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.493 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.95 156.92 34.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.01 178.41 4.75 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.793 2.328 . . . . 0.0 112.192 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.71 -112.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -123.66 26.49 7.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 -125.13 0.72 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.718 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -123.21 -19.26 6.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -1.137 . . . . 0.0 109.463 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 56' ' ' ALA . . . 139.49 135.58 3.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 55' ' ' GLY . . . 40.79 69.77 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -122.35 -64.97 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' GLU . . . -115.99 -158.58 11.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' GLY . 10.4 pt-20 -52.94 -172.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -1.139 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -114.29 165.93 12.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.33 9.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.29 134.0 56.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -1.126 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.49 130.13 39.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.561 ' O ' ' N ' ' A' ' 67' ' ' GLN . 13.6 m -81.23 131.08 35.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 64' ' ' SER . 1.7 ptpt -40.47 -40.24 1.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.16 67.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.29 -50.96 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.16 -41.7 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 71' ' ' GLU . 39.9 mt-10 -55.58 -41.6 73.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.9 t-20 -40.37 -19.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.648 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.5 mm-40 -114.37 -60.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -164.98 72.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' A' ' 69' ' ' GLU . . . -129.4 0.13 5.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -85.5 106.58 16.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.516 -0.99 . . . . 0.0 109.485 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.9 32.6 63.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -130.84 100.18 5.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -1.147 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.552 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 9.4 mtpm? -46.55 155.09 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.49 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.5 -21.5 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.552 ' OE1' ' NZ ' ' A' ' 77' ' ' LYS . 9.6 mt-10 -69.0 -51.99 33.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.14 -42.94 83.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -48.21 -51.49 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.1 mt -61.21 -35.59 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.877 . . . . 0.0 109.535 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' LEU . 46.0 t0 -60.34 -66.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 83' ' ' ASP . 16.4 mt -40.47 -32.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 mt -80.57 -31.17 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.9 mt -77.66 -0.39 26.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -75.67 -40.86 55.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.621 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 0.4 OUTLIER -96.25 -73.38 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.88 117.31 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 mttt 53.97 60.02 11.57 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.56 91.54 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.829 2.353 . . . . 0.0 112.227 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 94' ' ' THR . 0.6 OUTLIER -152.2 -67.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.615 ' C ' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -69.53 17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 92' ' ' ASN . 77.8 p -66.84 23.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.615 ' H ' ' C ' ' A' ' 93' ' ' SER . 18.6 p -134.08 81.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.7 88.12 4.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.444 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.34 -178.1 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mp -52.78 170.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.943 . . . . 0.0 109.482 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -86.13 139.62 30.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -133.48 12.15 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 100' ' ' THR . 75.4 mttt 36.92 -121.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -180.0 -167.59 37.35 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 105' ' ' ALA . . . 170.89 -23.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.68 -2.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -1.183 . . . . 0.0 109.476 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 103' ' ' GLY . . . -82.77 153.92 25.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 108' ' ' LYS . . . 169.28 46.33 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 p -59.71 1.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -1.131 . . . . 0.0 109.504 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 106' ' ' GLY . 5.6 pttm -136.57 61.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -153.2 -78.25 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 109' ' ' ALA . 14.5 m-85 -38.85 -63.81 0.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.425 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.566 ' O ' ' O ' ' A' ' 2' ' ' SER . 30.5 tpp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 44.17 99.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -143.07 -14.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 167.14 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.26 159.43 15.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -121.73 132.43 54.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.645 ' OH ' HG11 ' A' ' 26' ' ' VAL . 1.9 m-85 -95.75 117.59 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -81.92 138.04 35.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -131.54 90.06 2.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.965 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -56.77 96.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 12' ' ' GLU . . . -71.51 -162.59 5.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' H ' ' CG ' ' A' ' 71' ' ' GLU . 1.1 tt0 -49.37 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.477 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.569 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -100.21 -0.63 38.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 109.478 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -113.05 174.85 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -117.26 122.49 44.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.663 HD22 ' CG1' ' A' ' 47' ' ' VAL . 53.1 mt -106.17 132.24 52.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.3 mt -118.55 146.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.593 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG21 HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -131.11 169.81 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -103.37 155.23 18.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.84 -171.4 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.52 2.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -168.69 135.52 1.9 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -45.69 -24.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.66 -65.64 0.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.438 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.65 -20.42 21.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.645 HG11 ' OH ' ' A' ' 7' ' ' TYR . 4.4 t -79.15 -52.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -44.36 96.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 109.406 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.8 mt-10 -56.5 -54.88 40.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 68.4 t80 -46.98 -44.13 19.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.46 -20.57 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.323 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 14.2 mtmt -92.81 -22.34 19.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 31' ' ' LYS . 9.0 m-20 -143.57 66.16 15.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' SER . 42.2 Cg_endo -71.53 170.03 19.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.801 2.334 . . . . 0.0 112.208 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER 166.92 22.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 35' ' ' ILE . 38.3 mm 47.13 13.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' SER . . . -107.48 -53.59 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -71.86 -25.75 62.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 38' ' ' LEU . 15.2 tp -48.7 -22.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 36' ' ' GLY . 2.7 p -71.39 -18.39 62.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -98.18 -20.94 16.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.84 -42.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.44 141.6 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.485 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' HD23 ' A' ' 44' ' ' LEU . 39.1 mt-10 -102.09 -44.48 5.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 43' ' ' GLU . 7.5 mt -121.7 105.92 10.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -66.43 72.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CG ' ' H ' ' A' ' 47' ' ' VAL . 5.8 tt0 -152.65 178.57 9.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.663 ' CG1' HD22 ' A' ' 16' ' ' LEU . 82.2 t -123.5 131.73 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.569 ' C ' HG22 ' A' ' 49' ' ' THR . 57.7 m-85 -118.35 176.83 5.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER 173.94 151.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.84 -178.4 3.1 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.839 2.359 . . . . 0.0 112.156 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.433 ' NE2' ' OD1' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -160.41 16.03 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.918 . . . . 0.0 109.466 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD1' ' NE2' ' A' ' 51' ' ' GLN . 7.4 p-10 -158.88 0.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.15 176.95 46.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -92.66 37.85 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -1.115 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.18 24.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.18 28.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -123.95 22.13 8.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.87 -120.6 0.69 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -60.93 114.21 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.21 -179.26 3.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.9 -177.87 38.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.75 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.612 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -63.49 -178.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -103.22 136.16 43.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 3.5 mttt -43.28 -27.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.52 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -78.45 -20.5 50.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.581 ' N ' ' O ' ' A' ' 64' ' ' SER . 10.5 mt-30 -81.17 -39.66 25.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.77 -32.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.7 mt-10 -62.41 -21.58 65.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -82.35 -33.77 28.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.579 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -80.82 -24.19 38.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.69 -30.02 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . 115.79 -130.45 9.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 75' ' ' GLY . 5.3 mtpt -67.02 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.142 -1.211 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . 40.08 66.79 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 77' ' ' LYS . 30.2 mttp -51.71 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -1.194 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 76' ' ' LYS . 28.3 mttp -41.13 130.97 2.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 79' ' ' GLU . 2.7 tp -41.9 -37.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 78' ' ' ILE . 10.8 mt-10 -52.91 -56.72 13.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.55 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -53.05 -41.5 64.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 82' ' ' ILE . 7.5 t -58.7 -68.19 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.456 ' N ' HG12 ' A' ' 81' ' ' VAL . 15.8 mt -42.95 -39.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 109.486 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -61.74 -63.82 1.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 83' ' ' ASP . 5.5 mt -43.64 -35.29 1.72 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.49 HG21 HG21 ' A' ' 18' ' ' VAL . 71.7 mt -65.22 -66.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.421 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 5.0 mt -49.62 -26.71 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.739 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -42.19 -43.88 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -77.53 0.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.6 132.85 3.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 5.4 mmtp 46.88 51.85 10.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 45.7 Cg_endo -72.32 92.97 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.776 2.317 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.475 ' OD1' ' N ' ' A' ' 92' ' ' ASN . 3.6 p30 -97.68 114.96 27.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 m -97.4 -89.32 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 94' ' ' THR . 5.6 t -153.79 129.52 10.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.68 7.82 8.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.395 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.42 88.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -127.52 5.23 6.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.57 87.12 3.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.5 tttp -164.37 -67.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.46 48.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.3 mttm 47.41 27.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.455 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.0 44.67 6.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.32 161.15 0.67 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.94 -169.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.44 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.09 -81.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 121.45 -96.12 0.58 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.81 13.51 0.81 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -1.127 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.09 34.05 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -77.57 91.12 3.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 109' ' ' ALA . 53.5 m-85 40.14 87.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.474 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' C ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 41.22 33.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.446 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 m -47.44 -25.84 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.426 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.45 -170.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.35 158.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -118.34 139.44 51.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.483 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -114.86 117.64 31.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.379 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.18 126.61 45.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.853 . . . . 0.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -120.88 106.51 11.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -79.36 94.83 5.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.93 -166.84 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -63.13 -53.74 48.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.38 -1.54 3.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 137.32 54.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.52 121.64 45.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -119.19 147.19 44.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.6 mt -116.81 147.55 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.65 161.93 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -95.16 149.38 21.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.03 144.36 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.92 -69.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 149.37 46.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.08 -35.51 80.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.24 -58.29 8.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB3' HG22 ' A' ' 41' ' ' VAL . 9.2 mt -50.07 -59.26 4.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.508 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.483 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 4.4 t -39.88 -59.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -48.41 -42.36 31.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 25' ' ' LEU . 6.0 mt-10 -60.65 -46.22 91.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.848 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' N ' ' NZ ' ' A' ' 37' ' ' LYS . 31.0 t80 -49.83 -54.92 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.2 mt -52.55 -22.87 5.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -88.27 -26.51 22.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -130.89 58.35 38.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 93.94 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.896 2.397 . . . . 0.0 112.245 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.8 t -155.66 27.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 36' ' ' GLY . 27.8 mm 59.41 169.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.589 ' N ' HG22 ' A' ' 35' ' ' ILE . . . 92.92 -38.54 3.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.587 ' NZ ' ' N ' ' A' ' 29' ' ' TYR . 25.9 tttm -105.5 -6.36 19.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -1.123 . . . . 0.0 109.453 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.93 -23.11 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.23 -33.38 59.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.47 -27.56 61.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 25' ' ' LEU . 40.7 t -86.59 -64.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.76 146.66 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -97.9 -55.5 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.42 154.71 19.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.01 65.9 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -156.53 157.27 35.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.81 140.65 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.2 m-85 -114.92 170.13 8.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.23 152.98 72.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.54 126.43 11.52 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.57 5.83 48.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 109.472 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -171.34 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.494 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.98 -5.37 2.76 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ALA . 16.9 mtm180 -131.21 -26.91 2.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -1.189 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -68.96 67.9 0.46 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' ARG . . . -70.8 6.23 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -1.208 . . . . 0.0 109.516 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 55' ' ' GLY . 4.4 mm-40 -133.57 -173.76 3.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.87 -131.58 12.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.454 ' C ' ' OE1' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -137.01 147.43 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -1.145 . . . . 0.0 109.461 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.44 -164.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.433 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.05 -174.19 27.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.5 49.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -1.131 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 128.88 36.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.27 150.04 47.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -50.32 -25.23 3.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.505 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.12 -42.65 79.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 68' ' ' VAL . 4.2 tt0 -62.64 -61.51 2.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 67' ' ' GLN . 19.0 t -42.96 -48.34 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -47.92 -24.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.39 -19.97 55.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' VAL . 5.6 mm-40 -92.18 -66.05 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -156.8 66.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.93 130.31 2.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -164.74 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.98 -22.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -72.16 -165.57 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.6 mttm -109.78 -161.98 0.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -90.81 -42.77 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -49.82 -55.47 14.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -56.3 -48.83 75.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 77' ' ' LYS . 21.2 t -44.56 -54.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.46 -35.55 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -53.93 -49.3 68.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' ARG . 16.4 mt -57.16 -54.54 45.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 84' ' ' LEU . 56.3 mt -43.19 -44.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.3 mt -69.52 -27.29 65.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 84' ' ' LEU . 4.2 tpt180 -51.75 -28.41 15.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.545 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -115.53 -83.17 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 69.13 127.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' GLY . 7.0 mttp 42.4 56.72 10.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 44.3 Cg_endo -72.4 18.09 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.904 2.403 . . . . 0.0 112.246 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -47.29 151.28 0.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.76 159.44 36.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.874 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -106.5 70.46 0.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 95' ' ' THR . 7.4 m -86.49 91.12 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.2 p -63.94 172.34 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.77 156.58 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.51 -24.57 22.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -62.08 -156.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.53 169.59 10.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -61.17 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.33 88.26 1.0 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -138.87 -38.91 0.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -141.34 0.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 0.0 109.425 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.24 -54.09 20.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.183 -0.948 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.78 124.48 1.98 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' ALA . 1.6 t -88.08 15.32 7.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.83 -90.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.448 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 107' ' ' THR . . . -174.92 -160.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.7 59.67 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' C ' ' OG ' ' A' ' 2' ' ' SER . 6.5 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.8 OUTLIER -171.41 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.479 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER -43.43 173.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.907 . . . . 0.0 109.468 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 m -85.07 -172.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -146.33 146.15 30.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' A' ' 6' ' ' LYS . 11.0 mtpp -114.73 133.31 55.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.498 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.87 132.01 43.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.94 147.22 24.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -141.1 107.85 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -89.73 92.64 9.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 13' ' ' ASN . . . -56.46 171.33 2.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.5 -5.81 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -1.145 . . . . 0.0 109.542 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' GLY . 23.1 t30 -161.09 -54.81 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.509 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -84.91 152.87 23.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -115.87 130.58 56.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.83 156.92 46.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 mt -121.75 152.75 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.49 166.78 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.503 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.51 153.4 22.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.45 161.41 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.5 -76.17 0.28 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -135.9 155.04 50.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -67.06 -31.62 72.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -50.1 -61.13 2.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.458 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 28' ' ' GLU . 12.6 mt -55.55 -52.45 63.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' LEU . 10.9 t -45.5 -50.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.9 -24.56 67.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 42.4 mm-40 -79.53 -37.63 36.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.474 ' CE1' HD13 ' A' ' 38' ' ' LEU . 60.3 t80 -60.35 -44.38 95.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.06 -35.62 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.498 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -76.39 -37.98 56.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.4 72.08 80.21 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.53 136.77 20.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.857 2.371 . . . . 0.0 112.248 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.06 130.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.48 -44.21 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -10.52 5.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -49.27 5.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -1.122 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD13 ' CE1' ' A' ' 29' ' ' TYR . 3.4 tp -47.2 -21.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -32.06 73.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.21 -45.76 11.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.6 -54.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG11 ' CD1' ' A' ' 45' ' ' PHE . 91.6 t -71.62 134.33 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 35.17 3.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.41 -40.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CD1' HG11 ' A' ' 42' ' ' VAL . 36.2 m-85 56.4 62.01 2.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.539 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -158.1 161.73 37.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.61 123.78 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -110.59 171.18 7.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.68 159.01 37.0 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.66 168.84 21.58 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.856 2.371 . . . . 0.0 112.192 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 52' ' ' ASP . 1.1 tp60 -124.98 168.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.407 ' H ' ' HG3' ' A' ' 51' ' ' GLN . 3.5 m-20 -64.57 117.35 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -46.37 0.31 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 177.34 -21.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.56 -75.89 0.31 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 57' ' ' GLU . . . -86.18 -66.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -1.14 . . . . 0.0 109.461 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.5 mm-40 38.65 33.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 46.22 -162.23 0.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 45.02 70.64 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.487 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -86.79 165.45 16.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.58 152.51 20.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.54 146.18 26.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -1.14 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.8 -170.76 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.6 m -113.38 147.24 38.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 74.5 mttt -49.04 -32.58 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.704 ' O ' ' ND2' ' A' ' 70' ' ' ASN . . . -64.6 -42.72 95.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.48 -38.27 86.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.48 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' GLU . 41.4 t -66.34 -55.19 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 73' ' ' GLY . 2.0 mt-10 -44.96 -35.55 2.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.704 ' ND2' ' O ' ' A' ' 66' ' ' ALA . 27.8 m-80 -66.29 -17.97 65.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 68' ' ' VAL . 2.3 mp0 -108.88 -6.97 15.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.545 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -146.1 16.74 1.38 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 48.32 -133.96 19.31 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER -42.78 109.03 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -1.155 . . . . 0.0 109.447 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.13 87.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' LYS . 16.7 mttt -66.52 -179.1 0.78 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.398 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -47.82 138.76 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.37 -22.41 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.92 -28.97 62.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.563 ' CA ' ' OE1' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.05 -47.95 14.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.514 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -50.99 -48.83 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.506 HG22 HD11 ' A' ' 86' ' ' LEU . 74.4 mt -63.96 -36.52 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' LEU . 56.8 t0 -58.66 -64.18 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ASP . 98.5 mt -42.18 -46.32 4.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 87' ' ' ARG . 74.2 mt -57.86 -58.16 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.506 HD11 HG22 ' A' ' 82' ' ' ILE . 10.2 mt -56.16 -7.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.701 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -111.21 -20.82 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -140.91 66.44 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.57 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -147.64 -138.92 3.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 89' ' ' GLY . 16.8 ttpp -35.09 98.75 0.16 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.494 ' N ' ' O ' ' A' ' 89' ' ' GLY . 31.7 Cg_exo -55.07 91.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.535 2.157 . . . . 0.0 112.13 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -71.63 153.45 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.597 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 92' ' ' ASN . 8.2 p 43.34 80.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.509 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 p -76.73 61.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.4 m -140.91 129.46 22.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 t -116.04 -23.66 8.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 98.8 p -76.78 115.77 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 100' ' ' THR . 3.5 mt -108.88 -144.4 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' CG ' ' O ' ' A' ' 99' ' ' LYS . 9.5 tttm 51.27 14.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.402 ' N ' ' C ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -125.35 -49.42 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -0.879 . . . . 0.0 109.482 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -80.65 79.71 7.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.18 168.01 31.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.74 70.87 1.07 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -152.03 -74.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -1.14 . . . . 0.0 109.457 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.69 68.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.37 117.35 3.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -80.15 -24.36 40.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -1.171 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 110' ' ' TYR . 14.8 mttt 52.35 33.02 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.78 28.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.494 ' H ' ' C ' ' A' ' 108' ' ' LYS . 5.7 m-85 -120.62 160.13 23.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.542 ' N ' ' OD1' ' A' ' 111' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.44 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.271 0.558 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.479 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.32 148.29 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.95 -169.9 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.8 142.57 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -102.4 131.6 48.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 26' ' ' VAL . 1.1 m-85 -99.85 116.58 32.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 17.9 m-85 -91.23 142.9 27.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -132.72 102.2 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -81.4 93.37 6.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.14 -156.57 8.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -46.77 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -119.26 -13.82 9.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.59 147.49 23.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -117.28 115.85 26.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.95 152.69 24.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.8 mt -137.77 114.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -172.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.415 ' CD2' ' CD1' ' A' ' 44' ' ' LEU . 4.5 m-85 -104.57 169.63 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.15 149.79 5.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.69 -59.54 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 p -155.92 142.92 19.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -53.69 -33.93 57.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.225 -0.922 . . . . 0.0 109.514 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 13.6 tt0 -54.65 -64.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.8 mt -44.64 -58.04 3.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' LEU . 96.1 t -40.39 -45.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -60.51 -36.06 77.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 25' ' ' LEU . 5.6 mt-10 -67.28 -23.14 65.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -85.07 -28.69 25.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.93 -40.42 95.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -74.45 -32.77 62.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.561 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -124.67 73.52 62.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.74 114.37 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.76 2.306 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -144.27 -112.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -162.68 -14.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.11 -52.49 4.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -65.45 -8.38 18.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.149 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.14 -54.31 31.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 p -48.84 -20.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -84.06 -44.09 14.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.66 -70.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 42' ' ' VAL . 2.4 t -68.14 129.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.419 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.77 -36.45 15.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -123.89 112.51 17.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.485 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.44 80.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' LEU . 4.6 tp10 -165.39 157.25 14.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.91 129.55 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -111.97 160.01 17.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 168.62 16.15 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -47.02 161.28 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.838 2.359 . . . . 0.0 112.233 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -94.91 -78.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 109.501 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -162.14 85.72 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.48 -127.07 7.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.719 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -65.77 116.42 6.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -1.16 . . . . 0.0 109.405 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.14 159.03 25.09 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -170.79 2.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -167.25 -173.81 2.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 -138.46 16.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.692 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 2.1 mp0 -87.54 80.53 8.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -1.183 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.29 -169.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.47 178.97 16.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.73 148.8 47.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -1.172 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.7 150.55 21.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.72 174.6 6.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.426 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -70.58 -31.84 69.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.16 -43.3 87.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -62.71 -52.48 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' GLU . 95.3 t -60.05 -41.99 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.972 . . . . 0.0 109.541 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -45.04 -42.44 8.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.9 . . . . 0.0 109.525 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -69.96 -26.07 63.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -81.58 -25.43 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -137.66 -71.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.51 -172.02 36.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 75' ' ' GLY . 56.5 tttp -115.33 159.22 21.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 74' ' ' LYS . . . 101.62 -22.37 38.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -78.67 -168.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -1.113 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 78' ' ' ILE . 22.8 mttm -124.71 137.87 54.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -39.55 -45.39 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 4.8 mt-10 -64.22 -43.92 93.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' LYS . 2.5 tp10 -59.2 -36.24 75.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' C ' ' A' ' 82' ' ' ILE . 6.5 t -70.44 -60.38 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 81' ' ' VAL . 94.8 mt -39.54 -42.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.497 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -56.6 -57.08 13.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -54.63 -30.97 56.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 86' ' ' LEU . 1.9 mm -68.44 -64.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.45 ' N ' HG22 ' A' ' 85' ' ' ILE . 4.8 mt -45.19 -42.92 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -46.46 -53.26 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.81 -82.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.476 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.49 119.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -128.72 77.77 77.06 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -1.107 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.26 -37.28 24.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.866 2.377 . . . . 0.0 112.213 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -55.88 173.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.7 t 55.81 55.87 6.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 95' ' ' THR . 1.2 t -100.33 -176.21 3.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 95' ' ' THR . 2.6 t -167.6 95.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.519 ' O ' ' C ' ' A' ' 97' ' ' SER . 26.7 p -120.3 160.5 22.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.405 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -36.62 -55.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.42 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.83 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 97' ' ' SER . 45.4 tttt -167.69 -23.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 101' ' ' LYS . 29.2 m -78.03 -23.53 48.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 100' ' ' THR . 16.8 mmtm 41.78 -131.0 0.5 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.53 43.43 24.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.81 55.37 4.49 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -110.24 136.02 50.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.394 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -172.22 77.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 109.534 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.513 ' O ' ' OG1' ' A' ' 107' ' ' THR . . . 88.9 -29.25 6.0 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 106' ' ' GLY . 7.5 p 58.57 112.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -85.95 -13.03 48.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.06 -125.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -132.1 45.92 2.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.471 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -74.16 -56.19 5.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.646 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -96.21 -168.05 1.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.456 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.646 ' N ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -79.85 -179.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 m -93.6 139.43 30.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.5 115.79 30.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.683 ' OH ' HG11 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -95.39 137.83 33.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 41.8 m-85 -115.4 150.47 36.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.572 ' HB2' HG23 ' A' ' 85' ' ' ILE . 67.0 t80 -139.78 123.91 17.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -101.0 99.79 10.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.71 -147.52 0.08 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -97.08 -43.22 7.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.468 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.6 -3.29 3.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.927 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.58 158.62 40.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.7 144.33 47.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -134.91 160.85 36.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 92.2 mt -140.89 140.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.13 156.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -93.25 154.28 18.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.66 168.9 18.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.12 -58.36 2.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.4 p -156.11 148.82 23.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.96 -26.68 68.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.76 -41.18 75.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.483 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.2 mt -69.97 -26.32 64.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.683 HG11 ' OH ' ' A' ' 7' ' ' TYR . 45.7 t -76.6 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' VAL . 1.5 t0 -43.61 -43.45 5.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.333 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 1.7 mt-10 -61.58 -45.7 93.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.493 ' OH ' ' O ' ' A' ' 34' ' ' SER . 91.6 t80 -59.86 -33.29 71.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 30' ' ' LEU . 40.1 mt -69.36 -40.03 77.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -59.87 -23.92 63.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.562 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 5.6 p-10 -153.72 81.37 4.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.78 144.62 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.836 2.357 . . . . 0.0 112.296 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.493 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -154.42 -169.78 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -126.52 -19.6 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.1 -57.64 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -49.66 -25.5 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tp -47.0 -24.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.427 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -69.95 -62.5 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.52 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.68 -39.78 37.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.28 -48.31 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 44' ' ' LEU . 21.7 t -105.53 128.85 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 -1.86 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.665 ' H ' HG12 ' A' ' 42' ' ' VAL . 2.7 tp -157.18 123.72 4.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.36 94.43 8.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -168.68 152.21 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.975 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 t -120.03 119.15 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.493 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.1 152.18 23.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.411 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -117.13 149.87 45.12 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 51' ' ' GLN . 43.9 Cg_endo -71.94 157.52 54.59 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.784 2.323 . . . . 0.0 112.147 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.9 mm-40 -59.79 -131.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.519 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 54' ' ' ARG . 42.4 p-10 -108.72 70.13 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.61 -41.81 0.18 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.5 ttp180 -91.58 113.69 26.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 109.446 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.06 134.85 6.66 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.1 4.5 2.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -1.11 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -160.58 87.1 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 176.36 92.4 0.08 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.09 82.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -1.078 . . . . 0.0 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt -80.46 156.47 26.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.68 36.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.3 49.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -1.15 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 169.99 10.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.0 161.64 13.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -57.78 -46.23 84.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.62 -22.16 12.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -83.36 -58.62 2.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.34 -29.14 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.9 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' GLU . 46.5 mt-10 -71.55 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 69' ' ' GLU . 7.9 t30 -38.53 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.518 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 69' ' ' GLU . 15.6 mm-40 -75.74 -62.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.667 ' CE2' HG13 ' A' ' 81' ' ' VAL . 90.8 m-85 -94.08 -72.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.567 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.29 177.45 41.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -96.87 170.61 9.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -1.096 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.1 -29.9 4.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -76.85 156.4 32.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -1.131 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -97.35 -176.31 3.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.905 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 79' ' ' GLU . 2.9 tp -73.87 -36.37 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 78' ' ' ILE . 10.8 pt-20 -62.77 -49.51 74.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -55.64 -60.85 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.667 HG13 ' CE2' ' A' ' 72' ' ' PHE . 3.4 t -41.68 -62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 83' ' ' ASP . 17.0 mt -45.14 -51.52 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -37.32 -55.26 1.04 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 45.6 mt -56.03 -59.64 4.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 9' ' ' TYR . 76.9 mt -38.26 -41.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.98 -33.75 76.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 84' ' ' LEU . 14.5 ttt180 -62.95 -14.08 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -105.35 -89.11 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.75 127.5 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' N ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 tptt -139.09 60.55 17.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 90' ' ' LYS . 52.2 Cg_exo -48.41 132.72 24.83 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.855 2.37 . . . . 0.0 112.149 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 93' ' ' SER . 44.9 t30 -55.17 125.41 20.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 109.43 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 92' ' ' ASN . 44.6 m -40.96 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' ASN . 9.2 p -81.86 149.48 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 p -122.2 54.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.4 t -163.38 111.31 1.22 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 p -158.9 123.87 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.51 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.71 -50.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.955 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.63 48.16 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 101' ' ' LYS . 6.8 p -117.51 -62.9 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.424 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' N ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -81.87 144.7 30.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.6 0.08 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 136.75 -64.83 0.57 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -141.06 156.37 46.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.47 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -138.48 -163.93 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.91 -164.93 40.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -130.77 135.18 47.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -154.81 -105.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.504 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.2 57.37 1.81 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -67.23 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.403 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.661 ' SD ' ' OG ' ' A' ' 2' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.661 ' OG ' ' SD ' ' A' ' 1' ' ' MET . 66.2 m -116.28 -9.58 11.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 2' ' ' SER . 89.2 m -170.59 83.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.53 -169.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.475 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.13 133.57 54.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.455 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -106.17 117.6 34.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CZ ' ' HD2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -89.45 126.82 35.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 2.3 m-85 -89.25 160.14 17.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.521 ' HB2' HG23 ' A' ' 85' ' ' ILE . 44.8 t80 -150.63 105.61 3.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.45 126.27 29.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.72 -149.61 24.93 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -70.86 -31.28 67.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -153.39 -51.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -77.4 169.53 18.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD2' ' CD2' ' A' ' 8' ' ' PHE . 48.8 t0 -116.59 134.86 54.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 16' ' ' LEU . 91.5 mt -111.24 136.2 50.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.0 mt -115.98 131.74 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 m -117.74 156.67 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -92.27 150.8 20.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.94 166.03 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.1 -50.21 5.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -165.03 142.53 6.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.468 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.87 -35.76 69.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.444 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -63.89 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -50.22 -45.68 54.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.95 -49.08 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -60.93 -38.15 84.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.4 -36.07 81.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.95 -32.68 69.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 30' ' ' LEU . 6.0 mt -54.05 -31.88 52.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.468 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 31' ' ' LYS . 7.4 tttm -96.32 32.9 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -175.37 58.41 0.19 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.36 99.02 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.879 2.386 . . . . 0.0 112.232 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 m -127.31 -107.04 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 tp -159.32 -23.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -81.52 -73.5 1.19 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -41.17 -22.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.422 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.0 tp -66.81 -38.86 87.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -58.87 -36.12 74.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 41' ' ' VAL . 2.3 tt0 -74.27 -57.38 3.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 40' ' ' GLU . 53.6 t -41.68 -35.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 75.3 t -104.43 122.15 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.02 -27.04 30.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 2.3 mp -129.38 140.26 51.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.28 59.27 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -153.39 163.86 39.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -117.47 151.71 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.91 148.83 51.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.452 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -151.1 155.78 35.02 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 143.03 37.76 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.861 2.374 . . . . 0.0 112.224 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.559 ' CG ' ' N ' ' A' ' 52' ' ' ASP . 9.2 pt20 -133.64 -51.52 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 0.1 OUTLIER -73.75 -39.21 64.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.91 -154.68 8.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.714 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -110.78 -157.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -1.145 . . . . 0.0 109.556 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.49 110.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.62 90.3 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.15 -21.68 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.78 -5.92 12.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -105.13 44.74 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -1.184 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 12.3 mt -74.4 171.89 12.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.43 135.88 11.53 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.1 158.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -1.153 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -88.89 155.71 19.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.2 p -83.04 145.29 29.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -56.17 -16.0 4.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.14 -36.27 16.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.86 -41.72 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.898 . . . . 0.0 109.496 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.06 -46.22 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.516 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.63 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.4 mt-10 -47.73 -38.6 15.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -78.64 -20.99 49.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.75 -31.21 59.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 81' ' ' VAL . 50.7 m-85 -126.69 -18.52 4.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 117.52 -152.59 17.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -138.75 92.96 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -1.126 . . . . 0.0 109.512 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.49 -18.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -95.54 -178.03 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 0.0 109.448 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -107.98 -157.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.88 -31.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -59.93 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.05 -31.35 7.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 72' ' ' PHE . 6.4 t -68.57 -61.96 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' A' ' 85' ' ' ILE . 45.9 mt -55.92 -21.58 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -66.28 -56.12 12.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mt -59.19 -25.54 64.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 82' ' ' ILE . 72.6 mt -69.93 -50.85 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 16.0 mt -72.19 -5.81 38.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.39 -34.98 11.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.48 42.19 1.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -104.97 -133.67 7.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 89' ' ' GLY . 33.2 tttm 36.11 75.0 0.53 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.9 -68.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.831 2.354 . . . . 0.0 112.2 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 45.69 -163.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.498 ' O ' ' OG ' ' A' ' 93' ' ' SER . 14.2 p -112.02 82.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 120.45 9.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.7 p -69.12 156.27 38.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -65.45 152.72 43.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -84.99 143.1 29.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 97' ' ' SER . 9.4 mt 39.81 -133.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -101.05 -89.07 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.97 119.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -87.72 150.47 23.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.84 102.41 0.54 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.74 176.02 16.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.84 10.16 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.93 112.76 24.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 108' ' ' LYS . . . 171.7 141.98 3.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.93 5.73 1.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -1.178 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 106' ' ' GLY . 21.6 mttm -79.38 -94.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.85 178.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -88.07 99.24 12.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 p30 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.526 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' SER . 33.0 mtt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 70.6 -79.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.425 ' O ' HG13 ' A' ' 4' ' ' VAL . 19.4 m -150.49 158.72 44.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -153.54 -170.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.444 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 6' ' ' LYS . 14.9 m -106.69 166.86 10.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.419 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 5' ' ' THR . 13.7 mtpt -128.4 143.76 51.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.643 ' OH ' HG11 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -123.65 113.12 18.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.0 109.479 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -83.66 164.02 19.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 109.408 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -154.21 131.98 11.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.475 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -110.79 112.6 24.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.548 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.0 -149.27 4.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -79.8 -47.37 15.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.453 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.87 -26.65 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 158.25 16.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.6 t0 -114.17 154.76 27.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.421 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.673 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 44.0 mt -137.52 157.72 45.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.73 151.42 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.48 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.9 154.87 27.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 162.68 32.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.47 -65.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.74 129.05 18.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -46.57 -38.88 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.19 -61.44 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' C ' ' A' ' 26' ' ' VAL . 32.0 mt -47.26 -59.6 3.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.643 HG11 ' OH ' ' A' ' 7' ' ' TYR . 97.8 t -38.21 -46.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -46.15 84.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.98 -46.78 87.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -47.22 -52.64 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.64 -25.91 60.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -71.49 -31.68 67.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -158.88 80.36 2.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.19 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.804 2.336 . . . . 0.0 112.271 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 36' ' ' GLY . 1.6 t -118.48 120.26 37.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.245 -0.91 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.55 0.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 34' ' ' SER . . . -85.48 -16.17 64.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' LEU . 4.6 ptmm? -115.66 -10.81 11.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.133 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -38.42 -53.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 41' ' ' VAL . 4.6 p -52.77 -61.37 2.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 39' ' ' SER . 4.6 mm-40 -37.77 -22.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.7 t -96.54 -54.86 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.5 149.38 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.57 -16.46 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.68 98.33 2.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -63.29 89.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -169.04 118.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.406 ' CG1' HD22 ' A' ' 16' ' ' LEU . 61.6 t -79.67 144.82 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.54 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -130.86 163.39 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.13 163.82 37.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 126.19 10.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.823 2.348 . . . . 0.0 112.24 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.2 tt0 -109.12 -177.35 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -50.6 179.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.461 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.67 -131.59 8.59 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -139.14 18.14 2.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 109.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.63 -80.06 0.16 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.96 54.21 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -1.149 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -118.58 156.02 29.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 59' ' ' GLU . . . 83.86 165.27 38.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' GLY . 46.4 tt0 -43.54 115.5 0.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.3 mt -64.04 155.89 29.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.79 137.19 15.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 152.44 22.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.463 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.73 -168.8 1.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.441 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.27 166.42 18.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -20.66 66.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.18 -44.83 13.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -59.38 -41.44 89.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.22 -56.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.73 -34.98 70.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.85 . . . . 0.0 109.515 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -55.39 -27.89 50.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.33 -66.77 0.86 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.536 ' CE1' HG13 ' A' ' 81' ' ' VAL . 25.5 m-85 -71.38 -67.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.38 175.25 21.56 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.86 172.9 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.42 9.94 74.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -131.78 171.0 14.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -1.202 . . . . 0.0 109.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -119.21 -163.16 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.57 -35.22 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.525 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -64.44 -31.59 72.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' CD ' ' N ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -84.17 -45.24 13.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.536 HG13 ' CE1' ' A' ' 72' ' ' PHE . 22.8 t -58.56 -34.86 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.05 -46.56 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.21 -45.38 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 84' ' ' LEU . 79.5 mt -61.32 -56.57 18.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mt -47.14 -50.92 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' N ' ' A' ' 88' ' ' ASN . 45.0 mt -58.83 -31.12 68.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -55.74 -9.41 0.54 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 86' ' ' LEU . 4.5 m-80 -134.22 -91.68 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 65.51 125.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 89' ' ' GLY . 23.3 mtmt 35.75 62.76 2.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.344 -1.092 . . . . 0.0 109.545 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -73.59 157.79 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 50.96 84.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 p -149.75 51.42 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.7 m -105.3 -75.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -90.8 72.43 6.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.81 108.72 10.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 p -149.82 -2.2 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 99' ' ' LYS . 4.1 mm? -71.27 -92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.385 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 98' ' ' LEU . 9.5 mttt 37.42 -148.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 p -137.82 62.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -62.59 -53.75 49.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.4 96.23 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 105' ' ' ALA . . . -131.13 44.81 1.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.481 ' O ' ' OD1' ' A' ' 104' ' ' ASN . 59.6 t-20 -72.96 29.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 103' ' ' GLY . . . -117.24 15.84 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.36 120.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -65.24 123.23 19.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -1.185 . . . . 0.0 109.528 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.37 -74.64 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.13 -148.28 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -97.29 -52.68 3.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.495 -179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.28 0.562 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -100.95 147.16 26.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -116.7 136.58 52.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.429 ' HB2' HG23 ' A' ' 18' ' ' VAL . 2.3 m-85 -118.68 122.73 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -90.82 159.59 16.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -147.49 91.11 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -53.59 113.77 1.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.14 -161.85 33.27 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.3 mm-40 -70.92 -45.25 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.01 -41.69 2.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t -101.42 177.89 4.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.41 124.63 49.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.88 127.66 49.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.358 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.18 155.08 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' HB2' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -131.82 154.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.54 153.92 17.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.16 159.18 44.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.96 -73.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 t -145.66 169.89 17.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.53 -26.65 66.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 25' ' ' LEU . 57.7 tt0 -65.49 -74.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' GLU . 5.2 mt -42.39 -33.4 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 27' ' ' ASP . 3.7 t -67.32 -70.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 26' ' ' VAL . 45.4 t0 -41.11 -39.87 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 109.479 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 29' ' ' TYR . 3.1 mm-40 -58.05 -58.8 6.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' GLU . 76.2 t80 -43.33 -51.86 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.938 . . . . 0.0 109.446 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.73 -40.32 83.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -68.55 -4.51 15.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -175.62 79.43 0.3 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.47 140.42 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.769 2.312 . . . . 0.0 112.216 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 t -164.33 94.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -48.54 -27.49 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.59 -9.64 74.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 38' ' ' LEU . 18.2 tttm -112.28 -25.46 9.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -39.13 -31.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -60.79 -69.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.494 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' SER . 35.9 mt-10 -41.33 -36.39 0.8 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.17 -70.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.7 t -85.12 130.31 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 44' ' ' LEU . 2.0 pt-20 -95.17 -31.49 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 43' ' ' GLU . 8.0 mp -111.15 121.42 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -91.6 77.62 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 30.4 tt0 -165.86 143.88 5.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.464 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.58 127.29 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 72.7 m-85 -113.26 154.22 27.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 109.547 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -132.87 164.14 46.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 49' ' ' THR . 66.6 Cg_exo . . . . . 0 C--N 1.306 -1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.217 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.61 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.98 -173.84 14.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.18 151.07 26.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.85 132.88 39.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -74.75 149.29 39.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 29.9 mttt -43.82 -51.36 7.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.76 -34.92 20.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -73.05 -36.71 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -66.13 -34.45 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 109.447 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.53 -28.72 70.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.521 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -52.92 -19.65 2.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -113.75 -73.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -148.46 72.5 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' C ' ' A' ' 74' ' ' LYS . . . -135.24 0.54 3.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 73' ' ' GLY . 10.7 tptm -37.37 -49.37 0.99 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.467 -1.019 . . . . 0.0 109.475 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 3.32 0.83 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -75.64 -175.97 3.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -114.37 -140.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.31 -23.93 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -64.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' ASP . 37.4 mt-10 -47.08 -53.22 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 80' ' ' GLU . 4.7 t -44.3 -58.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.06 -22.47 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 3.9 t0 -69.35 -61.08 1.94 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.45 -46.17 47.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.84 -59.31 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 87' ' ' ARG . 19.5 mt -46.21 -33.78 3.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.74 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -35.78 -66.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.429 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.87 75.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.336 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.31 -117.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.344 -1.092 . . . . 0.0 109.412 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -122.37 131.57 53.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -105.96 131.62 53.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 4.5 m-85 -97.31 123.38 41.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.65 149.69 22.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 9' ' ' TYR . 22.8 t80 -144.69 119.0 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -95.03 132.97 39.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -109.26 -154.2 15.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.2 tp10 -42.82 -82.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -117.78 -34.56 4.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.614 ' CB ' HE22 ' A' ' 67' ' ' GLN . 1.4 t -79.0 174.05 11.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.42 145.35 48.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mt -130.38 156.88 43.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 18' ' ' VAL . 48.4 mt -134.98 155.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.927 . . . . 0.0 109.559 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.426 ' N ' HG22 ' A' ' 17' ' ' ILE . 18.9 m -136.1 155.93 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -98.46 140.49 32.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.34 168.31 20.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.93 -87.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 p -136.11 171.89 13.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.517 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -68.58 -13.01 62.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.14 -74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.498 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -47.45 -46.63 26.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.527 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 47.6 t -51.72 -54.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -53.42 -45.86 69.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.81 -30.09 63.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 33' ' ' PRO . 60.4 t80 -72.22 -61.24 1.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.402 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.513 HD21 ' O ' ' A' ' 86' ' ' LEU . 10.6 mt -48.27 -44.4 33.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -72.33 -20.94 61.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -150.31 70.59 9.11 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 34' ' ' SER . 54.2 Cg_endo -74.32 162.55 38.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.881 2.387 . . . . 0.0 112.209 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 33' ' ' PRO . 73.8 m -171.26 -104.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.476 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 tp -169.08 -20.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.93 -40.33 5.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -69.05 -18.31 64.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -1.13 . . . . 0.0 109.415 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.99 -29.12 67.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.918 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -33.47 75.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -78.4 -57.25 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -46.62 -60.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.5 122.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.527 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -104.49 -1.37 26.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp -156.29 107.4 2.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.39 87.35 3.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.7 114.22 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.77 144.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -129.7 165.78 21.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.34 151.82 11.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.836 2.358 . . . . 0.0 112.173 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -142.83 174.81 23.39 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.05 127.4 51.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.157 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 144.69 54.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -93.09 155.31 17.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.411 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -38.96 -50.14 1.74 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -56.16 -59.8 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.614 HE22 ' CB ' ' A' ' 14' ' ' THR . 20.7 mm100 -35.91 -39.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 38.4 t -84.01 -31.76 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 66' ' ' ALA . 49.5 tt0 -65.37 -39.26 92.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -18.87 65.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.61 -70.18 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -160.07 54.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.09 170.2 21.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 177.81 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 109.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.58 7.15 0.33 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -82.49 166.11 19.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -71.84 -149.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tp -109.4 -13.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.06 -18.72 62.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 -53.33 4.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.43 -39.74 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -72.28 -49.5 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -44.57 -44.79 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' ARG . 14.3 mt -67.44 -60.6 2.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.428 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 84' ' ' LEU . 13.3 mt -40.4 -39.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' HD21 ' A' ' 30' ' ' LEU . 84.6 mt -70.44 -36.01 73.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.716 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -41.7 -62.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.509 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.44 -86.94 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.08 117.14 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.0 mttp . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.23 -1.159 . . . . 0.0 109.543 179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 163.46 12.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -122.84 130.6 53.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 6.0 m-85 -114.68 114.34 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -83.65 142.08 31.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -123.74 144.6 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -114.98 129.12 56.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.05 24.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.51 -34.06 58.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -1.151 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -149.7 -35.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 15' ' ' ASP . 85.1 m -89.51 157.92 17.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 39.3 t0 -106.17 152.17 23.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.634 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 42.9 mt -136.34 160.03 39.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.462 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 mt -145.01 148.87 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.01 147.35 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -86.21 142.37 28.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.94 -171.75 2.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.05 -90.68 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 m -121.53 171.62 8.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.69 -9.6 59.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.03 -54.62 4.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.22 -38.6 83.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.479 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 75.8 t -63.8 -55.94 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.508 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -54.68 -50.5 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -52.39 -31.52 34.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 76.2 t80 -68.3 -41.87 80.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.6 mt -60.46 -23.43 64.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -90.64 -4.49 56.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -167.66 71.55 0.93 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HA ' ' CE1' ' A' ' 29' ' ' TYR . 56.9 Cg_endo -75.29 139.67 23.81 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.812 2.341 . . . . 0.0 112.258 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 m -160.67 -133.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.2 tp -135.44 15.7 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -112.79 -82.97 1.21 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 36' ' ' GLY . 4.1 ttmt -45.05 -22.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.483 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 36' ' ' GLY . 6.0 tp -49.28 -62.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.5 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.89 -47.64 31.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.426 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -29.04 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 37' ' ' LYS . 34.6 t -86.98 -54.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 82' ' ' ILE . 21.5 t -87.63 113.44 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.15 -43.26 24.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 tp -111.15 115.16 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.893 . . . . 0.0 109.453 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.428 ' CE1' ' OE2' ' A' ' 79' ' ' GLU . 46.8 m-85 -73.93 65.92 1.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.72 174.9 10.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.447 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.3 t -134.85 128.17 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.93 151.92 22.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.35 150.76 77.35 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 C-N-CA 122.854 2.369 . . . . 0.0 112.176 -179.969 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.4 172.09 23.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.67 154.81 17.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -1.138 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.54 133.71 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 169.36 18.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ALA . 63.5 tttt -57.38 -65.86 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.437 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' LYS . . . -43.97 -39.9 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -57.17 -24.08 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -68.23 -24.95 64.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -72.66 -21.34 61.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -105.62 -63.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -165.84 64.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -128.21 -0.01 6.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 73' ' ' GLY . 20.1 tttt -51.69 -101.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.455 -1.027 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 44.56 1.6 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -121.7 133.16 54.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -1.112 . . . . 0.0 109.473 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -56.41 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -84.96 -42.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 8.2 mm-40 -49.48 -55.44 13.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 83' ' ' ASP . 2.1 mt-10 -48.3 -54.26 14.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -45.47 -46.46 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.907 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.557 HG21 HG21 ' A' ' 42' ' ' VAL . 19.1 mm -62.87 -25.93 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.149 -0.969 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' GLU . 52.0 t0 -70.97 -61.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 65.5 mt -49.12 -29.87 5.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 88' ' ' ASN . 58.3 mt -67.74 -66.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ILE . 95.8 mt -43.82 -46.4 7.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -56.58 -30.93 63.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 7.1 t-20 -83.76 -81.79 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 57.08 116.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 tptm . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.213 -1.169 . . . . 0.0 109.521 179.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -127.81 147.18 50.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -105.27 159.24 16.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.05 112.17 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.45 162.74 28.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -153.3 100.42 2.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -66.74 104.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.55 33.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -47.01 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -1.19 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -106.98 -52.15 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -80.66 174.08 11.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 6.8 t70 -119.43 156.28 30.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.431 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.492 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 22.3 mt -123.2 157.32 33.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.21 143.76 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.24 142.18 36.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.59 -178.45 5.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.16 -73.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.11 166.48 27.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.23 -37.18 77.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.07 -51.79 29.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -51.08 -43.93 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.28 -41.7 97.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.377 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -65.36 -35.03 79.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -65.65 -54.07 32.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.4 mt -52.31 -19.86 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.62 -44.06 52.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.372 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.05 76.48 77.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.448 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.586 ' O ' ' CB ' ' A' ' 34' ' ' SER . 55.5 Cg_exo -47.01 164.19 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.836 2.358 . . . . 0.0 112.24 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 159.61 -173.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.587 ' N ' ' OG ' ' A' ' 34' ' ' SER . 0.6 OUTLIER -114.98 -14.27 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.84 -17.99 76.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -103.14 -18.97 14.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -1.142 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -63.05 -33.31 75.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p -70.32 -20.5 63.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -83.77 -50.41 8.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.64 -36.4 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.97 110.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -80.51 -18.36 48.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.08 142.09 23.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -98.99 68.55 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.0 tp10 -150.65 128.34 11.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 2.0 t -93.09 128.39 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 91.2 m-85 -114.21 155.06 26.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -131.83 152.09 79.7 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 C--N 1.305 -1.749 0 C-N-CA 122.743 2.295 . . . . 0.0 112.192 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.249 0.547 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.96 113.13 2.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.37 111.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -1.141 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.533 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -65.48 130.49 43.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' ALA . 73.0 m -93.22 139.66 30.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.1 mttt -41.26 -27.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.423 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -61.4 -39.36 90.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.482 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.11 -57.94 3.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 68' ' ' VAL . 5.6 t -53.16 -24.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.389 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 17.9 mt-10 -68.77 -45.97 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.03 -19.81 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.604 ' OE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.5 tm-20 -88.68 -52.53 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.604 ' CZ ' ' OE1' ' A' ' 71' ' ' GLU . 67.9 m-85 -116.22 32.05 6.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 46.65 -160.32 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.7 29.69 7.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -1.134 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.92 -32.62 8.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -98.3 155.59 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -1.2 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -83.28 -177.55 6.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -15.52 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -70.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -52.8 -35.62 57.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 82' ' ' ILE . 3.0 t -56.4 -64.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.473 ' N ' HG12 ' A' ' 81' ' ' VAL . 31.1 mt -48.79 -31.67 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.469 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -59.47 -73.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -35.56 -44.11 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mt -60.59 -32.28 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.419 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.672 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.6 mt -72.04 -20.4 61.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.897 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.665 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -88.29 -3.48 58.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -113.92 -86.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 67.16 121.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.16 148.03 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -106.89 129.68 54.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.42 120.63 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -82.07 158.38 23.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -145.44 102.55 3.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.499 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -85.5 104.3 15.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 -157.41 11.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -58.93 -49.24 78.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -1.153 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.65 -33.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -84.78 134.91 34.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.564 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -105.76 138.05 42.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 mt -134.99 151.49 50.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.572 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.6 mt -120.27 150.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.82 151.19 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.521 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.2 144.55 25.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.04 177.64 8.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 -88.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.88 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 26' ' ' VAL . 18.0 t -125.62 168.93 13.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.19 -29.9 34.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -56.53 -47.99 78.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.32 -47.88 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 22' ' ' SER . 94.7 t -49.93 -43.06 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -24.95 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.5 -47.03 28.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 32' ' ' ASN . 63.9 t80 -57.89 -50.02 74.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.471 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 30' ' ' LEU . 82.8 mt -43.82 -32.75 1.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.479 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 4.0 mptp? -91.19 10.03 28.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' TYR . 49.5 m-80 -161.25 62.11 1.49 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 47.1 Cg_endo -72.81 113.46 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.815 2.343 . . . . 0.0 112.191 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.518 ' O ' ' OG ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -173.07 34.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.889 HG22 ' H ' ' A' ' 36' ' ' GLY . 29.3 mm 51.24 -177.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.889 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 87.29 -74.78 2.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -67.56 -10.9 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -1.133 . . . . 0.0 109.458 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' VAL . 1.1 tp -59.2 -54.45 46.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' LEU . 70.3 m -43.18 -37.8 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.566 ' N ' ' CD ' ' A' ' 40' ' ' GLU . 1.7 mp0 -70.09 -35.88 74.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' LEU . 41.7 t -71.68 -54.8 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.574 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 118.44 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.18 -26.26 25.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tp -125.55 124.05 40.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -90.5 95.99 10.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -167.87 140.09 3.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.428 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -108.96 141.14 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -128.78 178.83 6.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.03 149.08 29.06 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 C--N 1.306 -1.668 0 C-N-CA 122.735 2.29 . . . . 0.0 112.138 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.293 0.568 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.41 128.16 9.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.36 168.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -1.156 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.91 7.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' GLN . 2.8 t -99.49 133.12 44.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -46.7 -30.56 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.442 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.97 64.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.0 mm-40 -69.98 -27.82 65.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.65 -44.5 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 23.5 mt-10 -57.33 -39.36 75.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -49.71 -17.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 69' ' ' GLU . 28.5 mt-10 -98.8 -52.21 3.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.546 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.43 -28.96 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 104.6 -178.32 24.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -91.22 -157.57 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.416 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.14 -8.02 9.38 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -120.48 162.49 19.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -1.171 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -108.88 -150.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -93.62 -18.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.948 . . . . 0.0 109.502 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.15 -43.29 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.0 -55.16 24.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' ILE . 14.6 t -50.74 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.501 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.7 mm -44.72 -62.14 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 82' ' ' ILE . 6.0 t70 -37.98 -51.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 85' ' ' ILE . 81.4 mt -57.03 -53.19 60.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 84' ' ' LEU . 46.0 mm -42.03 -49.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.392 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.469 ' O ' ' C ' ' A' ' 87' ' ' ARG . 49.4 mt -57.7 -40.67 80.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -40.36 -34.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.433 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -105.21 -82.87 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 96.13 0.23 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.5 mttt . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.269 -1.136 . . . . 0.0 109.551 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -111.57 139.2 47.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -113.6 160.25 18.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -122.05 139.83 53.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -98.26 160.39 14.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.42 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -150.4 94.88 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -65.04 113.64 4.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.46 172.83 49.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -46.55 -30.38 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.591 ' ND2' ' N ' ' A' ' 14' ' ' THR . 2.6 p-10 -149.6 -50.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.591 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 53.9 m -83.48 146.58 28.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.77 135.47 46.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.46 162.01 21.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.9 mt -138.04 153.4 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.09 177.9 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -103.45 168.42 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 5' ' ' THR . . . -157.78 152.84 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.416 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.11 -99.85 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.37 145.46 32.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -44.75 96.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.54 -32.89 8.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.68 -51.82 11.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.7 t -50.01 -54.01 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -53.61 54.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -48.38 -41.73 29.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 70.5 t80 -61.99 -46.72 88.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 30' ' ' LEU . 7.3 mt -46.65 -41.23 14.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.837 . . . . 0.0 109.459 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -81.66 1.57 33.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 29' ' ' TYR . 9.8 t30 -154.66 64.66 4.51 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 38.8 Cg_endo -70.72 109.46 2.5 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.849 2.366 . . . . 0.0 112.199 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.449 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 1.8 m -143.17 -136.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tp -138.76 1.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.46 -74.16 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.536 ' NZ ' ' CG2' ' A' ' 41' ' ' VAL . 37.0 tttm -52.9 -14.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -1.151 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tp -49.45 -65.47 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.445 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -50.52 -46.28 57.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -52.19 -16.9 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.536 ' CG2' ' NZ ' ' A' ' 37' ' ' LYS . 92.0 t -102.55 -60.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.06 124.18 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.575 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.17 -29.36 12.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mt -119.49 117.46 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -87.77 76.76 8.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.653 ' OE2' ' CE2' ' A' ' 48' ' ' PHE . 15.6 tt0 -161.75 138.31 8.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.12 116.19 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.653 ' CE2' ' OE2' ' A' ' 46' ' ' GLU . 34.6 m-85 -99.21 148.34 24.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.466 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -147.94 154.54 43.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.822 2.348 . . . . 0.0 112.203 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.324 0.583 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.63 -173.82 25.84 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.88 157.1 28.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -105.98 -174.54 2.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 66' ' ' ALA . 27.1 t -134.01 153.15 51.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 17.1 mmtm -43.47 -23.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -77.48 -50.55 12.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.34 -43.69 79.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.94 -21.46 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.393 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.4 mt-10 -82.94 -60.29 2.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-20 -41.08 -31.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 69' ' ' GLU . 12.6 mm-40 -82.06 -77.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 81' ' ' VAL . 76.5 m-85 -72.31 -48.93 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.439 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 110.52 150.02 12.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 75' ' ' GLY . 4.5 ttpp -64.91 162.18 16.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.462 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 74' ' ' LYS . . . 116.88 -19.88 11.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -117.37 177.58 4.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -1.162 . . . . 0.0 109.453 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.52 -177.25 3.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 78' ' ' ILE . 10.3 tp -74.38 -21.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.85 -51.94 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -63.36 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.55 HG13 ' CE2' ' A' ' 72' ' ' PHE . 2.9 t -65.65 -58.08 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.5 mt -49.24 -25.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' LEU . 50.3 t0 -65.97 -62.27 1.59 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 83' ' ' ASP . 79.7 mt -44.04 -32.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mt -68.05 -49.8 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.47 -11.41 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -77.71 -26.45 50.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.672 HD22 ' NZ ' ' A' ' 90' ' ' LYS . 1.4 m120 -102.77 -67.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.1 125.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.672 ' NZ ' HD22 ' A' ' 88' ' ' ASN . 25.7 mttm . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.488 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.03 164.9 12.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -131.35 144.96 51.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -114.43 146.59 40.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 9.6 m-85 -112.21 155.27 24.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 85' ' ' ILE . 61.7 t80 -143.32 94.91 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -67.0 98.59 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -73.88 173.25 50.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.55 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 3.3 tp10 -41.96 -42.8 2.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.477 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 7.0 m120 -144.4 -37.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.478 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -87.46 142.22 28.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.26 130.69 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.49 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.436 HD22 HG11 ' A' ' 47' ' ' VAL . 8.2 mt -118.32 138.93 52.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.1 mt -120.21 146.1 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.49 165.01 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.528 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -92.09 166.23 12.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.42 151.37 22.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.465 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 -72.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.724 ' O ' HG23 ' A' ' 26' ' ' VAL . 19.4 t -140.22 156.88 46.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.98 -51.58 53.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -45.2 -54.55 6.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 25' ' ' LEU . 56.5 mt -57.49 -31.53 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 22' ' ' SER . 87.3 t -71.74 -70.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.532 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -40.97 -20.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -82.67 -49.08 10.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 32' ' ' ASN . 40.4 t80 -52.06 -50.57 61.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 29' ' ' TYR . 6.9 mt -40.78 -42.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -77.88 -13.92 59.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.665 ' N ' ' O ' ' A' ' 29' ' ' TYR . 10.7 m120 -129.35 73.39 81.67 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.34 125.31 9.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.746 2.298 . . . . 0.0 112.232 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 172.61 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 35' ' ' ILE . 45.8 mm -73.5 61.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.99 -47.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -87.52 -28.17 22.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 109.449 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -54.38 -24.73 20.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 p -72.86 -31.62 64.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -79.26 -26.03 42.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.93 -64.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 62.6 t -71.94 128.27 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.85 -50.82 10.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.912 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 4.5 mp -111.13 147.77 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.67 88.24 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -168.72 -173.53 1.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.436 HG11 HD22 ' A' ' 16' ' ' LEU . 38.9 t -131.49 126.48 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.98 150.74 36.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -148.12 165.31 18.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--N 1.305 -1.754 0 C-N-CA 122.851 2.368 . . . . 0.0 112.262 -179.998 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 60' ' ' LEU . 25.1 mt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.09 143.22 8.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 151.24 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -94.59 -171.55 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -118.62 164.72 14.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -64.27 -32.75 74.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -44.3 68.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.409 ' HA ' HD22 ' A' ' 70' ' ' ASN . 26.6 mt-30 -72.13 -60.22 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.32 -26.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -70.68 -39.13 73.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 67' ' ' GLN . 80.5 m-20 -60.09 -21.5 61.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 10.0 mp0 -96.76 -67.01 0.87 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -161.53 76.6 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.409 ' C ' ' CG ' ' A' ' 74' ' ' LYS . . . -127.74 -129.01 3.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' CG ' ' C ' ' A' ' 73' ' ' GLY . 9.3 mttt 68.04 -75.07 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -1.178 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' GLY . . . -123.4 30.69 4.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -118.22 100.47 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -1.193 . . . . 0.0 109.52 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -50.47 163.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -0.821 . . . . 0.0 109.537 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tp -54.75 -29.4 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.872 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.13 -60.7 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 83' ' ' ASP . 21.0 mt-10 -55.06 -55.12 34.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 80' ' ' GLU . 9.4 t -38.33 -50.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.429 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 85' ' ' ILE . 37.3 mt -61.95 -37.72 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.475 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.624 ' OD2' ' NH2' ' A' ' 87' ' ' ARG . 9.0 t0 -65.93 -65.14 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 83' ' ' ASP . 85.7 mt -38.17 -30.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 9' ' ' TYR . 41.4 mt -73.92 -68.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.414 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.1 mt -46.55 -12.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.402 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.734 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -75.66 -43.45 47.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.464 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.582 ' ND2' ' C ' ' A' ' 88' ' ' ASN . 0.6 OUTLIER -149.93 66.44 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.15 -113.7 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.208 -1.172 . . . . 0.0 109.531 -179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.2 m . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 m -113.89 141.25 47.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -110.58 136.85 49.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.544 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.724 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 1.7 m-85 -103.69 110.5 22.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.868 . . . . 0.0 109.501 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.32 162.57 23.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.51 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 57.9 t80 -161.23 137.7 8.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 108.2 19.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.426 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.55 -154.9 0.22 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.04 -39.6 92.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -1.167 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -146.69 -36.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -83.78 169.16 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.9 . . . . 0.0 109.482 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 9' ' ' TYR . 43.2 t0 -115.3 137.02 52.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.9 153.49 39.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -131.4 143.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.16 152.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -90.06 152.97 20.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.13 -171.59 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.39 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.922 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.7 t -153.52 135.8 14.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 22' ' ' SER . 5.4 tt0 -40.0 -28.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' SER . 23.8 tt0 -62.58 -76.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.943 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 24' ' ' GLU . 11.2 mt -44.11 -35.53 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.724 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 t -62.11 -57.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.496 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -51.38 -52.25 47.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -48.52 -41.03 28.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.469 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.19 -59.32 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 42.9 mt -53.6 -27.86 29.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -23.61 61.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -160.09 77.49 2.73 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -51.69 118.75 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.817 2.344 . . . . 0.0 112.164 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -156.55 139.12 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.04 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.43 -80.11 0.26 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.38 -16.74 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -1.178 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.12 -47.46 85.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -57.6 -27.9 63.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.8 -33.78 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.8 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.814 HG21 HG21 ' A' ' 82' ' ' ILE . 89.5 t -79.66 134.95 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -96.3 -52.24 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.97 134.94 46.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -93.92 59.81 2.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.514 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 16.9 tt0 -140.59 123.44 16.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.5 139.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.524 ' C ' HG22 ' A' ' 49' ' ' THR . 20.5 m-85 -117.66 174.82 5.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -168.36 155.73 7.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.305 -1.753 0 C-N-CA 122.86 2.373 . . . . 0.0 112.189 179.967 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 tt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.298 0.571 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -163.58 -156.2 8.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.7 117.07 21.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -1.14 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.43 173.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.91 148.43 50.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.419 ' O ' ' CD ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -46.47 -26.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.13 34.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.31 -50.29 72.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 t -60.21 -20.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 65' ' ' LYS . 14.2 mt-10 -76.91 -25.27 52.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.542 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 -22.21 45.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.23 -54.7 2.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -167.94 70.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 138.05 6.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -166.97 -27.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.85 31.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -103.69 177.57 4.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.395 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' ILE . 16.3 mttm -83.95 133.86 34.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 5.3 tp -40.54 -32.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' LYS . 60.8 mt-10 -54.71 -56.16 22.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 tp10 -48.63 -62.64 1.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 80' ' ' GLU . 65.8 t -39.66 -58.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.421 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.814 HG21 HG21 ' A' ' 42' ' ' VAL . 96.7 mt -50.32 -20.35 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 80' ' ' GLU . 1.2 t70 -76.47 -69.17 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 83' ' ' ASP . 7.7 mt -38.55 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.6 mt -74.58 -70.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.571 ' N ' HG22 ' A' ' 85' ' ' ILE . 8.2 mt -42.16 -38.26 1.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -43.79 -26.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 86' ' ' LEU . 9.5 t-20 -107.78 -70.85 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 123.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.155 -1.203 . . . . 0.0 109.457 -179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 m -158.64 150.47 21.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -111.95 123.72 50.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.12 123.55 37.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.11 140.93 29.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.457 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.34 104.5 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -81.97 124.73 30.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 -153.12 28.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -52.98 -70.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -125.31 -21.02 4.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -92.37 161.26 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -121.73 144.95 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -137.95 148.6 45.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.1 mt -120.64 153.78 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 173.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.424 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -109.84 154.03 23.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.392 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' ALA . . . -154.05 128.24 9.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' ALA . . . -47.37 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.503 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.35 165.97 12.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -73.99 -28.17 61.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.33 -56.72 17.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.02 -51.48 69.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.396 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -46.44 -45.89 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 27' ' ' ASP . 1.6 t70 -62.66 -43.58 98.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 37' ' ' LYS . 6.4 mt-10 -60.94 -27.87 68.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -70.38 -36.56 74.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.86 -48.83 77.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -25.21 50.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.448 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 1.1 t-20 -136.21 68.16 62.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 154.23 53.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.849 2.366 . . . . 0.0 112.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.35 173.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 tp -88.24 -31.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.96 -14.38 80.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.48 ' O ' HG23 ' A' ' 41' ' ' VAL . 67.5 tttt -101.93 -12.4 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.57 -48.75 53.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' VAL . 3.1 m -49.23 -45.37 44.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.54 -56.96 14.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' LYS . 55.5 t -50.21 -59.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 82' ' ' ILE . 2.7 t -78.27 126.89 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.33 -0.51 46.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.404 ' H ' HG12 ' A' ' 42' ' ' VAL . 12.1 tp -163.72 122.16 1.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.414 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -77.15 83.69 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -163.12 155.12 17.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.8 t -123.29 132.94 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.86 154.7 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.1 164.56 24.42 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.305 -1.757 0 C-N-CA 122.849 2.366 . . . . 0.0 112.244 -179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.41 159.37 24.4 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.75 156.26 17.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -1.19 . . . . 0.0 109.422 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.55 171.6 7.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' LYS . 76.7 p -121.89 150.52 41.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' SER . 7.8 pttt -41.92 -30.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 67' ' ' GLN . . . -73.65 -58.53 3.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.244 -0.91 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -38.16 -49.05 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.31 -51.87 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.639 ' O ' ' N ' ' A' ' 73' ' ' GLY . 31.1 tt0 -49.33 -29.01 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 109.399 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.94 -19.21 63.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.92 -27.02 14.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CE2' HG13 ' A' ' 81' ' ' VAL . 84.3 m-85 -113.14 -11.0 13.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.488 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 62.14 0.31 2.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 72' ' ' PHE . 6.4 mtpp -139.09 -49.37 0.5 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.495 -1.003 . . . . 0.0 109.537 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 81' ' ' VAL . . . 78.74 -61.7 3.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 49.49 -168.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -56.59 133.18 53.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 tp -55.36 -26.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -56.44 -41.91 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 81' ' ' VAL . 35.5 mt-10 -73.42 -58.62 3.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.473 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 72' ' ' PHE . 2.9 t -42.48 -38.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.515 HG21 HG21 ' A' ' 42' ' ' VAL . 61.2 mt -63.68 -46.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 35.7 t0 -60.58 -52.29 65.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.6 mt -45.29 -41.85 9.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.87 -40.25 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 88' ' ' ASN . 82.2 mt -60.24 -42.72 95.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -44.95 -20.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.43 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' LEU . 10.5 m120 -124.51 -81.98 0.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 75.15 124.74 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 89' ' ' GLY . 5.2 mmmt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.217 -1.167 . . . . 0.0 109.373 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.313 0.578 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -92.62 161.47 14.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -113.1 122.65 48.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.46 ' CE1' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -92.63 104.61 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.18 137.57 47.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.91 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.13 105.91 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -75.95 114.43 14.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' ASN . . . -75.44 170.89 54.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.65 -17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -1.177 . . . . 0.0 109.389 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 t-20 -168.93 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 118.65 29.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 132.75 49.97 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.18 -0.95 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -129.18 142.53 50.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.37 142.37 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.5 175.13 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.75 160.84 14.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.46 164.57 29.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.82 -76.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 152.03 40.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -38.29 85.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.82 -61.32 2.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.3 mt -58.64 -63.58 1.23 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 25' ' ' LEU . 90.6 t -35.53 -35.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' LEU . 19.6 t0 -77.3 -35.02 55.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.368 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 25' ' ' LEU . 4.8 pt-20 -64.9 -28.2 69.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.416 ' N ' ' HG2' ' A' ' 28' ' ' GLU . 48.0 t80 -74.67 -50.23 18.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.7 mt -46.62 -23.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -74.07 -45.36 49.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -123.95 78.02 58.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.0 109.426 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 34' ' ' SER . 56.4 Cg_exo -47.17 156.87 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.792 2.328 . . . . 0.0 112.204 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 162.39 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 35' ' ' ILE . 22.0 mm -88.52 20.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.29 -45.39 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.621 ' HZ3' ' HG3' ' A' ' 28' ' ' GLU . 24.6 tttt -73.76 -11.29 60.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 109.435 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.25 -27.43 65.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.47 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -67.21 -18.27 65.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -89.21 -41.21 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.86 -66.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -70.24 113.64 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 109.549 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.63 -60.76 2.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.18 150.89 21.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -103.6 52.45 0.77 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -137.16 159.76 40.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.47 144.41 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 14.0 m-85 -118.91 154.23 33.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -144.75 156.71 55.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.425 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.175 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.28 -170.26 24.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.2 115.68 20.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -1.128 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -53.78 154.99 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 66' ' ' ALA . 4.7 m -98.09 147.85 24.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.535 ' O ' ' OE1' ' A' ' 69' ' ' GLU . 4.5 pttp -43.79 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -83.81 -48.29 10.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.603 ' C ' ' NE2' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -54.86 -43.68 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.22 -41.52 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 28.1 mt-10 -64.01 -40.22 95.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.4 -40.17 81.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.26 -67.68 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -90.91 -75.88 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.05 166.68 11.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.2 -2.55 52.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.527 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.78 -7.19 20.81 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -133.37 149.14 51.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -67.98 -167.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -86.53 -37.83 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.452 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -61.67 -28.26 69.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.64 -44.47 33.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 t -53.35 -46.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.543 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.583 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.6 mp -60.67 -40.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -48.35 -53.71 16.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.55 -32.36 68.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 82' ' ' ILE . 85.8 mt -67.68 -29.19 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.549 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.7 mt -82.39 -26.32 32.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -93.2 3.63 55.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 88' ' ' ASN . 1.1 t-20 -161.54 57.73 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.92 -131.04 6.53 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 tttp . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.495 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.0 m -149.79 135.47 18.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -99.06 129.07 45.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.605 ' O ' HG23 ' A' ' 17' ' ' ILE . 1.3 m-85 -104.13 160.31 14.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -127.95 157.39 40.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -142.87 129.72 20.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.858 . . . . 0.0 109.509 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -105.03 105.79 15.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.67 -150.58 24.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.429 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 15.1 mm-40 -49.67 -51.27 39.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -148.01 -46.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.447 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -72.54 143.6 48.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.77 138.07 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 16' ' ' LEU . 76.1 mt -113.13 157.17 21.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.475 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 7' ' ' TYR . 7.8 mt -130.26 154.32 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.424 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.627 HG21 HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -137.9 179.91 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.88 153.45 35.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.51 177.3 11.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.51 -46.81 5.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.65 137.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -49.55 -31.3 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.436 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -67.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.06 -48.43 44.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' A' ' 27' ' ' ASP . 76.3 t -50.8 -66.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.539 ' C ' ' O ' ' A' ' 26' ' ' VAL . 37.6 t70 -36.3 -43.33 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.92 -50.61 70.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 32' ' ' ASN . 62.1 t80 -51.3 -49.7 60.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 30' ' ' LEU . 19.9 mt -41.72 -56.29 2.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -73.9 -3.5 29.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 29' ' ' TYR . 8.7 m120 -135.83 69.36 65.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -73.64 131.6 16.24 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.873 2.382 . . . . 0.0 112.219 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.25 154.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -85.72 66.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.46 -50.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -75.69 -26.02 57.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD13 ' CZ ' ' A' ' 29' ' ' TYR . 2.7 tp -57.9 -33.37 68.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -36.62 76.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.78 -39.24 66.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' A' ' 26' ' ' VAL . 48.7 t -70.76 -69.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.67 117.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.429 ' C ' HD12 ' A' ' 44' ' ' LEU . 95.2 mt-10 -81.76 -40.97 21.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 43' ' ' GLU . 9.3 mp -112.27 128.38 56.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.67 78.29 4.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -163.73 159.95 22.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.08 143.15 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -128.1 155.22 44.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.488 ' O ' HD23 ' A' ' 60' ' ' LEU . 41.5 p -118.99 149.38 46.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 C--N 1.305 -1.728 0 C-N-CA 122.75 2.3 . . . . 0.0 112.221 -179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 49' ' ' THR . 5.8 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.74 108.33 0.82 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.34 142.12 17.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -1.182 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.29 28.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -88.26 148.04 24.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.6 mttt -41.43 -19.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -68.2 -61.51 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -53.23 -34.73 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.18 -31.32 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.1 mt-10 -68.91 -63.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 69' ' ' GLU . 20.0 m-20 -39.36 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -85.52 -67.71 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.454 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 71' ' ' GLU . 20.4 m-85 -115.02 25.5 10.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.506 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.65 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 52.72 -162.12 2.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 76' ' ' LYS . 2.3 tttp -109.94 -149.46 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -1.152 . . . . 0.0 109.454 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 -26.14 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 74' ' ' LYS . 21.4 mttt -91.42 -172.35 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -122.99 157.17 33.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tp -51.41 -30.74 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.41 -50.29 66.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.413 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -57.69 -52.83 63.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.1 t -47.87 -59.08 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.97 -42.47 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.495 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 28.5 t0 -52.68 -51.02 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.459 ' O ' ' OD1' ' A' ' 88' ' ' ASN . 10.5 mt -60.03 -43.15 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.627 HG21 HG21 ' A' ' 18' ' ' VAL . 27.9 mm -47.98 -62.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.3 -23.3 22.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -67.02 -36.37 81.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -93.48 -77.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.469 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.58 130.25 1.16 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 tptp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.43 179.969 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -101.67 -173.61 2.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.649 ' NZ ' HG21 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -136.01 133.92 37.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -99.14 119.35 37.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.59 166.24 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -165.31 109.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -90.31 103.08 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.58 -157.36 0.79 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 3.8 tt0 -48.23 -67.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.146 . . . . 0.0 109.427 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.434 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 2.9 m120 -128.54 -26.26 2.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.12 155.38 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -113.45 136.86 52.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -132.7 153.44 51.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.649 HG21 ' NZ ' ' A' ' 6' ' ' LYS . 41.1 mt -134.18 145.21 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.922 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.24 173.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -108.72 148.05 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.09 178.58 6.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.446 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.03 -55.01 3.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -172.4 166.63 5.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -72.02 -21.96 61.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.57 -66.61 0.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -53.81 -49.58 68.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -49.32 -50.37 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.83 -29.4 64.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.73 -34.69 64.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 32' ' ' ASN . 54.0 t80 -62.55 -48.06 81.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' TYR . 67.8 mt -43.36 -59.53 2.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.867 . . . . 0.0 109.498 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -18.95 65.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TYR . 64.5 t30 -121.98 87.44 47.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.42 54.43 5.18 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -106.13 105.02 14.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.443 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' SER . 14.6 tt -42.64 -32.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.26 -41.2 78.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -73.12 -27.48 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -1.164 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.09 -39.84 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.0 t -58.22 -21.04 46.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -87.18 -34.73 18.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 42' ' ' VAL . 9.3 t -75.81 -72.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.509 ' N ' HG12 ' A' ' 41' ' ' VAL . 23.3 t -57.73 118.26 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.26 -32.78 20.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -137.31 114.95 11.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.98 94.22 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -167.4 158.17 11.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.81 140.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.54 -170.27 1.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.43 150.12 0.97 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo . . . . . 0 C--N 1.305 -1.732 0 C-N-CA 122.833 2.355 . . . . 0.0 112.254 179.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.21 -167.45 11.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.96 110.21 16.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -1.188 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.8 155.65 1.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -93.87 155.91 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.937 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -59.03 -16.07 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 -39.54 13.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -60.26 -46.28 90.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.74 -42.97 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.56 -23.34 66.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.85 -26.68 49.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.27 -32.79 55.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.832 ' CE2' HG13 ' A' ' 81' ' ' VAL . 78.5 m-85 -104.41 -61.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.63 136.9 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -64.4 98.48 0.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.05 -6.8 0.12 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -101.63 129.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -1.107 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -59.78 -165.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.1 tp -91.89 -34.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.46 -35.28 73.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.07 -43.69 82.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.832 HG13 ' CE2' ' A' ' 72' ' ' PHE . 54.8 t -65.55 -60.77 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 82' ' ' ILE . 5.9 mm -46.04 -32.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 84' ' ' LEU . 19.8 t70 -66.94 -65.14 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' ASP . 15.5 mt -38.44 -30.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' ASP . 90.1 mt -76.95 -50.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.903 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -58.26 -13.93 6.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -82.46 -38.08 24.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 1.9 t-20 -85.28 -68.07 0.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 59.68 119.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.5 tttp . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.457 179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.3 m -148.39 142.19 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -108.26 127.54 53.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.903 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.13 144.44 30.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.495 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -113.06 121.13 43.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 10' ' ' LYS . 69.6 t80 -126.92 140.85 52.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.485 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 9.7 tttt -101.26 140.96 34.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.94 -166.68 27.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -94.99 -33.07 12.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.134 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.44 -30.01 7.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 t -145.28 179.1 7.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.1 t70 -98.1 161.99 13.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 62.1 mt -140.24 140.03 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.9 136.99 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 109.409 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 171.3 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.95 163.49 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.446 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.99 -177.05 6.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.62 -71.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.388 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.13 140.09 37.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 26' ' ' VAL . 39.0 mt-10 -50.75 -55.95 14.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.918 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 23' ' ' GLU . 13.5 tp10 -37.65 -44.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.56 -27.28 64.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' A' ' 23' ' ' GLU . 89.6 t -73.3 -54.08 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.2 -24.22 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -75.31 -38.56 60.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 32' ' ' ASN . 76.6 t80 -60.04 -49.54 77.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mt -45.68 -32.43 2.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -91.06 -3.0 57.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' TYR . 52.5 m-80 -142.72 61.47 11.08 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.85 93.31 0.95 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.85 2.366 . . . . 0.0 112.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -162.53 132.31 4.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.3 mm -46.46 117.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.11 -63.1 0.38 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -79.88 -28.67 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.401 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' LYS . 5.0 tp -42.77 -40.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 t -67.83 -37.19 81.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' LYS . 17.6 tt0 -62.7 -18.34 62.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.93 -74.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 42' ' ' VAL . 5.7 t -57.55 157.54 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.378 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -117.87 -68.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.1 tp -95.38 111.57 23.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.86 74.37 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 47' ' ' VAL . 11.6 tp10 -156.03 157.87 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.428 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 6.6 t -128.17 128.29 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.56 156.98 22.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.493 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.95 156.92 34.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 C--N 1.305 -1.733 0 C-N-CA 122.793 2.328 . . . . 0.0 112.192 179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.33 9.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.29 134.0 56.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -1.126 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.49 130.13 39.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.561 ' O ' ' N ' ' A' ' 67' ' ' GLN . 13.6 m -81.23 131.08 35.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 64' ' ' SER . 1.7 ptpt -40.47 -40.24 1.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.16 67.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.29 -50.96 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.16 -41.7 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 71' ' ' GLU . 39.9 mt-10 -55.58 -41.6 73.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.9 t-20 -40.37 -19.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.648 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.5 mm-40 -114.37 -60.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -164.98 72.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' A' ' 69' ' ' GLU . . . -129.4 0.13 5.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -85.5 106.58 16.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.516 -0.99 . . . . 0.0 109.485 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.9 32.6 63.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -130.84 100.18 5.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -1.147 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.552 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 9.4 mtpm? -46.55 155.09 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.49 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.5 -21.5 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.552 ' OE1' ' NZ ' ' A' ' 77' ' ' LYS . 9.6 mt-10 -69.0 -51.99 33.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.14 -42.94 83.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -48.21 -51.49 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.1 mt -61.21 -35.59 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.877 . . . . 0.0 109.535 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' LEU . 46.0 t0 -60.34 -66.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 83' ' ' ASP . 16.4 mt -40.47 -32.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 mt -80.57 -31.17 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.9 mt -77.66 -0.39 26.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -75.67 -40.86 55.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.621 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 0.4 OUTLIER -96.25 -73.38 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.88 117.31 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 mttt . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.427 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.262 0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.26 159.43 15.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -121.73 132.43 54.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.645 ' OH ' HG11 ' A' ' 26' ' ' VAL . 1.9 m-85 -95.75 117.59 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -81.92 138.04 35.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -131.54 90.06 2.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.965 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -56.77 96.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 12' ' ' GLU . . . -71.51 -162.59 5.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.579 ' H ' ' CG ' ' A' ' 71' ' ' GLU . 1.1 tt0 -49.37 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.477 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.569 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -100.21 -0.63 38.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 109.478 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -113.05 174.85 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -117.26 122.49 44.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.663 HD22 ' CG1' ' A' ' 47' ' ' VAL . 53.1 mt -106.17 132.24 52.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.3 mt -118.55 146.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.593 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.49 HG21 HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -131.11 169.81 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -103.37 155.23 18.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.84 -171.4 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.52 2.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -168.69 135.52 1.9 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -45.69 -24.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.66 -65.64 0.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.438 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.65 -20.42 21.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.645 HG11 ' OH ' ' A' ' 7' ' ' TYR . 4.4 t -79.15 -52.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -44.36 96.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 109.406 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.8 mt-10 -56.5 -54.88 40.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 68.4 t80 -46.98 -44.13 19.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.46 -20.57 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.323 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 14.2 mtmt -92.81 -22.34 19.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 31' ' ' LYS . 9.0 m-20 -143.57 66.16 15.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' SER . 42.2 Cg_endo -71.53 170.03 19.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.801 2.334 . . . . 0.0 112.208 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER 166.92 22.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 35' ' ' ILE . 38.3 mm 47.13 13.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' SER . . . -107.48 -53.59 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -71.86 -25.75 62.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 38' ' ' LEU . 15.2 tp -48.7 -22.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 36' ' ' GLY . 2.7 p -71.39 -18.39 62.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -98.18 -20.94 16.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.84 -42.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.44 141.6 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.485 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' HD23 ' A' ' 44' ' ' LEU . 39.1 mt-10 -102.09 -44.48 5.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 43' ' ' GLU . 7.5 mt -121.7 105.92 10.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -66.43 72.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CG ' ' H ' ' A' ' 47' ' ' VAL . 5.8 tt0 -152.65 178.57 9.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.663 ' CG1' HD22 ' A' ' 16' ' ' LEU . 82.2 t -123.5 131.73 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.569 ' C ' HG22 ' A' ' 49' ' ' THR . 57.7 m-85 -118.35 176.83 5.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER 173.94 151.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.304 -1.776 0 C-N-CA 122.839 2.359 . . . . 0.0 112.156 179.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.9 -177.87 38.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.75 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.734 ' HB1' HE21 ' A' ' 67' ' ' GLN . . . -63.49 -178.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -103.22 136.16 43.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 3.5 mttt -43.28 -27.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.52 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -78.45 -20.5 50.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.734 HE21 ' HB1' ' A' ' 63' ' ' ALA . 3.2 mt-30 -81.17 -39.66 25.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.77 -32.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.7 mt-10 -62.41 -21.58 65.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -82.35 -33.77 28.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.579 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -80.82 -24.19 38.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.69 -30.02 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . 115.79 -130.45 9.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 75' ' ' GLY . 5.3 mtpt -67.02 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.142 -1.211 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . 40.08 66.79 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 77' ' ' LYS . 30.2 mttp -51.71 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -1.194 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 76' ' ' LYS . 28.3 mttp -41.13 130.97 2.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 79' ' ' GLU . 2.7 tp -41.9 -37.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 78' ' ' ILE . 10.8 mt-10 -52.91 -56.72 13.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.55 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -53.05 -41.5 64.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 82' ' ' ILE . 7.5 t -58.7 -68.19 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.456 ' N ' HG12 ' A' ' 81' ' ' VAL . 15.8 mt -42.95 -39.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 109.486 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -61.74 -63.82 1.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 83' ' ' ASP . 5.5 mt -43.64 -35.29 1.72 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.49 HG21 HG21 ' A' ' 18' ' ' VAL . 71.7 mt -65.22 -66.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.421 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 5.0 mt -49.62 -26.71 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.739 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -42.19 -43.88 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -77.53 0.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.6 132.85 3.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.494 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.35 158.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -118.34 139.44 51.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.483 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -114.86 117.64 31.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.379 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.18 126.61 45.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.853 . . . . 0.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -120.88 106.51 11.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -79.36 94.83 5.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.93 -166.84 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -63.13 -53.74 48.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.38 -1.54 3.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 137.32 54.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.52 121.64 45.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -119.19 147.19 44.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.6 mt -116.81 147.55 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.65 161.93 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -95.16 149.38 21.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.03 144.36 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.92 -69.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 149.37 46.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.08 -35.51 80.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.24 -58.29 8.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB3' HG22 ' A' ' 41' ' ' VAL . 9.2 mt -50.07 -59.26 4.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.508 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.483 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 4.4 t -39.88 -59.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -48.41 -42.36 31.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 25' ' ' LEU . 6.0 mt-10 -60.65 -46.22 91.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.848 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.587 ' N ' ' NZ ' ' A' ' 37' ' ' LYS . 31.0 t80 -49.83 -54.92 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.2 mt -52.55 -22.87 5.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -88.27 -26.51 22.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -130.89 58.35 38.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 93.94 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.896 2.397 . . . . 0.0 112.245 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.8 t -155.66 27.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 36' ' ' GLY . 27.8 mm 59.41 169.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.589 ' N ' HG22 ' A' ' 35' ' ' ILE . . . 92.92 -38.54 3.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.587 ' NZ ' ' N ' ' A' ' 29' ' ' TYR . 25.9 tttm -105.5 -6.36 19.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -1.123 . . . . 0.0 109.453 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.93 -23.11 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.23 -33.38 59.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.47 -27.56 61.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 25' ' ' LEU . 40.7 t -86.59 -64.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.76 146.66 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -97.9 -55.5 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.42 154.71 19.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.01 65.9 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -156.53 157.27 35.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.81 140.65 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.2 m-85 -114.92 170.13 8.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.23 152.98 72.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 -180.0 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.05 -174.19 27.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.5 49.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -1.131 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 128.88 36.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.27 150.04 47.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -50.32 -25.23 3.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.505 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.12 -42.65 79.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 68' ' ' VAL . 4.2 tt0 -62.64 -61.51 2.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 67' ' ' GLN . 19.0 t -42.96 -48.34 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -47.92 -24.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.39 -19.97 55.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' VAL . 5.6 mm-40 -92.18 -66.05 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -156.8 66.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.93 130.31 2.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -164.74 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.98 -22.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -72.16 -165.57 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.6 mttm -109.78 -161.98 0.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -90.81 -42.77 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -49.82 -55.47 14.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -56.3 -48.83 75.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 77' ' ' LYS . 21.2 t -44.56 -54.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.46 -35.55 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -53.93 -49.3 68.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' ARG . 16.4 mt -57.16 -54.54 45.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 84' ' ' LEU . 56.3 mt -43.19 -44.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.3 mt -69.52 -27.29 65.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 84' ' ' LEU . 4.2 tpt180 -51.75 -28.41 15.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.545 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.456 ' ND2' ' H ' ' A' ' 88' ' ' ASN . 0.0 OUTLIER -115.53 -83.17 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 69.13 127.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 89' ' ' GLY . 7.0 mttp . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 0.0 109.353 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -146.33 146.15 30.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' A' ' 6' ' ' LYS . 11.0 mtpp -114.73 133.31 55.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.498 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.87 132.01 43.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.94 147.22 24.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -141.1 107.85 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -89.73 92.64 9.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 13' ' ' ASN . . . -56.46 171.33 2.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.5 -5.81 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -1.145 . . . . 0.0 109.542 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' GLY . 23.1 t30 -161.09 -54.81 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.509 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -84.91 152.87 23.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -115.87 130.58 56.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.83 156.92 46.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 mt -121.75 152.75 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.49 166.78 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.503 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.51 153.4 22.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.45 161.41 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.5 -76.17 0.28 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -135.9 155.04 50.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -67.06 -31.62 72.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -50.1 -61.13 2.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.458 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 28' ' ' GLU . 12.6 mt -55.55 -52.45 63.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' LEU . 10.9 t -45.5 -50.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.9 -24.56 67.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 42.4 mm-40 -79.53 -37.63 36.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.474 ' CE1' HD13 ' A' ' 38' ' ' LEU . 60.3 t80 -60.35 -44.38 95.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.06 -35.62 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.498 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -76.39 -37.98 56.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.4 72.08 80.21 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.53 136.77 20.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.857 2.371 . . . . 0.0 112.248 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.06 130.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.48 -44.21 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -10.52 5.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -49.27 5.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -1.122 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD13 ' CE1' ' A' ' 29' ' ' TYR . 3.4 tp -47.2 -21.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -32.06 73.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.21 -45.76 11.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.6 -54.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.466 HG11 ' CD1' ' A' ' 45' ' ' PHE . 91.6 t -71.62 134.33 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 35.17 3.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.41 -40.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CD1' HG11 ' A' ' 42' ' ' VAL . 36.2 m-85 56.4 62.01 2.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.539 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -158.1 161.73 37.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.61 123.78 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -110.59 171.18 7.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.68 159.01 37.0 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 C--N 1.305 -1.748 0 C-N-CA 122.856 2.371 . . . . 0.0 112.192 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.58 152.51 20.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.54 146.18 26.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -1.14 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.8 -170.76 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.6 m -113.38 147.24 38.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 74.5 mttt -49.04 -32.58 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.556 ' O ' ' OD1' ' A' ' 70' ' ' ASN . . . -64.6 -42.72 95.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.48 -38.27 86.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.48 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' GLU . 41.4 t -66.34 -55.19 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 73' ' ' GLY . 2.0 mt-10 -44.96 -35.55 2.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.556 ' OD1' ' O ' ' A' ' 66' ' ' ALA . 14.9 m120 -66.29 -17.97 65.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 68' ' ' VAL . 2.3 mp0 -108.88 -6.97 15.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.545 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -146.1 16.74 1.38 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 48.32 -133.96 19.31 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER -42.78 109.03 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -1.155 . . . . 0.0 109.447 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.13 87.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' LYS . 16.7 mttt -66.52 -179.1 0.78 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.398 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -47.82 138.76 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.37 -22.41 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.92 -28.97 62.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.563 ' CA ' ' OE1' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.05 -47.95 14.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.514 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -50.99 -48.83 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.506 HG22 HD11 ' A' ' 86' ' ' LEU . 74.4 mt -63.96 -36.52 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' LEU . 56.8 t0 -58.66 -64.18 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ASP . 98.5 mt -42.18 -46.32 4.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 87' ' ' ARG . 74.2 mt -57.86 -58.16 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.506 HD11 HG22 ' A' ' 82' ' ' ILE . 10.2 mt -56.16 -7.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.701 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -111.21 -20.82 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -140.91 66.44 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.57 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -147.64 -138.92 3.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 89' ' ' GLY . 16.8 ttpp . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.573 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.293 0.568 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.8 142.57 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -102.4 131.6 48.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 26' ' ' VAL . 1.1 m-85 -99.85 116.58 32.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 17.9 m-85 -91.23 142.9 27.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -132.72 102.2 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -81.4 93.37 6.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.14 -156.57 8.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -46.77 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -13.82 9.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.59 147.49 23.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -117.28 115.85 26.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.95 152.69 24.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.8 mt -137.77 114.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -172.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.415 ' CD2' ' CD1' ' A' ' 44' ' ' LEU . 4.5 m-85 -104.57 169.63 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.15 149.79 5.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.69 -59.54 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 p -155.92 142.92 19.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -53.69 -33.93 57.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.225 -0.922 . . . . 0.0 109.514 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 13.6 tt0 -54.65 -64.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.8 mt -44.64 -58.04 3.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' LEU . 96.1 t -40.39 -45.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -60.51 -36.06 77.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 25' ' ' LEU . 5.6 mt-10 -67.28 -23.14 65.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -85.07 -28.69 25.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.93 -40.42 95.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -74.45 -32.77 62.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.561 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -124.67 73.52 62.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.74 114.37 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.76 2.306 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -144.27 -112.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -162.68 -14.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.11 -52.49 4.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -65.45 -8.38 18.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.149 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.14 -54.31 31.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 p -48.84 -20.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -84.06 -44.09 14.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.66 -70.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 42' ' ' VAL . 2.4 t -68.14 129.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.419 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.77 -36.45 15.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -123.89 112.51 17.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.485 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.44 80.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' LEU . 4.6 tp10 -165.39 157.25 14.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.91 129.55 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -111.97 160.01 17.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 168.62 16.15 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo . . . . . 0 C--N 1.305 -1.741 0 C-N-CA 122.838 2.359 . . . . 0.0 112.233 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 mt . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.47 178.97 16.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.73 148.8 47.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -1.172 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.7 150.55 21.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.72 174.6 6.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.426 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -70.58 -31.84 69.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.16 -43.3 87.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -62.71 -52.48 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' GLU . 95.3 t -60.05 -41.99 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.972 . . . . 0.0 109.541 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -45.04 -42.44 8.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.9 . . . . 0.0 109.525 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -69.96 -26.07 63.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -81.58 -25.43 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -137.66 -71.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.51 -172.02 36.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 75' ' ' GLY . 56.5 tttp -115.33 159.22 21.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 74' ' ' LYS . . . 101.62 -22.37 38.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -78.67 -168.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -1.113 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 78' ' ' ILE . 22.8 mttm -124.71 137.87 54.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -39.55 -45.39 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 4.8 mt-10 -64.22 -43.92 93.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' LYS . 2.5 tp10 -59.2 -36.24 75.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' C ' ' A' ' 82' ' ' ILE . 6.5 t -70.44 -60.38 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 81' ' ' VAL . 94.8 mt -39.54 -42.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.497 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -56.6 -57.08 13.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -54.63 -30.97 56.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 86' ' ' LEU . 1.9 mm -68.44 -64.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.45 ' N ' HG22 ' A' ' 85' ' ' ILE . 4.8 mt -45.19 -42.92 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -46.46 -53.26 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.81 -82.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.476 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.49 119.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.318 -1.107 . . . . 0.0 109.465 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 m -93.6 139.43 30.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.5 115.79 30.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.683 ' OH ' HG11 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -95.39 137.83 33.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 41.8 m-85 -115.4 150.47 36.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.572 ' HB2' HG23 ' A' ' 85' ' ' ILE . 67.0 t80 -139.78 123.91 17.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -101.0 99.79 10.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.71 -147.52 0.08 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -97.08 -43.22 7.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.468 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.6 -3.29 3.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.927 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.58 158.62 40.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.7 144.33 47.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -134.91 160.85 36.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 92.2 mt -140.89 140.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.13 156.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -93.25 154.28 18.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.66 168.9 18.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.12 -58.36 2.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.4 p -156.11 148.82 23.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.96 -26.68 68.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.76 -41.18 75.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.483 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.2 mt -69.97 -26.32 64.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.683 HG11 ' OH ' ' A' ' 7' ' ' TYR . 45.7 t -76.6 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' VAL . 1.5 t0 -43.61 -43.45 5.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.333 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 1.7 mt-10 -61.58 -45.7 93.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.493 ' OH ' ' O ' ' A' ' 34' ' ' SER . 91.6 t80 -59.86 -33.29 71.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 30' ' ' LEU . 40.1 mt -69.36 -40.03 77.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -59.87 -23.92 63.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.562 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 5.6 p-10 -153.72 81.37 4.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.78 144.62 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.836 2.357 . . . . 0.0 112.296 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.493 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -154.42 -169.78 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -126.52 -19.6 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.1 -57.64 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -49.66 -25.5 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tp -47.0 -24.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.427 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -69.95 -62.5 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.52 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.68 -39.78 37.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.28 -48.31 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 44' ' ' LEU . 21.7 t -105.53 128.85 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 -1.86 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.665 ' H ' HG12 ' A' ' 42' ' ' VAL . 2.7 tp -157.18 123.72 4.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.36 94.43 8.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -168.68 152.21 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.975 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 t -120.03 119.15 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.493 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.1 152.18 23.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.411 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -117.13 149.87 45.12 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo . . . . . 0 C--N 1.306 -1.671 0 C-N-CA 122.784 2.323 . . . . 0.0 112.147 179.947 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.68 36.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.3 49.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -1.15 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 169.99 10.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.0 161.64 13.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -57.78 -46.23 84.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.62 -22.16 12.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -83.36 -58.62 2.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.34 -29.14 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.9 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' GLU . 46.5 mt-10 -71.55 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 69' ' ' GLU . 7.9 t30 -38.53 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.518 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 69' ' ' GLU . 15.6 mm-40 -75.74 -62.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.667 ' CE2' HG13 ' A' ' 81' ' ' VAL . 90.8 m-85 -94.08 -72.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.567 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.29 177.45 41.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -96.87 170.61 9.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -1.096 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.1 -29.9 4.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -76.85 156.4 32.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -1.131 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -97.35 -176.31 3.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.905 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 79' ' ' GLU . 2.9 tp -73.87 -36.37 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 78' ' ' ILE . 10.8 pt-20 -62.77 -49.51 74.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -55.64 -60.85 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.667 HG13 ' CE2' ' A' ' 72' ' ' PHE . 3.4 t -41.68 -62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 83' ' ' ASP . 17.0 mt -45.14 -51.52 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -37.32 -55.26 1.04 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 45.6 mt -56.03 -59.64 4.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 9' ' ' TYR . 76.9 mt -38.26 -41.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.98 -33.75 76.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 84' ' ' LEU . 14.5 ttt180 -62.95 -14.08 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -105.35 -89.11 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.75 127.5 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.5 tptt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.497 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.13 133.57 54.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.455 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -106.17 117.6 34.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CZ ' ' HD2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -89.45 126.82 35.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 2.3 m-85 -89.25 160.14 17.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.521 ' HB2' HG23 ' A' ' 85' ' ' ILE . 44.8 t80 -150.63 105.61 3.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.45 126.27 29.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.72 -149.61 24.93 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -70.86 -31.28 67.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -153.39 -51.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -77.4 169.53 18.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD2' ' CD2' ' A' ' 8' ' ' PHE . 48.8 t0 -116.59 134.86 54.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 16' ' ' LEU . 91.5 mt -111.24 136.2 50.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.0 mt -115.98 131.74 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 m -117.74 156.67 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -92.27 150.8 20.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.94 166.03 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.1 -50.21 5.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -165.03 142.53 6.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.468 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.87 -35.76 69.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.444 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -63.89 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -50.22 -45.68 54.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.95 -49.08 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -60.93 -38.15 84.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.4 -36.07 81.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.95 -32.68 69.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 30' ' ' LEU . 6.0 mt -54.05 -31.88 52.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.468 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.499 ' CG ' ' O ' ' A' ' 31' ' ' LYS . 7.4 tttm -96.32 32.9 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -175.37 58.41 0.19 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.36 99.02 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.879 2.386 . . . . 0.0 112.232 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 m -127.31 -107.04 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 tp -159.32 -23.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -81.52 -73.5 1.19 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -41.17 -22.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.422 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.0 tp -66.81 -38.86 87.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -58.87 -36.12 74.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 41' ' ' VAL . 2.3 tt0 -74.27 -57.38 3.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 40' ' ' GLU . 53.6 t -41.68 -35.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 75.3 t -104.43 122.15 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.02 -27.04 30.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 2.3 mp -129.38 140.26 51.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.28 59.27 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -153.39 163.86 39.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -117.47 151.71 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.91 148.83 51.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.452 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -151.1 155.78 35.02 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.305 -1.726 0 C-N-CA 122.861 2.374 . . . . 0.0 112.224 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.3 mt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -119.43 135.88 11.53 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.1 158.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -1.153 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -88.89 155.71 19.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.2 p -83.04 145.29 29.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -56.17 -16.0 4.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.14 -36.27 16.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.86 -41.72 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.898 . . . . 0.0 109.496 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.06 -46.22 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.516 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.63 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.4 mt-10 -47.73 -38.6 15.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -78.64 -20.99 49.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.75 -31.21 59.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 81' ' ' VAL . 50.7 m-85 -126.69 -18.52 4.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 117.52 -152.59 17.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -138.75 92.96 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -1.126 . . . . 0.0 109.512 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.49 -18.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -95.54 -178.03 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 0.0 109.448 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -107.98 -157.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.88 -31.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -59.93 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.05 -31.35 7.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 72' ' ' PHE . 6.4 t -68.57 -61.96 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' A' ' 85' ' ' ILE . 45.9 mt -55.92 -21.58 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -66.28 -56.12 12.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mt -59.19 -25.54 64.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 82' ' ' ILE . 72.6 mt -69.93 -50.85 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 16.0 mt -72.19 -5.81 38.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.39 -34.98 11.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.48 42.19 1.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -104.97 -133.67 7.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 89' ' ' GLY . 33.2 tttm . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 6' ' ' LYS . 14.9 m -106.69 166.86 10.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.419 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 5' ' ' THR . 13.7 mtpt -128.4 143.76 51.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.643 ' OH ' HG11 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -123.65 113.12 18.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.0 109.479 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -83.66 164.02 19.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 109.408 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -154.21 131.98 11.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.475 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -110.79 112.6 24.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.548 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.0 -149.27 4.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -79.8 -47.37 15.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.453 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.87 -26.65 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 158.25 16.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.6 t0 -114.17 154.76 27.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.421 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.673 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 44.0 mt -137.52 157.72 45.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.73 151.42 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.48 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.9 154.87 27.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 162.68 32.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.47 -65.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.74 129.05 18.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -46.57 -38.88 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.19 -61.44 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' C ' ' A' ' 26' ' ' VAL . 32.0 mt -47.26 -59.6 3.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.643 HG11 ' OH ' ' A' ' 7' ' ' TYR . 97.8 t -38.21 -46.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -46.15 84.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.98 -46.78 87.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -47.22 -52.64 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.64 -25.91 60.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -71.49 -31.68 67.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -158.88 80.36 2.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.19 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.804 2.336 . . . . 0.0 112.271 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 36' ' ' GLY . 1.6 t -118.48 120.26 37.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.245 -0.91 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.55 0.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 34' ' ' SER . . . -85.48 -16.17 64.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' LEU . 4.6 ptmm? -115.66 -10.81 11.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.133 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -38.42 -53.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 41' ' ' VAL . 4.6 p -52.77 -61.37 2.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 39' ' ' SER . 4.6 mm-40 -37.77 -22.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.7 t -96.54 -54.86 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.5 149.38 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.57 -16.46 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.68 98.33 2.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -63.29 89.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -169.04 118.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.406 ' CG1' HD22 ' A' ' 16' ' ' LEU . 61.6 t -79.67 144.82 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.54 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -130.86 163.39 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.13 163.82 37.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.305 -1.758 0 C-N-CA 122.823 2.348 . . . . 0.0 112.24 -179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.79 137.19 15.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 152.44 22.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.463 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.73 -168.8 1.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.441 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.27 166.42 18.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -20.66 66.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.18 -44.83 13.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.38 -41.44 89.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.22 -56.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.73 -34.98 70.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.85 . . . . 0.0 109.515 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -27.89 50.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.33 -66.77 0.86 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.536 ' CE1' HG13 ' A' ' 81' ' ' VAL . 25.5 m-85 -71.38 -67.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.38 175.25 21.56 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.86 172.9 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.42 9.94 74.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -131.78 171.0 14.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -1.202 . . . . 0.0 109.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -119.21 -163.16 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.57 -35.22 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.525 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -64.44 -31.59 72.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -84.17 -45.24 13.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.536 HG13 ' CE1' ' A' ' 72' ' ' PHE . 22.8 t -58.56 -34.86 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.05 -46.56 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.21 -45.38 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 84' ' ' LEU . 79.5 mt -61.32 -56.57 18.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mt -47.14 -50.92 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' N ' ' A' ' 88' ' ' ASN . 45.0 mt -58.83 -31.12 68.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -55.74 -9.41 0.54 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 86' ' ' LEU . 2.8 m120 -134.22 -91.68 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 65.51 125.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 89' ' ' GLY . 23.3 mtmt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.344 -1.092 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.4 mtt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.273 0.559 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t 173.82 6.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.388 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 68.9 p -133.01 136.53 46.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.923 . . . . 0.0 109.421 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 19.1 m -89.87 162.84 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.508 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 84.8 m -100.95 147.16 26.48 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -116.7 136.58 52.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.429 ' HB2' HG23 ' A' ' 18' ' ' VAL . 2.3 m-85 -118.68 122.73 43.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.529 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -90.82 159.59 16.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -147.49 91.11 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -53.59 113.77 1.29 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.452 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.14 -161.85 33.27 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 1.3 mm-40 -70.92 -45.25 64.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.334 -1.098 . . . . 0.0 109.538 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -125.01 -41.69 2.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t -101.42 177.89 4.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.499 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.41 124.63 49.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.219 -0.926 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 88.4 mt -102.88 127.66 49.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.358 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.18 155.08 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.484 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.429 HG23 ' HB2' ' A' ' 7' ' ' TYR . 0.3 OUTLIER -131.82 154.11 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.48 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -95.54 153.92 17.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.443 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -150.16 159.18 44.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.499 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.96 -73.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.222 -0.924 . . . . 0.0 109.54 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.1 t -145.66 169.89 17.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -67.53 -26.65 66.43 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.255 -0.903 . . . . 0.0 109.45 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 25' ' ' LEU . 57.7 tt0 -65.49 -74.72 0.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.249 -0.907 . . . . 0.0 109.461 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' C ' ' O ' ' A' ' 24' ' ' GLU . 5.2 mt -42.39 -33.4 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.899 . . . . 0.0 109.434 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 27' ' ' ASP . 3.7 t -67.32 -70.61 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.908 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.543 ' N ' HG12 ' A' ' 26' ' ' VAL . 45.4 t0 -41.11 -39.87 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -0.852 . . . . 0.0 109.479 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 29' ' ' TYR . 3.1 mm-40 -58.05 -58.8 6.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.557 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.417 ' C ' ' O ' ' A' ' 28' ' ' GLU . 76.2 t80 -43.33 -51.86 6.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.938 . . . . 0.0 109.446 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.73 -40.32 83.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.492 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 14.7 mmtp -68.55 -4.51 15.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.408 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -175.62 79.43 0.3 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.262 -0.899 . . . . 0.0 109.481 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -48.47 140.42 21.33 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.769 2.312 . . . . 0.0 112.216 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.6 t -164.33 94.41 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.261 -0.899 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.8 tt -48.54 -27.49 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.29 -0.881 . . . . 0.0 109.391 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -72.59 -9.64 74.44 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' O ' ' C ' ' A' ' 38' ' ' LEU . 18.2 tttm -112.28 -25.46 9.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.496 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -39.13 -31.61 0.08 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.491 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.9 OUTLIER -60.79 -69.82 0.21 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.494 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 39' ' ' SER . 35.9 mt-10 -41.33 -36.39 0.8 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.43 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.17 -70.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.88 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.7 t -85.12 130.31 36.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' C ' HD12 ' A' ' 44' ' ' LEU . 2.0 pt-20 -95.17 -31.49 13.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.488 HD12 ' C ' ' A' ' 43' ' ' GLU . 8.0 mp -111.15 121.42 45.26 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.896 . . . . 0.0 109.443 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -91.6 77.62 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.263 -0.898 . . . . 0.0 109.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 30.4 tt0 -165.86 143.88 5.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.464 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.58 127.29 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 72.7 m-85 -113.26 154.22 27.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.89 . . . . 0.0 109.547 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.535 ' O ' ' O ' ' A' ' 50' ' ' PRO . 0.2 OUTLIER -132.87 164.14 46.0 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.447 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.535 ' O ' ' O ' ' A' ' 49' ' ' THR . 66.6 Cg_exo -45.3 -172.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.794 2.329 . . . . 0.0 112.217 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.609 ' O ' ' N ' ' A' ' 53' ' ' GLY . 11.4 pt20 -94.19 172.85 7.96 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.401 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 27.0 p30 -62.94 59.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.907 . . . . 0.0 109.458 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 51' ' ' GLN . . . 155.51 -164.74 32.2 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -88.2 129.11 35.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -1.17 . . . . 0.0 109.43 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.82 112.34 1.05 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.19 -16.77 39.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.466 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -75.3 -10.91 59.89 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.321 -0.862 . . . . 0.0 109.439 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.13 -143.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 60' ' ' LEU . 51.9 mt-10 -113.65 94.66 4.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -1.177 . . . . 0.0 109.574 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.61 ' N ' HD23 ' A' ' 60' ' ' LEU . 0.9 OUTLIER -38.42 150.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -120.98 -173.84 14.83 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.18 151.07 26.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -1.128 . . . . 0.0 109.446 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.85 132.88 39.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.481 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -74.75 149.29 39.83 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 29.9 mttt -43.82 -51.36 7.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 0.0 109.505 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -49.76 -34.92 20.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.26 -0.9 . . . . 0.0 109.475 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -73.05 -36.71 66.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.228 -0.92 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 42.3 t -66.13 -34.45 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 109.447 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.53 -28.72 70.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.28 -0.888 . . . . 0.0 109.521 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -52.92 -19.65 2.74 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.444 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 46.4 mp0 -113.75 -73.03 0.67 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.246 -0.909 . . . . 0.0 109.454 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.748 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -148.46 72.5 1.2 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.186 -0.946 . . . . 0.0 109.433 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.508 ' O ' ' C ' ' A' ' 74' ' ' LYS . . . -135.24 0.54 3.58 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.508 ' C ' ' O ' ' A' ' 73' ' ' GLY . 10.7 tptm -37.37 -49.37 0.99 Allowed 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.467 -1.019 . . . . 0.0 109.475 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -147.69 3.32 0.83 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -75.64 -175.97 3.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -1.128 . . . . 0.0 109.441 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -114.37 -140.87 0.38 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.876 . . . . 0.0 109.538 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.5 tp -105.31 -23.93 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.86 . . . . 0.0 109.492 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -64.17 1.03 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.283 -0.886 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 83' ' ' ASP . 37.4 mt-10 -47.08 -53.22 13.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.473 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.425 ' C ' ' O ' ' A' ' 80' ' ' GLU . 4.7 t -44.3 -58.95 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.487 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 57.6 mt -58.06 -22.47 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.406 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' GLU . 3.9 t0 -69.35 -61.08 1.94 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.45 -46.17 47.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.275 -0.891 . . . . 0.0 109.438 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 44.4 mt -58.84 -59.31 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' C ' ' A' ' 87' ' ' ARG . 19.5 mt -46.21 -33.78 3.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.74 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -35.78 -66.61 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.886 . . . . 0.0 109.429 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -167.87 75.62 0.13 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.218 -0.926 . . . . 0.0 109.336 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.31 -117.51 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.5 mttt -143.79 92.92 6.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.344 -1.092 . . . . 0.0 109.412 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -48.5 165.27 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.711 2.274 . . . . 0.0 112.178 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -119.82 139.68 51.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.244 -0.91 . . . . 0.0 109.513 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.06 -61.99 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.351 -0.843 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 t -166.37 165.03 17.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.4 m -107.39 56.19 0.64 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.283 -0.885 . . . . 0.0 109.525 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.467 ' O ' ' OG ' ' A' ' 97' ' ' SER . 7.0 t -53.56 172.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 96' ' ' SER . 0.8 OUTLIER -171.34 -77.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 mp -91.46 -13.79 31.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.491 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.26 -160.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 101' ' ' LYS . 2.7 t -147.73 -165.91 2.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.47 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.506 ' N ' ' OG1' ' A' ' 100' ' ' THR . 41.8 mttp -88.13 -157.86 0.44 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -0.917 . . . . 0.0 109.508 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.22 161.44 10.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 73.55 88.69 0.18 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -158.47 -78.86 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -1.153 . . . . 0.0 109.441 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -135.13 53.61 1.97 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.87 151.21 0.37 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 25.1 p -107.19 -20.07 13.4 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -1.151 . . . . 0.0 109.495 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -149.86 3.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.473 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.62 -94.31 0.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -111.72 131.84 55.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.3 p30 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.026 -0.988 . . . . 0.0 109.526 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.403 ' H3 ' ' HG2' ' A' ' 1' ' ' MET . 5.3 ptt? . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.6 p -133.47 14.08 4.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.545 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -133.72 91.52 2.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.459 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.2 m -55.27 -179.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.885 . . . . 0.0 109.45 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -122.37 131.57 53.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.454 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.7 mtmm -105.96 131.62 53.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.252 -0.905 . . . . 0.0 109.475 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 4.5 m-85 -97.31 123.38 41.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.587 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -89.65 149.69 22.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.209 -0.932 . . . . 0.0 109.405 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 9' ' ' TYR . 22.8 t80 -144.69 119.0 9.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.517 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -95.03 132.97 39.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.391 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -109.26 -154.2 15.66 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 11' ' ' GLY . 1.2 tp10 -42.82 -82.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.479 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -117.78 -34.56 4.17 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.614 ' CB ' HE22 ' A' ' 67' ' ' GLN . 1.4 t -79.0 174.05 11.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.279 -0.888 . . . . 0.0 109.507 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -134.42 145.35 48.81 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.455 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 5.3 mt -130.38 156.88 43.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.92 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 18' ' ' VAL . 48.4 mt -134.98 155.85 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.218 -0.927 . . . . 0.0 109.559 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.426 ' N ' HG22 ' A' ' 17' ' ' ILE . 18.9 m -136.1 155.93 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.292 -0.88 . . . . 0.0 109.487 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -98.46 140.49 32.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.447 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.34 168.31 20.12 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.161 -0.962 . . . . 0.0 109.546 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.93 -87.19 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.291 -0.881 . . . . 0.0 109.46 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 6.2 p -136.11 171.89 13.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.517 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -68.58 -13.01 62.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.458 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -75.14 -74.06 0.22 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.498 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -47.45 -46.63 26.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.26 -0.9 . . . . 0.0 109.527 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 47.6 t -51.72 -54.69 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 109.449 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -53.42 -45.86 69.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 109.5 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -56.81 -30.09 63.38 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.244 -0.91 . . . . 0.0 109.457 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.403 ' O ' ' N ' ' A' ' 33' ' ' PRO . 60.4 t80 -72.22 -61.24 1.86 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.402 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.513 HD21 ' O ' ' A' ' 86' ' ' LEU . 10.6 mt -48.27 -44.4 33.52 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.6 mttm -72.33 -20.94 61.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.458 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -150.31 70.59 9.11 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.465 ' O ' ' OG ' ' A' ' 34' ' ' SER . 54.2 Cg_endo -74.32 162.55 38.22 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.881 2.387 . . . . 0.0 112.209 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 33' ' ' PRO . 73.8 m -171.26 -104.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.248 -0.907 . . . . 0.0 109.476 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.5 tp -169.08 -20.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.531 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -91.93 -40.33 5.26 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -69.05 -18.31 64.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -1.13 . . . . 0.0 109.415 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.7 tp -68.99 -29.12 67.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.918 . . . . 0.0 109.506 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -33.47 75.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.522 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -78.4 -57.25 3.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 94.9 t -46.62 -60.79 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.52 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.9 t -72.5 122.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.527 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -104.49 -1.37 26.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.494 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 14.2 tp -156.29 107.4 2.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.423 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -77.39 87.35 3.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -166.7 114.22 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.302 -0.874 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.2 t -83.77 144.79 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -129.7 165.78 21.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.1 OUTLIER -163.34 151.82 11.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.943 . . . . 0.0 109.446 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -71.86 140.66 35.63 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.836 2.358 . . . . 0.0 112.173 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.484 ' C ' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -144.8 -32.73 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.21 -0.931 . . . . 0.0 109.461 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.484 ' OD1' ' C ' ' A' ' 51' ' ' GLN . 0.6 OUTLIER -129.28 -32.29 2.01 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.414 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' GLY . . . -56.68 -16.88 18.45 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 57.94 -3.99 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -1.146 . . . . 0.0 109.44 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' GLY . . . -162.65 -151.12 6.24 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.29 10.66 40.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -1.167 . . . . 0.0 109.495 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -108.57 107.27 17.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.2 -131.79 2.94 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -129.85 9.75 5.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -1.158 . . . . 0.0 109.527 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt 57.54 -170.55 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -142.83 174.81 23.39 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.05 127.4 51.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.234 -1.157 . . . . 0.0 109.518 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -68.42 144.69 54.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.236 -0.915 . . . . 0.0 109.441 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.492 ' O ' ' C ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -93.09 155.31 17.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.94 . . . . 0.0 109.411 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 64' ' ' SER . 0.8 OUTLIER -38.96 -50.14 1.74 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.516 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' GLU . . . -56.16 -59.8 4.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.614 HE22 ' CB ' ' A' ' 14' ' ' THR . 20.7 mm100 -35.91 -39.23 0.15 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' N ' ' O ' ' A' ' 66' ' ' ALA . 38.4 t -84.01 -31.76 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.497 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.565 ' N ' ' O ' ' A' ' 66' ' ' ALA . 49.5 tt0 -65.37 -39.26 92.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.249 -0.907 . . . . 0.0 109.541 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -18.87 65.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.61 -70.18 0.73 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.256 -0.903 . . . . 0.0 109.505 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -160.07 54.2 0.35 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.418 179.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -131.09 170.2 21.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt 177.81 -61.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -1.175 . . . . 0.0 109.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.58 7.15 0.33 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -82.49 166.11 19.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.276 -1.132 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -71.84 -149.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.427 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 tp -109.4 -13.63 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.892 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -71.06 -18.72 62.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -90.67 -53.33 4.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.5 t -50.43 -39.74 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.0 109.495 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 5.7 mt -72.28 -49.5 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -44.57 -44.79 9.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.235 -0.916 . . . . 0.0 109.42 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.507 ' O ' ' N ' ' A' ' 87' ' ' ARG . 14.3 mt -67.44 -60.6 2.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.428 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.463 ' C ' ' O ' ' A' ' 84' ' ' LEU . 13.3 mt -40.4 -39.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' HD21 ' A' ' 30' ' ' LEU . 84.6 mt -70.44 -36.01 73.71 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.716 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -41.7 -62.32 0.92 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.509 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -76.44 -86.94 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.08 117.14 1.52 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.542 ' O ' ' O ' ' A' ' 91' ' ' PRO . 47.0 mttp -140.34 62.37 19.56 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.23 -1.159 . . . . 0.0 109.543 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' O ' ' O ' ' A' ' 90' ' ' LYS . 50.8 Cg_exo -48.81 -160.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.805 2.336 . . . . 0.0 112.211 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -82.83 -11.83 57.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.262 -0.899 . . . . 0.0 109.48 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.13 78.27 6.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.235 -0.916 . . . . 0.0 109.477 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' THR . 11.2 p -135.38 4.99 3.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.153 -0.967 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.545 ' O ' ' O ' ' A' ' 94' ' ' THR . 12.5 p -51.14 -170.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.962 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.7 m -89.64 94.92 10.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.448 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.58 97.49 5.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' O ' ' CB ' ' A' ' 99' ' ' LYS . 3.2 mt -109.85 -80.23 0.58 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.297 -0.877 . . . . 0.0 109.392 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.4 tttp 80.34 93.06 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.467 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.81 149.6 24.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.8 tttp -51.29 110.24 0.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.337 -0.852 . . . . 0.0 109.491 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.25 -156.97 9.41 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.81 -62.19 0.36 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -168.81 104.88 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -1.144 . . . . 0.0 109.46 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -78.74 -146.25 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.497 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.43 28.8 65.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.86 98.71 6.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.282 -1.128 . . . . 0.0 109.511 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.44 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 8.0 mttt -76.95 -132.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.32 -0.862 . . . . 0.0 109.484 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.403 ' O ' ' CB ' ' A' ' 110' ' ' TYR . . . -95.67 6.3 49.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.234 -0.916 . . . . 0.0 109.541 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.403 ' CB ' ' O ' ' A' ' 109' ' ' ALA . 4.6 t80 70.43 175.4 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.448 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.549 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 t -104.56 -16.86 14.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.513 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -93.31 148.11 22.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.7 m -63.86 171.4 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.493 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.76 163.46 12.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -122.84 130.6 53.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.31 -0.869 . . . . 0.0 109.448 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.448 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 6.0 m-85 -114.68 114.34 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -83.65 142.08 31.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.293 -0.88 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -123.74 144.6 49.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.86 . . . . 0.0 109.481 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -114.98 129.12 56.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.34 -153.05 24.82 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -76.51 -34.06 58.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -1.151 . . . . 0.0 109.505 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -149.7 -35.27 0.17 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.472 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 15' ' ' ASP . 85.1 m -89.51 157.92 17.89 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.634 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 39.3 t0 -106.17 152.17 23.8 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.479 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.634 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 42.9 mt -136.34 160.03 39.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.203 -0.936 . . . . 0.0 109.462 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 11.0 mt -145.01 148.87 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -0.933 . . . . 0.0 109.5 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.1 m -139.01 147.35 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.451 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -86.21 142.37 28.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.94 -171.75 2.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.477 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.05 -90.68 0.41 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.149 -0.969 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 66.5 m -121.53 171.62 8.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -77.69 -9.6 59.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -85.03 -54.62 4.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.261 -0.899 . . . . 0.0 109.532 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.5 mt -60.22 -38.6 83.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.479 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 75.8 t -63.8 -55.94 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.334 -0.854 . . . . 0.0 109.508 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -54.68 -50.5 68.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 0.0 109.543 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -52.39 -31.52 34.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.218 -0.926 . . . . 0.0 109.534 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.437 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 76.2 t80 -68.3 -41.87 80.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.6 mt -60.46 -23.43 64.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.56 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.5 mttt -90.64 -4.49 56.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.52 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -167.66 71.55 0.93 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.24 -0.912 . . . . 0.0 109.57 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.437 ' HA ' ' CE1' ' A' ' 29' ' ' TYR . 56.9 Cg_endo -75.29 139.67 23.81 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.812 2.341 . . . . 0.0 112.258 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 m -160.67 -133.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.476 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.418 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.2 tp -135.44 15.7 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.228 -0.92 . . . . 0.0 109.424 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -112.79 -82.97 1.21 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 36' ' ' GLY . 4.1 ttmt -45.05 -22.83 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.243 -1.151 . . . . 0.0 109.483 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 36' ' ' GLY . 6.0 tp -49.28 -62.52 1.5 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.944 . . . . 0.0 109.5 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -47.89 -47.64 31.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.426 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -52.03 -29.04 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.457 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 37' ' ' LYS . 34.6 t -86.98 -54.76 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.912 . . . . 0.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.557 HG21 HG21 ' A' ' 82' ' ' ILE . 21.5 t -87.63 113.44 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -79.15 -43.26 24.32 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 tp -111.15 115.16 28.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.893 . . . . 0.0 109.453 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.428 ' CE1' ' OE2' ' A' ' 79' ' ' GLU . 46.8 m-85 -73.93 65.92 1.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.23 -0.919 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -143.72 174.9 10.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.288 -0.883 . . . . 0.0 109.447 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.3 t -134.85 128.17 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.93 151.92 22.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.125 -0.984 . . . . 0.0 109.487 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.35 150.76 77.35 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.413 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' GLN . 41.8 Cg_endo -71.56 138.11 31.68 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.854 2.369 . . . . 0.0 112.176 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.505 ' C ' ' O ' ' A' ' 50' ' ' PRO . 17.7 mt-30 -36.99 -89.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 109.372 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.2 p30 -162.06 -36.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.483 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.47 -137.63 9.02 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.6 mtm180 -91.07 136.34 33.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -1.136 . . . . 0.0 109.469 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.11 64.04 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.86 37.76 2.7 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.206 -1.173 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' CD ' ' C ' ' A' ' 57' ' ' GLU . 13.5 tm-20 -110.77 -37.4 5.44 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 59' ' ' GLU . . . -132.47 146.17 17.95 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' OE1' ' C ' ' A' ' 59' ' ' GLU . 0.4 OUTLIER 68.17 92.3 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.23 -1.159 . . . . 0.0 109.544 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -124.24 -169.35 1.95 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.25 -0.906 . . . . 0.0 109.437 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -139.4 172.09 23.41 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -98.67 154.81 17.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.265 -1.138 . . . . 0.0 109.448 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -78.54 133.71 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.27 -0.894 . . . . 0.0 109.475 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.59 169.36 18.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.327 -0.858 . . . . 0.0 109.519 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 66' ' ' ALA . 63.5 tttt -57.38 -65.86 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 0.0 109.437 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 65' ' ' LYS . . . -43.97 -39.9 4.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.331 -0.855 . . . . 0.0 109.443 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -49.89 -72.56 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 109.514 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -57.17 -24.08 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.234 -0.916 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -68.23 -24.95 64.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 0.0 109.467 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -72.66 -21.34 61.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.296 -0.877 . . . . 0.0 109.453 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -105.62 -63.85 1.2 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.414 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -165.84 64.36 0.11 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -128.21 -0.01 6.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 73' ' ' GLY . 20.1 tttt -51.69 -101.09 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.455 -1.027 . . . . 0.0 109.486 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.11 44.56 1.6 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 mmtp -121.7 133.16 54.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.31 -1.112 . . . . 0.0 109.473 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -56.41 179.26 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.441 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -84.96 -42.59 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.915 . . . . 0.0 109.28 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 8.2 mm-40 -49.48 -55.44 13.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' O ' ' N ' ' A' ' 83' ' ' ASP . 2.1 mt-10 -48.3 -54.26 14.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.231 -0.918 . . . . 0.0 109.529 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.5 t -45.47 -46.46 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.25 -0.907 . . . . 0.0 109.416 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.557 HG21 HG21 ' A' ' 42' ' ' VAL . 19.1 mm -62.87 -25.93 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.149 -0.969 . . . . 0.0 109.437 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' GLU . 52.0 t0 -70.97 -61.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 65.5 mt -49.12 -29.87 5.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.482 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 88' ' ' ASN . 58.3 mt -67.74 -66.77 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.498 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' ILE . 95.8 mt -43.82 -46.4 7.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -56.58 -30.93 63.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.261 -0.9 . . . . 0.0 109.519 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 89' ' ' GLY . 7.1 t-20 -83.76 -81.79 0.17 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 57.08 116.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -128.5 60.31 47.59 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.213 -1.169 . . . . 0.0 109.521 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.94 122.96 8.56 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.845 2.363 . . . . 0.0 112.172 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 92' ' ' ASN . 20.1 t-20 -152.99 68.31 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.257 -0.902 . . . . 0.0 109.494 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.92 57.74 1.66 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.1 p -136.42 128.98 30.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 97' ' ' SER . 21.3 p -82.59 -66.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.263 -0.898 . . . . 0.0 109.443 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.492 ' N ' ' OG1' ' A' ' 95' ' ' THR . 0.7 OUTLIER -58.92 80.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.434 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -89.65 -178.14 5.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 0.0 109.403 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mt -99.9 150.86 21.95 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.216 -0.927 . . . . 0.0 109.44 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 26.7 mtmt -115.88 117.91 31.5 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.478 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.55 ' O ' ' CB ' ' A' ' 101' ' ' LYS . 51.9 p -119.6 93.18 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.216 -0.927 . . . . 0.0 109.405 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.55 ' CB ' ' O ' ' A' ' 100' ' ' THR . 3.0 tttp 78.59 106.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -118.82 -147.82 8.27 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.2 -61.16 4.7 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.549 ' O ' ' O ' ' A' ' 105' ' ' ALA . 2.9 t-20 -161.17 -19.61 0.05 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 0.0 109.522 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.549 ' O ' ' O ' ' A' ' 104' ' ' ASN . . . 42.32 -171.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.524 ' O ' ' C ' ' A' ' 107' ' ' THR . . . -83.98 -107.82 0.57 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.524 ' C ' ' O ' ' A' ' 106' ' ' GLY . 25.2 p 36.17 -102.48 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -1.133 . . . . 0.0 109.467 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 109' ' ' ALA . 3.3 mttt -48.19 -56.86 6.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 109.487 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 110' ' ' TYR . . . 47.94 95.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 0.0 109.443 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.493 ' O ' ' O ' ' A' ' 109' ' ' ALA . 0.4 OUTLIER 59.6 124.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -0.905 . . . . 0.0 109.516 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.4 t30 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.477 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 mtt . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -124.16 119.69 30.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.449 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.3 p -99.48 61.41 1.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.923 . . . . 0.0 109.475 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.0 m -93.47 179.62 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.19 -0.944 . . . . 0.0 109.508 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.6 m -127.81 147.18 50.42 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.517 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -105.27 159.24 16.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.282 -0.886 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -126.05 112.17 15.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.447 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -75.45 162.74 28.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.494 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -153.3 100.42 2.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.271 -0.893 . . . . 0.0 109.481 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 tttt -66.74 104.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.55 33.83 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -47.01 -80.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -1.19 . . . . 0.0 109.499 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -106.98 -52.15 2.81 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.346 -0.846 . . . . 0.0 109.445 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -80.66 174.08 11.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.262 -0.899 . . . . 0.0 109.505 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 6.8 t70 -119.43 156.28 30.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.431 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.492 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 22.3 mt -123.2 157.32 33.3 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.264 -0.898 . . . . 0.0 109.51 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 6.1 mt -134.21 143.76 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 109.416 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.09 165.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.187 -0.946 . . . . 0.0 109.551 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -106.24 142.18 36.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.893 . . . . 0.0 109.452 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -139.59 -178.45 5.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.507 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.16 -73.54 0.58 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.192 -0.942 . . . . 0.0 109.502 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.11 166.48 27.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -69.23 -37.18 77.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.501 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.452 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -70.07 -51.79 29.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.4 t -51.08 -43.93 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.21 -0.931 . . . . 0.0 109.399 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -61.28 -41.7 97.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.377 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -65.36 -35.03 79.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -65.65 -54.07 32.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 54.4 mt -52.31 -19.86 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -0.901 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -74.62 -44.06 52.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.191 -0.943 . . . . 0.0 109.372 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.05 76.48 77.99 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.448 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.586 ' O ' ' CB ' ' A' ' 34' ' ' SER . 55.5 Cg_exo -47.01 164.19 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.781 0 C-N-CA 122.836 2.358 . . . . 0.0 112.24 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.587 ' OG ' ' N ' ' A' ' 35' ' ' ILE . 0.4 OUTLIER 159.61 -173.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.45 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.587 ' N ' ' OG ' ' A' ' 34' ' ' SER . 0.6 OUTLIER -114.98 -14.27 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.542 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -78.84 -17.99 76.08 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -103.14 -18.97 14.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -1.142 . . . . 0.0 109.525 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.4 tp -63.05 -33.31 75.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 109.457 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 60.3 p -70.32 -20.5 63.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.187 -0.946 . . . . 0.0 109.526 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -83.77 -50.41 8.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -67.64 -36.4 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 80.0 t -91.97 110.65 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -80.51 -18.36 48.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.08 142.09 23.93 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.2 -0.937 . . . . 0.0 109.522 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -98.99 68.55 1.71 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG2' ' CZ ' ' A' ' 48' ' ' PHE . 48.0 tp10 -150.65 128.34 11.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.184 -0.948 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 63' ' ' ALA . 2.0 t -93.09 128.39 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -0.911 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' CZ ' ' HG2' ' A' ' 46' ' ' GLU . 91.2 m-85 -114.21 155.06 26.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.159 -0.963 . . . . 0.0 109.465 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -131.83 152.09 79.7 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.189 -0.944 . . . . 0.0 109.458 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -70.22 122.42 8.97 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.743 2.295 . . . . 0.0 112.192 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.466 ' CG ' ' H ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -73.71 -143.63 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' H ' ' CG ' ' A' ' 51' ' ' GLN . 1.1 m-20 -53.54 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.463 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -66.56 132.89 32.48 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 -158.51 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.0 109.428 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 56' ' ' ALA . . . 76.09 25.09 67.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 55' ' ' GLY . . . 58.24 113.87 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.31 -1.111 . . . . 0.0 109.449 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -133.23 -52.9 0.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.488 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 148.83 -15.58 1.2 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.86 58.0 0.63 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -1.108 . . . . 0.0 109.497 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -69.91 -173.84 0.69 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.269 -0.895 . . . . 0.0 109.54 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -122.96 113.13 2.08 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.606 -1.397 . . . . 0.0 109.606 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.37 111.99 0.73 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -1.141 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.533 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -65.48 130.49 43.49 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.444 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' N ' ' A' ' 66' ' ' ALA . 73.0 m -93.22 139.66 30.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.1 mttt -41.26 -27.53 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.93 . . . . 0.0 109.423 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -61.4 -39.36 90.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.482 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.416 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.11 -57.94 3.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.412 ' H ' HG23 ' A' ' 68' ' ' VAL . 5.6 t -53.16 -24.81 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.389 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 17.9 mt-10 -68.77 -45.97 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.311 -0.868 . . . . 0.0 109.458 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.03 -19.81 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.395 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.604 ' OE1' ' CZ ' ' A' ' 72' ' ' PHE . 2.5 tm-20 -88.68 -52.53 5.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.443 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.604 ' CZ ' ' OE1' ' A' ' 71' ' ' GLU . 67.9 m-85 -116.22 32.05 6.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 46.65 -160.32 0.28 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.7 29.69 7.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -1.134 . . . . 0.0 109.436 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.92 -32.62 8.88 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -98.3 155.59 17.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.16 -1.2 . . . . 0.0 109.424 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -83.28 -177.55 6.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.192 -0.942 . . . . 0.0 109.443 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -72.8 -15.52 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.16 -70.81 0.34 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.534 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -52.8 -35.62 57.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 82' ' ' ILE . 3.0 t -56.4 -64.41 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 0.0 109.474 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.473 ' N ' HG12 ' A' ' 81' ' ' VAL . 31.1 mt -48.79 -31.67 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.469 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.672 ' O ' ' N ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -59.47 -73.65 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.238 -0.914 . . . . 0.0 109.497 -180.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.543 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.8 mt -35.56 -44.11 0.3 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.7 mt -60.59 -32.28 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.199 -0.938 . . . . 0.0 109.419 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.672 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.6 mt -72.04 -20.4 61.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.897 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.665 HH11 ' CB ' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -88.29 -3.48 58.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -113.92 -86.66 0.58 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.491 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 67.16 121.75 0.02 OUTLIER Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 89' ' ' GLY . 0.0 OUTLIER 39.93 59.25 7.0 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.186 -1.185 . . . . 0.0 109.464 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.451 ' HD3' ' N ' ' A' ' 90' ' ' LYS . 61.6 Cg_exo -46.39 149.68 2.58 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.773 2.315 . . . . 0.0 112.276 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 93' ' ' SER . 37.4 m-80 -134.31 -159.31 0.95 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.313 -0.867 . . . . 0.0 109.428 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.541 ' O ' ' C ' ' A' ' 94' ' ' THR . 1.0 OUTLIER 164.98 -93.25 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.467 -179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 93' ' ' SER . 60.7 p 35.94 -128.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.17 84.72 0.86 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 109.506 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 33.0 m -101.64 130.3 47.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.19 -0.944 . . . . 0.0 109.445 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 99' ' ' LYS . 0.8 OUTLIER -130.67 126.34 36.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.6 mt 47.25 -97.9 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 109.464 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 97' ' ' SER . 26.7 mtpt -71.22 107.46 4.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.506 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.0 m -45.1 137.72 4.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt 63.56 53.83 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 109.416 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -50.38 173.41 0.09 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -143.33 -76.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t30 -122.85 -149.32 0.42 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -1.149 . . . . 0.0 109.419 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -143.33 19.09 1.9 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.903 . . . . 0.0 109.503 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.58 116.64 3.05 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m -55.56 -59.55 4.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -1.102 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -159.27 -24.59 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.355 -0.841 . . . . 0.0 109.484 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -167.05 -118.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.22 -0.925 . . . . 0.0 109.465 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.447 ' O ' ' C ' ' A' ' 111' ' ' ASN . 55.5 m-85 52.16 32.52 10.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.477 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 110' ' ' TYR . 10.3 m120 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.48 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ttt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.1 -135.31 0.11 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.869 . . . . 0.0 109.401 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 31.4 p -117.05 119.87 36.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.17 -0.956 . . . . 0.0 109.485 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -75.06 139.78 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.501 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.16 148.03 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.527 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt -106.89 129.68 54.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.456 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -104.42 120.63 41.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -0.912 . . . . 0.0 109.485 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -82.07 158.38 23.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.451 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -145.44 102.55 3.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 109.499 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.6 tttp -85.5 104.3 15.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.438 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.99 -157.41 11.17 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 mm-40 -58.93 -49.24 78.58 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.239 -1.153 . . . . 0.0 109.516 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -141.65 -33.99 0.49 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 109.569 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -84.78 134.91 34.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 109.564 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -105.76 138.05 42.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.397 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.8 mt -134.99 151.49 50.87 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.237 -0.914 . . . . 0.0 109.572 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 34.6 mt -120.27 150.79 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -0.929 . . . . 0.0 109.423 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.82 151.19 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.278 -0.888 . . . . 0.0 109.521 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -90.2 144.55 25.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.434 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.04 177.64 8.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.0 109.541 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 -88.64 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.88 . . . . 0.0 109.466 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 26' ' ' VAL . 18.0 t -125.62 168.93 13.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.199 -0.938 . . . . 0.0 109.443 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.19 -29.9 34.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.259 -0.901 . . . . 0.0 109.452 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -56.53 -47.99 78.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 mt -68.32 -47.88 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.44 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 22' ' ' SER . 94.7 t -49.93 -43.06 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 0.0 109.573 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -24.95 63.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.5 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -75.5 -47.03 28.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.15 -0.969 . . . . 0.0 109.465 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.542 ' O ' ' N ' ' A' ' 32' ' ' ASN . 63.9 t80 -57.89 -50.02 74.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.471 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 30' ' ' LEU . 82.8 mt -43.82 -32.75 1.13 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.479 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 4.0 mptp? -91.19 10.03 28.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.934 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 29' ' ' TYR . 49.5 m-80 -161.25 62.11 1.49 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.539 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 47.1 Cg_endo -72.81 113.46 3.76 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 122.815 2.343 . . . . 0.0 112.191 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.518 ' O ' ' OG ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -173.07 34.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.503 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.889 HG22 ' H ' ' A' ' 36' ' ' GLY . 29.3 mm 51.24 -177.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.433 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.889 ' H ' HG22 ' A' ' 35' ' ' ILE . . . 87.29 -74.78 2.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -67.56 -10.9 56.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.274 -1.133 . . . . 0.0 109.458 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 41' ' ' VAL . 1.1 tp -59.2 -54.45 46.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 109.439 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' LEU . 70.3 m -43.18 -37.8 2.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.566 ' N ' ' CD ' ' A' ' 40' ' ' GLU . 1.7 mp0 -70.09 -35.88 74.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -0.889 . . . . 0.0 109.533 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 38' ' ' LEU . 41.7 t -71.68 -54.8 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.275 -0.891 . . . . 0.0 109.574 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.9 t -99.41 118.44 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -86.18 -26.26 25.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.369 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 tp -125.55 124.05 40.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.17 -0.957 . . . . 0.0 109.39 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -90.5 95.99 10.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 109.476 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' HB3' ' CZ ' ' A' ' 48' ' ' PHE . 0.4 OUTLIER -167.87 140.09 3.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.26 -0.9 . . . . 0.0 109.428 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.0 t -108.96 141.14 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.525 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CZ ' ' HB3' ' A' ' 46' ' ' GLU . 0.3 OUTLIER -128.78 178.83 6.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.888 . . . . 0.0 109.365 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.03 149.08 29.06 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.231 -0.918 . . . . 0.0 109.471 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.31 134.7 23.28 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.735 2.29 . . . . 0.0 112.138 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -90.1 68.28 7.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.915 . . . . 0.0 109.476 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.0 t0 51.13 50.87 18.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -0.896 . . . . 0.0 109.404 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -120.47 175.79 16.06 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -96.91 32.03 2.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.223 -1.163 . . . . 0.0 109.474 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.72 -157.02 22.19 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.43 151.26 39.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.192 -1.181 . . . . 0.0 109.507 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -130.29 -45.23 1.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 160.4 -29.08 0.34 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -136.02 89.78 2.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -1.131 . . . . 0.0 109.503 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 29.2 mt -77.17 161.26 28.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.256 -0.902 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -106.41 128.16 9.2 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.36 168.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -1.156 . . . . 0.0 109.443 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -114.7 170.91 7.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.422 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 67' ' ' GLN . 2.8 t -99.49 133.12 44.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 6.7 tttp -46.7 -30.56 2.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 109.442 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.3 -31.97 64.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.292 -0.88 . . . . 0.0 109.485 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.0 mm-40 -69.98 -27.82 65.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.163 -0.961 . . . . 0.0 109.504 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.65 -44.5 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.499 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.664 ' O ' ' N ' ' A' ' 73' ' ' GLY . 23.5 mt-10 -57.33 -39.36 75.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 109.525 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -49.71 -17.04 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.414 ' N ' ' C ' ' A' ' 69' ' ' GLU . 28.5 mt-10 -98.8 -52.21 3.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.924 . . . . 0.0 109.546 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -97.43 -28.96 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.664 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 104.6 -178.32 24.05 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -91.22 -157.57 0.51 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -1.165 . . . . 0.0 109.416 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.14 -8.02 9.38 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -120.48 162.49 19.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -1.171 . . . . 0.0 109.454 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -108.88 -150.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.915 . . . . 0.0 109.469 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -93.62 -18.31 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.948 . . . . 0.0 109.502 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -81.15 -43.29 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.448 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -64.0 -55.16 24.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.882 . . . . 0.0 109.484 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 82' ' ' ILE . 14.6 t -50.74 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.454 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.501 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.7 mm -44.72 -62.14 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.236 -0.915 . . . . 0.0 109.362 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 82' ' ' ILE . 6.0 t70 -37.98 -51.67 1.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.87 . . . . 0.0 109.446 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 85' ' ' ILE . 81.4 mt -57.03 -53.19 60.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.439 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.452 ' C ' ' O ' ' A' ' 84' ' ' LEU . 46.0 mm -42.03 -49.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.223 -0.923 . . . . 0.0 109.392 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.469 ' O ' ' C ' ' A' ' 87' ' ' ARG . 49.4 mt -57.7 -40.67 80.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.424 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.73 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -40.36 -34.93 0.37 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.433 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -105.21 -82.87 0.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.83 96.13 0.23 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.5 mttt 58.61 62.1 4.71 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.269 -1.136 . . . . 0.0 109.551 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -74.78 107.51 2.49 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.846 2.364 . . . . 0.0 112.262 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.762 HD22 ' N ' ' A' ' 93' ' ' SER . 0.2 OUTLIER -64.49 125.45 24.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.496 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.762 ' N ' HD22 ' A' ' 92' ' ' ASN . 22.8 t -72.02 137.36 47.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.5 p -71.11 -71.91 0.24 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 4.6 p 47.3 60.32 3.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.0 109.41 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 p -104.43 18.35 22.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 54.4 p -95.09 -133.42 0.18 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.908 . . . . 0.0 109.437 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 mt -104.06 156.14 18.11 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.192 -0.943 . . . . 0.0 109.465 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -96.23 -13.37 23.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.416 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.4 p -81.37 64.57 6.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.412 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.9 tttm -118.66 -27.22 5.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -120.46 6.21 11.69 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -107.85 -141.5 9.84 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.93 157.41 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.485 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -169.6 154.14 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.458 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' A' ' 108' ' ' LYS . . . -144.01 47.76 0.77 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 106' ' ' GLY . 23.3 p 50.68 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -1.163 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.584 ' N ' ' O ' ' A' ' 106' ' ' GLY . 0.5 OUTLIER 36.49 44.02 0.29 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.881 . . . . 0.0 109.485 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -108.99 95.21 5.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.9 . . . . 0.0 109.498 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -131.69 -73.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.428 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.1 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.484 179.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.533 ' C ' ' H ' ' A' ' 4' ' ' VAL . 3.6 m -57.01 -26.6 60.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.455 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.446 ' CB ' ' O ' ' A' ' 2' ' ' SER . 0.6 OUTLIER 70.7 -19.91 0.22 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.533 ' H ' ' C ' ' A' ' 2' ' ' SER . 6.7 m -145.11 -165.85 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.419 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -111.57 139.2 47.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.281 -0.887 . . . . 0.0 109.521 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 mtmt -113.6 160.25 18.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -122.05 139.83 53.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.499 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -98.26 160.39 14.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 109.42 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -150.4 94.88 2.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.447 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tttm -65.04 113.64 4.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -84.46 172.83 49.21 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -46.55 -30.38 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -1.124 . . . . 0.0 109.481 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.591 ' ND2' ' N ' ' A' ' 14' ' ' THR . 2.6 p-10 -149.6 -50.84 0.14 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.897 . . . . 0.0 109.508 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.591 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 53.9 m -83.48 146.58 28.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -104.77 135.47 46.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.45 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.3 mt -121.46 162.01 21.23 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.915 . . . . 0.0 109.528 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.9 mt -138.04 153.4 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.24 -0.913 . . . . 0.0 109.491 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.09 177.9 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -103.45 168.42 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 5' ' ' THR . . . -157.78 152.84 25.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.205 -0.934 . . . . 0.0 109.416 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.11 -99.85 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.37 145.46 32.87 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.466 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -61.49 -44.75 96.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.274 -0.891 . . . . 0.0 109.404 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -48.54 -32.89 8.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.489 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 36.6 mt -75.68 -51.82 11.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 63.7 t -50.01 -54.01 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.344 -0.847 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.45 -53.61 54.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.351 -0.843 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -48.38 -41.73 29.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.462 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 70.5 t80 -61.99 -46.72 88.0 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.265 -0.897 . . . . 0.0 109.408 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 30' ' ' LEU . 7.3 mt -46.65 -41.23 14.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -0.837 . . . . 0.0 109.459 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -81.66 1.57 33.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.376 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 29' ' ' TYR . 9.8 t30 -154.66 64.66 4.51 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 29' ' ' TYR . 38.8 Cg_endo -70.72 109.46 2.5 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.849 2.366 . . . . 0.0 112.199 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.449 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 1.8 m -143.17 -136.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 tp -138.76 1.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 109.513 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -93.46 -74.16 1.25 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.536 ' NZ ' ' CG2' ' A' ' 41' ' ' VAL . 37.0 tttm -52.9 -14.06 0.52 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -1.151 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tp -49.45 -65.47 0.56 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.445 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -50.52 -46.28 57.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.198 -0.939 . . . . 0.0 109.444 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -52.19 -16.9 0.91 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.906 . . . . 0.0 109.515 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.536 ' CG2' ' NZ ' ' A' ' 37' ' ' LYS . 92.0 t -102.55 -60.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.522 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.5 t -73.06 124.18 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.28 -0.887 . . . . 0.0 109.575 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -99.17 -29.36 12.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.383 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.6 mt -119.49 117.46 28.49 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.411 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -87.77 76.76 8.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.558 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.653 ' OE2' ' CE2' ' A' ' 48' ' ' PHE . 15.6 tt0 -161.75 138.31 8.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.925 . . . . 0.0 109.433 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.12 116.19 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.21 -0.932 . . . . 0.0 109.541 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.653 ' CE2' ' OE2' ' A' ' 46' ' ' GLU . 34.6 m-85 -99.21 148.34 24.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -0.902 . . . . 0.0 109.436 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.466 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.5 OUTLIER -147.94 154.54 43.51 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.454 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.6 151.34 52.43 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.822 2.348 . . . . 0.0 112.203 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.426 ' C ' ' N ' ' A' ' 53' ' ' GLY . 37.5 mt-30 -132.75 -85.0 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -50.41 -15.54 0.26 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.28 -0.888 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' N ' ' C ' ' A' ' 51' ' ' GLN . . . 80.45 171.11 43.11 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 52.23 64.35 1.89 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -1.149 . . . . 0.0 109.489 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.56 -96.31 0.54 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 46.46 42.96 11.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.213 -1.169 . . . . 0.0 109.529 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -165.7 -17.32 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 60' ' ' LEU . . . -105.37 -165.1 23.7 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -73.62 11.94 0.73 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.165 -1.197 . . . . 0.0 109.432 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 58' ' ' GLY . 15.3 mt 56.01 -177.17 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -103.63 -173.82 25.84 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.88 157.1 28.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.201 -1.176 . . . . 0.0 109.494 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.466 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -105.98 -174.54 2.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.893 . . . . 0.0 109.488 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' N ' ' A' ' 66' ' ' ALA . 27.1 t -134.01 153.15 51.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.436 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' SER . 17.1 mmtm -43.47 -23.21 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -77.48 -50.55 12.41 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -56.34 -43.69 79.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.0 t -71.94 -21.46 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.2 -0.938 . . . . 0.0 109.393 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 73' ' ' GLY . 9.4 mt-10 -82.94 -60.29 2.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.455 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.3 t-20 -41.08 -31.58 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.868 . . . . 0.0 109.544 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 69' ' ' GLU . 12.6 mm-40 -82.06 -77.83 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.438 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.55 ' CE2' HG13 ' A' ' 81' ' ' VAL . 76.5 m-85 -72.31 -48.93 38.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.236 -0.915 . . . . 0.0 109.439 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 110.52 150.02 12.3 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.426 ' HG2' ' H ' ' A' ' 75' ' ' GLY . 4.5 ttpp -64.91 162.18 16.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.244 -1.151 . . . . 0.0 109.462 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 74' ' ' LYS . . . 116.88 -19.88 11.97 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -117.37 177.58 4.69 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.225 -1.162 . . . . 0.0 109.453 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -111.52 -177.25 3.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.258 -0.901 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 78' ' ' ILE . 10.3 tp -74.38 -21.72 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -0.905 . . . . 0.0 109.423 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -75.85 -51.94 11.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.416 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -63.36 -33.19 75.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.55 HG13 ' CE2' ' A' ' 72' ' ' PHE . 2.9 t -65.65 -58.08 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.495 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.5 mt -49.24 -25.64 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.477 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.42 ' O ' ' C ' ' A' ' 84' ' ' LEU . 50.3 t0 -65.97 -62.27 1.59 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 83' ' ' ASP . 79.7 mt -44.04 -32.61 1.22 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.412 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.9 mt -68.05 -49.8 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.281 -0.887 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.47 -11.41 52.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.464 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 24.7 ttt180 -77.71 -26.45 50.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.296 -0.878 . . . . 0.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.672 HD22 ' NZ ' ' A' ' 90' ' ' LYS . 1.4 m120 -102.77 -67.53 0.87 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 65.1 125.46 0.01 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.672 ' NZ ' HD22 ' A' ' 88' ' ' ASN . 25.7 mttm -141.68 49.16 1.35 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.233 -1.157 . . . . 0.0 109.488 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 31.0 Cg_endo -67.44 9.99 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.764 2.309 . . . . 0.0 112.143 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.52 ' O ' ' O ' ' A' ' 93' ' ' SER . 31.3 m-20 -86.28 131.21 34.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.52 ' O ' ' O ' ' A' ' 92' ' ' ASN . 12.0 p 59.04 140.58 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 0.0 109.416 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.473 HG22 ' H ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -132.19 178.45 6.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.0 109.427 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.473 ' H ' HG22 ' A' ' 94' ' ' THR . 0.2 OUTLIER -104.09 52.54 0.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.247 -0.908 . . . . 0.0 109.466 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 26.7 p -119.94 -150.94 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 28.6 t -83.38 -140.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.904 . . . . 0.0 109.505 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.0 pp -107.45 156.7 18.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -145.22 -20.12 0.49 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.894 . . . . 0.0 109.494 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.494 ' O ' ' O ' ' A' ' 101' ' ' LYS . 1.2 m 63.8 118.69 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -0.858 . . . . 0.0 109.463 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' THR . 5.1 mttt -42.92 167.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.273 -0.892 . . . . 0.0 109.454 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.06 176.76 18.23 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.53 ' C ' HD22 ' A' ' 104' ' ' ASN . . . -100.71 51.53 0.98 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.606 ' O ' ' N ' ' A' ' 106' ' ' GLY . 1.3 m120 -112.17 82.89 1.71 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -1.177 . . . . 0.0 109.46 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 104' ' ' ASN . . . -43.81 90.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.486 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.606 ' N ' ' O ' ' A' ' 104' ' ' ASN . . . 84.09 -163.9 40.06 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.87 76.87 1.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -1.151 . . . . 0.0 109.454 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -105.67 118.11 35.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.487 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 54.24 -161.25 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.564 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -91.49 -62.29 1.46 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.301 -0.874 . . . . 0.0 109.503 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.508 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.526 ' O ' ' O ' ' A' ' 2' ' ' SER . 24.5 mtt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.322 0.582 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 1' ' ' MET . 70.9 m -39.66 -93.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.181 -0.95 . . . . 0.0 109.414 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.77 167.69 2.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.42 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 m -140.3 176.49 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.03 164.9 12.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.345 -0.847 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 ttmt -131.35 144.96 51.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 0.0 109.497 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -114.43 146.59 40.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.0 109.417 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 9.6 m-85 -112.21 155.27 24.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.422 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 85' ' ' ILE . 61.7 t80 -143.32 94.91 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.7 tttt -67.0 98.59 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.189 -0.944 . . . . 0.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 12' ' ' GLU . . . -73.88 173.25 50.39 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.55 ' O ' ' ND2' ' A' ' 13' ' ' ASN . 3.3 tp10 -41.96 -42.8 2.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -1.122 . . . . 0.0 109.477 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' ' 12' ' ' GLU . 7.0 m120 -144.4 -37.51 0.31 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.283 -0.886 . . . . 0.0 109.478 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.7 m -87.46 142.22 28.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.869 . . . . 0.0 109.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -101.26 130.69 47.44 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.227 -0.921 . . . . 0.0 109.49 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.436 HD22 HG11 ' A' ' 47' ' ' VAL . 8.2 mt -118.32 138.93 52.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.301 -0.874 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 39.1 mt -120.21 146.1 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.6 m -130.49 165.01 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.306 -0.871 . . . . 0.0 109.528 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -92.09 166.23 12.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 0.0 109.523 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.42 151.37 22.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.261 -0.9 . . . . 0.0 109.465 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 -72.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.496 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.724 ' O ' HG23 ' A' ' 26' ' ' VAL . 19.4 t -140.22 156.88 46.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.294 -0.879 . . . . 0.0 109.452 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.98 -51.58 53.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.532 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -45.2 -54.55 6.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 25' ' ' LEU . 56.5 mt -57.49 -31.53 66.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 22' ' ' SER . 87.3 t -71.74 -70.59 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.912 . . . . 0.0 109.532 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -40.97 -20.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.606 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -82.67 -49.08 10.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.232 -0.917 . . . . 0.0 109.484 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.665 ' O ' ' N ' ' A' ' 32' ' ' ASN . 40.4 t80 -52.06 -50.57 61.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.46 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' A' ' 29' ' ' TYR . 6.9 mt -40.78 -42.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -0.92 . . . . 0.0 109.459 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -77.88 -13.92 59.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.464 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.665 ' N ' ' O ' ' A' ' 29' ' ' TYR . 10.7 m120 -129.35 73.39 81.67 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.273 -0.892 . . . . 0.0 109.415 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -74.34 125.31 9.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.746 2.298 . . . . 0.0 112.232 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 172.61 145.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.402 HG22 ' O ' ' A' ' 35' ' ' ILE . 45.8 mm -73.5 61.69 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.452 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.99 -47.72 0.03 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -87.52 -28.17 22.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -1.154 . . . . 0.0 109.449 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.8 tp -54.38 -24.73 20.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.413 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.7 p -72.86 -31.62 64.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.425 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -79.26 -26.03 42.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 109.451 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 11.6 t -82.93 -64.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.471 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 62.6 t -71.94 128.27 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.164 -0.96 . . . . 0.0 109.443 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -78.85 -50.82 10.61 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.912 . . . . 0.0 109.441 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 4.5 mp -111.13 147.77 34.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 109.516 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -104.67 88.24 2.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.397 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -168.72 -173.53 1.9 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.451 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.436 HG11 HD22 ' A' ' 16' ' ' LEU . 38.9 t -131.49 126.48 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.98 150.74 36.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.3 OUTLIER -148.12 165.31 18.7 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 0.0 109.554 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -71.4 149.43 56.54 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.851 2.368 . . . . 0.0 112.262 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -139.81 -49.59 0.48 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.263 -0.898 . . . . 0.0 109.441 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.606 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 3.2 p30 -126.28 167.16 15.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.68 177.74 32.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 54' ' ' ARG . 1.5 mtt-85 -68.01 -38.2 82.32 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.33 -1.1 . . . . 0.0 109.53 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.665 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . 127.81 155.96 8.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . 73.08 149.01 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -1.149 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.8 tp10 38.75 21.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . -122.7 175.5 16.48 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 49.2 mp0 -58.37 170.06 0.78 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -1.175 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.437 HD23 ' HA ' ' A' ' 60' ' ' LEU . 25.1 mt -142.53 -177.38 5.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.226 -0.921 . . . . 0.0 109.439 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -166.09 143.22 8.22 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.67 151.24 47.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -1.187 . . . . 0.0 109.482 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HB2' HG21 ' A' ' 49' ' ' THR . . . -94.59 -171.55 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 66.4 m -118.62 164.72 14.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.907 . . . . 0.0 109.49 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -64.27 -32.75 74.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.51 -44.3 68.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.431 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.409 ' HA ' HD22 ' A' ' 70' ' ' ASN . 26.6 mt-30 -72.13 -60.22 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.299 -0.876 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.9 t -46.32 -26.15 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -70.68 -39.13 73.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.52 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.409 HD22 ' HA ' ' A' ' 67' ' ' GLN . 80.5 m-20 -60.09 -21.5 61.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' A' ' 72' ' ' PHE . 10.0 mp0 -96.76 -67.01 0.87 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.722 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -161.53 76.6 0.52 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.409 ' C ' ' CG ' ' A' ' 74' ' ' LYS . . . -127.74 -129.01 3.17 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' CG ' ' C ' ' A' ' 73' ' ' GLY . 9.3 mttt 68.04 -75.07 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.197 -1.178 . . . . 0.0 109.474 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 73' ' ' GLY . . . -123.4 30.69 4.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -118.22 100.47 7.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.171 -1.193 . . . . 0.0 109.52 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -50.47 163.28 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.386 -0.821 . . . . 0.0 109.537 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 tp -54.75 -29.4 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.872 . . . . 0.0 109.463 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -57.13 -60.7 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 83' ' ' ASP . 21.0 mt-10 -55.06 -55.12 34.58 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.299 -0.876 . . . . 0.0 109.533 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.504 ' C ' ' O ' ' A' ' 80' ' ' GLU . 9.4 t -38.33 -50.47 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.172 -0.955 . . . . 0.0 109.429 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.479 ' HA ' HD12 ' A' ' 85' ' ' ILE . 37.3 mt -61.95 -37.72 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.898 . . . . 0.0 109.475 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.624 ' OD2' ' NH2' ' A' ' 87' ' ' ARG . 9.0 t0 -65.93 -65.14 0.71 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 109.456 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 83' ' ' ASP . 85.7 mt -38.17 -30.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.582 HG23 ' HB2' ' A' ' 9' ' ' TYR . 41.4 mt -73.92 -68.41 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.243 -0.911 . . . . 0.0 109.414 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.1 mt -46.55 -12.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.402 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.734 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -75.66 -43.45 47.47 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.464 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.582 ' ND2' ' C ' ' A' ' 88' ' ' ASN . 0.6 OUTLIER -149.93 66.44 0.98 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.15 -113.7 0.03 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 ptpt -67.85 154.86 92.88 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.208 -1.172 . . . . 0.0 109.531 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.03 32.33 0.3 Allowed 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.805 2.337 . . . . 0.0 112.162 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.468 ' C ' ' OG ' ' A' ' 93' ' ' SER . 5.1 t30 -60.48 -15.61 28.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.252 -0.905 . . . . 0.0 109.495 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.468 ' OG ' ' C ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER 167.7 145.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.496 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 32.6 p -94.21 -176.79 4.08 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 109.457 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.75 65.36 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.214 -0.929 . . . . 0.0 109.479 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.14 130.12 34.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.281 -0.887 . . . . 0.0 109.464 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.1 p -68.33 108.96 3.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.176 -0.953 . . . . 0.0 109.478 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 99' ' ' LYS . 9.2 mt -122.7 106.7 11.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.89 . . . . 0.0 109.442 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' THR . 5.7 mttt 45.09 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 99' ' ' LYS . 0.2 OUTLIER 50.04 179.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -86.91 -9.12 56.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 157.38 175.05 27.86 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 123.2 68.83 0.23 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.52 ' ND2' ' N ' ' A' ' 104' ' ' ASN . 1.0 OUTLIER -91.34 82.7 5.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -1.161 . . . . 0.0 109.466 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -117.1 171.6 7.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.179 -0.95 . . . . 0.0 109.488 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.432 ' O ' ' C ' ' A' ' 107' ' ' THR . . . -82.92 76.11 2.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 106' ' ' GLY . 27.3 p 41.74 -130.81 0.5 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.137 -1.214 . . . . 0.0 109.421 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.403 ' N ' ' OG1' ' A' ' 107' ' ' THR . 40.1 mttt 49.32 40.02 17.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -141.94 95.18 2.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.287 -0.883 . . . . 0.0 109.401 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.491 ' C ' ' O ' ' A' ' 109' ' ' ALA . 73.4 m-85 -39.64 110.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.445 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.452 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 78.1 m-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.515 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mmm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.275 0.56 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -36.24 65.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.905 . . . . 0.0 109.47 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.8 t -142.84 140.84 31.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.414 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 4' ' ' VAL . 15.2 m -67.02 -177.4 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.4 m -113.89 141.25 47.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.495 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -110.58 136.85 49.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.544 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.724 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 1.7 m-85 -103.69 110.5 22.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.312 -0.868 . . . . 0.0 109.501 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -81.32 162.57 23.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.33 -0.856 . . . . 0.0 109.51 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.408 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 57.9 t80 -161.23 137.7 8.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.24 -0.913 . . . . 0.0 109.506 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -101.79 108.2 19.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.426 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.55 -154.9 0.22 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.04 -39.6 92.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.216 -1.167 . . . . 0.0 109.457 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -146.69 -36.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.3 -0.875 . . . . 0.0 109.499 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -83.78 169.16 15.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.261 -0.9 . . . . 0.0 109.482 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 9' ' ' TYR . 43.2 t0 -115.3 137.02 52.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.229 -0.92 . . . . 0.0 109.458 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 51.4 mt -122.9 153.49 39.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.9 mt -131.4 143.06 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.385 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 m -133.16 152.57 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.293 -0.879 . . . . 0.0 109.495 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -90.06 152.97 20.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.394 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.13 -171.59 2.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.39 -68.27 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.922 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.571 ' O ' HG23 ' A' ' 26' ' ' VAL . 15.7 t -153.52 135.8 14.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -0.934 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 22' ' ' SER . 5.4 tt0 -40.0 -28.98 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.888 . . . . 0.0 109.539 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 22' ' ' SER . 23.8 tt0 -62.58 -76.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.19 -0.943 . . . . 0.0 109.525 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.423 ' C ' ' O ' ' A' ' 24' ' ' GLU . 11.2 mt -44.11 -35.53 2.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.724 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 21.9 t -62.11 -57.3 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.24 -0.912 . . . . 0.0 109.496 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -51.38 -52.25 47.41 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -48.52 -41.03 28.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.469 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -65.19 -59.32 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.164 -0.96 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' H ' ' HG ' ' A' ' 30' ' ' LEU . 42.9 mt -53.6 -27.86 29.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.286 -0.884 . . . . 0.0 109.514 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -23.61 61.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.573 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 32' ' ' ASN . 0.6 OUTLIER -160.09 77.49 2.73 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -51.69 118.75 4.73 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.817 2.344 . . . . 0.0 112.164 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 p -156.55 139.12 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.8 tp -62.04 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.904 . . . . 0.0 109.508 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.43 -80.11 0.26 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.38 -16.74 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -1.178 . . . . 0.0 109.441 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.0 tp -60.12 -47.46 85.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.3 m -57.6 -27.9 63.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.8 -33.78 45.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.287 -0.883 . . . . 0.0 109.39 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.8 -61.16 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.537 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.814 HG21 HG21 ' A' ' 82' ' ' ILE . 89.5 t -79.66 134.95 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -96.3 -52.24 4.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.233 -0.917 . . . . 0.0 109.458 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.97 134.94 46.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -93.92 59.81 2.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' O ' ' CE2' ' A' ' 48' ' ' PHE . 16.9 tt0 -140.59 123.44 16.37 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.203 -0.936 . . . . 0.0 109.455 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.5 139.06 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.208 -0.932 . . . . 0.0 109.443 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.524 ' C ' HG22 ' A' ' 49' ' ' THR . 20.5 m-85 -117.66 174.82 5.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.63 ' O ' ' N ' ' A' ' 61' ' ' GLY . 0.5 OUTLIER -168.36 155.73 7.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.465 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.44 80.37 0.8 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.86 2.373 . . . . 0.0 112.189 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -125.36 -31.42 3.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -114.0 -139.4 0.38 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -157.87 87.78 0.12 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -161.94 45.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.228 -1.16 . . . . 0.0 109.532 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.663 ' O ' ' HB3' ' A' ' 56' ' ' ALA . . . 146.75 162.5 9.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . 74.54 -171.21 0.11 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -1.167 . . . . 0.0 109.478 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.62 ' OE2' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -48.22 -16.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.473 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 139.83 2.32 1.69 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -132.13 110.67 10.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.229 -1.159 . . . . 0.0 109.481 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 tt -148.17 152.99 38.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.463 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 49' ' ' THR . . . -163.58 -156.2 8.59 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.7 117.07 21.25 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -1.14 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.43 173.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.309 -0.869 . . . . 0.0 109.458 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -127.91 148.43 50.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' O ' ' CD ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -46.47 -26.84 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.417 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -49.13 34.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.24 -0.913 . . . . 0.0 109.523 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -62.31 -50.29 72.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.51 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 27.7 t -60.21 -20.96 21.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.92 . . . . 0.0 109.488 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' CD ' ' O ' ' A' ' 65' ' ' LYS . 14.2 mt-10 -76.91 -25.27 52.76 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.221 -0.925 . . . . 0.0 109.542 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -79.18 -22.21 45.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.182 -0.949 . . . . 0.0 109.405 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -98.23 -54.7 2.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.453 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.719 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -167.94 70.21 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 0.0 109.468 -179.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.44 138.05 6.97 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -166.97 -27.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -1.137 . . . . 0.0 109.476 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.85 31.31 0.02 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.7 mttt -103.69 177.57 4.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -1.177 . . . . 0.0 109.395 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' ILE . 16.3 mttm -83.95 133.86 34.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.465 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 5.3 tp -40.54 -32.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' LYS . 60.8 mt-10 -54.71 -56.16 22.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -0.875 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 83' ' ' ASP . 1.7 tp10 -48.63 -62.64 1.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.479 ' C ' ' O ' ' A' ' 80' ' ' GLU . 65.8 t -39.66 -58.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 109.421 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.814 HG21 HG21 ' A' ' 42' ' ' VAL . 96.7 mt -50.32 -20.35 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.486 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.611 ' N ' ' O ' ' A' ' 80' ' ' GLU . 1.2 t70 -76.47 -69.17 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.527 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' A' ' 83' ' ' ASP . 7.7 mt -38.55 -26.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.571 ' N ' ' O ' ' A' ' 83' ' ' ASP . 2.6 mt -74.58 -70.93 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.447 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.571 ' N ' HG22 ' A' ' 85' ' ' ILE . 8.2 mt -42.16 -38.26 1.67 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.469 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.731 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -43.79 -26.1 0.23 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.442 -179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 86' ' ' LEU . 9.5 t-20 -107.78 -70.85 0.78 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.506 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 70.18 123.59 0.04 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.546 ' O ' ' O ' ' A' ' 91' ' ' PRO . 17.7 mtpp -134.24 74.14 67.96 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.155 -1.203 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' O ' ' O ' ' A' ' 90' ' ' LYS . 52.8 Cg_exo -50.69 -145.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.782 2.321 . . . . 0.0 112.179 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -142.75 154.45 44.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.524 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' A' ' 94' ' ' THR . 0.1 OUTLIER -64.56 -179.3 0.47 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.535 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.528 ' N ' ' OG ' ' A' ' 93' ' ' SER . 19.1 p -101.38 96.1 6.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 97' ' ' SER . 0.2 OUTLIER -127.52 74.18 1.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.464 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.529 ' O ' ' OG ' ' A' ' 96' ' ' SER . 3.5 p -64.17 59.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.601 ' N ' ' O ' ' A' ' 95' ' ' THR . 3.7 m -108.73 55.69 0.63 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.545 HD12 ' C ' ' A' ' 97' ' ' SER . 7.9 mp -120.2 126.4 50.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.83 115.37 5.54 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.474 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.4 p -130.87 156.73 44.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -52.75 149.34 6.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.415 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 103' ' ' GLY . . . -77.94 -105.28 0.18 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.535 ' O ' ' O ' ' A' ' 102' ' ' GLY . . . 52.52 110.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -121.25 98.64 6.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.443 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -131.37 -166.26 1.68 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 161.92 22.87 0.02 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 107' ' ' THR . 15.1 t -165.09 132.97 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.448 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.7 mttm 53.79 67.86 0.94 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.27 -0.894 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -128.05 -176.98 3.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.238 -0.914 . . . . 0.0 109.44 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.465 ' CG ' ' O ' ' A' ' 110' ' ' TYR . 64.9 t80 57.76 17.94 4.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.446 -179.95 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ttm . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.17 120.89 8.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.903 . . . . 0.0 109.489 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 21' ' ' ALA . 1.4 p -88.62 86.3 6.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.259 -0.9 . . . . 0.0 109.492 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -66.84 166.08 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.17 -0.957 . . . . 0.0 109.449 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 m -158.64 150.47 21.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.209 -0.932 . . . . 0.0 109.535 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -111.95 123.72 50.85 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.12 123.55 37.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.5 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -91.11 140.93 29.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.457 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -144.34 104.5 4.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.234 -0.916 . . . . 0.0 109.492 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -81.97 124.73 30.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.255 -0.903 . . . . 0.0 109.427 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.85 -153.12 28.86 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -52.98 -70.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.225 -1.162 . . . . 0.0 109.558 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -125.31 -21.02 4.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.558 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -92.37 161.26 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -121.73 144.95 48.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.2 mt -137.95 148.6 45.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.175 -0.953 . . . . 0.0 109.495 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 26.1 mt -120.64 153.78 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.0 173.63 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.233 -0.917 . . . . 0.0 109.424 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -109.84 154.03 23.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.392 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 21' ' ' ALA . . . -154.05 128.24 9.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.268 -0.895 . . . . 0.0 109.507 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 20' ' ' ALA . . . -47.37 -95.16 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.888 . . . . 0.0 109.503 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.35 165.97 12.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -73.99 -28.17 61.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.33 -0.856 . . . . 0.0 109.506 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.33 -56.72 17.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.4 mt -57.02 -51.48 69.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.396 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -46.44 -45.89 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.347 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' C ' ' OD1' ' A' ' 27' ' ' ASP . 1.6 t70 -62.66 -43.58 98.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 0.0 109.346 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 37' ' ' LYS . 6.4 mt-10 -60.94 -27.87 68.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 0.0 109.33 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -70.38 -36.56 74.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.895 . . . . 0.0 109.456 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.6 mt -62.86 -48.83 77.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.36 -25.21 50.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.423 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.448 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 1.1 t-20 -136.21 68.16 62.19 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.446 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.91 154.23 53.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.849 2.366 . . . . 0.0 112.264 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.35 173.35 0.83 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.331 -0.855 . . . . 0.0 109.499 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.4 tp -88.24 -31.9 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.266 -0.896 . . . . 0.0 109.461 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -73.96 -14.38 80.26 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.48 ' O ' HG23 ' A' ' 41' ' ' VAL . 67.5 tttt -101.93 -12.4 18.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -1.122 . . . . 0.0 109.396 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.57 -48.75 53.75 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.479 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.512 ' O ' ' O ' ' A' ' 42' ' ' VAL . 3.1 m -49.23 -45.37 44.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -61.54 -56.96 14.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.502 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 37' ' ' LYS . 55.5 t -50.21 -59.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.499 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 82' ' ' ILE . 2.7 t -78.27 126.89 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.31 -0.869 . . . . 0.0 109.533 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -97.33 -0.51 46.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.421 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' H ' HG12 ' A' ' 42' ' ' VAL . 12.1 tp -163.72 122.16 1.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.414 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -77.15 83.69 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.501 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -163.12 155.12 17.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.897 . . . . 0.0 109.533 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.8 t -123.29 132.94 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.417 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -118.86 154.7 32.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.271 -0.893 . . . . 0.0 109.442 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.1 164.56 24.42 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 109.477 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.85 164.53 35.31 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.849 2.366 . . . . 0.0 112.244 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.5 ' O ' ' C ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -112.74 173.04 6.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 51' ' ' GLN . 18.1 t0 37.03 -99.68 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.892 . . . . 0.0 109.472 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.528 ' O ' ' C ' ' A' ' 54' ' ' ARG . . . -148.73 -126.97 1.58 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.644 ' H ' ' CD ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -37.0 107.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -1.143 . . . . 0.0 109.436 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.94 136.45 3.02 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -169.7 79.28 0.11 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -1.127 . . . . 0.0 109.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -144.69 -131.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.213 -0.929 . . . . 0.0 109.451 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -81.87 -26.28 50.07 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -86.09 102.99 14.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.297 -1.119 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 mt -115.66 -170.17 1.73 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.484 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -136.41 159.37 24.4 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -99.75 156.26 17.19 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.178 -1.19 . . . . 0.0 109.422 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.55 171.6 7.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.236 -0.915 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.451 ' O ' ' C ' ' A' ' 65' ' ' LYS . 76.7 p -121.89 150.52 41.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.512 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 64' ' ' SER . 7.8 pttt -41.92 -30.46 0.27 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' O ' ' C ' ' A' ' 67' ' ' GLN . . . -73.65 -58.53 3.24 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.244 -0.91 . . . . 0.0 109.563 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.503 ' C ' ' O ' ' A' ' 66' ' ' ALA . 0.0 OUTLIER -38.16 -49.05 1.31 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 109.505 179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.4 t -69.31 -51.87 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.639 ' O ' ' N ' ' A' ' 73' ' ' GLY . 31.1 tt0 -49.33 -29.01 5.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 109.399 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -69.94 -19.21 63.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -98.92 -27.02 14.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.408 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.589 ' CE2' HG13 ' A' ' 81' ' ' VAL . 84.3 m-85 -113.14 -11.0 13.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.913 . . . . 0.0 109.488 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 62.14 0.31 2.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 72' ' ' PHE . 6.4 mtpp -139.09 -49.37 0.5 Allowed 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.495 -1.003 . . . . 0.0 109.537 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 81' ' ' VAL . . . 78.74 -61.7 3.98 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.4 mtmt 49.49 -168.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.52 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.3 mttp -56.59 133.18 53.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.269 -0.894 . . . . 0.0 109.504 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.3 tp -55.36 -26.46 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.295 -0.878 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -56.44 -41.91 77.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 81' ' ' VAL . 35.5 mt-10 -73.42 -58.62 3.18 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.939 . . . . 0.0 109.473 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 72' ' ' PHE . 2.9 t -42.48 -38.13 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.397 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.515 HG21 HG21 ' A' ' 42' ' ' VAL . 61.2 mt -63.68 -46.04 95.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.897 . . . . 0.0 109.422 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.493 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 35.7 t0 -60.58 -52.29 65.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.367 -0.833 . . . . 0.0 109.501 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 83' ' ' ASP . 10.6 mt -45.29 -41.85 9.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.403 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 27.7 mt -65.87 -40.25 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 88' ' ' ASN . 82.2 mt -60.24 -42.72 95.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -44.95 -20.24 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 0.0 109.43 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.494 ' N ' ' O ' ' A' ' 86' ' ' LEU . 10.5 m120 -124.51 -81.98 0.64 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 75.15 124.74 0.15 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.497 ' C ' ' O ' ' A' ' 89' ' ' GLY . 5.2 mmmt 38.77 58.51 5.6 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.217 -1.167 . . . . 0.0 109.373 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' C ' ' N ' ' A' ' 93' ' ' SER . 34.8 Cg_endo -68.35 -48.58 1.15 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.825 2.35 . . . . 0.0 112.3 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 8.7 m120 50.18 14.27 0.14 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.184 -0.948 . . . . 0.0 109.375 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.446 ' N ' ' C ' ' A' ' 91' ' ' PRO . 0.8 OUTLIER -94.78 20.41 8.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.308 -0.87 . . . . 0.0 109.498 179.993 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.1 p -96.6 154.63 17.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -0.915 . . . . 0.0 109.446 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -146.28 -169.83 3.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.481 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -142.5 9.64 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.307 -0.871 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -140.61 111.08 6.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.216 -0.928 . . . . 0.0 109.493 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.07 100.54 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.9 mmtt -123.44 108.79 13.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.445 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 79.1 p -112.74 174.34 5.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.444 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.61 ' O ' ' N ' ' A' ' 103' ' ' GLY . 8.9 mmtm -81.7 76.33 8.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.213 -0.929 . . . . 0.0 109.534 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -64.8 50.85 0.1 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 101' ' ' LYS . . . -108.44 16.19 34.92 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.41 ' OD1' ' N ' ' A' ' 104' ' ' ASN . 16.7 p-10 -115.53 97.32 6.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -1.168 . . . . 0.0 109.507 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.83 100.62 11.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.158 -0.964 . . . . 0.0 109.485 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.53 158.67 14.15 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.05 96.6 6.77 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -1.14 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.83 -52.66 39.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.212 -0.93 . . . . 0.0 109.424 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.4 155.72 36.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.211 -0.931 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.492 ' C ' HD22 ' A' ' 111' ' ' ASN . 1.8 m-85 -56.76 -40.38 75.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 109.496 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.773 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.521 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -166.09 179.71 5.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 0.0 109.42 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.593 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -176.61 -171.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.449 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.593 ' N ' ' OG1' ' A' ' 3' ' ' THR . 1.6 m -127.07 147.08 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -92.62 161.47 14.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.484 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -113.1 122.65 48.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.46 ' CE1' HG11 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -92.63 104.61 16.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.18 137.57 47.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.245 -0.91 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -140.13 105.91 5.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 109.475 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -75.95 114.43 14.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.313 -0.867 . . . . 0.0 109.545 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 13' ' ' ASN . . . -75.44 170.89 54.39 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -46.65 -17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -1.177 . . . . 0.0 109.389 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 24.9 t-20 -168.93 -36.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.263 -0.898 . . . . 0.0 109.485 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.74 118.65 29.5 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.501 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.12 132.75 49.97 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.18 -0.95 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 61.5 mt -129.18 142.53 50.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.422 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.37 142.37 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.4 m -123.5 175.13 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.513 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -105.75 160.84 14.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.505 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -161.46 164.57 29.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.51 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.82 -76.89 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -144.1 152.03 40.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.17 -38.29 85.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -50.82 -61.32 2.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.225 -0.922 . . . . 0.0 109.491 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.639 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.3 mt -58.64 -63.58 1.23 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' C ' ' O ' ' A' ' 25' ' ' LEU . 90.6 t -35.53 -35.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 109.447 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 25' ' ' LEU . 19.6 t0 -77.3 -35.02 55.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 109.368 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.639 ' N ' ' O ' ' A' ' 25' ' ' LEU . 4.8 pt-20 -64.9 -28.2 69.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.41 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.416 ' N ' ' HG2' ' A' ' 28' ' ' GLU . 48.0 t80 -74.67 -50.23 18.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.259 -0.901 . . . . 0.0 109.41 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.7 mt -46.62 -23.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tptm -74.07 -45.36 49.81 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.457 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -123.95 78.02 58.27 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.0 109.426 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.514 ' O ' ' CB ' ' A' ' 34' ' ' SER . 56.4 Cg_exo -47.17 156.87 0.74 Allowed 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.792 2.328 . . . . 0.0 112.204 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 33' ' ' PRO . 0.9 OUTLIER 162.39 146.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.92 . . . . 0.0 109.466 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 35' ' ' ILE . 22.0 mm -88.52 20.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.466 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -111.29 -45.39 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.621 ' HZ3' ' HG3' ' A' ' 28' ' ' GLU . 24.6 tttt -73.76 -11.29 60.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 109.435 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tp -69.25 -27.43 65.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.47 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.1 t -67.21 -18.27 65.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -89.21 -41.21 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 t -77.86 -66.13 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.1 t -70.24 113.64 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 109.549 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -75.63 -60.76 2.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.452 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.18 150.89 21.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -103.6 52.45 0.77 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.458 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -137.16 159.76 40.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 0.0 109.434 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -115.47 144.41 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -0.949 . . . . 0.0 109.485 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 14.0 m-85 -118.91 154.23 33.3 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.462 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.433 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -144.75 156.71 55.86 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.33 -0.856 . . . . 0.0 109.425 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -70.82 135.39 27.84 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.81 2.34 . . . . 0.0 112.175 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -60.67 -26.41 67.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -117.93 -116.8 0.32 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.235 -0.915 . . . . 0.0 109.487 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.66 -24.31 0.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.736 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -129.92 97.66 4.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -1.134 . . . . 0.0 109.478 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.14 119.61 0.8 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.41 0.98 12.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -1.111 . . . . 0.0 109.481 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -117.97 146.14 44.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.896 . . . . 0.0 109.418 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.47 -157.4 16.32 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -100.64 171.52 7.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.327 -1.102 . . . . 0.0 109.515 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.4 mt -118.61 172.81 7.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.165 -0.96 . . . . 0.0 109.498 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -104.28 -170.26 24.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.2 115.68 20.8 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -1.128 . . . . 0.0 109.467 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -53.78 154.99 3.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.294 -0.879 . . . . 0.0 109.503 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.615 ' O ' ' N ' ' A' ' 66' ' ' ALA . 4.7 m -98.09 147.85 24.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.535 ' O ' ' OE1' ' A' ' 69' ' ' GLU . 4.5 pttp -43.79 -15.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.93 . . . . 0.0 109.469 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.615 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -83.81 -48.29 10.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.458 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.603 ' C ' ' NE2' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -54.86 -43.68 73.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.332 -0.855 . . . . 0.0 109.564 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 71.6 t -69.22 -41.52 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.313 -0.867 . . . . 0.0 109.454 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 28.1 mt-10 -64.01 -40.22 95.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.239 -0.913 . . . . 0.0 109.489 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -58.4 -40.17 81.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.462 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -73.26 -67.68 0.56 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -90.91 -75.88 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.474 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.05 166.68 11.01 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -82.2 -2.55 52.71 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.288 -1.125 . . . . 0.0 109.527 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.78 -7.19 20.81 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.2 mttt -133.37 149.14 51.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -1.17 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -67.98 -167.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.877 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.452 HG23 ' N ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -86.53 -37.83 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.892 . . . . 0.0 109.477 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.452 ' N ' HG23 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -61.67 -28.26 69.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 109.491 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.64 -44.47 33.95 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 t -53.35 -46.62 58.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.543 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.583 ' HA ' HD12 ' A' ' 85' ' ' ILE . 1.6 mp -60.67 -40.39 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.313 -0.867 . . . . 0.0 109.497 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -48.35 -53.71 16.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.932 . . . . 0.0 109.482 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.4 mt -58.55 -32.36 68.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.478 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 82' ' ' ILE . 85.8 mt -67.68 -29.19 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.549 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 81.7 mt -82.39 -26.32 32.95 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.319 -0.863 . . . . 0.0 109.557 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -93.2 3.63 55.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.45 ' O ' ' CG ' ' A' ' 88' ' ' ASN . 1.1 t-20 -161.54 57.73 0.27 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.453 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -95.92 -131.04 6.53 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -153.98 62.65 3.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.203 -1.175 . . . . 0.0 109.495 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -73.54 114.23 3.98 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.818 2.345 . . . . 0.0 112.252 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -85.89 -71.5 0.53 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 0.0 109.449 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 92' ' ' ASN . 0.5 OUTLIER 59.56 119.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.488 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.2 p -117.15 114.09 23.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 97' ' ' SER . 78.0 m -163.95 -89.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.243 -0.91 . . . . 0.0 109.541 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.7 t 47.45 25.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.233 -0.917 . . . . 0.0 109.46 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.499 ' H ' HG22 ' A' ' 95' ' ' THR . 70.3 m -94.0 -154.99 0.43 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.454 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.58 171.68 14.73 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.245 -0.909 . . . . 0.0 109.536 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -63.3 112.09 2.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.245 -0.909 . . . . 0.0 109.498 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 100' ' ' THR . 5.1 t -124.36 69.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.441 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -106.06 179.23 4.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.925 . . . . 0.0 109.529 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 163.68 84.99 0.05 OUTLIER Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -84.62 124.25 6.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -117.4 11.65 13.99 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.11 . . . . 0.0 109.446 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -74.17 51.39 0.42 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.222 -0.924 . . . . 0.0 109.427 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.7 123.41 0.07 OUTLIER Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.8 m -96.93 -35.9 10.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.31 -1.112 . . . . 0.0 109.482 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 110' ' ' TYR . 76.5 mttt -132.45 102.16 5.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.862 . . . . 0.0 109.456 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -70.16 51.27 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.506 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' N ' ' O ' ' A' ' 108' ' ' LYS . 1.7 t80 63.43 54.21 2.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.467 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.552 179.948 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.52 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 t 179.18 149.91 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.219 -0.926 . . . . 0.0 109.445 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 3' ' ' THR . 5.0 t -122.61 110.92 16.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.14 -173.59 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.308 -0.87 . . . . 0.0 109.431 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.0 m -149.79 135.47 18.49 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.502 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -99.06 129.07 45.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.921 . . . . 0.0 109.47 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.605 ' O ' HG23 ' A' ' 17' ' ' ILE . 1.3 m-85 -104.13 160.31 14.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -127.95 157.39 40.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.265 -0.897 . . . . 0.0 109.491 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -142.87 129.72 20.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.326 -0.858 . . . . 0.0 109.509 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -105.03 105.79 15.99 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -90.67 -150.58 24.76 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.429 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 15.1 mm-40 -49.67 -51.27 39.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -1.154 . . . . 0.0 109.506 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -148.01 -46.53 0.16 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.302 -0.874 . . . . 0.0 109.447 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -72.54 143.6 48.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.0 109.486 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -106.77 138.07 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.45 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 16' ' ' LEU . 76.1 mt -113.13 157.17 21.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 0.0 109.475 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 7' ' ' TYR . 7.8 mt -130.26 154.32 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.935 . . . . 0.0 109.424 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.627 HG21 HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -137.9 179.91 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.328 -0.857 . . . . 0.0 109.509 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -119.88 153.45 35.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.293 -0.879 . . . . 0.0 109.42 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.51 177.3 11.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -97.51 -46.81 5.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.297 -0.877 . . . . 0.0 109.488 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.65 137.35 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.434 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -49.55 -31.3 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.436 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.85 -67.43 0.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.7 mp -49.06 -48.43 44.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.279 -0.888 . . . . 0.0 109.443 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' A' ' 27' ' ' ASP . 76.3 t -50.8 -66.25 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.331 -0.856 . . . . 0.0 109.439 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.539 ' C ' ' O ' ' A' ' 26' ' ' VAL . 37.6 t70 -36.3 -43.33 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.92 -50.61 70.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.431 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.579 ' O ' ' N ' ' A' ' 32' ' ' ASN . 62.1 t80 -51.3 -49.7 60.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 30' ' ' LEU . 19.9 mt -41.72 -56.29 2.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.455 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 26.0 mtmt -73.9 -3.5 29.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.395 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.579 ' N ' ' O ' ' A' ' 29' ' ' TYR . 8.7 m120 -135.83 69.36 65.21 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.492 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -73.64 131.6 16.24 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.873 2.382 . . . . 0.0 112.219 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 177.25 154.89 0.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.4 mm -85.72 66.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -162.46 -50.85 0.02 OUTLIER Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 7.6 tttm -75.69 -26.02 57.23 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -1.141 . . . . 0.0 109.437 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD13 ' CZ ' ' A' ' 29' ' ' TYR . 2.7 tp -57.9 -33.37 68.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.414 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -36.62 76.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -72.78 -39.24 66.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.245 -0.91 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' A' ' 26' ' ' VAL . 48.7 t -70.76 -69.58 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.67 117.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.476 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.429 ' C ' HD12 ' A' ' 44' ' ' LEU . 95.2 mt-10 -81.76 -40.97 21.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD12 ' C ' ' A' ' 43' ' ' GLU . 9.3 mp -112.27 128.38 56.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 0.0 109.524 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.67 78.29 4.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.281 -0.887 . . . . 0.0 109.427 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -163.73 159.95 22.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.237 -0.914 . . . . 0.0 109.484 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 t -113.08 143.15 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.49 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -128.1 155.22 44.75 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.269 -0.894 . . . . 0.0 109.469 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.488 ' O ' HD23 ' A' ' 60' ' ' LEU . 41.5 p -118.99 149.38 46.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.58 91.87 0.69 Allowed 'Trans proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.75 2.3 . . . . 0.0 112.221 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.73 -159.49 0.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.904 . . . . 0.0 109.507 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 58' ' ' GLY . 53.0 t0 -55.86 125.12 20.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.31 -0.869 . . . . 0.0 109.462 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 160.16 151.24 6.11 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.54 106.59 7.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.488 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 31.74 0.42 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.9 28.72 3.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.318 -1.107 . . . . 0.0 109.473 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.59 101.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 52' ' ' ASP . . . -176.86 90.52 0.08 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 52.6 79.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.277 -1.131 . . . . 0.0 109.537 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.488 HD23 ' O ' ' A' ' 49' ' ' THR . 5.8 mt -78.12 170.21 16.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.9 . . . . 0.0 109.509 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -130.74 108.33 0.82 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -52.34 142.12 17.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.191 -1.182 . . . . 0.0 109.427 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -86.49 142.29 28.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.197 -0.939 . . . . 0.0 109.477 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.623 ' O ' ' N ' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -88.26 148.04 24.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' SER . 24.6 mttt -41.43 -19.0 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -68.2 -61.51 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.536 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -53.23 -34.73 58.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.462 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.18 -31.32 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 0.0 109.473 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 73' ' ' GLY . 20.1 mt-10 -68.91 -63.63 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.457 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 69' ' ' GLU . 20.0 m-20 -39.36 -22.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.245 -0.909 . . . . 0.0 109.435 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 69' ' ' GLU . 0.6 OUTLIER -85.52 -67.71 0.78 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -0.928 . . . . 0.0 109.454 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 71' ' ' GLU . 20.4 m-85 -115.02 25.5 10.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.862 . . . . 0.0 109.506 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.65 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 52.72 -162.12 2.38 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.492 ' C ' ' H ' ' A' ' 76' ' ' LYS . 2.3 tttp -109.94 -149.46 0.44 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.241 -1.152 . . . . 0.0 109.454 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 73.22 -26.14 0.84 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 74' ' ' LYS . 21.4 mttt -91.42 -172.35 3.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -1.171 . . . . 0.0 109.476 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -122.99 157.17 33.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -0.867 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 tp -51.41 -30.74 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.266 -0.896 . . . . 0.0 109.444 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.41 -50.29 66.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 109.413 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -57.69 -52.83 63.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.0 109.483 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.1 t -47.87 -59.08 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.23 -0.919 . . . . 0.0 109.431 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 51.0 mt -54.97 -42.47 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.495 ' C ' ' OD1' ' A' ' 83' ' ' ASP . 28.5 t0 -52.68 -51.02 62.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.245 -0.909 . . . . 0.0 109.501 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.459 ' O ' ' OD1' ' A' ' 88' ' ' ASN . 10.5 mt -60.03 -43.15 95.52 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.235 -0.915 . . . . 0.0 109.555 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.627 HG21 HG21 ' A' ' 18' ' ' VAL . 27.9 mm -47.98 -62.96 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.188 -0.945 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.3 -23.3 22.67 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 0.0 109.504 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 tpp180 -67.02 -36.37 81.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.459 ' OD1' ' O ' ' A' ' 84' ' ' LEU . 0.5 OUTLIER -93.48 -77.98 0.44 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.469 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.58 130.25 1.16 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -123.44 68.67 40.42 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.269 -1.136 . . . . 0.0 109.43 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.463 ' C ' HD22 ' A' ' 92' ' ' ASN . 56.1 Cg_endo -74.95 3.02 5.96 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.86 2.373 . . . . 0.0 112.232 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.463 HD22 ' C ' ' A' ' 91' ' ' PRO . 2.4 m-80 -134.49 131.62 38.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.515 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.1 t -112.24 161.37 16.67 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.529 HG22 ' OG1' ' A' ' 95' ' ' THR . 1.4 m -139.33 144.4 38.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.253 -0.904 . . . . 0.0 109.518 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.578 HG22 ' H ' ' A' ' 96' ' ' SER . 0.2 OUTLIER 44.28 -165.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.176 -0.952 . . . . 0.0 109.417 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.578 ' H ' HG22 ' A' ' 95' ' ' THR . 60.1 p 47.8 94.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.449 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.2 p -149.57 -172.57 4.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 0.0 109.532 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.35 122.17 9.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.234 -0.916 . . . . 0.0 109.526 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -90.37 112.94 24.72 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.63 15.16 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.886 . . . . 0.0 109.504 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -137.43 144.6 42.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -0.9 . . . . 0.0 109.531 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 69.18 134.9 0.07 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ALA . . . 132.73 -26.59 3.61 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.98 61.54 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -1.117 . . . . 0.0 109.545 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' A' ' 103' ' ' GLY . . . -81.4 -60.05 2.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 172.96 -111.14 0.37 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 36.3 p -81.31 14.4 2.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.197 -1.178 . . . . 0.0 109.468 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -125.24 79.89 1.84 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.197 -0.939 . . . . 0.0 109.491 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.515 ' O ' ' CD1' ' A' ' 110' ' ' TYR . . . -145.22 -127.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.935 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.515 ' CD1' ' O ' ' A' ' 109' ' ' ALA . 26.4 m-85 -152.31 148.45 27.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.49 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.446 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.613 ' C ' ' SD ' ' A' ' 1' ' ' MET . 1.3 tmm? . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.552 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -72.58 33.41 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.879 . . . . 0.0 109.404 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 1' ' ' MET . 54.3 p -52.23 -90.67 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.298 -0.876 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.6 m -104.88 161.9 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.222 -0.924 . . . . 0.0 109.475 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -101.67 -173.61 2.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.649 ' NZ ' HG21 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -136.01 133.92 37.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.903 . . . . 0.0 109.426 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -99.14 119.35 37.7 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -82.59 166.24 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -165.31 109.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.918 . . . . 0.0 109.461 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -90.31 103.08 15.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.427 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.58 -157.36 0.79 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.434 ' OE1' ' OD1' ' A' ' 13' ' ' ASN . 3.8 tt0 -48.23 -67.92 0.23 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.146 . . . . 0.0 109.427 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.434 ' OD1' ' OE1' ' A' ' 12' ' ' GLU . 2.9 m120 -128.54 -26.26 2.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 109.447 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -82.12 155.38 25.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 109.487 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -113.45 136.86 52.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.0 mt -132.7 153.44 51.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.304 -0.872 . . . . 0.0 109.474 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.649 HG21 ' NZ ' ' A' ' 6' ' ' LYS . 41.1 mt -134.18 145.21 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.922 . . . . 0.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.0 m -133.24 173.2 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.919 . . . . 0.0 109.469 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -108.72 148.05 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.264 -0.897 . . . . 0.0 109.519 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -134.09 178.58 6.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -0.902 . . . . 0.0 109.446 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -93.03 -55.01 3.5 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.54 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.4 m -172.4 166.63 5.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.217 -0.927 . . . . 0.0 109.575 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -72.02 -21.96 61.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -70.57 -66.61 0.58 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mt -53.81 -49.58 68.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.925 . . . . 0.0 109.502 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.9 t -49.32 -50.37 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.83 -29.4 64.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.883 . . . . 0.0 109.476 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -73.73 -34.69 64.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.444 ' O ' ' N ' ' A' ' 32' ' ' ASN . 54.0 t80 -62.55 -48.06 81.13 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.443 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 29' ' ' TYR . 67.8 mt -43.36 -59.53 2.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.312 -0.867 . . . . 0.0 109.498 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.38 -18.95 65.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.284 -0.885 . . . . 0.0 109.409 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 29' ' ' TYR . 64.5 t30 -121.98 87.44 47.16 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -79.42 54.43 5.18 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.736 2.291 . . . . 0.0 112.279 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -106.13 105.02 14.86 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 109.443 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 34' ' ' SER . 14.6 tt -42.64 -32.22 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.254 -0.903 . . . . 0.0 109.526 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.26 -41.2 78.55 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.1 tttp -73.12 -27.48 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.221 -1.164 . . . . 0.0 109.505 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -52.09 -39.84 60.35 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.436 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 44.0 t -58.22 -21.04 46.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -87.18 -34.73 18.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.289 -0.882 . . . . 0.0 109.468 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.509 HG12 ' N ' ' A' ' 42' ' ' VAL . 9.3 t -75.81 -72.79 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.215 -0.928 . . . . 0.0 109.497 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.509 ' N ' HG12 ' A' ' 41' ' ' VAL . 23.3 t -57.73 118.26 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.933 . . . . 0.0 109.561 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -86.26 -32.78 20.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -0.914 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.4 tp -137.31 114.95 11.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.407 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -71.98 94.22 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.217 -0.927 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -167.4 158.17 11.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.878 . . . . 0.0 109.428 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.1 t -128.81 140.03 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.169 -0.957 . . . . 0.0 109.545 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -119.54 -170.27 1.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.0 109.356 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -176.43 150.12 0.97 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.86 92.55 0.71 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.833 2.355 . . . . 0.0 112.254 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.524 ' C ' ' OD1' ' A' ' 52' ' ' ASP . 1.1 tp-100 -55.51 -45.17 77.13 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' OD1' ' C ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -176.78 164.18 2.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.243 -0.91 . . . . 0.0 109.48 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 130.2 -21.59 4.87 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 59.17 101.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.279 -1.13 . . . . 0.0 109.531 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.91 172.29 12.49 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.11 138.98 37.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -1.156 . . . . 0.0 109.446 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 60.31 89.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' O ' ' CB ' ' A' ' 59' ' ' GLU . . . 165.68 88.22 0.07 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.509 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.1 tp10 75.69 79.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -108.2 178.69 4.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -143.21 -167.45 11.6 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.96 110.21 16.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.181 -1.188 . . . . 0.0 109.47 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -50.8 155.65 1.12 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 m -93.87 155.91 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.202 -0.937 . . . . 0.0 109.486 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -59.03 -16.07 16.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.274 -0.891 . . . . 0.0 109.448 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.57 -39.54 13.21 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -60.26 -46.28 90.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 t -71.74 -42.97 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.509 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.56 -23.34 66.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.448 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -77.85 -26.68 49.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.452 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -77.27 -32.79 55.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.194 -0.941 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.832 ' CE2' HG13 ' A' ' 81' ' ' VAL . 78.5 m-85 -104.41 -61.69 1.42 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.927 . . . . 0.0 109.493 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.63 136.9 2.68 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.2 pttm -64.4 98.48 0.24 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -1.162 . . . . 0.0 109.503 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.05 -6.8 0.12 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -101.63 129.87 47.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.318 -1.107 . . . . 0.0 109.439 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -59.78 -165.91 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.1 tp -91.89 -34.64 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.476 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.46 -35.28 73.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -67.07 -43.69 82.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.472 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.832 HG13 ' CE2' ' A' ' 72' ' ' PHE . 54.8 t -65.55 -60.77 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.412 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.413 ' H ' HG12 ' A' ' 82' ' ' ILE . 5.9 mm -46.04 -32.87 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.506 ' O ' ' C ' ' A' ' 84' ' ' LEU . 19.8 t70 -66.94 -65.14 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.455 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 83' ' ' ASP . 15.5 mt -38.44 -30.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.226 -0.921 . . . . 0.0 109.477 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.503 ' N ' ' O ' ' A' ' 83' ' ' ASP . 90.1 mt -76.95 -50.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.903 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -58.26 -13.93 6.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 109.52 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.6 mtt180 -82.46 -38.08 24.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 89' ' ' GLY . 1.9 t-20 -85.28 -68.07 0.75 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 88' ' ' ASN . . . 59.68 119.86 0.01 OUTLIER Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 92' ' ' ASN . 56.5 tttp -136.58 69.87 59.93 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.457 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -50.7 82.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.798 2.332 . . . . 0.0 112.202 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 90' ' ' LYS . 1.5 p30 -99.66 97.18 8.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.303 -0.873 . . . . 0.0 109.495 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.6 m -133.11 47.68 2.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.232 -0.917 . . . . 0.0 109.504 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.52 -13.55 53.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.258 -0.902 . . . . 0.0 109.434 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -81.43 1.81 31.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.212 -0.93 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.22 124.14 16.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.371 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.1 p 55.24 -166.51 0.1 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.495 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' H ' HD12 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -152.83 178.9 9.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.5 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.4 tttt -174.33 -22.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.31 -0.869 . . . . 0.0 109.453 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -176.7 119.31 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 109.514 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -139.75 9.5 2.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.06 -130.72 3.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -133.64 -139.87 4.25 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.55 ' C ' HD22 ' A' ' 104' ' ' ASN . 0.1 OUTLIER -127.03 76.89 1.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -1.156 . . . . 0.0 109.478 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 -4.74 52.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 148.99 -94.24 0.15 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 m 49.15 -135.03 1.27 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.175 -1.191 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.436 ' HA ' ' CE2' ' A' ' 110' ' ' TYR . 30.7 tttt -72.03 99.98 2.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.221 -0.924 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.95 30.16 2.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.49 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.436 ' CE2' ' HA ' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -94.05 145.6 24.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -0.898 . . . . 0.0 109.406 -179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 m120 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.469 179.955 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.1 m -125.38 89.94 3.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.458 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 21' ' ' ALA . 4.2 t -51.4 176.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -102.51 171.06 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.3 m -148.39 142.19 25.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.275 -0.891 . . . . 0.0 109.47 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -108.26 127.54 53.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.903 . . . . 0.0 109.545 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -101.13 144.44 30.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.305 -0.872 . . . . 0.0 109.495 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -113.06 121.13 43.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 10' ' ' LYS . 69.6 t80 -126.92 140.85 52.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.901 . . . . 0.0 109.485 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' O ' ' CE2' ' A' ' 9' ' ' TYR . 9.7 tttt -101.26 140.96 34.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.411 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -101.94 -166.68 27.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -94.99 -33.07 12.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.134 . . . . 0.0 109.427 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -110.44 -30.01 7.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 109.489 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 t -145.28 179.1 7.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.283 -0.886 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.1 t70 -98.1 161.99 13.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.228 -0.92 . . . . 0.0 109.411 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 62.1 mt -140.24 140.03 35.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.273 -0.892 . . . . 0.0 109.46 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.9 mt -118.9 136.99 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 109.409 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.84 171.3 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.208 -0.932 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -123.95 163.49 21.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.446 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -157.99 -177.05 6.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 3' ' ' THR . . . -106.62 -71.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.187 -0.945 . . . . 0.0 109.388 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.13 140.09 37.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.865 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.651 ' O ' ' N ' ' A' ' 26' ' ' VAL . 39.0 mt-10 -50.75 -55.95 14.3 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.918 . . . . 0.0 109.445 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' ' 23' ' ' GLU . 13.5 tp10 -37.65 -44.74 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.479 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -70.56 -27.28 64.01 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.651 ' N ' ' O ' ' A' ' 23' ' ' GLU . 89.6 t -73.3 -54.08 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -59.2 -24.22 62.93 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -75.31 -38.56 60.24 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.892 . . . . 0.0 109.399 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.51 ' O ' ' N ' ' A' ' 32' ' ' ASN . 76.6 t80 -60.04 -49.54 77.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mt -45.68 -32.43 2.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.493 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -91.06 -3.0 57.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.468 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 29' ' ' TYR . 52.5 m-80 -142.72 61.47 11.08 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.264 -0.898 . . . . 0.0 109.541 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -74.85 93.31 0.95 Allowed 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.85 2.366 . . . . 0.0 112.204 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.2 t -162.53 132.31 4.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.497 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.3 mm -46.46 117.04 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.453 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 152.11 -63.1 0.38 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 38' ' ' LEU . 0.1 OUTLIER -79.88 -28.67 39.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -1.149 . . . . 0.0 109.401 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.438 ' C ' ' O ' ' A' ' 37' ' ' LYS . 5.0 tp -42.77 -40.55 2.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.916 . . . . 0.0 109.401 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.5 t -67.83 -37.19 81.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 37' ' ' LYS . 17.6 tt0 -62.7 -18.34 62.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 109.419 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 10.8 t -100.93 -74.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.411 ' H ' HG23 ' A' ' 42' ' ' VAL . 5.7 t -57.55 157.54 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 0.0 109.378 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -117.87 -68.77 0.89 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.186 -0.946 . . . . 0.0 109.525 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.1 tp -95.38 111.57 23.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.518 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -69.86 74.37 0.44 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.455 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 47' ' ' VAL . 11.6 tp10 -156.03 157.87 36.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.187 -0.946 . . . . 0.0 109.491 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.428 ' N ' ' HG3' ' A' ' 46' ' ' GLU . 6.6 t -128.17 128.29 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.471 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -113.56 156.98 22.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.361 -0.837 . . . . 0.0 109.493 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -151.95 156.92 34.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.89 . . . . 0.0 109.433 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -70.01 178.41 4.75 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.793 2.328 . . . . 0.0 112.192 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -86.71 -112.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.506 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -123.66 26.49 7.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 -125.13 0.72 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.718 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -123.21 -19.26 6.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -1.137 . . . . 0.0 109.463 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 56' ' ' ALA . . . 139.49 135.58 3.28 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 55' ' ' GLY . . . 40.79 69.77 0.31 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -1.122 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -122.35 -64.97 1.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' GLU . . . -115.99 -158.58 11.59 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 58' ' ' GLY . 10.4 pt-20 -52.94 -172.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -1.139 . . . . 0.0 109.45 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 70.3 mt -114.29 165.93 12.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.513 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.33 9.07 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.29 134.0 56.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.286 -1.126 . . . . 0.0 109.499 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.49 130.13 39.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.561 ' O ' ' N ' ' A' ' 67' ' ' GLN . 13.6 m -81.23 131.08 35.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.445 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.474 ' C ' ' O ' ' A' ' 64' ' ' SER . 1.7 ptpt -40.47 -40.24 1.18 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.264 -0.898 . . . . 0.0 109.455 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.09 -32.16 67.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.561 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -76.29 -50.96 12.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.947 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.16 -41.7 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.505 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.648 ' O ' ' N ' ' A' ' 71' ' ' GLU . 39.9 mt-10 -55.58 -41.6 73.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.309 -0.87 . . . . 0.0 109.525 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.472 ' C ' ' O ' ' A' ' 69' ' ' GLU . 1.9 t-20 -40.37 -19.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.472 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.648 ' N ' ' O ' ' A' ' 69' ' ' GLU . 5.5 mm-40 -114.37 -60.96 1.82 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.206 -0.934 . . . . 0.0 109.488 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -164.98 72.6 0.2 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.281 -0.887 . . . . 0.0 109.5 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' N ' ' HA ' ' A' ' 69' ' ' GLU . . . -129.4 0.13 5.91 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -85.5 106.58 16.93 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.516 -0.99 . . . . 0.0 109.485 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 71.9 32.6 63.49 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.2 mttp -130.84 100.18 5.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -1.147 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.552 ' NZ ' ' OE1' ' A' ' 79' ' ' GLU . 9.4 mtpm? -46.55 155.09 0.25 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.891 . . . . 0.0 109.49 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.5 -21.5 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.45 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.552 ' OE1' ' NZ ' ' A' ' 77' ' ' LYS . 9.6 mt-10 -69.0 -51.99 33.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -67.14 -42.94 83.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -48.21 -51.49 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.199 -0.938 . . . . 0.0 109.543 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.1 mt -61.21 -35.59 66.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.877 . . . . 0.0 109.535 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' LEU . 46.0 t0 -60.34 -66.22 0.56 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.211 -0.931 . . . . 0.0 109.587 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 83' ' ' ASP . 16.4 mt -40.47 -32.82 0.22 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.557 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 8.0 mt -80.57 -31.17 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 109.477 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' N ' ' O ' ' A' ' 83' ' ' ASP . 20.9 mt -77.66 -0.39 26.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.309 -0.869 . . . . 0.0 109.448 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -75.67 -40.86 55.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.469 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.621 ' N ' ' OD1' ' A' ' 88' ' ' ASN . 0.4 OUTLIER -96.25 -73.38 0.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.35 -0.844 . . . . 0.0 109.498 179.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 71.88 117.31 0.05 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.3 mttt 53.97 60.02 11.57 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.275 -1.132 . . . . 0.0 109.427 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.56 91.54 0.78 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.829 2.353 . . . . 0.0 112.227 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 94' ' ' THR . 1.2 m120 -152.2 -67.77 0.17 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.203 -0.936 . . . . 0.0 109.473 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.615 ' C ' ' H ' ' A' ' 95' ' ' THR . 0.1 OUTLIER -69.53 17.53 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.516 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 92' ' ' ASN . 77.8 p -66.84 23.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.615 ' H ' ' C ' ' A' ' 93' ' ' SER . 18.6 p -134.08 81.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.7 88.12 4.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.444 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.34 -178.1 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.393 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.7 mp -52.78 170.59 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.19 -0.943 . . . . 0.0 109.482 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.0 mttp -86.13 139.62 30.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.514 ' O ' ' C ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -133.48 12.15 4.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.238 -0.914 . . . . 0.0 109.509 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 100' ' ' THR . 75.4 mttt 36.92 -121.68 0.17 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.267 -0.896 . . . . 0.0 109.501 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -180.0 -167.59 37.35 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 105' ' ' ALA . . . 170.89 -23.59 0.09 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -57.68 -2.77 0.15 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.189 -1.183 . . . . 0.0 109.476 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 103' ' ' GLY . . . -82.77 153.92 25.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.211 -0.931 . . . . 0.0 109.532 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.525 ' C ' ' H ' ' A' ' 108' ' ' LYS . . . 169.28 46.33 0.03 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 p -59.71 1.81 0.09 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -1.131 . . . . 0.0 109.504 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.525 ' H ' ' C ' ' A' ' 106' ' ' GLY . 5.6 pttm -136.57 61.87 1.62 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.257 -0.902 . . . . 0.0 109.474 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -153.2 -78.25 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.477 ' C ' ' O ' ' A' ' 109' ' ' ALA . 14.5 m-85 -38.85 -63.81 0.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.292 -0.88 . . . . 0.0 109.504 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.425 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.566 ' O ' ' O ' ' A' ' 2' ' ' SER . 30.5 tpp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 44.17 99.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.885 . . . . 0.0 109.414 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -143.07 -14.23 0.71 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.485 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -87.36 167.14 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.26 159.43 15.71 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -121.73 132.43 54.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.54 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.645 ' OH ' HG11 ' A' ' 26' ' ' VAL . 1.9 m-85 -95.75 117.59 30.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.289 -0.882 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -81.92 138.04 35.07 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -131.54 90.06 2.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.157 -0.965 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 tttt -56.77 96.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.274 -0.891 . . . . 0.0 109.519 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 12' ' ' GLU . . . -71.51 -162.59 5.31 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.579 ' H ' ' CG ' ' A' ' 71' ' ' GLU . 1.1 tt0 -49.37 -98.45 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.477 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.569 ' N ' ' CG ' ' A' ' 12' ' ' GLU . 0.2 OUTLIER -100.21 -0.63 38.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.878 . . . . 0.0 109.478 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -113.05 174.85 5.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.195 -0.94 . . . . 0.0 109.42 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -117.26 122.49 44.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.473 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.663 HD22 ' CG1' ' A' ' 47' ' ' VAL . 53.1 mt -106.17 132.24 52.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.3 mt -118.55 146.01 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.217 -0.927 . . . . 0.0 109.593 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.49 HG21 HG21 ' A' ' 85' ' ' ILE . 0.0 OUTLIER -131.11 169.81 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.0 109.438 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -103.37 155.23 18.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.176 -0.952 . . . . 0.0 109.456 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -143.84 -171.4 3.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.455 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.36 -52.52 2.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.377 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 8.7 p -168.69 135.52 1.9 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.506 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -45.69 -24.94 0.41 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -71.66 -65.64 0.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.438 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.7 mt -56.65 -20.42 21.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.441 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.645 HG11 ' OH ' ' A' ' 7' ' ' TYR . 4.4 t -79.15 -52.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.199 -0.938 . . . . 0.0 109.482 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.75 -44.36 96.81 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 0.0 109.406 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' LYS . 6.8 mt-10 -56.5 -54.88 40.64 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.285 -0.884 . . . . 0.0 109.472 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 33' ' ' PRO . 68.4 t80 -46.98 -44.13 19.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.365 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mt -60.46 -20.57 60.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.323 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 14.2 mtmt -92.81 -22.34 19.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.221 -0.925 . . . . 0.0 109.409 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 31' ' ' LYS . 9.0 m-20 -143.57 66.16 15.26 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 34' ' ' SER . 42.2 Cg_endo -71.53 170.03 19.51 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.801 2.334 . . . . 0.0 112.208 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER 166.92 22.66 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.273 -0.892 . . . . 0.0 109.512 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 35' ' ' ILE . 38.3 mm 47.13 13.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 34' ' ' SER . . . -107.48 -53.59 0.67 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 55.9 tttt -71.86 -25.75 62.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.436 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 38' ' ' LEU . 15.2 tp -48.7 -22.77 0.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.486 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 36' ' ' GLY . 2.7 p -71.39 -18.39 62.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.917 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -98.18 -20.94 16.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.451 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.84 -42.12 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.445 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.1 t -91.44 141.6 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.485 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' O ' HD23 ' A' ' 44' ' ' LEU . 39.1 mt-10 -102.09 -44.48 5.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.237 -0.915 . . . . 0.0 109.512 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 43' ' ' GLU . 7.5 mt -121.7 105.92 10.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.445 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -66.43 72.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.456 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' CG ' ' H ' ' A' ' 47' ' ' VAL . 5.8 tt0 -152.65 178.57 9.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.255 -0.903 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.663 ' CG1' HD22 ' A' ' 16' ' ' LEU . 82.2 t -123.5 131.73 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.569 ' C ' HG22 ' A' ' 49' ' ' THR . 57.7 m-85 -118.35 176.83 5.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.612 HG21 ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER 173.94 151.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.241 -0.912 . . . . 0.0 109.507 -179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.84 -178.4 3.1 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 C-N-CA 122.839 2.359 . . . . 0.0 112.156 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.433 ' NE2' ' OD1' ' A' ' 52' ' ' ASP . 0.7 OUTLIER -160.41 16.03 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.232 -0.918 . . . . 0.0 109.466 -179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.433 ' OD1' ' NE2' ' A' ' 51' ' ' GLN . 7.4 p-10 -158.88 0.26 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 178.15 176.95 46.52 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -92.66 37.85 1.01 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.304 -1.115 . . . . 0.0 109.461 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.61 177.18 24.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -163.18 28.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -1.179 . . . . 0.0 109.484 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -123.95 22.13 8.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -155.87 -120.6 0.69 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -60.93 114.21 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -1.123 . . . . 0.0 109.519 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.2 mt -118.21 -179.26 3.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.87 . . . . 0.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -165.9 -177.87 38.38 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.99 135.75 55.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 109.458 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.734 ' HB1' HE21 ' A' ' 67' ' ' GLN . . . -63.49 -178.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.408 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -103.22 136.16 43.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.917 . . . . 0.0 109.533 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.493 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 3.5 mttt -43.28 -27.84 0.27 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.52 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 64' ' ' SER . . . -78.45 -20.5 50.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.734 HE21 ' HB1' ' A' ' 63' ' ' ALA . 3.2 mt-30 -81.17 -39.66 25.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.502 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.77 -32.75 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.227 -0.921 . . . . 0.0 109.506 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.7 mt-10 -62.41 -21.58 65.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.422 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -82.35 -33.77 28.72 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.579 ' CG ' ' H ' ' A' ' 12' ' ' GLU . 0.6 OUTLIER -80.82 -24.19 38.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.339 -0.851 . . . . 0.0 109.47 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -116.69 -30.02 5.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.92 . . . . 0.0 109.49 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.607 ' C ' ' H ' ' A' ' 75' ' ' GLY . . . 115.79 -130.45 9.08 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.467 ' O ' ' C ' ' A' ' 75' ' ' GLY . 5.3 mtpt -67.02 24.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.142 -1.211 . . . . 0.0 109.47 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.607 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . 40.08 66.79 0.75 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.458 ' O ' ' C ' ' A' ' 77' ' ' LYS . 30.2 mttp -51.71 179.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.171 -1.194 . . . . 0.0 109.463 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 76' ' ' LYS . 28.3 mttp -41.13 130.97 2.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.458 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.449 HG23 ' N ' ' A' ' 79' ' ' GLU . 2.7 tp -41.9 -37.34 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.25 -0.906 . . . . 0.0 109.452 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.449 ' N ' HG23 ' A' ' 78' ' ' ILE . 10.8 mt-10 -52.91 -56.72 13.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.315 -0.866 . . . . 0.0 109.55 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -53.05 -41.5 64.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.214 -0.929 . . . . 0.0 109.516 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 82' ' ' ILE . 7.5 t -58.7 -68.19 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 0.0 109.454 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.456 ' N ' HG12 ' A' ' 81' ' ' VAL . 15.8 mt -42.95 -39.66 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.302 -0.873 . . . . 0.0 109.486 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 84' ' ' LEU . 0.8 OUTLIER -61.74 -63.82 1.14 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 83' ' ' ASP . 5.5 mt -43.64 -35.29 1.72 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.267 -0.896 . . . . 0.0 109.407 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.49 HG21 HG21 ' A' ' 18' ' ' VAL . 71.7 mt -65.22 -66.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.421 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 ' O ' ' C ' ' A' ' 87' ' ' ARG . 5.0 mt -49.62 -26.71 3.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.739 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -42.19 -43.88 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -77.53 0.58 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.6 132.85 3.84 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.507 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 5.4 mmtp 46.88 51.85 10.99 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.25 -1.147 . . . . 0.0 109.494 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 45.7 Cg_endo -72.32 92.97 0.74 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.776 2.317 . . . . 0.0 112.196 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.835 ' ND2' ' H ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -97.68 114.96 27.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.951 . . . . 0.0 109.498 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.4 m -97.4 -89.32 0.28 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.45 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 94' ' ' THR . 5.6 t -153.79 129.52 10.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.453 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.68 7.82 8.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.0 109.395 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 57.42 88.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.208 -0.932 . . . . 0.0 109.525 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.8 p -127.52 5.23 6.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.336 -0.852 . . . . 0.0 109.389 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.57 87.12 3.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.287 -0.883 . . . . 0.0 109.407 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.5 tttp -164.37 -67.92 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.46 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.46 48.06 0.18 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.373 -0.829 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.3 mttm 47.41 27.51 0.94 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.895 . . . . 0.0 109.455 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.0 44.67 6.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 65.32 161.15 0.67 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -127.94 -169.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -1.186 . . . . 0.0 109.44 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -77.09 -81.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.895 . . . . 0.0 109.467 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 121.45 -96.12 0.58 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -149.81 13.51 0.81 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.283 -1.127 . . . . 0.0 109.456 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.09 34.05 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.467 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' ' C ' ' A' ' 110' ' ' TYR . . . -77.57 91.12 3.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -0.88 . . . . 0.0 109.548 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 109' ' ' ALA . 53.5 m-85 40.14 87.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.474 -179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' C ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.454 ' C ' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 41.22 33.6 0.26 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.275 -0.891 . . . . 0.0 109.446 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.0 m -47.44 -25.84 1.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.299 -0.875 . . . . 0.0 109.426 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -121.45 -170.37 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.456 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.35 158.21 31.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.9 mttm -118.34 139.44 51.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.214 -0.929 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.483 ' CZ ' HG11 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -114.86 117.64 31.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.301 -0.874 . . . . 0.0 109.379 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -99.18 126.61 45.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.334 -0.853 . . . . 0.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.4 t80 -120.88 106.51 11.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -79.36 94.83 5.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.93 -166.84 0.33 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -63.13 -53.74 48.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -1.148 . . . . 0.0 109.541 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.38 -1.54 3.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.29 -0.881 . . . . 0.0 109.493 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 137.32 54.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -108.52 121.64 45.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.196 -0.94 . . . . 0.0 109.466 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.2 mt -119.19 147.19 44.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.6 mt -116.81 147.55 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.298 -0.876 . . . . 0.0 109.479 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.65 161.93 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.487 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -95.16 149.38 21.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.03 144.36 30.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 109.415 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.92 -69.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.533 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.55 149.37 46.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.08 -35.51 80.48 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -55.24 -58.29 8.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.213 -0.929 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HB3' HG22 ' A' ' 41' ' ' VAL . 9.2 mt -50.07 -59.26 4.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.28 -0.887 . . . . 0.0 109.508 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.483 HG11 ' CZ ' ' A' ' 7' ' ' TYR . 4.4 t -39.88 -59.57 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -48.41 -42.36 31.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.478 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 25' ' ' LEU . 6.0 mt-10 -60.65 -46.22 91.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.848 . . . . 0.0 109.496 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.587 ' N ' ' NZ ' ' A' ' 37' ' ' LYS . 31.0 t80 -49.83 -54.92 16.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.412 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 30.2 mt -52.55 -22.87 5.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -88.27 -26.51 22.27 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -130.89 58.35 38.33 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 0.0 109.443 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.53 93.94 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 122.896 2.397 . . . . 0.0 112.245 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.8 t -155.66 27.3 0.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.301 -0.874 . . . . 0.0 109.47 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.589 HG22 ' N ' ' A' ' 36' ' ' GLY . 27.8 mm 59.41 169.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.445 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.589 ' N ' HG22 ' A' ' 35' ' ' ILE . . . 92.92 -38.54 3.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.587 ' NZ ' ' N ' ' A' ' 29' ' ' TYR . 25.9 tttm -105.5 -6.36 19.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -1.123 . . . . 0.0 109.453 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.8 tp -66.93 -23.11 65.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.329 -0.857 . . . . 0.0 109.442 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.23 -33.38 59.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.224 -0.923 . . . . 0.0 109.433 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -73.47 -27.56 61.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.447 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 25' ' ' LEU . 40.7 t -86.59 -64.96 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.211 -0.931 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 76.1 t -68.76 146.66 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.187 -0.945 . . . . 0.0 109.427 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -97.9 -55.5 2.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.433 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.8 mp -105.42 154.71 19.95 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.01 65.9 0.75 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.226 -0.921 . . . . 0.0 109.509 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -156.53 157.27 35.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 44.0 t -103.81 140.65 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CD1' ' N ' ' A' ' 48' ' ' PHE . 9.2 m-85 -114.92 170.13 8.57 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.485 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -138.23 152.98 72.68 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.54 126.43 11.52 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.741 2.294 . . . . 0.0 112.198 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.57 5.83 48.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.307 -0.87 . . . . 0.0 109.472 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.659 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -171.34 -67.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.494 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.98 -5.37 2.76 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 56' ' ' ALA . 16.9 mtm180 -131.21 -26.91 2.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -1.189 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 57' ' ' GLU . . . -68.96 67.9 0.46 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' ARG . . . -70.8 6.23 1.6 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -1.208 . . . . 0.0 109.516 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 55' ' ' GLY . 4.4 mm-40 -133.57 -173.76 3.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.41 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.87 -131.58 12.78 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.454 ' OE1' ' C ' ' A' ' 59' ' ' GLU . 0.6 OUTLIER -137.01 147.43 46.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -1.145 . . . . 0.0 109.461 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.44 -164.39 1.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 0.0 109.433 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -102.05 -174.19 27.73 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.5 49.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.278 -1.131 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -89.49 128.88 36.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.174 -0.954 . . . . 0.0 109.459 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -69.27 150.04 47.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.502 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -50.32 -25.23 3.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.16 -0.962 . . . . 0.0 109.505 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.12 -42.65 79.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.44 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 68' ' ' VAL . 4.2 tt0 -62.64 -61.51 2.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.499 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 67' ' ' GLN . 19.0 t -42.96 -48.34 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.338 -0.851 . . . . 0.0 109.493 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -47.92 -24.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.181 -0.949 . . . . 0.0 109.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.39 -19.97 55.39 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.206 -0.934 . . . . 0.0 109.532 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' VAL . 5.6 mm-40 -92.18 -66.05 0.96 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.655 ' CD1' ' N ' ' A' ' 72' ' ' PHE . 0.0 OUTLIER -156.8 66.22 0.53 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.93 130.31 2.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -164.74 -25.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.241 -1.152 . . . . 0.0 109.44 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.98 -22.41 0.04 OUTLIER Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.7 mttm -72.16 -165.57 0.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -1.205 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 81' ' ' VAL . 52.6 mttm -109.78 -161.98 0.78 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.393 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.451 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -90.81 -42.77 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 79' ' ' GLU . 0.0 OUTLIER -49.82 -55.47 14.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.542 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -56.3 -48.83 75.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.496 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 77' ' ' LYS . 21.2 t -44.56 -54.62 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.89 . . . . 0.0 109.482 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.3 mt -58.46 -35.55 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -53.93 -49.3 68.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.227 -0.92 . . . . 0.0 109.543 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 87' ' ' ARG . 16.4 mt -57.16 -54.54 45.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.55 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.425 ' C ' ' O ' ' A' ' 84' ' ' LEU . 56.3 mt -43.19 -44.52 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.3 mt -69.52 -27.29 65.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.503 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' A' ' 84' ' ' LEU . 4.2 tpt180 -51.75 -28.41 15.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.266 -0.896 . . . . 0.0 109.545 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.456 ' ND2' ' H ' ' A' ' 88' ' ' ASN . 0.0 OUTLIER -115.53 -83.17 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.441 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 69.13 127.66 0.04 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.476 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 7.0 mttp 42.4 56.72 10.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.255 -1.144 . . . . 0.0 109.353 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 90' ' ' LYS . 44.3 Cg_endo -72.4 18.09 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.904 2.403 . . . . 0.0 112.246 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 90' ' ' LYS . 1.8 p30 -47.29 151.28 0.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.234 -0.916 . . . . 0.0 109.418 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.76 159.44 36.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.301 -0.874 . . . . 0.0 109.527 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.3 m -106.5 70.46 0.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.471 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 95' ' ' THR . 7.4 m -86.49 91.12 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 81.2 p -63.94 172.34 2.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.175 -0.953 . . . . 0.0 109.463 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.77 156.58 16.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.888 . . . . 0.0 109.508 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.51 -24.57 22.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.9 mttp -62.08 -156.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.284 -0.885 . . . . 0.0 109.42 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.53 169.59 10.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.487 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 7.5 mttm -61.17 -168.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.33 88.26 1.0 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -138.87 -38.91 0.11 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -141.34 0.72 1.53 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -1.14 . . . . 0.0 109.425 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.24 -54.09 20.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.183 -0.948 . . . . 0.0 109.468 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.78 124.48 1.98 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 109' ' ' ALA . 1.6 t -88.08 15.32 7.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -1.129 . . . . 0.0 109.471 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.83 -90.47 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.448 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 107' ' ' THR . . . -174.92 -160.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -142.7 59.67 1.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.438 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.539 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' C ' ' OG ' ' A' ' 2' ' ' SER . 6.5 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 3' ' ' THR . 0.8 OUTLIER -171.41 32.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.479 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.56 ' O ' ' O ' ' A' ' 2' ' ' SER . 0.5 OUTLIER -43.43 173.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.907 . . . . 0.0 109.468 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.0 m -85.07 -172.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 m -146.33 146.15 30.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.401 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' A' ' 6' ' ' LYS . 11.0 mtpp -114.73 133.31 55.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.165 -0.959 . . . . 0.0 109.498 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -97.87 132.01 43.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.399 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.94 147.22 24.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.429 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -141.1 107.85 5.37 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -89.73 92.64 9.14 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.186 -0.946 . . . . 0.0 109.48 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 13' ' ' ASN . . . -56.46 171.33 2.32 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -59.5 -5.81 0.92 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.254 -1.145 . . . . 0.0 109.542 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' GLY . 23.1 t30 -161.09 -54.81 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.153 -0.967 . . . . 0.0 109.509 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.1 m -84.91 152.87 23.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.513 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -115.87 130.58 56.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.24 -0.912 . . . . 0.0 109.478 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 mt -132.83 156.92 46.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 5.5 mt -121.75 152.75 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.176 -0.952 . . . . 0.0 109.47 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.49 166.78 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 109.503 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -106.51 153.4 22.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.48 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.45 161.41 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.45 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.5 -76.17 0.28 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.258 -0.901 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.0 p -135.9 155.04 50.9 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 109.529 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -67.06 -31.62 72.25 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -50.1 -61.13 2.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.458 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.437 ' O ' ' N ' ' A' ' 28' ' ' GLU . 12.6 mt -55.55 -52.45 63.69 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -0.913 . . . . 0.0 109.485 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 25' ' ' LEU . 10.9 t -45.5 -50.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.231 -0.918 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -61.9 -24.56 67.03 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.907 . . . . 0.0 109.487 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 42.4 mm-40 -79.53 -37.63 36.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.202 -0.936 . . . . 0.0 109.462 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.474 ' CE1' HD13 ' A' ' 38' ' ' LEU . 60.3 t80 -60.35 -44.38 95.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -0.892 . . . . 0.0 109.467 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 mt -63.06 -35.62 80.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 0.0 109.498 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -76.39 -37.98 56.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.48 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -128.4 72.08 80.21 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.53 136.77 20.49 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.857 2.371 . . . . 0.0 112.248 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.06 130.57 0.3 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.0 mm -69.48 -44.21 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -0.91 . . . . 0.0 109.472 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.26 -10.52 5.51 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -49.27 5.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -1.122 . . . . 0.0 109.484 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD13 ' CE1' ' A' ' 29' ' ' TYR . 3.4 tp -47.2 -21.63 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -32.06 73.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -0.894 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.21 -45.76 11.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.242 -0.911 . . . . 0.0 109.461 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 24.6 t -59.6 -54.77 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.511 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.466 HG11 ' CD1' ' A' ' 45' ' ' PHE . 91.6 t -71.62 134.33 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.492 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.78 35.17 3.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.194 -0.941 . . . . 0.0 109.44 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -166.41 -40.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.299 -0.875 . . . . 0.0 109.367 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.466 ' CD1' HG11 ' A' ' 42' ' ' VAL . 36.2 m-85 56.4 62.01 2.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.539 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -158.1 161.73 37.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.91 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.61 123.78 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.0 109.512 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -110.59 171.18 7.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.275 -0.891 . . . . 0.0 109.519 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -149.68 159.01 37.0 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.217 -0.927 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -70.66 168.84 21.58 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.856 2.371 . . . . 0.0 112.192 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HG3' ' H ' ' A' ' 52' ' ' ASP . 1.1 tp60 -124.98 168.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.407 ' H ' ' HG3' ' A' ' 51' ' ' GLN . 3.5 m-20 -64.57 117.35 7.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.243 -0.91 . . . . 0.0 109.486 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 163.73 -46.37 0.31 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 177.34 -21.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.337 -1.096 . . . . 0.0 109.414 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.56 -75.89 0.31 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 57' ' ' GLU . . . -86.18 -66.53 0.89 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.262 -1.14 . . . . 0.0 109.461 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.5 mm-40 38.65 33.08 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 56' ' ' ALA . . . 46.22 -162.23 0.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 45.02 70.64 0.33 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -1.17 . . . . 0.0 109.487 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.1 mt -86.79 165.45 16.0 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.219 -0.926 . . . . 0.0 109.476 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -134.58 152.51 20.7 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -86.54 146.18 26.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.262 -1.14 . . . . 0.0 109.45 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.8 -170.76 3.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 72.6 m -113.38 147.24 38.1 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' O ' ' OE2' ' A' ' 69' ' ' GLU . 74.5 mttt -49.04 -32.58 9.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.556 ' O ' ' OD1' ' A' ' 70' ' ' ASN . . . -64.6 -42.72 95.36 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -0.894 . . . . 0.0 109.455 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -61.48 -38.27 86.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.24 -0.913 . . . . 0.0 109.48 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.482 ' O ' ' N ' ' A' ' 71' ' ' GLU . 41.4 t -66.34 -55.19 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.233 -0.917 . . . . 0.0 109.434 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.661 ' O ' ' N ' ' A' ' 73' ' ' GLY . 2.0 mt-10 -44.96 -35.55 2.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.207 -0.933 . . . . 0.0 109.444 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.556 ' OD1' ' O ' ' A' ' 66' ' ' ALA . 14.9 m120 -66.29 -17.97 65.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.211 -0.931 . . . . 0.0 109.385 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.482 ' N ' ' O ' ' A' ' 68' ' ' VAL . 2.3 mp0 -108.88 -6.97 15.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.545 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -146.1 16.74 1.38 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.179 -0.951 . . . . 0.0 109.461 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 48.32 -133.96 19.31 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 73' ' ' GLY . 0.5 OUTLIER -42.78 109.03 0.12 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -1.155 . . . . 0.0 109.447 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.13 87.69 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 74' ' ' LYS . 16.7 mttt -66.52 -179.1 0.78 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.296 -1.12 . . . . 0.0 109.398 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -47.82 138.76 8.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.446 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 tp -53.37 -22.41 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.293 -0.88 . . . . 0.0 109.457 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -72.92 -28.97 62.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.563 ' CA ' ' OE1' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -80.05 -47.95 14.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.514 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.1 t -50.99 -48.83 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 0.0 109.466 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.506 HG22 HD11 ' A' ' 86' ' ' LEU . 74.4 mt -63.96 -36.52 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.206 -0.934 . . . . 0.0 109.512 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.437 ' O ' ' C ' ' A' ' 84' ' ' LEU . 56.8 t0 -58.66 -64.18 1.02 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.173 -0.954 . . . . 0.0 109.47 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.437 ' C ' ' O ' ' A' ' 83' ' ' ASP . 98.5 mt -42.18 -46.32 4.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.438 ' C ' ' H ' ' A' ' 87' ' ' ARG . 74.2 mt -57.86 -58.16 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.506 HD11 HG22 ' A' ' 82' ' ' ILE . 10.2 mt -56.16 -7.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.468 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.701 ' CG ' HH11 ' A' ' 87' ' ' ARG . 0.0 OUTLIER -111.21 -20.82 12.19 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.182 -0.949 . . . . 0.0 109.508 -179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -140.91 66.44 1.37 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -0.935 . . . . 0.0 109.57 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.52 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -147.64 -138.92 3.15 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.52 ' C ' ' O ' ' A' ' 89' ' ' GLY . 16.8 ttpp -35.09 98.75 0.16 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.344 -1.092 . . . . 0.0 109.573 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.494 ' N ' ' O ' ' A' ' 89' ' ' GLY . 31.7 Cg_exo -55.07 91.19 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.535 2.157 . . . . 0.0 112.13 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 93' ' ' SER . 0.3 OUTLIER -71.63 153.45 42.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -0.91 . . . . 0.0 109.597 -179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 92' ' ' ASN . 8.2 p 43.34 80.59 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -0.893 . . . . 0.0 109.509 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.7 p -76.73 61.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.404 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 85.4 m -140.91 129.46 22.68 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.3 t -116.04 -23.66 8.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.24 -0.913 . . . . 0.0 109.409 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 98.8 p -76.78 115.77 16.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.259 -0.901 . . . . 0.0 109.531 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.402 ' C ' ' N ' ' A' ' 100' ' ' THR . 3.5 mt -108.88 -144.4 0.39 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.442 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' CG ' ' A' ' 99' ' ' LYS . 9.5 tttm 51.27 14.49 0.23 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.277 -0.889 . . . . 0.0 109.487 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.402 ' N ' ' C ' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -125.35 -49.42 1.67 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.293 -0.879 . . . . 0.0 109.482 -179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -80.65 79.71 7.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -153.18 168.01 31.89 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.74 70.87 1.07 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.421 ' OD1' ' N ' ' A' ' 104' ' ' ASN . 0.5 OUTLIER -152.03 -74.47 0.14 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.263 -1.14 . . . . 0.0 109.457 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.09 -31.69 68.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.34 -0.85 . . . . 0.0 109.475 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 114.37 117.35 3.25 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.7 p -80.15 -24.36 40.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -1.171 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.494 ' C ' ' H ' ' A' ' 110' ' ' TYR . 14.8 mttt 52.35 33.02 12.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -73.78 28.75 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.494 ' H ' ' C ' ' A' ' 108' ' ' LYS . 5.7 m-85 -120.62 160.13 23.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 111' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.44 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.271 0.558 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -157.81 98.88 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.479 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.32 148.29 43.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.413 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.4 m -150.95 -169.9 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.8 142.57 50.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.524 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttp -102.4 131.6 48.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.284 -0.885 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.412 ' CZ ' HG21 ' A' ' 26' ' ' VAL . 1.1 m-85 -99.85 116.58 32.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.454 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 17.9 m-85 -91.23 142.9 27.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.264 -0.897 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -132.72 102.2 5.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.517 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -81.4 93.37 6.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.47 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.14 -156.57 8.97 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -46.77 -84.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -1.138 . . . . 0.0 109.482 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.26 -13.82 9.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.938 . . . . 0.0 109.516 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.59 147.49 23.29 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.241 -0.912 . . . . 0.0 109.487 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -117.28 115.85 26.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 0.0 109.447 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.7 mt -108.95 152.69 24.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.948 . . . . 0.0 109.515 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 25.8 mt -137.77 114.45 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.235 -0.916 . . . . 0.0 109.456 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -97.49 -172.74 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.243 -0.91 . . . . 0.0 109.474 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.415 ' CD2' ' CD1' ' A' ' 44' ' ' LEU . 4.5 m-85 -104.57 169.63 8.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.247 -0.908 . . . . 0.0 109.461 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -168.15 149.79 5.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.276 -0.89 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.69 -59.54 2.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.1 p -155.92 142.92 19.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -53.69 -33.93 57.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.225 -0.922 . . . . 0.0 109.514 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 25' ' ' LEU . 13.6 tt0 -54.65 -64.02 0.97 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 28' ' ' GLU . 7.8 mt -44.64 -58.04 3.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.262 -0.899 . . . . 0.0 109.559 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.457 ' C ' ' O ' ' A' ' 25' ' ' LEU . 96.1 t -40.39 -45.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.159 -0.963 . . . . 0.0 109.536 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -60.51 -36.06 77.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.283 -0.885 . . . . 0.0 109.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 25' ' ' LEU . 5.6 mt-10 -67.28 -23.14 65.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.907 . . . . 0.0 109.56 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -85.07 -28.69 25.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.209 -0.932 . . . . 0.0 109.522 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.9 mt -61.93 -40.42 95.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.527 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -74.45 -32.77 62.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 109.561 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -124.67 73.52 62.45 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.571 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -75.74 114.37 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 C-N-CA 122.76 2.306 . . . . 0.0 112.29 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 m -144.27 -112.54 0.1 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.3 tt -162.68 -14.2 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.305 -0.872 . . . . 0.0 109.501 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -81.11 -52.49 4.27 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -65.45 -8.38 18.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -1.149 . . . . 0.0 109.441 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tp -65.14 -54.31 31.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.487 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 23.1 p -48.84 -20.05 0.45 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -84.06 -44.09 14.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.66 -70.92 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.432 ' H ' HG23 ' A' ' 42' ' ' VAL . 2.4 t -68.14 129.77 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.234 -0.916 . . . . 0.0 109.419 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.77 -36.45 15.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.886 . . . . 0.0 109.469 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' CD1' ' CD2' ' A' ' 19' ' ' PHE . 1.0 OUTLIER -123.89 112.51 17.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.913 . . . . 0.0 109.485 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -65.44 80.36 0.06 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 109.445 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 44' ' ' LEU . 4.6 tp10 -165.39 157.25 14.9 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 t -112.91 129.55 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.514 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -111.97 160.01 17.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.416 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.77 168.62 16.15 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.44 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -47.02 161.28 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.838 2.359 . . . . 0.0 112.233 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -94.91 -78.47 0.45 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 0.0 109.501 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -162.14 85.72 0.6 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.888 . . . . 0.0 109.484 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.48 -127.07 7.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.719 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -65.77 116.42 6.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -1.16 . . . . 0.0 109.405 179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.14 159.03 25.09 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -170.79 2.83 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -1.143 . . . . 0.0 109.418 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -167.25 -173.81 2.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.878 . . . . 0.0 109.451 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.12 -138.46 16.02 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.692 ' CD ' ' H ' ' A' ' 59' ' ' GLU . 2.1 mp0 -87.54 80.53 8.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -1.183 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 51.2 mt -67.29 -169.15 0.09 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.311 -0.868 . . . . 0.0 109.511 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -118.47 178.97 16.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.73 148.8 47.86 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -1.172 . . . . 0.0 109.45 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.7 150.55 21.6 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.484 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.72 174.6 6.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.426 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -70.58 -31.84 69.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.33 -0.856 . . . . 0.0 109.514 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.16 -43.3 87.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.25 -0.906 . . . . 0.0 109.498 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -62.71 -52.48 63.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 71' ' ' GLU . 95.3 t -60.05 -41.99 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.144 -0.972 . . . . 0.0 109.541 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -45.04 -42.44 8.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.259 -0.9 . . . . 0.0 109.525 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -69.96 -26.07 63.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 0.0 109.494 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -81.58 -25.43 35.79 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.434 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -137.66 -71.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.51 -172.02 36.05 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HG2' ' N ' ' A' ' 75' ' ' GLY . 56.5 tttp -115.33 159.22 21.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.289 -1.124 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.409 ' N ' ' HG2' ' A' ' 74' ' ' LYS . . . 101.62 -22.37 38.9 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -78.67 -168.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -1.113 . . . . 0.0 109.428 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 78' ' ' ILE . 22.8 mttm -124.71 137.87 54.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.179 -0.951 . . . . 0.0 109.518 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.524 ' CG2' ' N ' ' A' ' 79' ' ' GLU . 0.4 OUTLIER -39.55 -45.39 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.27 -179.882 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' N ' ' CG2' ' A' ' 78' ' ' ILE . 4.8 mt-10 -64.22 -43.92 93.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.517 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' LYS . 2.5 tp10 -59.2 -36.24 75.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.188 -0.945 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.478 ' O ' ' C ' ' A' ' 82' ' ' ILE . 6.5 t -70.44 -60.38 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.496 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 81' ' ' VAL . 94.8 mt -39.54 -42.71 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.293 -0.88 . . . . 0.0 109.497 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -56.6 -57.08 13.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.469 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 49.5 mt -54.63 -30.97 56.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.28 -0.888 . . . . 0.0 109.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 86' ' ' LEU . 1.9 mm -68.44 -64.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.907 . . . . 0.0 109.492 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.45 ' N ' HG22 ' A' ' 85' ' ' ILE . 4.8 mt -45.19 -42.92 9.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.517 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -46.46 -53.26 11.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.24 -0.912 . . . . 0.0 109.512 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.81 -82.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.266 -0.896 . . . . 0.0 109.476 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 66.49 119.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -128.72 77.77 77.06 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.318 -1.107 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -47.26 -37.28 24.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.866 2.377 . . . . 0.0 112.213 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -55.88 173.51 0.14 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 27.7 t 55.81 55.87 6.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.208 -0.932 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.457 ' OG1' ' N ' ' A' ' 95' ' ' THR . 1.2 t -100.33 -176.21 3.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.893 . . . . 0.0 109.443 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.565 HG23 ' O ' ' A' ' 95' ' ' THR . 2.6 t -167.6 95.05 0.44 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.519 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.519 ' O ' ' C ' ' A' ' 97' ' ' SER . 26.7 p -120.3 160.5 22.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.405 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.519 ' C ' ' O ' ' A' ' 96' ' ' SER . 0.0 OUTLIER -36.62 -55.6 0.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.292 -0.88 . . . . 0.0 109.42 -179.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.83 94.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -0.881 . . . . 0.0 109.461 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 97' ' ' SER . 45.4 tttt -167.69 -23.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.32 -0.863 . . . . 0.0 109.435 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 101' ' ' LYS . 29.2 m -78.03 -23.53 48.16 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.215 -0.928 . . . . 0.0 109.432 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 100' ' ' THR . 16.8 mmtm 41.78 -131.0 0.5 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.438 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.53 43.43 24.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.81 55.37 4.49 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 49.8 m-80 -110.24 136.02 50.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -1.103 . . . . 0.0 109.394 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -172.22 77.72 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 0.0 109.534 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.513 ' O ' ' OG1' ' A' ' 107' ' ' THR . . . 88.9 -29.25 6.0 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 106' ' ' GLY . 7.5 p 58.57 112.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -85.95 -13.03 48.93 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.06 -125.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -132.1 45.92 2.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.456 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.471 -179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -74.16 -56.19 5.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.455 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.646 ' OG1' ' N ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -96.21 -168.05 1.68 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.456 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.646 ' N ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -79.85 -179.82 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.256 -0.903 . . . . 0.0 109.432 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.0 m -93.6 139.43 30.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.5 115.79 30.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.454 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.683 ' OH ' HG11 ' A' ' 26' ' ' VAL . 0.9 OUTLIER -95.39 137.83 33.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CD1' ' N ' ' A' ' 8' ' ' PHE . 41.8 m-85 -115.4 150.47 36.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.572 ' HB2' HG23 ' A' ' 85' ' ' ILE . 67.0 t80 -139.78 123.91 17.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -101.0 99.79 10.3 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.71 -147.52 0.08 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -97.08 -43.22 7.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -1.167 . . . . 0.0 109.468 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -131.6 -3.29 3.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.927 . . . . 0.0 109.503 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.58 158.62 40.51 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -119.7 144.33 47.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -134.91 160.85 36.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.199 -0.938 . . . . 0.0 109.456 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 92.2 mt -140.89 140.11 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.39 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.13 156.99 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -0.9 . . . . 0.0 109.595 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -93.25 154.28 18.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.66 168.9 18.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.12 -58.36 2.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.304 -0.872 . . . . 0.0 109.475 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 26' ' ' VAL . 2.4 p -156.11 148.82 23.93 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.507 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -63.96 -26.68 68.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -69.76 -41.18 75.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.917 . . . . 0.0 109.483 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.2 mt -69.97 -26.32 64.05 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.297 -0.877 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.683 HG11 ' OH ' ' A' ' 7' ' ' TYR . 45.7 t -76.6 -61.44 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.456 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 26' ' ' VAL . 1.5 t0 -43.61 -43.45 5.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.177 -0.952 . . . . 0.0 109.333 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 1.7 mt-10 -61.58 -45.7 93.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 0.0 109.388 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.493 ' OH ' ' O ' ' A' ' 34' ' ' SER . 91.6 t80 -59.86 -33.29 71.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 30' ' ' LEU . 40.1 mt -69.36 -40.03 77.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.887 . . . . 0.0 109.404 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -59.87 -23.92 63.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.562 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 5.6 p-10 -153.72 81.37 4.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.372 -0.83 . . . . 0.0 109.347 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.78 144.62 7.71 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.836 2.357 . . . . 0.0 112.296 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.493 ' O ' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -154.42 -169.78 3.33 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 109.442 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.5 tp -126.52 -19.6 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.457 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.1 -57.64 1.77 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 20.4 tttp -49.66 -25.5 2.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.269 -1.136 . . . . 0.0 109.499 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 9.5 tp -47.0 -24.66 0.65 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 109.427 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.537 ' O ' ' O ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -69.95 -62.5 1.36 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.52 179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.68 -39.78 37.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.311 -0.868 . . . . 0.0 109.542 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.28 -48.31 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.665 HG12 ' H ' ' A' ' 44' ' ' LEU . 21.7 t -105.53 128.85 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.272 -0.892 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -91.53 -1.86 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.245 -0.91 . . . . 0.0 109.513 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.665 ' H ' HG12 ' A' ' 42' ' ' VAL . 2.7 tp -157.18 123.72 4.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.472 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -85.36 94.43 8.96 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.39 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -168.68 152.21 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.141 -0.975 . . . . 0.0 109.455 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 t -120.03 119.15 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.493 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -105.1 152.18 23.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.342 -0.849 . . . . 0.0 109.411 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 p -117.13 149.87 45.12 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.928 . . . . 0.0 109.514 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 51' ' ' GLN . 43.9 Cg_endo -71.94 157.52 54.59 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.784 2.323 . . . . 0.0 112.147 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.504 ' O ' ' O ' ' A' ' 50' ' ' PRO . 1.9 mm-40 -59.79 -131.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.519 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 54' ' ' ARG . 42.4 p-10 -108.72 70.13 0.74 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.247 -0.908 . . . . 0.0 109.481 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.61 -41.81 0.18 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.549 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.5 ttp180 -91.58 113.69 26.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -1.161 . . . . 0.0 109.446 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.06 134.85 6.66 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.1 4.5 2.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -1.11 . . . . 0.0 109.498 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -160.58 87.1 0.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 109.465 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 176.36 92.4 0.08 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.09 82.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.367 -1.078 . . . . 0.0 109.487 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.9 mt -80.46 156.47 26.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.196 -0.94 . . . . 0.0 109.441 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -95.76 -178.68 36.45 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -127.08 150.3 49.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.246 -1.15 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -90.67 169.99 10.52 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.553 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.0 161.64 13.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -0.928 . . . . 0.0 109.432 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.3 mtpm? -57.78 -46.23 84.87 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.459 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.62 -22.16 12.64 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.131 -0.981 . . . . 0.0 109.49 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -83.36 -58.62 2.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.545 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 96.4 t -52.34 -29.14 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.259 -0.9 . . . . 0.0 109.528 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.598 ' O ' ' N ' ' A' ' 71' ' ' GLU . 46.5 mt-10 -71.55 -64.73 0.87 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 69' ' ' GLU . 7.9 t30 -38.53 -24.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.518 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.598 ' N ' ' O ' ' A' ' 69' ' ' GLU . 15.6 mm-40 -75.74 -62.98 1.4 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -0.931 . . . . 0.0 109.44 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.667 ' CE2' HG13 ' A' ' 81' ' ' VAL . 90.8 m-85 -94.08 -72.76 0.6 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.266 -0.896 . . . . 0.0 109.567 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 171.29 177.45 41.09 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -96.87 170.61 9.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -1.096 . . . . 0.0 109.496 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.1 -29.9 4.13 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -76.85 156.4 32.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -1.131 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -97.35 -176.31 3.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -0.905 . . . . 0.0 109.415 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 79' ' ' GLU . 2.9 tp -73.87 -36.37 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 78' ' ' ILE . 10.8 pt-20 -62.77 -49.51 74.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 109.572 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 81' ' ' VAL . 0.0 OUTLIER -55.64 -60.85 2.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.667 HG13 ' CE2' ' A' ' 72' ' ' PHE . 3.4 t -41.68 -62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 109.474 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.517 ' O ' ' C ' ' A' ' 83' ' ' ASP . 17.0 mt -45.14 -51.52 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.498 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 82' ' ' ILE . 1.0 OUTLIER -37.32 -55.26 1.04 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -0.911 . . . . 0.0 109.493 -180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.579 ' O ' ' N ' ' A' ' 87' ' ' ARG . 45.6 mt -56.03 -59.64 4.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.572 HG23 ' HB2' ' A' ' 9' ' ' TYR . 76.9 mt -38.26 -41.91 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.524 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.2 mt -63.98 -33.75 76.44 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -0.893 . . . . 0.0 109.533 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' N ' ' O ' ' A' ' 84' ' ' LEU . 14.5 ttt180 -62.95 -14.08 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.914 . . . . 0.0 109.512 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -105.35 -89.11 0.43 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 73.75 127.5 0.13 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' N ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 tptt -139.09 60.55 17.95 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.25 -1.147 . . . . 0.0 109.497 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.455 ' HD3' ' N ' ' A' ' 90' ' ' LYS . 52.2 Cg_exo -48.41 132.72 24.83 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.855 2.37 . . . . 0.0 112.149 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.466 ' O ' ' C ' ' A' ' 93' ' ' SER . 44.9 t30 -55.17 125.41 20.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.386 -0.821 . . . . 0.0 109.43 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 92' ' ' ASN . 44.6 m -40.96 99.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.474 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 92' ' ' ASN . 9.2 p -81.86 149.48 28.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.298 -0.876 . . . . 0.0 109.487 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 22.4 p -122.2 54.78 1.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 109.531 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 10.4 t -163.38 111.31 1.22 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.204 -0.935 . . . . 0.0 109.446 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 24.3 p -158.9 123.87 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.302 -0.874 . . . . 0.0 109.51 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.71 -50.09 0.18 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -0.955 . . . . 0.0 109.501 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.63 48.16 1.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 0.0 109.459 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 101' ' ' LYS . 6.8 p -117.51 -62.9 1.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.0 109.424 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.508 ' N ' ' OG1' ' A' ' 100' ' ' THR . 0.0 OUTLIER -81.87 144.7 30.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.449 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 170.63 91.6 0.08 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 136.75 -64.83 0.57 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -141.06 156.37 46.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -1.15 . . . . 0.0 109.47 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -138.48 -163.93 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.217 -0.927 . . . . 0.0 109.484 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.91 -164.93 40.74 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.2 m -130.77 135.18 47.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -154.81 -105.65 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.248 -0.908 . . . . 0.0 109.504 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -133.2 57.37 1.81 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.467 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -67.23 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.403 -179.952 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.661 ' SD ' ' OG ' ' A' ' 2' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.661 ' OG ' ' SD ' ' A' ' 1' ' ' MET . 66.2 m -116.28 -9.58 11.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.282 -0.886 . . . . 0.0 109.457 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.529 ' OG1' ' O ' ' A' ' 2' ' ' SER . 89.2 m -170.59 83.58 0.1 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.247 -0.908 . . . . 0.0 109.418 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.53 -169.48 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.475 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -112.13 133.57 54.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.455 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -106.17 117.6 34.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.508 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.446 ' CZ ' ' HD2' ' A' ' 90' ' ' LYS . 0.4 OUTLIER -89.45 126.82 35.72 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.236 -0.915 . . . . 0.0 109.409 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.417 ' CD2' ' OD2' ' A' ' 15' ' ' ASP . 2.3 m-85 -89.25 160.14 17.07 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.521 ' HB2' HG23 ' A' ' 85' ' ' ILE . 44.8 t80 -150.63 105.61 3.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.951 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -72.45 126.27 29.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 109.501 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.72 -149.61 24.93 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -70.86 -31.28 67.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.266 -1.138 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -153.39 -51.01 0.1 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -0.888 . . . . 0.0 109.373 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.3 t -77.4 169.53 18.16 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.246 -0.909 . . . . 0.0 109.48 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.417 ' OD2' ' CD2' ' A' ' 8' ' ' PHE . 48.8 t0 -116.59 134.86 54.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.413 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HA ' HD23 ' A' ' 16' ' ' LEU . 91.5 mt -111.24 136.2 50.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 46.0 mt -115.98 131.74 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.407 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.6 m -117.74 156.67 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.135 -0.978 . . . . 0.0 109.545 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -92.27 150.8 20.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.186 -0.946 . . . . 0.0 109.452 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -138.94 166.03 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.209 -0.932 . . . . 0.0 109.466 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.1 -50.21 5.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.215 -0.928 . . . . 0.0 109.437 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 m -165.03 142.53 6.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.91 . . . . 0.0 109.468 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -56.87 -35.76 69.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.278 -0.889 . . . . 0.0 109.444 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -56.35 -63.89 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.907 . . . . 0.0 109.464 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -50.22 -45.68 54.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.274 -0.891 . . . . 0.0 109.53 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -53.95 -49.08 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.478 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -60.93 -38.15 84.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.447 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -66.4 -36.07 81.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.335 -0.853 . . . . 0.0 109.461 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -70.95 -32.68 69.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 0.0 109.432 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 30' ' ' LEU . 6.0 mt -54.05 -31.88 52.88 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.891 . . . . 0.0 109.468 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' ' CG ' ' A' ' 31' ' ' LYS . 7.4 tttm -96.32 32.9 1.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.909 . . . . 0.0 109.406 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -175.37 58.41 0.19 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.328 -0.858 . . . . 0.0 109.498 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -69.36 99.02 0.68 Allowed 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.879 2.386 . . . . 0.0 112.232 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 m -127.31 -107.04 0.31 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.222 -0.924 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 tp -159.32 -23.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.564 ' O ' ' N ' ' A' ' 38' ' ' LEU . . . -81.52 -73.5 1.19 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 36' ' ' GLY . 1.0 OUTLIER -41.17 -22.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.251 -1.146 . . . . 0.0 109.422 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.564 ' N ' ' O ' ' A' ' 36' ' ' GLY . 41.0 tp -66.81 -38.86 87.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 36' ' ' GLY . 0.7 OUTLIER -58.87 -36.12 74.1 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.414 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 41' ' ' VAL . 2.3 tt0 -74.27 -57.38 3.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.24 -0.913 . . . . 0.0 109.427 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 40' ' ' GLU . 53.6 t -41.68 -35.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 44' ' ' LEU . 75.3 t -104.43 122.15 57.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.02 -27.04 30.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.517 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 2.3 mp -129.38 140.26 51.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.209 -0.932 . . . . 0.0 109.462 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.28 59.27 2.99 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.428 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -153.39 163.86 39.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.494 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.6 t -117.47 151.71 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.284 -0.885 . . . . 0.0 109.461 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.91 148.83 51.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.523 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.452 ' CG2' ' HB2' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -151.1 155.78 35.02 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.223 -0.923 . . . . 0.0 109.405 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.48 143.03 37.76 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.861 2.374 . . . . 0.0 112.224 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.559 ' CG ' ' N ' ' A' ' 52' ' ' ASP . 19.2 pt20 -133.64 -51.52 0.86 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.559 ' N ' ' CG ' ' A' ' 51' ' ' GLN . 0.1 OUTLIER -73.75 -39.21 64.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -167.91 -154.68 8.85 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.714 HH11 ' CG ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -110.78 -157.88 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -1.145 . . . . 0.0 109.556 179.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.49 110.81 0.05 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.62 90.3 2.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 109.439 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -95.15 -21.68 18.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 0.0 109.454 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.78 -5.92 12.56 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -105.13 44.74 1.01 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.187 -1.184 . . . . 0.0 109.464 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 60' ' ' LEU . 12.3 mt -74.4 171.89 12.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.907 . . . . 0.0 109.466 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' HA3' ' NE2' ' A' ' 51' ' ' GLN . . . -119.43 135.88 11.53 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.1 158.29 1.55 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -1.153 . . . . 0.0 109.503 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.452 ' HB2' ' CG2' ' A' ' 49' ' ' THR . . . -88.89 155.71 19.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.512 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 53.2 p -83.04 145.29 29.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -56.17 -16.0 4.6 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -88.14 -36.27 16.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.486 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -59.86 -41.72 92.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.898 . . . . 0.0 109.496 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.1 t -77.06 -46.22 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.183 -0.948 . . . . 0.0 109.516 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.63 ' O ' ' N ' ' A' ' 73' ' ' GLY . 5.4 mt-10 -47.73 -38.6 15.7 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -78.64 -20.99 49.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 109.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.75 -31.21 59.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.501 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.47 ' CE2' HG13 ' A' ' 81' ' ' VAL . 50.7 m-85 -126.69 -18.52 4.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.551 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 69' ' ' GLU . . . 117.52 -152.59 17.64 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -138.75 92.96 2.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -1.126 . . . . 0.0 109.512 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.49 -18.07 0.04 OUTLIER Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -95.54 -178.03 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.351 -1.088 . . . . 0.0 109.448 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.4 mttm -107.98 -157.03 0.6 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.905 . . . . 0.0 109.435 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 tp -88.88 -31.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.291 -0.881 . . . . 0.0 109.473 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -59.93 2.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -49.05 -31.35 7.6 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.242 -0.911 . . . . 0.0 109.475 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.47 HG13 ' CE2' ' A' ' 72' ' ' PHE . 6.4 t -68.57 -61.96 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.224 -0.922 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' A' ' 85' ' ' ILE . 45.9 mt -55.92 -21.58 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -66.28 -56.12 12.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mt -59.19 -25.54 64.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.872 . . . . 0.0 109.472 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 82' ' ' ILE . 72.6 mt -69.93 -50.85 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.485 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 16.0 mt -72.19 -5.81 38.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 0.0 109.43 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.39 -34.98 11.92 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -0.959 . . . . 0.0 109.485 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.48 42.19 1.75 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.284 -0.885 . . . . 0.0 109.479 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.513 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . -104.97 -133.67 7.79 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.807 ' NZ ' HD22 ' A' ' 92' ' ' ASN . 33.2 tttm 36.11 75.0 0.53 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.9 -68.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 122.831 2.354 . . . . 0.0 112.2 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.807 HD22 ' NZ ' ' A' ' 90' ' ' LYS . 5.8 t-20 45.69 -163.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.46 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.498 ' O ' ' OG ' ' A' ' 93' ' ' SER . 14.2 p -112.02 82.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.207 -0.933 . . . . 0.0 109.479 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.81 120.45 9.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 109.442 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 30.7 p -69.12 156.27 38.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.414 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 15.1 m -65.45 152.72 43.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.478 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -84.99 143.1 29.16 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.217 -0.927 . . . . 0.0 109.535 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' A' ' 97' ' ' SER . 9.4 mt 39.81 -133.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.451 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.3 mmmt -101.05 -89.07 0.36 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.275 -0.89 . . . . 0.0 109.436 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.97 119.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.3 -0.875 . . . . 0.0 109.469 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 5.8 mmtm -87.72 150.47 23.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -129.84 102.41 0.54 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -116.74 176.02 16.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -84.84 10.16 12.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.282 -1.128 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.93 112.76 24.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' A' ' 108' ' ' LYS . . . 171.7 141.98 3.55 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -68.93 5.73 1.07 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.197 -1.178 . . . . 0.0 109.458 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' A' ' 106' ' ' GLY . 21.6 mttm -79.38 -94.13 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.891 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 56.85 178.05 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.219 -0.926 . . . . 0.0 109.48 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -88.07 99.24 12.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.2 p30 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.526 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' CB ' ' A' ' 2' ' ' SER . 33.0 mtt . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.44 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 70.6 -79.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -0.89 . . . . 0.0 109.488 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.425 ' O ' HG13 ' A' ' 4' ' ' VAL . 19.4 m -150.49 158.72 44.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.446 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.425 HG13 ' O ' ' A' ' 3' ' ' THR . 0.9 OUTLIER -153.54 -170.2 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.26 -0.9 . . . . 0.0 109.444 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.487 HG22 ' N ' ' A' ' 6' ' ' LYS . 14.9 m -106.69 166.86 10.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.419 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.487 ' N ' HG22 ' A' ' 5' ' ' THR . 13.7 mtpt -128.4 143.76 51.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.643 ' OH ' HG11 ' A' ' 26' ' ' VAL . 0.7 OUTLIER -123.65 113.12 18.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.0 109.479 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -83.66 164.02 19.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.256 -0.903 . . . . 0.0 109.408 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -154.21 131.98 11.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 109.475 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -110.79 112.6 24.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.548 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.0 -149.27 4.69 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -79.8 -47.37 15.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.453 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.87 -26.65 2.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.593 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.49 158.25 16.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.243 -0.911 . . . . 0.0 109.463 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.673 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 12.6 t0 -114.17 154.76 27.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.421 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.673 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 44.0 mt -137.52 157.72 45.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 19.6 mt -134.73 151.42 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.348 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.48 174.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.27 -0.894 . . . . 0.0 109.505 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -114.9 154.87 27.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.471 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 162.68 32.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.47 -65.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.74 129.05 18.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 109.452 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -46.57 -38.88 10.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.22 -0.925 . . . . 0.0 109.447 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -49.19 -61.44 2.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.311 -0.868 . . . . 0.0 109.45 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' C ' ' A' ' 26' ' ' VAL . 32.0 mt -47.26 -59.6 3.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.252 -0.905 . . . . 0.0 109.529 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.643 HG11 ' OH ' ' A' ' 7' ' ' TYR . 97.8 t -38.21 -46.93 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.246 -0.909 . . . . 0.0 109.473 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -46.15 84.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.98 -46.78 87.76 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.318 -0.864 . . . . 0.0 109.506 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -47.22 -52.64 15.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.64 -25.91 60.83 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.238 -0.914 . . . . 0.0 109.468 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.5 tttp -71.49 -31.68 67.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.4 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -158.88 80.36 2.82 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.293 -0.879 . . . . 0.0 109.485 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.19 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.804 2.336 . . . . 0.0 112.271 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 36' ' ' GLY . 1.6 t -118.48 120.26 37.0 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.245 -0.91 . . . . 0.0 109.479 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -64.55 0.28 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.937 . . . . 0.0 109.451 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' H ' ' C ' ' A' ' 34' ' ' SER . . . -85.48 -16.17 64.71 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' O ' ' C ' ' A' ' 38' ' ' LEU . 4.6 ptmm? -115.66 -10.81 11.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.273 -1.133 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 37' ' ' LYS . 3.0 tp -38.42 -53.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 0.0 109.484 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.664 ' O ' ' N ' ' A' ' 41' ' ' VAL . 4.6 p -52.77 -61.37 2.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.516 ' C ' ' O ' ' A' ' 39' ' ' SER . 4.6 mm-40 -37.77 -22.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 109.501 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 39' ' ' SER . 57.7 t -96.54 -54.86 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.442 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.7 t -73.5 149.38 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.57 -16.46 6.28 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.68 98.33 2.61 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.446 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -63.29 89.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -169.04 118.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.248 -0.908 . . . . 0.0 109.378 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.406 ' CG1' HD22 ' A' ' 16' ' ' LEU . 61.6 t -79.67 144.82 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.269 -0.894 . . . . 0.0 109.54 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -130.86 163.39 27.52 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.471 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.13 163.82 37.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.481 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.06 126.19 10.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.823 2.348 . . . . 0.0 112.24 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.431 ' O ' ' O ' ' A' ' 52' ' ' ASP . 8.2 tt0 -109.12 -177.35 3.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.279 -0.888 . . . . 0.0 109.549 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -50.6 179.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.461 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.67 -131.59 8.59 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.3 mtm180 -139.14 18.14 2.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -1.17 . . . . 0.0 109.435 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.63 -80.06 0.16 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -159.96 54.21 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -1.149 . . . . 0.0 109.486 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -118.58 156.02 29.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.438 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 59' ' ' GLU . . . 83.86 165.27 38.41 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 58' ' ' GLY . 46.4 tt0 -43.54 115.5 0.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.3 mt -64.04 155.89 29.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.495 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -83.79 137.19 15.81 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -85.86 152.44 22.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -1.154 . . . . 0.0 109.463 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.73 -168.8 1.78 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.441 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.27 166.42 18.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 0.0 109.486 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.19 -20.66 66.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.18 -44.83 13.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.2 -0.937 . . . . 0.0 109.461 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -59.38 -41.44 89.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.404 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 93.9 t -69.22 -56.67 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.456 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -57.73 -34.98 70.08 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.339 -0.85 . . . . 0.0 109.515 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.39 -27.89 50.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -85.33 -66.77 0.86 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.344 -0.848 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.536 ' CE1' HG13 ' A' ' 81' ' ' VAL . 25.5 m-85 -71.38 -67.86 0.49 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 149.38 175.25 21.56 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -89.86 172.9 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.276 -1.132 . . . . 0.0 109.456 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.42 9.94 74.86 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -131.78 171.0 14.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.157 -1.202 . . . . 0.0 109.411 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -119.21 -163.16 0.95 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.205 -0.935 . . . . 0.0 109.5 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.57 -35.22 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.293 -0.879 . . . . 0.0 109.525 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -64.44 -31.59 72.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' N ' ' CD ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -84.17 -45.24 13.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.536 HG13 ' CE1' ' A' ' 72' ' ' PHE . 22.8 t -58.56 -34.86 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.262 -0.899 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 10.7 mt -70.05 -46.56 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.329 -0.857 . . . . 0.0 109.486 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -47.21 -45.38 23.19 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.507 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' HA ' HD23 ' A' ' 84' ' ' LEU . 79.5 mt -61.32 -56.57 18.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.468 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.8 mt -47.14 -50.92 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.179 -0.95 . . . . 0.0 109.438 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' N ' ' A' ' 88' ' ' ASN . 45.0 mt -58.83 -31.12 68.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 0.0 109.505 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.9 ttt180 -55.74 -9.41 0.54 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.466 HD22 ' HB3' ' A' ' 91' ' ' PRO . 2.8 m120 -134.22 -91.68 0.34 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.534 ' O ' ' C ' ' A' ' 90' ' ' LYS . . . 65.51 125.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.534 ' C ' ' O ' ' A' ' 89' ' ' GLY . 23.3 mtmt 35.75 62.76 2.54 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.344 -1.092 . . . . 0.0 109.545 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.466 ' HB3' HD22 ' A' ' 88' ' ' ASN . 51.0 Cg_endo -73.59 157.79 48.25 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 C-N-CA 122.838 2.359 . . . . 0.0 112.092 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 50.96 84.15 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.465 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 p -149.75 51.42 0.93 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.287 -0.883 . . . . 0.0 109.488 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.7 m -105.3 -75.86 0.62 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.446 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 17.5 p -90.8 72.43 6.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.81 108.72 10.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.925 . . . . 0.0 109.476 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.3 p -149.82 -2.2 0.42 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.243 -0.911 . . . . 0.0 109.41 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.507 ' O ' ' C ' ' A' ' 99' ' ' LYS . 4.1 mm? -71.27 -92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.385 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.507 ' C ' ' O ' ' A' ' 98' ' ' LEU . 9.5 mttt 37.42 -148.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.479 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 10.9 p -137.82 62.75 1.56 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.514 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.0 mttm -62.59 -53.75 49.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.4 96.23 0.17 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' A' ' 105' ' ' ALA . . . -131.13 44.81 1.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.635 ' ND2' ' O ' ' A' ' 104' ' ' ASN . 0.3 OUTLIER -72.96 29.57 0.06 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -1.162 . . . . 0.0 109.438 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 103' ' ' GLY . . . -117.24 15.84 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.243 -0.911 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.36 120.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -65.24 123.23 19.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -1.185 . . . . 0.0 109.528 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.37 -74.64 0.08 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.188 -0.945 . . . . 0.0 109.461 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -93.13 -148.28 0.25 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -97.29 -52.68 3.73 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.215 -0.928 . . . . 0.0 109.476 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.9 m120 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.495 -179.99 . . . . . . . . 0 0 . 1 stop_ save_